0001567619-17-000463.txt : 20170316 0001567619-17-000463.hdr.sgml : 20170316 20170316170225 ACCESSION NUMBER: 0001567619-17-000463 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170316 DATE AS OF CHANGE: 20170316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VirnetX Holding Corp CENTRAL INDEX KEY: 0001082324 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 770390628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33852 FILM NUMBER: 17695303 BUSINESS ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 BUSINESS PHONE: (831) 438-8200 MAIL ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 FORMER COMPANY: FORMER CONFORMED NAME: PASW INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC SOFTWORKS INC DATE OF NAME CHANGE: 19990322 10-K 1 h10042025x1_10k.htm 10-K

TABLE OF CONTENTS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2016

or

oTRANSITION REPORT PURSUANT TO SECTION 13 Or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                   

Commission File Number: 001-33852

VirnetX Holding Corporation
(Exact name of registrant as specified in its charter)

Delaware
77-0390628
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification Number)
   
 
308 Dorla Court, Suite 206
Zephyr Cove, Nevada
89448
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: 775-548-1785
Former name, former address and former fiscal year, if changed since last report:
Securities registered pursuant to Section 12(b) of the Act:

Title of Class
Name of Exchange on Which Registered
Common Stock, par value $0.0001 per share
NYSE MKT LLC

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No ☒

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o
Accelerated filer ☒
Non-accelerated filer o
Smaller reporting company o
(Do not check if a smaller reporting company)
 
 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant as of June 30, 2016, was $225,740,380 based upon the closing price of the common shares of the Registrant on June 30, 2016. This calculation does not reflect a determination that certain persons are affiliates of the Registrant for any other purpose.

58,144,888 shares of Registrant’s Common Stock were outstanding as of March 10, 2017.

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of this Annual Report on Form 10-K incorporate by reference information from the Registrant’s Proxy Statement to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2016 in connection with the solicitation of proxies for the Registrant’s 2017 Annual Meeting of Stockholders.

TABLE OF CONTENTS

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by us or on our behalf. We have included or incorporated by reference in this Annual Report on Form 10-K (including in the section entitled Management’s Discussion and Analysis of Financial Condition and Results of Operations), and from time to time we may make statements that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based upon our current expectations, estimates, assumptions and beliefs concerning future events and conditions and may discuss, among other things, anticipated future performance (including sales and earnings), expected growth, future business plans and costs and potential liability for environmental-related matters. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result in,” and similar expressions. These statements include our belief and statements regarding general industry and market conditions and growth rates, as well as general domestic and international economic conditions. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside our control, which could cause actual results to differ materially from such statements and from our historical results and experience. These risks, uncertainties and other factors include, but are not limited to those described in Item 1A - Risk Factors of this Annual Report on Form 10-K and elsewhere in the Annual Report and those described from time to time in our future reports filed with the Securities and Exchange Commission. Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results and that the risks described herein should not be considered to be a complete list. Any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

EXCEPT AS REQUIRED BY LAW, WE UNDERTAKE NO OBLIGATION TO UPDATE OR REVISE ANY FORWARD LOOKING STATEMENT AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE.

TABLE OF CONTENTS

PART I

Item1.Business.

The Company

We are an Internet security software and technology Company with patented technology for secure communications including 4G LTE security. Our software and technology solutions, including our Secure Domain Name Registry and GABRIEL Connection Technology™, are designed to facilitate secure communications and provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer, remote desktop and Machine-to-Machine, or M2M communications. Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information. Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 49 U.S. and 69 foreign patents with approximately 50 pending patent applications worldwide. Our patent portfolio is primarily focused on securing real-time 2017 communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, M2M communications in the new initiatives like “Smart City”, “Connected Car” and “Connected Home” that would connect everything from social services and citizen engagement to public safety, transportation and economic development to the internet to enable more productivity, features and efficiency in our everyday lives. The subject matter of all our U.S. and foreign patents and pending applications relates generally to securing communication over the internet, and as such covers all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, Inc., (f/k/a Science Applications International Corporation, or SAIC) in 2006 and we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

Our product Gabriel Secure Communication Platform™, unlike other collaboration and communication products and services on the market today, does not require access to user’s confidential data and reduces the threat of hacking and data mining. It enables individuals and organizations to maintain complete ownership and control over their personal and confidential data, secured within their own private network, while enabling authorized secure encrypted access from anywhere at any time. Our Gabriel Collaboration Suite™ is a set of applications that run on top of our Gabriel Secure Communication Platform™. It enables seamless and secure cross-platform communications between user’s devices that have our software installed. Our Gabriel Collaboration Suite™ is available for download and free trial, for Android, iOS, Windows, Linux and Mac OS X platforms, at http://www.gabrielsecure.com/. We continue to enhance our products and add new functionality to our products. We will provide updates to new and existing customers as they are released to the general public. Over 80 small and medium businesses have installed our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products in their corporate networks. We continue to rapidly expand our customer base with targeted promotions and direct sales initiatives.

We have executed a number of patent and technology licenses and intend to seek further licensees for our technology, including our GABRIEL Connection Technology™ to original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE Advanced.

We have submitted a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into deploying 4G/LTE Advanced devices and solutions.

We have an ongoing Gabriel Licensing Program under which we offer licenses to a portion of our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. Our Gabriel Connection Technology™ License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products. We have developed GABRIEL

3

TABLE OF CONTENTS

Connection Technology™ Software Development Kit (SDK) to assist with rapid integration of these techniques into existing software implementations with minimal code changes and include object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology. Customers who want to develop their own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques that are covered by our patent portfolio for establishing secure communication links, can purchase a patent license. The number of patents licensed, and therefore the cost of the patent license to the customer, will depend upon which of the patents are used in a particular product or service. These licenses will typically include an initial license fee, as well as an ongoing royalty.

We have signed Patent License Agreements with Avaya Inc., Aastra USA, Inc., Microsoft, Mitel Networks Corporation, NEC Corporation and NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of our patents, for a one-time payment and/or an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current and future IP-encrypted products. We have engaged IPVALUE Management Inc. to assist us in commercializing our portfolio of patents on securing real-time communications over the Internet. Under the multi-year agreement, IPVALUE is expected to originate and assist us with negotiating transactions related to patent licensing worldwide with respect to certain third parties.

We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE Advanced wireless networks and M2M communications in areas including Smart City, Connected Car and Connected Home. We also believe that all 4G/LTE Advanced mobile devices will require unique secure domain names and become part of a secure domain name registry.

We intend to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE.

Our employees include the core development team behind our patent portfolio, technology and software. This team has worked together for over ten years and is the same team that invented and developed this technology while working at Leidos, Inc. (“Leidos”). Leidos is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos, and expanded the set of patents we acquired in 2006 from Leidos, into a larger portfolio of over 110 U.S. and international patents and with over 75 pending applications. This portfolio now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.

Please see Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Operations – Research and Development Expenses for a description of our research and development expenses for the past three fiscal years.

We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to early licensing targets or asserting our rights for use of our patents. We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers and others) and build our secure domain name registry.

Industry Overview

We believe that the rapid growth of mobile devices (smartphones/tablets/ultra-mobile PCs), with always-on network access, and need to socially interact with friends and family while maintaining a constant online presence has transformed the “Internet of Web 2.0” in to the “The Internet of the People”. It has become an evolving, rich and complex medium used by individuals and businesses to conduct commerce, share information and engage in real-time communications including email, text messaging, IM, and voice and video calls. We believe the user

4

TABLE OF CONTENTS

demand for high speed broadband access along with the quality of experience wherever they are and whatever BYOD (bring your own device) they may be using; Mobility, IP video delivery, and the move to cloud have dramatically changed the way service providers deliver services. While wireline networks remain the primary mechanism for delivering premium and high bandwidth services, its growth has held steady compared to the growth of the mobile communications. The cost barrier to obtaining a mobile device with data access has disappeared allowing billions of people to have online access on fixed and mobile networks, and those users accessing social networking websites, using peer-to-peer, or P2P applications, and uploading live content over the internet, which in turn is downloaded by millions, has led to significant growth in packet traffic. Not only is traffic growing and changing in nature, its location of origin and timing has become completely unpredictable. There is a significant impact on the mobile signaling network, brought on by smartphone penetration and consumer use of “chatty” applications that conduct frequent network queries.

We believe that as the users become more comfortable with using their smartphones/tablets and other connected devices, they will increasingly treat their mobile and fixed/WiFi networks as a single network and demand seamless transition from one network type to another without any disruption of service. The 4G/LTE standard was developed with the goal of creating a single IP network that is efficient, flexible, open up new business models and services revenues and eventually lead to true “virtual networks” or software-defined networks (SDN). The service providers were forced to perform complete overhaul of their telecom network infrastructure in order to move from TDM paradigm to next generation IP networks based on 4G/LTE for dealing with this rapidly growing demand. Before these network overhauls could be completed, some service providers decided to label their hybrid 3.5G/HSPA+/partial LTE implementations as 4G networks in order to mitigate the risk of losing revenue. We believe this has led to significant confusion and misunderstanding among users.

Adding to the demand for mobile and fixed broadband services is the fast adoption of connected machines or devices, or embedded systems capable of M2M communication. These M2M communications are made possible by a device (non-phone/tablet/pc such as a sensor) that is attached to a machine to capture an event that is relayed over a network via 3G/4G routers or fixed broadband lines, delivering data or events (such as temperature, location, consumption, heart rate, stress levels, light, movement, altitude and speed) to applications creating an “Internet of Things” or IoT. As the service providers start deploying true 4G (Long Term Evolution-Advanced, or LTE-Advanced) and this pace picks up, we believe that almost every device will get its own unique identity and a high-speed connection to the internet over a high speed IP (Internet Protocol) based telecommunication network making it an “Internet of Everything”.

We believe that growing security concerns and vulnerabilities in a large number of use-case scenarios due to the inherent “open” nature of this architecture can throttle the successful adoption of these technologies. Security can no longer exist as a point solution, and enterprises are currently upgrading core IT infrastructure (systems, networks, and management) to integrate security into everything. Because of the complexity of today’s networks and the requirement to connect users from any location at any time on any device, enterprise buyers looking to improve security posture have to evaluate everything from software solutions for smartphones to routers and switches with integrated security, massive security appliances for data centers, cloud-based security services, and security solutions for virtualized environments and public and private clouds.

The portions of the IP-telephony, mobility, fixed-mobile convergence and unified communications markets that could benefit from our software and technology solutions, as forecasted by Infonetics and by our internal estimates, are expected to grow from approximately $96 billion of worldwide revenues in 2012 to approximately $342 billion by 2017, representing a compound annual growth rate, or CAGR, of approximately 29%. We believe that this growing trend represents a significant opportunity for us to license our technology and software, and establish our secure domain name registry.

Enterprise Telephony – Unified Communications, VoIP, Telepresence and Video Conferencing

Enterprise Telephony includes technologies that use Internet Protocol’s packet-switched connections to exchange voice, fax, and other forms of information traditionally carried over the dedicated circuit-switched connections of the public switched telephone network, or PSTN. The adoption of Enterprise Telephony has helped businesses significantly lower network operating costs by using a common network for voice and data. As the workforce becomes increasingly dispersed, mobile features enabled by Internet protocol-based communications such as presence, unified messaging, peer-to-peer applications, find me/follow me, white-boarding and document sharing have become more commonplace. However, the development of the related security infrastructure has lagged behind,

5

TABLE OF CONTENTS

leaving next-generation networks vulnerable to a multitude of threats including man-in-middle, eavesdropping, domain hijacking, distributed denial of service, or DDoS, spam over Internet telephony, or SPIT, and spam over instant messaging, or SPIM. These threats continue to highlight the need for securing next-generation networks. As the use of Enterprise Telephony systems extends beyond the boundaries of an organization’s private network, security is likely to become an even bigger concern. Enterprises are increasingly deploying an array of communication methodologies integrated into a single communications experience is often referred to as unified communications. We believe that unified communications have higher utility and can increase productivity for users. The basic components of unified communications include: a directory for storing addresses, various modes of communication with each user/contact (desk phone, mobile phone, IM, etc.), message storage for all messages regardless of communication method and secure presence of a user's status for each mode of communication (available, away, busy, etc.).

Based on our estimates using Infonetics and other market data, we believe that worldwide revenue from IP telephony products like IP-PBX including IP phones, service provider VoIP and IMS equipment, VoIP gateways, Enterprise Telepresence and Video Conferencing for businesses and Unified Communication clients, is expected to grow from approximately $38 billion in 2012 to approximately $60 billion in 2017, representing a CAGR of approximately 9%. We believe our unique and patented solution provides a robust security platform for providing on-demand secure communication links between enterprises intending to communicate securely without manually configuring the connections. We believe a standard security solution such as ours will further accelerate the adoption of Enterprise telephony products in the market and allow enterprises to take full advantage of these rich content applications and real-time communications over the Internet, thereby significantly increasing their return on investment.

IP Mobility- Smartphones, Embedded Devices, Machine-to-Machine (M2M) Devices (LTE)

We believe that telecommunication markets are rapidly changing and presenting new challenges to the equipment and service providers, including but not limited to increasing user demand for mobile, always-on connections with multiple devices. We also believe that traffic growth, video acceleration, cloud services and a rapidly growing number of subscribers challenge currently available network architectures and that, because of this, service providers and carriers will eventually use a single network for fixed and mobile communications, private/premium communications and Internet access, in spite of the difficulties involved challenging their business models and forcing the consideration of new network architectures. We believe that LTE technology will deliver users the benefits of faster data speeds and new services by creating a new radio access technology that's optimized for IP-based traffic and offers operators a simple upgrade path from 3G networks.

Smartphones are multi-functional devices that handle a wide variety of business-critical applications and support increasingly complex functions including enhanced data processing, Internet access, e-mail access, calendars and scheduling, contact management and the ability to view electronic documents. Users have continual access to these applications while on the move making them an increasingly essential business tool for the mobile worker. These devices enable mobile workers to have similar functionality inside or outside the office thereby increasing employee efficiency. However, it is critical that this mobile environment have the same level of security as an enterprise's internal network.

Embedded mobile broadband computing devices include PCs, netbooks, tablets, and mobile Internet devices (MIDs) with embedded mobile broadband modems to enable Internet access via a mobile broadband network. A growing number of these devices are now shipping enabled with LTE/4G. Mobile Internet devices (MIDs) include handheld mobile Internet devices; e.g. eReader, gaming console, digital picture frame, digital camera, with embedded mobile broadband modems. Mobile broadband routers have mobile broadband modems or antenna as the broadband connection; have multiple Ethernet ports and integrated wireless access points for local area connectivity and bandwidth sharing; can have integrated hub or switch; may have an integrated stateful firewall or IPSec VPN and are also known as mobile hotspot routers.

Machine-to-Machine, or M2M, connected devices, or embedded systems; connected machines are fast becoming the eyes and ears of the enterprise. By adding sensors and networking technologies to the products they sell and the equipment they employ, companies are finding new ways to gather powerful insights and use new forms of data, thus creating a vast “internet of things”. This communication is made possible by a device (such as an intelligent sensor) that is attached to a machine to capture an event, such as such as temperature, location, consumption, heart rate, stress levels, light, movement, altitude and speed, that is relayed over a network delivering data to applications. The potential applications for this technology are numerous and as such include smart meters in energy and utilities (the

6

TABLE OF CONTENTS

“smart grid”), connected vehicles in automotive and logistics, heart monitors in healthcare, RFID tagged inventory in retail and manufacturing, and digital signage in media and communications to name a few. Another fast growing application is in the wearable technology products namely, fitness and wellness, infotainment (information-based media content), healthcare and medical, and industrial and military. The fitness and wellness segment comprises products like smart clothing and smart sensors, activity monitors, sleep sensors and others, whereas the Infotainment sector consists of products like smart watches, heads-up displays, smart glasses and others. The products like continuous glucose monitor, drug delivery, monitors, wearable patches and others have been covered under healthcare and medical segment and products like hand worn terminals, augmented reality headsets and others have been mentioned under industrial and military segment. We believe that the large revenue potential for M2M services that has attracted the attention of carriers globally risks being thwarted by the growing security concerns in M2M applications. Porous security is exposing vulnerabilities in a large number of use-case scenarios, including cars, energy management systems, telemedicine, and telemetry. While built-in security is a high priority in all other information and communication technologies, it is yet to be considered, even at a basic level, in most M2M applications. The rapid and successful adoption of M2M in automobiles, healthcare, industrial installations, and consumer homes may be jeopardized if communication security is not designed in to all M2M devices and applications. All these new devices will require a unique identity addressable by a secure domain name and all their communications, with application servers and other devices, completely secured automatically and on-demand. IP mobility services require an environment where wired and wireless phones work together with Internet Protocol to deliver services (voice, video, data and combinations thereof) uniformly across multiple access networks, including, among others, LTE, WiMAX, WiFi cellular and fixed. Based on our estimates using Infonetics and other market data, we believe that worldwide revenue from IP mobility products like smartphones, embedded devices, hotspots and mobile data cards, femtocell equipment, M2M communication devices and services is expected to grow from approximately $57 billion in 2012 to approximately $282 billion by 2017, representing a CAGR of approximately 37%. We believe in order to realize the full functionality of IP mobility, several challenges including security must be overcome. When users are mobile, connections and data need to cross multiple network boundaries, each of which poses a security threat. Wireless networks may be threatened or compromised by rogue users who enter through (insecure wireless access points. We believe that providing authenticated access to the M2M networks and enterprise applications are important requirements and represent a significant market opportunity for our patented technology and secure domain names to provide users or machines fully authenticated secure access on a “zero-click” or “single-click” basis.

Our Solutions

Our software and technology solutions, including our secure domain name registry, our patents and our GABRIEL Connection Technology™ are designed to secure real-time communications over the Internet. Our technology uses industry standard encryption methods with our patented DNS lookup mechanisms to create a secure communication link between users intending to communicate in real time over the Internet. Our technology can be built into network infrastructure, operating systems or silicon chips developed for a communication or computing device to secure real-time communications over the Internet between numerous devices. Our technology automatically encrypts data allowing organizations and individuals to establish communities of secure, registered users and transmit information between multiple devices, networks and operating systems. These secure network communities, which we call secure private domains, or SPDs, are designed to be fully-customizable and support rich content applications such as IM, VoIP, mobile services, streaming video, file transfer and remote desktop in a completely secure environment. Our approach is a unique and patented solution that we believe provides the robust security platform required by these rich content applications and real-time communications over the Internet. We believe the key benefits and features of our technology include the following:

Automatic and seamless to the user. After a one-time registration, users connect securely on a “zero-click” or “single-click” basis.
Secure data communications. Users create secure networks with people they trust and communicate over a secure channel.
Control of data at all times. Users can secure and customize their unified communication and collaboration applications such as file sharing and remote desktop with policy-based access and secure presence information.
Authenticated users. Users know they are communicating with authenticated users with secure domain names.

7

TABLE OF CONTENTS

Application-agnostic technology. Our solution provides security at the IP layer of the network by using patented DNS lookup mechanisms to make connections between secure domain names, thereby obviating the need to provide application specific security.

Our Products

Our Gabriel Secure Communication Platform™, unlike other collaboration and communication products and services on the market today, does not require access to users’ confidential data and reduces the threat of hacking and data mining. It enables individuals and organizations to maintain complete ownership and control over their personal and confidential data, secured within their own private network, while enabling authorized secure encrypted access from anywhere at any time. Our Gabriel Collaboration Suite™ is a set of applications that run on top of our Gabriel Secure Communication Platform™. It enables seamless and secure cross-platform communications between users’ devices. The following applications are included in the current release and can be easily accessed through the Gabriel interface:

Secure chat - allows users to quickly send and receive text, files and screen shots
Secure share - allows users to grant coworkers read/write access to desired folders
Secure video/voice - provides users ability to conduct audio and/or video conferencing securely with any other Gabriel user
Secure mail - allows users to send email and attachments directly from sender to recipient without requiring a centralized mail server
Secure sync/backup - allows users to quickly push single files or automatically backup your files to one or multiple Gabriel destinations

Our Gabriel Collaboration Suite™ is available for download and free trial, for Android, iOS, Windows, Linux and Mac OS X platforms, at http://www.gabrielsecure.com/. We continue to enhance our products and add new functionality to our products. We will provide updates to new and existing customers as they are released publically. Over 80 small and medium businesses have installed our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products in their corporate networks. We continue to rapidly expand our customer base with targeted promotions and direct sales initiatives.

Competitive Strengths

We believe the following competitive strengths will enable our success in the marketplace:

Unique patented technology. We are focused on developing innovative technology for securing real-time communications over the Internet, and establishing the exclusive secure domain name registry in the United States and other key markets around the world. Our unique solutions combine industry standard encryption methods and communication protocols with our patented techniques for automated DNS lookup mechanisms. Our technology and patented approach enables users to create a secure communication link by generating secure domain names. We currently own approximately 49 U.S. and 69 foreign patents with approximately 50 pending patents applications worldwide. Our portfolio includes patents and pending patent applications in the United States and other key markets that support our secure domain name registry service for the Internet.
Scalable licensing business model. We are actively engaged in pursuing additional licensing agreements with OEMs, service providers and system integrators within the IP-telephony, mobility, mobile-to-mobile communications, fixed-mobile convergence and unified communications end-markets.
Highly experienced research and development team. Our research and development team is comprised of nationally recognized network security and encryption technology scientists and experts that have worked together as a team for over ten years. During their careers, this team has developed several cutting-edge technologies for U.S. national defense, intelligence and civilian agencies, many of which remain critical to our national security today. Prior to joining VirnetX, our team worked for Leidos, during which time they invented the technology that is the foundation of our technology, and software. Based on the collective knowledge and experience of our development team, we believe that we have one of the most experienced and sophisticated groups of security experts researching vulnerability and threats to real-time communication over the Internet and developing solutions to mitigate these problems.

8

TABLE OF CONTENTS

Our Strategy

Our strategy is to become the market leader in securing real-time communications over the Internet and to establish our GABRIEL Communications Technology™ as the industry standard security platform. Key elements of our strategy are to:

Actively promote our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products in the general market for sale directly to end-user enterprises with targeted promotions and other marketing programs.
Continue to grow our technology licensing program to commercialize our intellectual property, including our GABRIEL Connection Technology™ by adding more licensees in partnership with IPValue.
Establish VirnetX as the exclusive universal registry of secure domain names and to enable our customers to act as registrars for their users and broker secure communication between users on different registries.

We have submitted a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We have also submitted a number of updates to our original declaration, identifying additional technical specifications that would also require a license to our US and International patents.

License and Service Offerings

We offer a diversified portfolio of license and service offerings focused on securing real-time communications over the Internet, including:

VirnetX technology licensing: Customers who want to develop their own implementation of the VirnetX code module for supporting secure domain names, or who want to use their own techniques that are covered by our patent portfolio for establishing secure communication links, could purchase a technology license. We anticipate that these licenses would typically include an initial license fee, as well as an ongoing royalty. We expect that these licenses will include a one-time delivery of GABRIEL software development kit including object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement of the techniques we have developed.
GABRIEL Connection Technology Software Development Kit or SDK: OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products could purchase an SDK license. The software development kit consists of object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology. These tools are comprised of software for a secure domain name connection test server, a relay test server and a registration test server. We expect that customers would pay an up-front license fee to purchase an SDK license and a royalty fee for every product shipped with the embedded VirnetX code module.
Secure domain name registrar service: Customers, including service providers, telecommunication companies, ISPs, system integrators and OEMs could purchase a license to our secure domain name registrar service. We would provide the software suite and technology support to enable such customers to provision devices with secure domain names and facilitate secure connections between registered devices. This suite includes the following server software modules:
Registrar server software: We anticipate that our registrar server software would enable customers to operate as a secure domain name registrar that provisions devices with secure domain names. The registrar server software is designed to provide an interface for our customers to register new virtual private domains and sub-domain names. This server module must be enrolled with the VirnetX secure domain name master registry to obtain its credentials before functioning as an authorized registrar.
Connection server software: We anticipate that our connection server software would allow customers to provide connection services to enrolled devices. The connection services include registration of presence information for authenticated users and devices, presence information query request services, enforcement of policies and support for communication with peers behind firewalls.

9

TABLE OF CONTENTS

Relay server software: We anticipate that our relay server software would allow customers to dynamically maintain connections and relay data to private IP addresses for network devices that reside behind firewalls. Secure domain name registrar service customers will enter into a technology licensing and revenue sharing agreement with VirnetX whereby we will typically receive an up-front licensing fee for the secure domain name registrar technology, as well as ongoing annual royalties for each secure domain name issued by the customer.
Secure domain name master registry and connection service: As part of enabling the secure domain name registrar service, we expect that we will maintain and manage the secure domain name master registry. This service is expected to enroll all secure domain name registrar customers and generate the credentials required to function as an authorized registrar. It also is expected to provide connection services and universal name resolution, presence information and secure connections between authorized devices with secure domain names.
Technical support services: We intend to provide high-quality technical support services to licensees and customers for the rapid customization and deployment of GABRIEL Connection Technology™ in an individual customer’s products and services.

Our research and development team was the team responsible for inventing the claimed subject matter of the patents that form the foundation of our technology. This team has worked together for over ten years. We intend to leverage this experience and continue investing in research and development and, over time, expect to strengthen and expand our patent portfolio, technology, and software. While we are currently focused on securing real-time communications over the Internet and establishing the first and only secure domain name registry, we believe our existing and future intellectual property portfolio will extend to additional areas including, among others, network security and operating systems for fixed and mobile devices.

Customers

Our Gabriel Collaboration Suite™ is available for download and free trial, for Android, iOS, Windows, Linux and Mac OS X platforms, at http://www.gabrielsecure.com/. We continue to enhance our products and add new functionality to our products. We will provide updates to new and existing customers as they are released publically. Over 80 small and medium businesses have installed our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products in their corporate networks. We continue to rapidly expand our customer base with targeted promotions and direct sales initiatives.

We have signed Patent License Agreements with Aastra USA, Inc. Avaya, Inc., Microsoft, Mitel Networks Corporation, NEC Corporation and NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of our patents, for a one-time payment and an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current and future IP-encrypted products.

We are seeking further licensing of our technology, including our GABRIEL Connection Technology™ to developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future license negotiations.

Marketing and Sales

We plan to employ a leveraged, partner-oriented, marketing strategy for our technology licenses and software product offerings. We are actively working on a number of sales and marketing promotions that may involve online and direct sales programs as we seek to build out our customer base in 2017.

We plan to directly market our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products, domain name registry services to our service provider and system integrator customers. We market our Gabriel line of products directly to small and medium businesses using online marketing programs and tools. We hope to leverage our relationship with Leidos, to extend our offering to departments and agencies within the federal government. Leidos is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy

10

TABLE OF CONTENTS

and the environment, critical infrastructure, and health. We intend to leverage our sales team for managing current accounts and pursuing sales opportunities with new customers.

Competition

We believe our technology and solutions will compete primarily against various proprietary security solutions. We group these solutions into three main categories:

Proprietary or home-grown application specific security solutions have been developed by vendors and integrated directly into their products for our target markets including IP-telephony, mobility, fixed-mobile convergence, and unified communications. These proprietary solutions have been developed due to the lack of standardized approaches to securing real-time communications. This approach has led to corporate networks that are isolated and, as a result, restrict enterprises to using these next-generation networks within the boundaries of their private network. These solutions generally do not provide security for communications over the Internet or require network administrators to manually exchange keys and other security parameters with each destination network outside their corporate network boundary. The cost-savings and other benefits of IP-based real-time communications are significantly limited by this approach to securing real-time communications.
A session border controller, or SBC, is a device used in networks to exert control over the signaling and media streams involved in establishing, conducting and terminating VoIP calls. A traditional firewall or network address translation, or NAT, device typically block information like endpoint IP addresses and port numbers required by signaling protocols, such as SIP and XMPP, to reach and communicate with their intended destination. SBCs are used in physical networks to address these limitations and enable real-time session traffic to cross the boundaries created by firewalls and other NAT devices and enable VoIP calls to be established successfully. However, SBCs must decrypt and analyze every single data packet for the information to be transmitted successfully, thereby preventing end-to-end encryption. This network design results in SBCs becoming a single point of congestion on the network, as well as a single point of failure. SBCs are also limited to the physical network they secure.
SIP firewalls, or SIP-aware firewalls, and application layer gateways, manage and protect the traffic, flow and quality of VoIP and other SIP-related communications. They perform real-time network address translation, dynamic firewall functions; support multiple signaling protocols, and media functionality, allowing secure interconnection and the flow of IP media streams across multiple networks. While SIP firewalls assist in analyzing SIP traffic transmitted over the corporate network to filter out various threats, they do not necessarily encrypt the traffic. As a result, this traffic is not entirely secure from end-to-end nor is it protected against threats like man-in-middle and eavesdropping.

Intellectual Property and Patent Rights

Our intellectual property is primarily comprised of trade secrets, patented know-how, issued and pending patents, copyrights and technological innovation.

We currently own approximately 49 U.S. and 69 foreign patents with approximately 50 pending patent applications worldwide. Our portfolio includes a number of patents that describe unique systems and methods for securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our software and technology solutions also may have additional applications relating to operating systems and network security. A complete list of our US patents is available on our website located at www.virnetx.com. Each patent is publicly accessible on the Internet website of the U.S. Patent and Trademark Office at www.uspto.gov. The term of each of our issued U.S. and foreign patents will expire during the period from 2019 to 2024.

Notwithstanding anything to the contrary set forth in any of our filings under the Securities Act of 1933 or the Securities Exchange Act of 1934 that might incorporate future filings, the information set forth on the United States Patent and Trademark Office, or the USPTO Website, shall not be deemed to be a part of or incorporated by reference into any such filings. The Company does not warrant the accuracy, or completeness or adequacy of the USPTO Website, and expressly disclaims liability for errors or omissions on such website.

11

TABLE OF CONTENTS

Assignment of Patents

Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Leidos, pursuant to an Assignment Agreement dated December 21, 2006, and a Patent License and Assignment Agreement dated August 12, 2005, as amended on November 2, 2006, including documents prepared pursuant to the November amendment, and as further amended on March 12, 2008. We recorded the assignment from Leidos, with the U.S. Patent Office on December 21, 2006.

Key terms of these agreements are as follows:

Patent Assignment. Leidos, unconditionally and irrevocably conveyed, transferred, assigned and quitclaimed all its right, title and interest in and to the patents and patent applications, as specifically set forth on Exhibit A to the assignment document recorded with the U.S. Patent Office, including, without limitation, the right to sue for past infringement.

License to Leidos, Outside the Field of Use. Effective March 12, 2008, we granted to Leidos, a non-exclusive, royalty free, fully paid, perpetual, worldwide, irrevocable, sub licensable and transferable right and license permitting Leidos, and its assignees to make, have made, import, use, offer for sale, and sell products and services covered by, and to make improvements to, the patents and patent applications we acquired from Leidos, solely outside our field of use.

Compensation Obligations. As consideration for the assignment of the patents and for the rights we obtained from Leidos, as amended, we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations. As of June 30, 2010, we met our maximum royalty payment requirement; however, Leidos, is also entitled under certain circumstances to receive a portion of the proceeds paid to us for certain acquisitions of VirnetX and the settlement of certain patent infringement claims of ours.

Government Regulation

The laws governing online secure communications remain largely unsettled, even in areas where there has been legislative action. It may take years to determine whether and how existing laws governing intellectual property, privacy and libel apply to online communications and media. Such legislation may interfere with the growth in use of online secure communications and decrease the acceptance of online secure communications as a viable solution, which could adversely affect our business.

Due to the Internet’s popularity and increasing use, new laws regulating secure communications may be adopted. These laws and regulations may cover, among other things, issues relating to privacy, pricing, taxation, telecommunications over the Internet, content, copyrights, distribution and quality of products and services. We intend to comply with all new laws and regulations as they are adopted.

The U.S. government has controlled the authoritative domain name system, or DNS, root server since the inception of the Internet. On July 1, 1997, the President of the United States directed the U.S. Secretary of Commerce to privatize the management of the domain name system in a manner that increases competition and facilitates international participation in its management.

On September 29, 2006, the U.S. Department of Commerce extended its delegation of authority by entering into a new agreement with the Internet Corporation for Assigned Names and Numbers, or ICANN, a California non-profit corporation headquartered in Marina Del Rey, California. ICANN is responsible for managing the accreditation of registry providers and registrars that manage the assignment of top level domain names associated with the authoritative DNS root directory. Although it is possible to create and manage other DNS root directories privately without accreditation from ICANN, the possibility of conflicting name and number assignments makes it less likely that users would widely adopt a top level domain name associated with an alternative DNS root directory provided by a non-ICANN-accredited registry service.

Employees

As of December 31, 2016 we had 20 full and part-time employees.

Corporate Overview and History

VirnetX, Inc., was incorporated in the State of Delaware in August 2005. In November 2006, VirnetX acquired certain patents from Leidos. In July 2007, we effected a reverse merger between PASW, Inc. and VirnetX, which became our

12

TABLE OF CONTENTS

principal operating subsidiary. As a result of this merger, the former security holders of VirnetX came to own a majority of our outstanding common stock. On October 29, 2007 we changed our name from PASW, Inc. to VirnetX Holding Corporation.

Available Information

We file or furnish various reports, such as registration statements, periodic and current reports, proxy statements and other materials with the SEC. Our Internet website address is www.virnetx.com. You may obtain, free of charge on our Internet website, copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post is intended for reference purposes only; none of the information posted on our website is part of this report or incorporated by reference herein.

In addition to the materials that are posted on our website, you may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and other information statements, and other information regarding issuers, including us, that file electronically with the SEC. The Internet address of the SEC’s Internet site is http://www.sec.gov.

Item 1A.Risk Factors

Our operations and financial results are subject to various risks and uncertainties, including those described below, which could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common and capital stock. You should carefully consider the following information and the other information in this Form 10-K in evaluating our business and prospects before making an investment decision with respect to our common stock. The risks and uncertainties we describe below are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also affect our business.

Risks Related to Our Business and Our Financial Reporting

We are involved and will continue to be involved in litigation defending our patent portfolio, which can be time-consuming and costly and we cannot anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation. We believe that this litigation and others that we may pursue in the future could continue for years and consume significant financial and management resources. The counterpart to our litigation is a large, well-financed company with substantially greater resources than us. We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us. In addition, even if we obtain favorable interim rulings or verdicts, they may be inconsistent with the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects, which could encumber our ability to develop and commercialize our products.

We may seek additional capital to support our business growth, and this capital may be dilutive, cause our stock price to drop or may not be available on acceptable terms, if at all.

We may seek additional capital to support our business growth or to respond to business opportunities, challenges or unforeseen circumstances, including sales pursuant to our ATM Offering. Our ability to obtain additional capital, if and when required, will depend on our business plans, investor demand, our operating performance, the condition of the capital markets, the terms of our current contractual obligations and other factors. If we raise additional funds through the issuance of equity, equity-linked or debt securities, including those pursuant to our ATM Offering, those securities may have rights, preferences, or privileges senior to the rights of our common stock, and our existing stockholders may experience dilution. Additionally, we are unable to predict the success of our current ATM offering. Sales of a substantial number of shares of our common stock in the public market, the perception that these sales or other financings might occur, could depress the market price of our common stock and could also impair our ability to raise capital through the sale of additional equity securities. If we issue debt securities or incur indebtedness, the incurrence of indebtedness would result in increased fixed payment obligations and could also result in restrictive

13

TABLE OF CONTENTS

covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we are unable to obtain additional capital, or are unable to obtain additional capital on satisfactory terms, our ability to continue to support our business growth or to respond to business opportunities, challenges, or other circumstances could be adversely affected, and our business may be harmed.

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

Our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we could reach through direct sales and marketing efforts; as such, our business strategy and revenues will depend on intellectual property licensing fees and royalties for the majority of our revenues. We currently derive minimal revenue from licensing activities and we cannot assure you that we will successfully capitalize on our market opportunities or that our current business strategy will succeed. Factors that may affect our ability to execute our current business strategy include, but are not limited to:

Although to date we have entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing relationships, or if we are successful in entering into such relationships, the acquisition of them may be expensive, and they, as well as our existing settlement and license agreements may not generate the financial results we expect;
Third parties may challenge the validity of our patents;
The pendency of our various litigations may cause potential licensees not to do business with us;
We face, and we expect to continue to face, intense competition from new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and
It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours.

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

We believe our patents are valid, enforceable and valuable. Notwithstanding this belief, third parties may make claims of infringement or invalidity claims with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our revenues related to such patents, or otherwise materially and adversely affect our business. Similar challenges could also prevent us from obtaining additional patents in the future. Additionally, several of our patents are currently, and other patents may in the future be, subject to USPTO post-grant inter partes review proceedings (“IPR”) which may result in all or part of these patents being invalidated or the claims of our patents being limited. Unfavorable or adverse outcomes in our litigation or IPRs may result in losses, exhaustion of financial resources, reduction in our ability to enforce our intellectual property rights, or other adverse effects, which could encumber our ability to develop and commercialize our products. Even if we are successful in enforcing our intellectual property rights, our patents may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect. These risks may be heightened in countries other than the United States where laws regarding patent protection are less developed, and may be negatively affected by the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and still evolving. In addition, there are a significant number of United States and foreign patents and patent applications in our areas of interest, and we expect that significant litigation in these areas will continue, and will add uncertainty to the value of certain patents and other intellectual property rights in our areas of interest. If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute or “ETSI”, and the Alliance for Telecommunications Industry Solutions or “ATIS”, we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights or “IPR” policies. This was in response to our Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3rd Generation Partnership Project (3GPP) Long Term Evolution or “LTE”, Systems Architecture Evolution or “SAE” project. We will make available a non-exclusive patent license under

14

TABLE OF CONTENTS

FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) for the patents identified by us that are or become essential, to applicants desiring to implement the Technical Specifications identified by us, as set forth in the updated licensing declaration under the ATIS and ETSI IPR policies. Our licensing declarations under the ATIS and ETSI IPR policies may limit our flexibility in determining royalties and license terms for certain of our patents. Consequently, we cannot assure you that the licensing of the essential security patents will be successful or that third parties will be willing to enter into licenses with us on reasonable terms or at all, which could have an adverse effect on our business and harm our competitive position.

Because our business is conducted or expected to be conducted in an environment that is subject to rapid change, we may be subject to various developments in regulation, law and consumer preferences to which we may not be able to adapt successfully.

The current regulatory environment for our products and services remains unclear. We can give no assurance that our planned product offerings will be in compliance with laws and regulations of local, state, United States federal or foreign authorities. Further, we can give no assurance that we will not unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the future which would cause us to be in violation of such laws or regulations. For example, Voice-over-Internet Protocol or “VoIP” services are not currently subject to all of the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and that these could result in substantial costs to us which could adversely affect the marketability of our products and planned products related to VoIP. For further example, the use of the Internet and private Internet Protocol or “IP” networks for communication is largely unregulated within the United States, but may become regulated in the future; also several foreign governments have enacted measures that could restrict or prohibit voice communications services over the Internet or private IP networks.

Our business depends on the growth of instant messaging, VoIP, mobile services, streaming video, file transfer and remote desktop and other next-generation Internet-based applications. A decline in the use of these applications due to complexity or cost of these applications relative to alternate traditional or newly developed communications channels, or development of alternative technologies, could cause a material decline in the number of users in these areas.

More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically may materially and adversely affect our business, financial condition, operating results and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue. For instance, the United States Supreme Court has recently modified some tests used by the United States Patent and Trademark Office or “USPTO” in granting patents during the past 20 years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or license. In addition, the United States recently enacted sweeping changes to the United States patent system under the Leahy-Smith America Invents Act or “AIA”, including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for challenging issued patents.
More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.
Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.
As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

15

TABLE OF CONTENTS

If we experience security breaches, we could be exposed to liability and our reputation and business could suffer.

We expect to retain certain confidential customer information in our secure data centers and secure domain name registry. It will be critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure. Our secure domain name registry operations will also depend on our ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and potentially depend on protection by other registrars in the shared registration system. The secure domain name servers that we will operate will be critical hardware to our registry services operations. Therefore, we expect to have to expend significant time and money to maintain or increase the security of our facilities and infrastructure. Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in the techniques for attacking security solutions could make some or all of our products obsolete or unmarketable. Likewise, if any of our products are found to have significant security vulnerabilities, then we may need to dedicate engineering and other resources to eliminate the vulnerabilities and to repair or replace products already sold or licensed to our customers. Despite our security measures, our infrastructure may be vulnerable to physical break-ins, computer viruses, attacks by hackers or similar disruptive problems. It is possible that we may have to expend additional financial and other resources to address such problems. Any physical or electronic break-in or other security breach or compromise of the information stored at our secure data centers and domain name registration systems may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers. In such an event, we could face significant liability and customers could be reluctant to use our services. Such an occurrence could also result in adverse publicity and therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services.

A security breach could require a substantial level of financial resources to rectify and could result in a product liability claim that causes us to incur substantial liability and related legal and other costs. A security breach may also harm our reputation and make it more difficult or impossible for us to successfully market to others. These matters could harm our operating results and financial condition.

Privacy and data security concerns, and data collection and transfer restrictions and related domestic or foreign regulations may limit the use and adoption of our solutions and adversely affect our business.

Personal privacy, information security, and data protection are significant issues in the United States, Europe and many other jurisdictions where we have operations or offer our products. The regulatory framework governing the collection, processing, storage and use of confidential and proprietary business information and personal data is rapidly evolving. The U.S. federal and various state and foreign governments have adopted or proposed requirements regarding the collection, distribution, use, security and storage of personally identifiable information and other data relating to individuals, and federal and state consumer protection laws are being applied to enforce regulations related to the online collection, use and dissemination of data.

Further, many foreign countries and governmental bodies, including the European Union, or EU, where we conduct business, have laws and regulations concerning the collection and use of personal data obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some jurisdictions, Internet Protocol, or IP, addresses.

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the United States, the EU, and other jurisdictions. For example, the European Commission recently adopted a General Data Protection Regulation, effective in May 2018, that will supersede current EU data protection legislation, impose more stringent EU data protection requirements, and provide for greater penalties for noncompliance. We cannot yet determine the impact such future laws, regulations and standards may have on our business. Such laws and regulations are often subject to differing interpretations, may be inconsistent among jurisdictions, and may be alleged to be inconsistent with our current or future practices. Additionally, we may be bound by contractual requirements applicable to our collection, use, processing, and disclosure of various types of data, including personal data, and may be bound by, or voluntarily comply with, self-regulatory or other industry standards relating to these matters. These and other requirements could reduce demand for our products, increase our costs, impair our ability to grow our business, or restrict our ability to store and process data or, in some cases, impact our ability to offer our service in some locations and may subject us to liability. Any failure or perceived failure to comply with applicable laws, regulations, industry standards, and

16

TABLE OF CONTENTS

contractual obligations may adversely affect our business. Further, in view of new or modified federal, state or foreign laws and regulations, industry standards, contractual obligations and other legal obligations, or any changes in their interpretation, we may find it necessary or desirable to fundamentally change our business activities and practices or to expend significant resources to modify our product and otherwise adapt to these changes. We may be unable to make such changes and modifications in a commercially reasonable manner or at all, and our ability to develop new products and features could be limited.

The costs of compliance with and other burdens imposed by laws, regulations and standards may limit the use and adoption of our service and reduce overall demand for it, or lead to significant fines, penalties or liabilities for any noncompliance. Privacy, information security, and data protection concerns, whether valid or not valid, may inhibit market adoption of our platform, particularly in certain industries and foreign countries.

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

We expect that our sales cycles will be long and unpredictable due to a number of factors, including but not limited to:

The need to educate potential customers about our patent rights and our product and service capabilities;
Our customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;
Our customers’ budgetary constraints;
The timing of our customers’ budget cycles;
Delays caused by customers’ internal review processes; and
Long sales cycles that may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.

If we are unable to expand our revenue sources or establish, sustain, grow or replace relationships with a diversified customer base, our revenues may be limited.

We currently generate revenue from a limited number of customers that have entered into Settlement and License Agreements. Although our GABRIEL Collaboration Suite is not currently generating revenue, it will take time for us to grow our installed user base and generate new customers. Additionally, there is no guarantee that we will be able to derive revenue from new customers, sustain or increase revenue from existing customers or replace customers from whom we currently generate revenue. As a result, our revenue may be limited or static.

We have limited technical resources and are at an early stage in the development and commercialization of our GABRIEL Collaboration Suite.

We recently launched our first commercial product, the GABRIEL Collaboration Suite. As such, we have a small technical team, which limits our ability to rapidly adapt our product to customer requirements or add new product features to maintain our competitive edge and drive adoption. Based on the scale of our technical resources, our limited historical financial data upon which to base our projected revenue or planned operating expenses related to our GABRIEL Collaboration Suite, we may not be able to effectively:

generate revenues or profit from product sales;
drive adoption of our products;
attract and retain customers for our products;
provide appropriate levels of customer training and support for our products;
implement an effective marketing strategy to promote awareness of our products;
focus our research and development efforts in areas that generate returns on our efforts;
anticipate and adapt to changes in our market; or
protect our products from any system failures or other breaches.

17

TABLE OF CONTENTS

In addition, a high percentage of our expenses are and will continue to be fixed. Accordingly, if we do not generate revenue as and when anticipated, our losses may be greater than expected and our operating results will suffer.

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects. Despite testing, some errors in our products may only be discovered after a product has been installed and used by customers. Any errors or defects discovered in our products after commercial release could result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business, operating results and financial condition. In addition, we could face claims for product liability, tort or breach of warranty, including claims relating to changes to our products made by our channel partners. The performance of our products could have unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which could result in legal claims against us, harming our business. Furthermore, we expect to provide implementation, consulting and other technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing and communications systems. We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations, which may not be upheld. Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s perception of us and our products. In addition, if our business liability insurance coverage proves inadequate or future coverage is unavailable on acceptable terms or at all, our business, operating results and financial condition could be adversely impacted.

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks that we cannot control.

Our business will depend upon, among other things, the capacity, reliability and security of the infrastructure owned by third parties that we will use to deploy our offerings. We have no control over the operation, quality or maintenance of a significant portion of that infrastructure or whether or not those third parties will upgrade or improve their equipment. We depend on these companies to maintain the operational integrity of our connections. If one or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted. Also, to the extent that the number of users of networks utilizing our current or future products suddenly increases, the technology platform and secure hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions. System interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users. In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures. These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and communication networks that we establish. To the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions or delays or system failures. Our systems and operations will also be vulnerable to damage or interruption from, among other things:

power loss, transmission cable cuts and other telecommunications failures;
damage or interruption caused by fire, earthquake, and other natural disasters;
computer viruses or software defects; and
physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control.

System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users. These types of occurrences could

18

TABLE OF CONTENTS

cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

Any significant problem with our systems or operations could result in lost revenue, customer dissatisfaction or lawsuits against us. A failure in the operation of our secure domain name registration system could result in the inability of one or more registrars to register and maintain secure domain names for a period of time. A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation of assigned secure domain names for a period of time. The inability of the registrar systems we establish, including our back office billing and collections infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial degradation in our customer support service and our ability to process registration requests in a timely manner.

Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high-quality technical support services could have a material adverse effect on our sales and results of operations.

If we do not effectively assist our customers in deploying our products, succeed in helping our customers quickly resolve post-deployment issues and provide effective ongoing support, or if potential customers perceive that we may not be able achieve to the foregoing, our ability to sell our products would be adversely affected, and our reputation with current and potential customers could be harmed. In addition, as we expand our operations internationally, our technical support team will face additional challenges, including those associated with delivering support, training and documentation in languages other than English. Our failure to deliver and maintain high-quality technical support services to our customers could result in customers choosing to use our competitors’ products and support services instead of ours in the future.

Telephone carriers have petitioned governmental agencies to enforce regulatory tariffs, which, if granted, would increase the cost of online communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in service. As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP telephony traffic that crosses over their traditional telephone networks. If the relief sought in these petitions is granted, the costs of communicating via online could increase substantially, potentially adversely affecting the growth in the use of online secure communications. Any of these developments could have an adverse effect on our business.

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our strategic plan and may result in additional severance costs to us.

Our success largely depends on the skills, experience and efforts of our key personnel, including Kendall Larsen, our Chief Executive Officer and President. We have no employment agreements with any of our key executives that prevent them from leaving us at any time. In addition, we do not maintain key person life insurance for any of our officers or key employees. The loss of Mr. Larsen, or our failure to retain other key personnel, would jeopardize our ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our future success will depend, in part, on our ability to attract and retain qualified engineering, operations, marketing, sales and executive personnel. Inability to attract and retain such personnel could adversely affect our business. Competition for engineering, operations, marketing, sales and executive personnel is intense, particularly in the technology and Internet sectors and in the regions where we conduct our business. We can provide no assurance that we will attract or retain such personnel.

We may identify future material weakness which may result in late filings, increased costs or declines in our share price.

Although we believe that we currently maintain effective control over our disclosures and procedures and internal control over financial reporting, we may in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting. If we experience any material weaknesses in our internal

19

TABLE OF CONTENTS

control over financial reporting the future or are unable to provide unqualified management or attestation reports about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and any of which could cause our share price to decline.

Risks Related to Our Stock

We do not currently pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their investments.

Our dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities. We therefore cannot make assurances that our Board of Directors will determine to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to look to appreciation of our common stock to realize a gain on their investment. This appreciation may not occur.

The exercise of our outstanding stock options and issuance of new shares would result in a dilution of our current stockholders’ voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of our stock.

The exercise of our outstanding vested stock options would dilute the ownership interests of our existing stockholders. As of December 31, 2016, we had outstanding options to purchase an aggregate of 5,378,571 shares of common stock representing 9.25% of our total shares outstanding of which 4,472,193 were vested and therefore exercisable. To the extent outstanding stock options are exercised, additional shares of common stock will be issued, existing stockholders’ percentage voting interests will decline and the number of shares eligible for resale in the public market will increase. Such increase may have a negative effect on the value or market trading price of our common stock.

Trading in our common shares is limited and the price of our common shares may be subject to substantial volatility.

Our common stock is listed on NYSE MKT. Over the past years the market price of our common stock has experienced significant fluctuations. Between January 1, 2016, and December 31, 2016, the reported last adjusted closing price on NYSE MKT for our common stock ranged between $2.00 and $7.31 per share. The price of our common stock may continue to be volatile as a result of a number of factors, some of which are beyond our control. These factors include, but not limited to, the following:

developments or lack thereof in any then-outstanding litigation;
quarterly variations in our operating results;
large purchases or sales of common stock or derivative transactions related to our stock;
actual or anticipated announcements of new products or services by us or competitors;
general conditions in the markets in which we compete; and
general social, political, economic and financial conditions, including the significant volatility in the global financial markets as a result of the announcement of the Referendum of the United Kingdom’s membership of the European Union, referred to as Brexit.

In addition, we believe there has been and may continue to be substantial trading in derivatives of our stock, including short selling activity or related similar activities, which are beyond our control and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority or “FINRA”. While the SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation, such activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our stock; however, there can be no assurance that should there be any illegal manipulation in the trading of our stock, it will be detected, prosecuted or successfully eradicated. Significant short selling or other types of market manipulation could cause our stock trading price to decline, to become more volatile, or both.

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or similar factors. We had a net loss of $9.9 million for the year ended

20

TABLE OF CONTENTS

December 31, 2014, and a net loss of $29.2 million for the year ended December 31, 2015 and a net loss $28.6 million for the period ended December 31, 2016, with an accumulated deficit of $158.2 million. The following include some of the factors that may cause our operating results to fluctuate:

the outcome of actions to enforce our intellectual property rights currently in progress or that we may undertake in the future, and the timing thereof;
the amount and timing of receipt of license fees from potential infringers, licensees or customers;
the rate of adoption of our patented technologies;
the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc.;
the success of a licensee in selling products that use our patented technologies; and
the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights.

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common stock.

The market price of our common stock has been and may continue to be volatile, and you could lose all or part of your investment.

The trading price of our common stock has been volatile since our initial public offering, and is likely to continue to be volatile. Factors that could cause fluctuations in the market price of our common stock include the following:

price and volume fluctuations in the overall stock market from time to time;
volatility in the market prices and trading volumes of companies in our industry or companies that investors consider comparable;
changes in operating performance and stock market valuations of other companies generally, or those in our industry in particular;
sales of shares of our common stock by us or our stockholders;
failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow us, or our failure to meet these estimates or the expectations of investors;
the financial projections we may provide to the public, any changes in those projections or our failure to meet those projections;
announcements by us or our competitors of new products or services;
the public’s reaction to our press releases, other public announcements and filings with the SEC;
rumors and market speculation involving us or other companies in our industry;
actual or anticipated changes in our results of operations;
changes in tax and other incentives that we rely upon in order to raise tax equity investment funds;
changes in the regulatory environment and utility policies and pricing, including those that could reduce the savings we are able to offer to customers;
actual or anticipated developments in our business, our competitors’ businesses or the competitive landscape generally;
litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;
announced or completed acquisitions of businesses or technologies by us or our competitors;
new laws or regulations or new interpretations of existing laws or regulations applicable to our business;

21

TABLE OF CONTENTS

changes in accounting standards, policies, guidelines, interpretations or principles;
any significant change in our management; and
general economic conditions and slow or negative growth of our markets.

Further, in recent years the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. In addition, the stock prices of many renewable energy companies have experienced wide fluctuations that have often been unrelated to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions, government shutdowns, interest rate changes the stability of the EU and the exit of the United Kingdom or international currency fluctuations, may cause the market price of our common stock to decline. In the past, following periods of volatility in the overall market and the market price of a particular company’s securities, securities class action litigation has often been instituted against these companies.

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of December 31, 2016, our executive officers and directors beneficially owned approximately 19% of our outstanding common stock. In addition, a group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 8.4% of our then outstanding common stock, have entered into a voting agreement with us that requires them to vote all of their shares of our voting stock in favor of the director nominees approved by our Board of Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters submitted to the stockholders for a vote. However, we cannot be certain how many shares of our common stock this group of stockholders currently owns. Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that are contrary to your interests. This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging with us.

Our protective provisions could make it difficult for a third party to successfully acquire us even if you would like to sell your stock to them.

We have a number of protective provisions that could delay, discourage or prevent a third party from acquiring control of us without the approval of our Board of Directors. Our protective provisions include:

A staggered Board of Directors: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting. This has the effect of delaying the ability of stockholders to effect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.
Blank check preferred stock: Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock. Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you. In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors. We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval.
Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings: Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting. This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.
No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders. Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.

22

TABLE OF CONTENTS

Super majority requirement for stockholder amendments to the By-laws: Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.
No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings of the stockholders. This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In addition, the provisions of Section 203 of the Delaware General Corporate Law govern us. These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.

These and other provisions in our amended and restated certificate of incorporation, our By-laws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being lower than it would be without these provisions.

Item 1B.Unresolved Staff Comments.

None

Item 2.Properties

Our principal executive offices are located at 308 Dorla Court, Suite 206, Zephyr Cove, Nevada, 89448. We lease this property, which comprises approximately 2,090 square feet of office space, from a third party for a term that ends in October 2017. We have no other properties and believe that our office facility is suitable and appropriately supports our current business needs.

Item 3.Legal Proceedings

We have nine intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division, and United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)

On March 30, 2015, the United States Court for the Eastern District of Texas, Tyler Division, issued an order finding substantial overlap between the remanded portions of the Civil Action Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.), and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. The jury trial in this case was held on January 25, 2016. On February 4, 2016, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us $625.6 million in a verdict against Apple Inc. for infringing four of our US patents, marking it the second time a federal jury has found Apple liable for infringing VirnetX’s patented technology. The verdict includes royalties awarded to us based on an earlier patent infringement finding (Case 6:10-CV-00417-LED) against Apple. The jury found that Apple’s modified VPN On-Demand, iMessage and FaceTime services infringed VirnetX’s patents and that Apple’s infringement was willful. In addition to determining the royalty owed by Apple for its prior infringement, this verdict also includes an award based on the jury’s finding that Apple’s modified VPN On Demand, iMessage and FaceTime services have continued to infringe VirnetX’s patents. The post-trial hearing was held on May 25, 2016 in the United States Court for the Eastern District of Texas, Texarkana Division. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases (Case No. 6:10-cv-417, Docket No. 878 (“Apple I case”); Case No. 6:12-cv-855, Docket No. 220 (“Apple II case”)), ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II case will be retried after Apple I case. Events and developments subsequent to the order from the court are described to support Apple I and Apple II matters.

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra USA. Inc. (“Aastra”), Apple, Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought

23

TABLE OF CONTENTS

damages and injunctive relief. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and try only the case against Apple on the scheduled trial date. The jury trial of our case against Cisco was held on March 4, 2013. The jury in our case against Cisco came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents were denied and the case against Cisco was closed.

The jury trial of our case against Apple was held on October 31, 2012. On November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. On December 16, 2014, USCAFC denied our petition requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision and remanded the case back to the Eastern District of Texas, Tyler Division, for further proceedings consistent with its opinion. On February 25, 2015, USCAFC granted Apple’s motions to lift stay of proceedings and vacate Case 6:13-CV-00211-LED. On March 30, 2015, the court issued an order finding substantial overlap between the remanded portions of this case and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case.

On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case.

The jury trial in this case was held on September 26, 2016. On September 30, 2016, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, in the case VirnetX Inc., et al. v. Apple Inc., No. Apple I, has awarded VirnetX $302.4 million in a verdict against Apple Corporation for infringing four VirnetX patents, marking the third time a federal jury has found Apple liable for infringing VirnetX’s patented technology.

The verdict includes royalties awarded to VirnetX, for unresolved issues in the Apple I case, remanded back from the USCAFC, related to (1) damages owed to VirnetX for infringement by Apple’s original VPN-on-Demand (VOD) and (2) the alleged infringement by Apple’s original FaceTime product, under the new claim construction of “secure communication link” pertaining to the ’504 and ’211 patents by the USCAFC, and the damages associated with that infringement. The hearing on all the post-trial motions was held on November 22, 2016. We are currently awaiting the court ruling and final judgement in this case.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

On November 6, 2012, we filed a new complaint against Apple in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh

24

TABLE OF CONTENTS

computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case was scheduled for October 13, 2015. On March 30, 2015, the court issued an order finding substantial overlap between this case and the remanded portions of Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case. We are awaiting court order setting the date for a new jury trial in Apple II case.

VirnetX Inc. v. Apple, Inc. (Case 15-1934)

On July 10, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the United States Patent and Trademark Office, Patent Trial and Appeal Board (“PTAB”) in IPR2014-00237 and IPR2014-00238, related to U.S. Patent No. 8,504,697. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00238. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1211)

On September 28, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2014-00403 and IPR2014-00404 and on October 22, 2015 for IPR2014-00481 and IPR2014-00482 involving our U.S. Patent Nos. 7,188,180, and 7,987,274. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00403 and IPR2014-00481. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1480)

On November 30, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-partes reexamination no. 95/001,949 related to U.S. Patent No. 8,051,181. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on certain grounds. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (case 16-119)

On March 4, 2016, we filed a petition for writ of mandamus with the USCAFC, requesting the USCAFC’s intervention to revoke the PTAB’s decision joining Apple to IPR2015-01046 and IPR2015-01047, related to U.S. Patent Nos. 6,502,135 and 7,490,151. On March 18, 2016, the USCAFC denied the petition without prejudice to us raising the arguments on appeal after the PTAB’s final decisions. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 17-1131)

On October 31, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-00810, IPR2015-00812, on November 9, 2016 for IPR2015-00811, and on November 28, 2016 for IPR2015-00866, IPR2015-00868, IPR2015-00870, IPR2015-00871 involving our U.S. Patent Nos.8,868,705, 8,850,009, 8,458,341, 8,516,131, and 8,560,705. These appeals have been consolidated.

VirnetX Inc. v. The Mangrove Partners (Case 17-1368)

On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC.

25

TABLE OF CONTENTS

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

Item 4.Mine Safety Disclosure.

Not applicable

26

TABLE OF CONTENTS

PART II

Item 5.Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock currently trades under the symbol “VHC” on the NYSE MKT LLC.

The following table shows the price range of our common stock, as reported on the NYSE MKT LLC, for each quarter ended during the last two fiscal years.

Quarter Ended
High
Low
3/31/15
$
8.09
 
$
4.66
 
6/30/15
$
7.48
 
$
4.02
 
9/30/15
$
4.76
 
$
2.71
 
12/31/15
$
4.29
 
$
2.12
 
3/31/16
$
9.64
 
$
1.95
 
6/30/16
$
6.50
 
$
3.99
 
9/30/16
$
4.64
 
$
2.29
 
12/31/16
$
5.13
 
$
2.10
 

The closing price of our common stock on the NYSE MKT LLC on March 10, 2017 was $2.20 per share.

Holders

As of March 10, 2017, we had 45 stockholders of record. Because many of our shares of common stock are held of record by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial stockholders represented by such record holders.

Dividends

We do not currently intend to begin paying a regular dividend in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant.

Performance Graph

This performance graph shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference into any filing of VirnetX under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


27

TABLE OF CONTENTS

The stock price performance reflected on this graph is not necessarily indicative of future stock price performance. See the disclosure in part I, Item 1A. “Risk Factors”

 
12/11
12/12
12/13
12/14
12/15
12/16
VirnetX Holding Corp
 
100.00
 
 
117.26
 
 
77.73
 
 
21.99
 
 
10.29
 
 
8.81
 
S&P 500
 
100.00
 
 
116.00
 
 
153.58
 
 
174.60
 
 
177.01
 
 
198.18
 
RDG Technology Composite
 
100.00
 
 
114.61
 
 
152.95
 
 
178.50
 
 
183.08
 
 
206.81
 

Recent Sales of Unregistered Securities

During the year ended December 31, 2016, we had no sales of unregistered securities and no repurchases of stock.

Item 6.Selected Financial Data. (in thousands except per share data)

The consolidated statement of operations data for the three years ended December 31, 2016, 2015 and 2014 and the balance sheet data at December 31, 2016 and 2015, are derived from our audited financial statements included elsewhere in this Annual Report on Form 10-K. The consolidated statement of operations data for the two years ended December 31, 2013 and 2012 and the balance sheet data at December 31, 2014, 2013 and 2012 are derived from our audited financial statements not included in this annual report on Form 10-K.

The selected consolidated financial data below are not necessarily indicative of future performance and should be read in conjunction with Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and related notes thereto included in Item 8 of this Annual Report on Form 10-K.

 
For the year ended December 31,
 
2016
2015
2014
2013
2012
Consolidated Statement of Operations Data:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
1,550
 
$
1,555
 
$
1,249
 
$
2,197
 
$
412
 
Gain on settlement
$
 
$
 
$
23,000
 
$
 
 
 
Other operating expenses
$
(30,055
)
$
(30,732
)
$
(36,414
)
$
(30,784
)
$
(39,273
)
Income tax (expense) benefit
$
(133
)
$
(8
)
$
(15
)
$
(751
)
$
12,535
 
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
$
(27,608
)
$
(26,924
)
Loss per share
$
(0.51
)
$
(0.56
)
$
(0.19
)
$
(0.54
)
$
(0.53
)
Consolidated Balance Sheet Data:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
6,627
 
$
8,726
 
$
18,658
 
$
19,173
 
$
19,661
 
Investments available for sale
$
9.249
 
$
9,954
 
$
22,571
 
$
19,815
 
$
26,493
 
Total assets
$
18,871
 
$
22,172
 
$
45,090
 
$
39,398
 
$
61,313
 
Stockholders’ equity
$
11,147
 
$
15,095
 
$
32,627
 
$
34,024
 
$
53,944
 
(a)The gain on settlement in 2014 relates to a cash settlement of litigation with Microsoft.
(b)In 2010, we had a taxable income of $75 million, which allowed us to carry back 2012 NOLs for tax refunds. Due to the tax refunds derived from carrying back the 2012 NOLs, we recognized the tax benefit of $12.5 million in 2012. In addition, we made a determination to provide a full valuation allowance for our net deferred tax assets at the end of 2012, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable it to realize its deferred tax assets.
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Company Overview

We develop software and technology solutions for securing real-time communications over the Internet. Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. Our Gabriel Collaboration Suite™ is available for download and free trial, for Android, iOS, Windows, Linux and Mac OS X platforms, at http://www.gabrielsecure.com/. We continue to enhance our products and add new functionality to our products. We will provide updates to new and existing customers as they are released to the general public. Over 80

28

TABLE OF CONTENTS

small and medium businesses have installed our Gabriel Secure Communication Platform™ and Gabriel Collaboration Suite™ products in their corporate networks. We continue to rapidly expand our customer base with targeted promotions and direct sales initiatives. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.

Our portfolio of intellectual property is the foundation of our business model. We currently own over 100 U.S. and international patents with over 50 pending applications. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, M2M communications in areas of Smart City, Connected Car and Connected Home.

We have submitted a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.

We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE Advanced wireless networks and M2M communications in areas including Smart City, Connected Car and Connected Home. We also believe that all 4G/LTE Advanced mobile devices will require unique secure domain names and become part of a secure domain name registry.

We intend to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will use these rates and guidelines in all future license negotiations.

Our software and technology solutions, including our Secure Domain Name Registry and GABRIEL Connection Technology™, are designed to facilitate secure communications and provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer, remote desktop and, or M2M communications. Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

Our product Gabriel Secure Communication Platform™, unlike other collaboration and communication products and services on the market today, does not require access to user’s confidential data and minimizes the threat of hacking and data mining. It enables individuals and organizations to maintain complete ownership and control over their personal and confidential data, secured within their own private network, while enabling authorized secure encrypted access from anywhere at any time. Our Gabriel Collaboration Suite™ is a set of applications that run on top of our Gabriel Secure Communication Platform™. It enables seamless and secure cross-platform communications between user’s devices that have our software installed. Our Gabriel Collaboration Suite™ is available for download and free trial, for Android, iOS, Windows, Linux and Mac OS X platforms, at http://www.gabrielsecure.com/. We continue to enhance our products and add new functionality to our products. We will provide updates to new and existing customers as they are released to the general public.

We have signed Patent License Agreements with Avaya Inc., Aastra USA, Inc., Microsoft, Mitel Networks Corporation, NEC Corporation and NEC Corporation of America, Siemens Enterprise Communications GmbH & Co. KG, and Siemens Enterprise Communications Inc. to license certain of our patents, for a one-time payment and/or an ongoing royalty for all future sales through the expiration of the licensed patents with respect to certain current

29

TABLE OF CONTENTS

and future IP-encrypted products. We have engaged IPVALUE Management Inc. to assist us in commercializing our portfolio of patents on securing real-time communications over the Internet. Under the multi-year agreement, IPVALUE will originate and assist us with negotiating transactions related to patent licensing worldwide with respect to certain third parties.

Our employees include the core development team behind our patent portfolio, technology and software. This team has worked together for over ten years and is the same team that invented and developed this technology while working at Leidos, is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos, and expanded the set of patents we acquired in 2006 from Leidos, into a larger portfolio with over 100 U.S. and international patents with over 50 pending applications. This portfolio now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio. See – Operations – Research and Development Expenses for a description of our research and development expenses for the past three fiscal years discussed below.

We continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to early licensing targets or asserting our rights for use of our patents. We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.

Developments in the Year Ended December 31, 2016

Litigation

We have nine intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division, and United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)

On March 30, 2015, the United States Court for the Eastern District of Texas, Tyler Division, issued an order finding substantial overlap between the remanded portions of the Civil Action Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.), and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. The jury trial in this case was held on January 25, 2016. On February 4, 2016, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us $625.6 million in a verdict against Apple Inc. for infringing four of our US patents, marking it the second time a federal jury has found Apple liable for infringing VirnetX’s patented technology. The verdict includes royalties awarded to us based on an earlier patent infringement finding (Case 6:10-CV-00417-LED) against Apple. The jury found that Apple’s modified VPN On-Demand, iMessage and FaceTime services infringed VirnetX’s patents and that Apple’s infringement was willful. In addition to determining the royalty owed by Apple for its prior infringement, this verdict also includes an award based on the jury’s finding that Apple’s modified VPN On Demand, iMessage and FaceTime services have continued to infringe VirnetX’s patents. The post-trial hearing was held on May 25, 2016 in the United States Court for the Eastern District of Texas, Texarkana Division. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases (Case No. 6:10-cv-417, Docket No. 878 (“Apple I case”); Case No. 6:12-cv-855, Docket No. 220 (“Apple II case”)), ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II case will be retried after Apple I case. Events and developments subsequent to the order from the court are described to support Apple I and Apple II matters.

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra USA. Inc. (“Aastra”), Apple, Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial

30

TABLE OF CONTENTS

for each defendant, and try only the case against Apple on the scheduled trial date. The jury trial of our case against Cisco was held on March 4, 2013. The jury in our case against Cisco came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents were denied and the case against Cisco was closed.

The jury trial of our case against Apple was held on October 31, 2012. On November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. On December 16, 2014, USCAFC denied our petition requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision and remanded the case back to the Eastern District of Texas, Tyler Division, for further proceedings consistent with its opinion. On February 25, 2015, USCAFC granted Apple’s motions to lift stay of proceedings and vacate Case 6:13-CV-00211-LED. On March 30, 2015, the court issued an order finding substantial overlap between the remanded portions of this case and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case.

On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case.

The jury trial in this case was held on September 26, 2016. On September 30, 2016, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, in the case VirnetX Inc., et al. v. Apple Inc., No. Apple I, has awarded VirnetX $302.4 million in a verdict against Apple Corporation for infringing four VirnetX patents, marking the third time a federal jury has found Apple liable for infringing VirnetX’s patented technology.

The verdict includes royalties awarded to VirnetX, for unresolved issues in the Apple I case, remanded back from the USCAFC, related to (1) damages owed to VirnetX for infringement by Apple’s original VPN-on-Demand (VOD) and (2) the alleged infringement by Apple’s original FaceTime product, under the new claim construction of “secure communication link” pertaining to the ’504 and ’211 patents by the USCAFC, and the damages associated with that infringement. The hearing on all the post-trial motions was held on November 22, 2016. We are currently awaiting the court ruling and final judgement in this case.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

On November 6, 2012, we filed a new complaint against Apple in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern

31

TABLE OF CONTENTS

District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case was scheduled for October 13, 2015. On March 30, 2015, the court issued an order finding substantial overlap between this case and the remanded portions of Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case. We are awaiting court order setting the date for a new jury trial in Apple II case.

VirnetX Inc. v. Apple, Inc. (Case 15-1934)

On July 10, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the United States Patent and Trademark Office, Patent Trial and Appeal Board (“PTAB”) in IPR2014-00237 and IPR2014-00238, related to U.S. Patent No. 8,504,697. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00238. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1211)

On September 28, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2014-00403 and IPR2014-00404 and on October 22, 2015 for IPR2014-00481 and IPR2014-00482 involving our U.S. Patent Nos. 7,188,180, and 7,987,274. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00403 and IPR2014-00481. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1480)

On November 30, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-partes reexamination no. 95/001,949 related to U.S. Patent No. 8,051,181. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on certain grounds. We are currently evaluating our options in this case.

VirnetX, Inc. v. Apple, Inc. (case 16-119)

On March 4, 2016, we filed a petition for writ of mandamus with the USCAFC, requesting the USCAFC’s intervention to revoke the PTAB’s decision joining Apple to IPR2015-01046 and IPR2015-01047, related to U.S. Patent Nos. 6,502,135 and 7,490,151. On March 18, 2016, the USCAFC denied the petition without prejudice to us raising the arguments on appeal after the PTAB’s final decisions. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 17-1131)

On October 31, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-00810, IPR2015-00812, on November 9, 2016 for IPR2015-00811, and on November 28, 2016 for IPR2015-00866, IPR2015-00868, IPR2015-00870, IPR2015-00871 involving our U.S. Patent Nos.8,868,705, 8,850,009, 8,458,341, 8,516,131, and 8,560,705. These appeals have been consolidated.

VirnetX Inc. v. The Mangrove Partners (Case 17-1368)

On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC.

32

TABLE OF CONTENTS

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

Patents

On June 30, 2016, the USPTO granted a petition for IPR filed by Apple Inc., seeking review of certain claims of our U.S. Patent No. 8,504,696.

On July 1, 2016, the USPTO granted a petition for IPR filed by Apple Inc., seeking review of certain claims of our U.S. Patent No. 8,504,696.

On August 30, 2016, the USPTO entered two final decisions in IPR proceedings filed by Apple Inc., finding certain claims of our U.S. Patent Nos. 8,868,705 and 8,850,009 to be unpatentable. We have filed appeals in the U.S. Court of Appeals for the Federal Circuit with respect to these decisions.

On September 8, 2016, the USPTO entered a final decision in an IPR proceeding filed by Apple Inc., finding certain claims of our U.S. Patent Nos. 8,868,705 to be unpatentable. We have filed an appeal in the U.S. Court of Appeals for the Federal Circuit with respect to this decision.

On September 9, 2016, the USPTO granted a petition for IPR filed by Black Swamp IP, LLC seeking review of certain claims of our U.S. Patent No. 7,921,211. On the same day, the USPTO granted a petition for IPR filed by Black Swamp IP, LLC seeking review of certain claims of our U.S. Patent No. 7,418,504. On the same day, the USPTO entered a final decision in an IPR proceeding filed by The Mangrove Partners Master Fund, Ltd., finding certain claims of our U.S. Patent No. 6,502,135 to be unpatentable. We have filed an appeal in the U.S. Court of Appeals for the Federal Circuit with respect to this decision. Apple Inc. is also a party to this appeal. On the same day, the USPTO entered final decisions in an IPR proceeding filed by The Mangrove Partners Master Fund, Ltd., finding certain claims of our U.S. Patent No. 7,490,151 to be unpatentable. We have filed an appeal in the U.S. Court of Appeals for the Federal Circuit with respect to this decision. Apple Inc. and Black Swamp IP, LLC are also parties to this appeal.

One September 12, 2016, the USPTO entered decisions in inter-partes reexamination nos. 95/001,788 and 95/001,851 related to U.S. Patent No. 7,418,504 and inter-partes reexamination nos. 95/001,789 and 95/001,856 related to U.S. Patent No. 7,921,211, finding certain claims of these patents to be invalid. We have appealed in the U.S. Court of Appeals for the Federal Circuit with respect to three of the decisions and have filed a request to reopen prosecution in one of the proceedings.

On September 28, 2016, the USPTO entered a final decision in IPR proceedings filed by Apple Inc., finding certain claims of our U.S. Patent Nos. 8,458,341, 8,516,131, and 8,560,705 to be unpatentable. We have filed appeals in the U.S. Court of Appeals for the Federal Circuit with respect to these decisions.

On October 18, 2016, the USPTO entered final decisions in two IPR proceeding filed by Apple Inc., finding certain claims of our U.S. Patent No. 8,843,643 to be patentable and certain claims to be invalid.

Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2017. We recognize rent expense on a straight-line basis over the term of the lease.

We lease the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company. We incurred approximately $772 and $593 in rental fees and reimbursements to the LLC during the years ended December 31, 2016 and 2015, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. On January 31, 2015 we entered into a 12-month non-exclusive lease with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The lease renews on an annual basis unless terminated by the lessor or lessee. Neither party has exercised their termination rights.

33

TABLE OF CONTENTS

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, fair values of stock-based awards, income taxes, and derivative liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, “Revenue Arrangements with Multiple Deliverables.” This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, including licenses entered upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, because delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.

34

TABLE OF CONTENTS

Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.
Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.

Deferred revenue

In August 2013 we began receiving annual payments on a contract that requires payment to us over 4 years of $10,000 (“August 2013 Contract Settlement”). From the inception of that license to December 31, 2016, we received cash totaling $10,000, all of which is non-refundable. We recognized $1,500, $1,500 and $1,167 of revenue related to the August 2013 Contract Settlement during the years ended December 31, 2016, 2015 and 2014 respectively.

Activity under the August 2013 Contract Settlement was as follows (in thousands):

 
2016
2015
2014
Deferred Revenue, beginning of year
$
3,000
 
$
2,000
 
$
667
 
Payment received
 
2,500
 
 
2,500
 
 
2,500
 
Less: Amount amortized as revenue
 
1,500
 
 
1,500
 
 
1,167
 
Deferred Revenue, end of year
$
4,000
 
$
3,000
 
$
2,000
 

Royalty Expense

Royalty expense for the years ended December 31, 2016, 2015 and 2014 was $884, $5,265 and $6,100, respectively, and was a result of our royalty agreement with Leidos. The agreement provides for revenue sharing and legal reimbursements related to attorney time and expenses incurred by Leidos during discovery and other aspects of litigation involving the defense of our patents which have been resolved.

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During the years ended 2016, 2015 and 2014 we incurred losses. Therefore, the effect of any Common Stock equivalent is anti-dilutive during those periods.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation. During the year ended December 31, 2016, and 2015 we had, at times, funds which were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

35

TABLE OF CONTENTS

Derivative Instruments

Our Series I Warrants contained an anti-dilution provision which prevented them from being considered indexed to our stock. As a result, the warrants were required to be accounted for as derivative instruments during 2015. The remaining balance of Series 1 Warrants expired during the year ended December 31, 2015.

We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.

Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing if we will realize our deferred tax assets, we consider whether it is more likely than not that some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. Consistent with our policy, and because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates.

36

TABLE OF CONTENTS

Stock-based Compensation

We account for stock-based compensation using the fair value recognition method. We recognize these compensation costs net of the applicable forfeiture rate and recognize the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is generally the option vesting term of 4 years. We estimate the forfeiture rate based on our historical experience, if any.

In addition, we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity investments issued as they vest over the performance period.

Fair Value

We apply fair value accounting to all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

Our financial instruments are stated at amounts that equal, or are intended to approximate, fair value. When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique. We use quoted valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

New Accounting Pronouncements

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard on our consolidated financial statements.

In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

37

TABLE OF CONTENTS

In November 2015, the FASB issued “Accounting Standards Update No. 2015-17—Income Taxes (Topic 740)”. Current GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, this Update requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. We do not expect the implementation of this ASU to have a material impact on our financial position or statement of operations.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, “Presentation of Financial Statements – Going Concern”, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The amendments in this ASU apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or results of operations.

In May 2014, the FASB issued ASU No. 2014-09 “Revenue from Contracts with Customers” (Topic 606). This ASU was subsequently amended by ASU No. 2016-10 and 2016-12. As amended, Topic 606 supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition” including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments create a new Subtopic 340-40, “Other Assets and Deferred Costs—Contracts with Customers”. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this update are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

Results of Operations (all amounts in this section are expressed in thousands)

Revenue

 
2016
2015
2014
Revenue
$
1,550
 
$
1,555
 
$
1,249
 

Revenue generated for the year ended December 31, 2016 was $1,550 compared to December 31, 2015 of $1,555, and December 31, 2014 revenue of approximately $1,249. Revenue for the year ended December 31, 2016 of $1,550, was largely attributable to the 2013 Contract Settlement described under the heading “Deferred Revenue” above. Under the terms of the 2013 Contract Settlement we were paid annual payments of $2,500 over the contract period for a total of $10,000. During the year ended December 31, 2016 we recognized $1,500 of revenue for royalties from the 2013 Contract Settlement and $50 of revenue for royalties from other licensees.

In addition to the settlement discussed above, during 2016, 2015 and 2014 we recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see Note 14 “Litigation”). These revenues relate to payment for use of our patented technology prior to the signing of a license agreement, and royalty payments after the execution of the license agreements. No amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales as no such amounts were requested or received.

38

TABLE OF CONTENTS

Research and Development Expenses

 
2016
2015
2014
Research and Development
$
2,499
 
$
2,277
 
$
2,004
 

Research and development costs include expenses paid to outside development consultants and compensation-related expenses for our engineering staff. Research and development costs are expensed as incurred.

Our research and development expenses for the year ended December 31, 2016 was $2,499 compared to December 31, 2015 of $2,227 and $2,004 for the year ended December 31, 2014. The increase in 2016 compared to 2015 was primarily due to the increase in staff, wages and bonuses. The increase in 2015 compared to 2014 was primarily due to increase in wages and bonuses paid in 2015 compared to 2014.

Selling, General and Administrative Expenses

 
2016
2015
2014
Selling, General and Administrative
$
26,672
 
$
23,190
 
$
28,310
 

Selling, general and administrative expenses include compensation expense for management and administrative personnel, as well as expenses for outside legal, accounting, and consulting services.

Our selling, general and administrative expenses for the year ended December 31, 2016 was $26,672 compared to December 31, 2015 of $23,190 and $28,310 for the year ended December 31, 2014. The increase in 2016 was primarily due to an increase in legal fees, mostly related to cases involving the defense of our patents. The decreases in 2015 were primarily due to the decrease in legal fees. Legal fees represent approximately 49% of general and administrative expenses for 2016 as compared to 42% for 2015 and 49% for 2014.

Within selling, general and administrative expenses, legal fees for the year ended December 31, 2016 were $13,002 compared to the year ended December 31, 2015 of $9,638 and $14,020 for the year ended December 31, 2014.

Also included in selling, general and administrative expense in 2016, 2015 and 2014 is royalty expense of $884 for the year ended December 31, 2016, $5,265 for the year ended December 31, 2015 and $6,100 for the year ended December 31, 2014, paid to Leidos, in connection with the settlement with Microsoft, Avaya and Mitel et al.

Gain on Settlement

 
2016
2015
2014
Gain on Settlement
$
 
$
 
$
(23,000
)

In December 2014, we received a $23,000 cash settlement resulting from litigation with Microsoft. In June 2010, we received a $200,000 cash settlement from litigation with Microsoft, in which we agreed to dismiss the pending lawsuits and any damages. The 2010 settlement agreement was amended in December 2014 to settle a subsequent lawsuit with Microsoft, raising the total cash settlement with Microsoft, as amended, to $223,000. In both the original settlement and the December 2014 amendment, we could not practically and objectively separate any settlement portion from the revenue element as discussed under the guidance of Accounting Standards Codification, or ASC, 605 and as a result, the settlement proceeds are classified as a gain on settlement in our statement of operations.

Other Income and Expenses

 
2016
2015
2014
Other Income and Expense
$
69
 
$
(49
)
$
2,278
 

Our non-cash gain (loss) related to the periodic revaluation of our Series I Warrants liability for the year ended December 31, 2015 was ($117) compared to $2,238 for the year ended December 31, 2014. During the year ended December 31, 2015 our Series I Warrants liability increased by $117 compared to a decrease in the value of our Series I Warrants liability for the year ended December 31, 2014. The increase in 2015 was due to the exercise of Series I Warrants and termination of Warrants. All outstanding Series 1 Warrants expired in March 2015.

Interest income for the year ended December 31, 2016 was $69, compared to December 31, 2015 of $68 and $40 for the year ended December 31, 2014. These changes are due to timing on the maturity of the investments as well as the amount of cash available for investments.

39

TABLE OF CONTENTS

Effective Income Tax Rate

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

 
Year Ended
December 31,2016
Year Ended
December 31,2015
Year Ended
December 31,2014
United States federal statutory rate
 
35.00
%
 
35.00
%
 
35.00
%
State taxes, net of federal benefit
 
(0.31
)%
 
(0.04
)%
 
(0.02
)%
Valuation allowance
 
(35.43
)%
 
(33.36
)%
 
(41.67
)%
Stock options
 
 
 
(1.62
)%
 
0.39
%
Prior year adjustment
 
(0.06
)%
 
0.03
%
 
(0.13
)%
R&D Credit
 
0.66
%
 
0.38
%
 
 
Warrants
 
 
 
(0.14
)%
 
7.92
%
Other
 
(0.33
)%
 
(0.29
)%
 
(1.64
)%
Effective income tax rate
 
(0.47
)%
 
(0.04
)%
 
(0.15
)%

In 2016, 2015 and 2014, we had pre-tax losses of $28, $29 and $10 million, respectively, which are available for carry forward to offset future taxable income. We made determinations to provide full valuation allowances for our net deferred tax assets at the end of 2016, 2015 and 2014, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax.

Liquidity and Capital Resources

For the year ended December 31, 2016, our cash and cash equivalents totaled $6,627 and our short-term investments totaled $9,249 compared to $8,726 and $9,954, respectively, for the year ended December 31, 2015.

We expect that our cash and cash equivalents and short-term investments as of December 31, 2016 will be sufficient to fund our current operations and provide working capital for general corporate purposes and legal expenses for the foreseeable future. We may undertake additional opportunities to seek to grow our business and as a result, we may seek to raise capital in some form within the next twelve months including the actions described below under “Universal Shelf Registration and ATM Offering”. Over the long term, we expect to derive the majority of our revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain name registry in the United States and other markets around the world.

Universal Shelf Registration and ATM Offering

In August 2015, we filed a universal shelf registration statement with the SEC enabling us to offer and sell from time to time up to $100 million of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC in August 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35 million. We have and expect to use proceeds from this offering for GABRIEL product development and marketing, and general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses. As of December 31, 2016, common stock with an aggregate value of up to $11,831 remains available for offer and sale under the ATM agreement.

We sold 4,760,594 and 835,056 shares of common stock under the ATM program during the years ended December 31, 2016 and 2015, respectively. The average sales price per common share sold during the year ended December 31, 2016 was $4.16 and the aggregate proceeds from the sales totaled $19,791 during the period. Sales commissions, fees and other costs associated with the ATM transactions totaled $594 for 2016. The average sales price per common share sold during the year ended December 31, 2015 was $4.04 and the aggregate proceeds from the sales totaled $3,378 during the period. Sales commissions, fees and other costs associated with the ATM totaled $101 for 2015.

40

TABLE OF CONTENTS

Contractual Commitments

 
Total
2017
Thereafter
Leases
$
46
 
$
46
 
$
 
Total
$
46
 
$
46
 
$
 

Off-Balance Sheet Arrangements

As of December 31, 2016, we had no off-balance sheet arrangements.

Item 7A.Quantitative and Qualitative Disclosures about Market Risk

We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities. By policy, we limit the amount of credit exposure to any one issuer.

Investments in fixed rate earning securities carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates. Due in part to these factors, our income from investments may decrease in the future.

We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points could be experienced in the near term but would have an immaterial impact in the fair value of our marketable securities as they will be maturing in six months or less.

The embedded liability in the Series I Warrant obligations was recorded at estimated fair value. That estimated fair value was determined in large part by reference to our assumptions and estimates of various factors. Notably, our liability increased and incurred significant non-cash expenses, all other factors being constant, when the market price of our common shares increased. Conversely, our liability decreased and we recognized significant non-cash gains, all other factors being constant, when the market price of our common shares decreased. All remaining outstanding Series I Warrants expired in March 2015.

41

TABLE OF CONTENTS

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
VirnetX Holding Corporation

We have audited the accompanying consolidated balance sheets of VirnetX Holding Corporation (the “Company”) as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2016. VirnetX Holding Corporation’s management is responsible for these consolidated financial statements. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of VirnetX Holding Corporation, Inc. as of December 31, 2016 and 2015, and the consolidated results of their operations, and cash flows for each of the three years in the period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), VirnetX Holding Corporation’s internal control over financial reporting as of December 31, 2016, based on criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 16, 2017 expressed an unqualified opinion as to the effectiveness of the Company’s control over financial reporting.

 
/s/ Farber Hass Hurley LLP
   
 
Chatsworth, California
March 16, 2017
 

43

TABLE OF CONTENTS

VIRNETX HOLDING CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)

 
As of
December 31, 2016
As of
December 31, 2015
ASSETS
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
$
6,627
 
$
8,726
 
Investments available for sale
 
9,249
 
 
9,954
 
Prepaid expenses and other current assets
 
588
 
 
685
 
Total current assets
 
16,464
 
 
19,365
 
Prepaid expenses, non-current
 
2,374
 
 
2,759
 
Property and equipment, net
 
33
 
 
48
 
Total assets
$
18,871
 
$
22,172
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
1,806
 
$
2,283
 
Accrued payroll and related expenses
 
1,522
 
 
1,383
 
Related-party payable
 
 
 
11
 
Income tax liability
 
396
 
 
400
 
Deferred revenue, current portion
 
1,500
 
 
1,500
 
Total current liabilities
 
5,224
 
 
5,577
 
 
 
 
 
 
 
 
Deferred revenue, non-current portion
 
2,500
 
 
1,500
 
Commitments and contingencies (Note 5)
 
 
 
 
Total liabilities
 
7,724
 
 
7,077
 
 
 
 
 
 
 
 
Stockholders’ equity:
 
 
 
 
 
 
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2016 and December 31, 2015, Issued and outstanding: 0 shares at December 31, 2016 and December 31, 2015
 
 
 
 
Common stock, par value $0.0001 per share
 
 
 
 
 
 
Authorized: 100,000,000 shares at December 31, 2016 and December 31, 2015, Issued and outstanding: 58,144,888 shares and 53,198,835 shares, at December 31, 2016 and December 31, 2015, respectively
 
6
 
 
5
 
Additional paid-in capital
 
169,391
 
 
144,778
 
Accumulated deficit
 
(158,238
)
 
(129,669
)
Accumulated other comprehensive loss
 
(12
)
 
(19
)
Total stockholders’ equity
 
11,147
 
 
15,095
 
Total liabilities and stockholders’ equity
$
18,871
 
$
22,172
 

See accompanying notes to consolidated financial statements.

44

TABLE OF CONTENTS

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Revenue
$
1,550
 
$
1,555
 
$
1,249
 
Operating expense:
 
 
 
 
 
 
 
 
 
Royalty expense
 
884
 
 
5,265
 
 
6,100
 
Research and development
 
2,499
 
 
2,277
 
 
2,004
 
Selling, general and administrative expenses
 
26,672
 
 
23,190
 
 
28,310
 
Gain of settlement (Note 3)
 
 
 
 
 
(23,000
)
Total operating expense
 
30,055
 
 
30,732
 
 
13,414
 
Loss from operations
 
(28,505
)
 
(29,177
)
 
(12,165
)
Gain (loss) on change in value of derivative liability
 
 
 
(117
)
 
2,238
 
Interest and other income, net
 
69
 
 
68
 
 
40
 
Loss before taxes
 
(28,436
)
 
(29,226
)
 
(9,887
)
Income tax expense
 
(133
)
 
(8
)
 
(15
)
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
Basic and diluted loss per share
$
(0.51
)
$
(0.56
)
$
(0.19
)
Weighted average shares outstanding basic and diluted
 
55,984,825
 
 
52,384,494
 
 
51,570,472
 

VIRNETX HOLDING CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(in thousands)

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
Other comprehensive gain (loss), net of tax:
 
 
 
 
 
 
 
 
 
Change in equity adjustment from foreign currency translation, net of tax
 
3
 
 
(1
)
 
 
Change in unrealized gain (loss) on investments, net of tax
 
4
 
 
(3
)
 
22
 
Total other comprehensive income (loss), net of tax
 
7
 
 
(4
)
 
22
 
Comprehensive loss
$
(28,562
)
$
(29,238
)
$
(9,880
)

See accompanying notes to consolidated financial statements.

45

TABLE OF CONTENTS

VirnetX Holding Corporation
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share amounts)

 
   
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Loss
Total
Stockholders'
Equity
(Deficit)
 
Shares
Amount
Balance at December 31, 2013
 
51,236,141
 
$
5
 
$
124,589
 
$
(90,533
)
$
(37
)
$
34,024
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock issued for cash exercise of warrants at $3.59 per share, net
 
2,500
 
 
 
 
 
9
 
 
 
 
 
 
 
 
9
 
Stock-based compensation
 
 
 
 
 
 
 
8,189
 
 
 
 
 
 
 
 
8,189
 
Exercise of options
 
679,321
 
 
 
 
 
278
 
 
 
 
 
 
 
 
278
 
Vested RSUs
 
78,739
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liability
 
 
 
 
 
 
 
7
 
 
 
 
 
 
 
 
7
 
Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 
 
 
 
 
 
 
 
 
 
(9,902
)
 
 
 
 
(9,902
)
Other comprehensive income, net of tax
 
 
 
 
 
 
 
 
 
 
 
 
 
22
 
 
22
 
Comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(9,880
)
Balance at December 31, 2014
 
51,996,701
 
$
5
 
$
133,072
 
$
(100,435
)
$
(15
)
$
32,627
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock issued for cash exercise of warrants at $3.59 per share, net
 
120,161
 
 
 
 
 
431
 
 
 
 
 
 
 
 
431
 
Stock issued for cash at $4.04 per share, net
 
835,056
 
 
 
 
 
3,276
 
 
 
 
 
 
 
 
3,276
 
Advisor warrant issuance
 
 
 
 
 
 
 
121
 
 
 
 
 
 
 
 
121
 
Stock-based compensation
 
 
 
 
 
 
 
7,275
 
 
 
 
 
 
 
 
7,275
 
Exercise of options
 
143,100
 
 
 
 
 
165
 
 
 
 
 
 
 
 
165
 
Vested RSUs
 
103,817
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative liability
 
 
 
 
 
 
 
438
 
 
 
 
 
 
 
 
438
 
Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 
 
 
 
 
 
 
 
 
 
(29,234
)
 
 
 
 
(29,234
)
Other comprehensive loss, net of tax
 
 
 
 
 
 
 
 
 
 
 
 
 
(4
)
 
(4
)
Comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(29,238
)
Balance at December 31, 2015
 
53,198,835
 
$
5
 
$
144,778
 
$
(129,669
)
$
(19
)
$
15,095
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock issued for cash at $3.00 -$5.05 per share, net
 
4,760,594
 
 
1
 
 
19,195
 
 
 
 
 
 
 
 
19,196
 
Stock-based compensation
 
 
 
 
 
 
 
5,398
 
 
 
 
 
 
 
 
5,398
 
Exercise of options
 
50,357
 
 
 
 
 
20
 
 
 
 
 
 
 
 
20
 
Vested RSUs
 
135,102
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 
 
 
 
 
 
 
 
 
 
(28,569
)
 
 
 
 
(28,569
)
Other comprehensive income, net of tax
 
 
 
 
 
 
 
 
 
 
 
 
 
7
 
 
7
 
Comprehensive loss
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(28,562
)
Balance at December 31, 2016
 
58,144,888
 
$
6
 
$
169,391
 
$
(158,238
)
$
(12
)
$
11,147
 

See accompanying notes to consolidated financial statements.

46

TABLE OF CONTENTS

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 
Twelve Months
Ended
December 31, 2016
Twelve Months
Ended
December 31, 2015
Twelve Months
Ended
December 31, 2014
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
 
 
 
 
 
 
 
 
 
Depreciation
 
28
 
 
26
 
 
25
 
Amortization of warrant issuance costs
 
30
 
 
91
 
 
 
Stock-based compensation
 
5,398
 
 
7,275
 
 
8,189
 
Change in value of derivative liability
 
 
 
117
 
 
(2,238
)
Changes in assets and liabilities:
 
 
 
 
 
 
 
 
 
Prepaid expenses and other current assets
 
66
 
 
(2
)
 
(296
)
Prepaid expense – Non-current
 
385
 
 
385
 
 
(3,144
)
Accounts payable and accrued liabilities
 
(477
)
 
(1,044
)
 
1,806
 
Accrued payroll and related expenses
 
139
 
 
1,156
 
 
 
Royalty payable
 
 
 
(6,100
)
 
6,100
 
Related-party payable
 
(11
)
 
(70
)
 
81
 
Income tax liability
 
(4
)
 
(8
)
 
13
 
Deferred revenue
 
1,000
 
 
1,000
 
 
1,333
 
Net cash (used in) provided by operating activities
 
(22,015
)
 
(26,408
)
 
1,967
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Purchase of property and equipment
 
(13
)
 
(10
)
 
(35
)
Purchase of investments
 
(10,527
)
 
(10,673
)
 
(45,500
)
Proceeds from sale or maturity of investments
 
11,240
 
 
23,287
 
 
42,766
 
Net cash (used in) provided by investing activities
 
700
 
 
12,604
 
 
(2,769
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from exercise of options
 
20
 
 
165
 
 
278
 
Proceeds from exercise of warrants
 
 
 
431
 
 
9
 
Proceeds from sale of common stock
 
19,196
 
 
3,276
 
 
 
Net cash provided by financing activities
 
19,216
 
 
3,872
 
 
287
 
Net decrease in cash and cash equivalents
 
(2,099
)
 
(9,932
)
 
(515
)
Cash and cash equivalents, beginning of period
 
8,726
 
 
18,658
 
 
19,173
 
Cash and cash equivalents, end of period
$
6,627
 
$
8,726
 
$
18,658
 
Cash paid for income taxes
$
126
 
$
6
 
$
2
 
Cash paid for interest
$
 
$
 
$
 
Non-cash transactions
 
 
 
 
 
 
 
 
 
Fair value of warrants issued for services
$
 
$
121
 
$
 

See accompanying notes to consolidated financial statements.

47

TABLE OF CONTENTS

VirnetX Holding Corporation
NOTES TO FINANCIAL STATEMENTS
(in thousands except share and per share amounts)

Note 1 − Formation and Business of the Company

VirnetX Holding Corporation, which we refer to as” we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Prior to 2012 our revenue was limited to an insignificant amount of software royalties pursuant to the terms of a single license agreement. During 2013 and 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement (see “Revenue Recognition”).

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 49 U.S. and 69 foreign patents with approximately 50 pending patent applications worldwide. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, M2M communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S and foreign patents and pending applications relates generally to securing communications over the internet and such covers all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, (f/k/a Science Applications International Corporation or SAIC) in 2006 and we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

Note 2 − Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include,

48

TABLE OF CONTENTS

without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, “Revenue Arrangements with Multiple Deliverables.” This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, including licenses entered upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, because delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.
Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.

49

TABLE OF CONTENTS

Deferred Revenue

In August 2013 we began receiving annual payments on a contract that requires payment to us over 4 years totaling $10,000 (“August 2013 Contract Settlement”). As of December 31, 2016, we received cash totaling $10,000, all of which is non-refundable. We recognized $1,500, $1,500 and $1,167 of revenue related to the August 2013 Contract Settlement during the years ended December 31, 2016, 2015 and 2014 respectively.

Activity under the August 2013 Contract Settlement was as follows:

 
2016
2015
2014
Deferred Revenue, beginning of year
$
3,000
 
$
2,000
 
$
667
 
Payment received
 
2,500
 
 
2,500
 
 
2,500
 
Less: Amount amortized as revenue
 
1,500
 
 
1,500
 
 
1,167
 
Deferred Revenue, end of year
$
4,000
 
$
3,000
 
$
2,000
 

Royalty Expense

Royalty expense for the years ended December 31, 2016, 2015 and 2014 was $884, $5,265 and $6,100, respectively and was a result of our royalty agreement with Leidos. The agreement provides for revenue sharing and legal reimbursements related to attorney time and expenses incurred by Leidos during discovery and other aspects of litigation matters that have been resolved.

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Prepaid Expenses and Other Current Assets

Prepaid Expense and Other Current Assets at December 31, 2016 includes the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. Beginning March 2014, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid Expenses-Non-current on the consolidated balance sheet.

Investments

Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized. Unrealized gains and losses on our investments are included in other comprehensive income. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. During the year ended December 31, 2016 and 2015, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

50

TABLE OF CONTENTS

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing if we will realize our deferred tax assets, we consider whether it is more likely than not that some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. Consistent with our policy, and because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP. The purpose of this method is to clarify accounting for uncertain tax positions recognized. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not

51

TABLE OF CONTENTS

threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates. We include interest and penalties, if any, in income tax expense. During the years ended December 31, 2016, 2015 and 2014, income tax expense included interest and penalties totaling $48, $0 and $11, respectively.

Derivative Instruments

Our Series I Warrants were accounted for as derivative instruments as a result of an anti-dilution provision which, in accordance with U.S. GAAP, prevented them from being considered indexed to our stock and qualified for an exception to derivative accounting. The balance of our Series I Warrants expired during the year ended December 31, 2015.

We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs net of the applicable forfeiture rate and recognize the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is generally the vesting term of 4 years. We estimate the forfeiture rate based on our historical experience if any. See Note 7 - Stock-Based Compensation for additional information concerning our share-based compensation awards.

In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.

Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during these periods.

Reclassifications

Certain prior year amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year’s presentation.

New Accounting Pronouncements

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

52

TABLE OF CONTENTS

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard on our consolidated financial statements.

In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In November 2015, the FASB issued “Accounting Standards Update No. 2015-17—Income Taxes (Topic 740)”. Current GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, this Update requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. We do not expect the implementation of this ASU to have a material impact on our financial position or statement of operations.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, “Presentation of Financial Statements – Going Concern”, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The amendments in this ASU apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or results of operations.

In May 2014, the FASB issued ASU No. 2014-09 “Revenue from Contracts with Customers” (Topic 606). This ASU was subsequently amended by ASU No. 2016-10 and 2016-12. As amended, Topic 606 supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition” including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments create a new Subtopic 340-40, “Other Assets and Deferred Costs—Contracts with Customers”. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

Note 3 − Gain on Settlement

In June 2010, we received a $200,000 cash settlement from litigation with Microsoft, in which we agreed to dismiss the pending lawsuits and any damages. In December 2014, we received a $23,000 cash settlement resulting from litigation with Microsoft. The 2010 settlement agreement was amended in December 2014 to settle a subsequent lawsuit with Microsoft, raising the total cash settlement with Microsoft, as amended, to $223,000. In both the original

53

TABLE OF CONTENTS

settlement and the December 2014 amendment, we could not practically and objectively separate any settlement portion from the revenue element as discussed under the guidance of Accounting Standards Codification, or ASC, 605, “Revenue Recognition”, and as a result, the settlement proceeds are classified as a gain on settlement in our consolidated statement of operations.

Note 4 − Property and Equipment

Our major classes of property and equipment were as follows:

 
December 31
 
2016
2015
2014
Office furniture
$
79
 
$
70
 
$
70
 
Computer equipment
 
172
 
 
168
 
 
157
 
Total
 
251
 
 
238
 
 
227
 
Less accumulated depreciation
 
(218
)
 
(190
)
 
(163
)
 
$
33
 
$
48
 
$
64
 

Depreciation expense for the years ended December 31, 2016, 2015 and 2014 was $28, $26 and $25, respectively.

Note 5 − Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2017. We recognize rent expense on a straight-line basis over the term of the lease. Rent expense was $56, for each of the years ended December 31, 2016, 2015 and 2014. Future minimum rents due under the lease total $46 in 2017, when the lease expires.

During 2016, 2015 and 2014 we leased the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company. We incurred approximately $772, $593 and $296 in rental fees (including fees and other reimbursements) to the LLC during the year ended December 31, 2016, 2015 and 2014, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. On January 31, 2015 we entered into a 12-month non-exclusive lease with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The lease renews on an annual basis unless terminated by the Lessor or Lessee. Neither party has yet exercised their termination rights.

Note 6 − Stock Plan

We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “Plan”), which has been approved by our stockholders. The 2013 Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the 2013 Plan. The 2013 Plan provides for the granting of stock options and restricted stock purchase rights (“RSU”) to our employees and consultants. Stock options granted under the 2013 Plan may be incentive stock options or nonqualified stock options. Incentive stock options (“ISO”) may only be granted to our employees (including officers and directors). Nonqualified stock options (“NSO”) and stock purchase rights may be granted to our employees and consultants.

The 2013 Plan will expire in 2023. Options may be granted under the 2013 Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO. The exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the 2013 Plan typically vest over four years and have a 10-year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years. At December 31, 2016 there were 421,221 shares available for grant under the 2013 Plan.

54

TABLE OF CONTENTS

Note 7 − Stock-Based Compensation

The following tables summarize information about stock-options and RSUs outstanding at December 31, 2016:

Options Outstanding
Options Vested and Exercisable
Range of
Exercise Prices
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
$   0.24-   1.58 
 
771,045
 
 
2.26
 
$
1.16
 
 
771,045
 
 
2.26
 
$
1.16
 
$   1.74-   6.95 
 
3,353,901
 
 
3.66
 
 
4.74
 
 
2,558,275
 
 
2.00
 
 
4.82
 
$ 14.52- 35.25 
 
1,253,625
 
 
5.71
 
 
23.16
 
 
1,142,873
 
 
5.56
 
 
23.73
 
 
 
5,378,571
 
 
3.94
 
$
8.52
 
 
4,472,193
 
 
2.96
 
$
9.02
 

The following tables summarize activity under the Plan for the indicated periods:

 
Options
 
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
Outstanding at December 31, 2013
 
4,976,849
 
$
7.86
 
 
 
 
 
Options granted
 
261,500
 
 
15.21
 
 
 
 
 
Options exercised
 
(679,321
)
 
0.41
 
 
 
 
 
Options cancelled
 
(70,000
)
 
13.38
 
 
 
 
 
Outstanding at December 31, 2014
 
4,489,028
 
$
9.33
 
 
 
 
 
Options granted
 
694,000
 
 
4.47
 
 
 
 
 
Options exercised
 
(143,100
)
 
1.15
 
 
 
 
 
Options cancelled
 
(40,000
)
 
25.61
 
 
 
 
 
Outstanding at December 31, 2015
 
4,999,928
 
$
8.76
 
 
 
 
 
Options granted
 
429,000
 
 
4.77
 
 
 
 
 
Options exercised
 
(50,357
)
 
0.40
 
 
 
 
 
Options cancelled
 
 
 
 
 
 
 
 
Outstanding at December 31, 2016
 
5,378,571
 
$
8.52
 
 
3.94
 
$
810
 
Options exercisable at December 31, 2016
 
4,472,193
 
$
9.02
 
 
2.96
 
$
810
 
 
RSUs
 
Number of
RSUs
Weighted
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
Outstanding at December 31, 2013
 
248,915
 
$
24.10
 
$
 
RSUs granted
 
154,332
 
 
15.30
 
 
 
RSUs vested
 
(88,686
)
 
24.08
 
 
 
RSUs cancelled
 
(4,167
)
 
24.13
 
 
 
Outstanding at December 31, 2014
 
310,394
 
$
19.74
 
$
 
RSUs granted
 
162,665
 
 
5.57
 
 
 
RSUs vested
 
(113,103
)
 
20.11
 
 
 
RSUs cancelled
 
 
 
 
 
 
Outstanding at December 31, 2015
 
359,956
 
$
13.22
 
$
 
RSUs granted
 
219,331
 
 
4.75
 
 
 
RSUs vested
 
(155,852
)
 
15.27
 
 
 
RSUs cancelled
 
 
 
 
 
 
Outstanding at December 31, 2016
 
423,435
 
$
8.08
 
$
 

55

TABLE OF CONTENTS

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2016, which was $2.20, and the exercise price of the options. For options exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise. We received cash proceeds of $20, $165 and $278 from stock options exercised in 2016, 2015 and 2014, respectively. The total intrinsic value of options exercised was $91, $203 and $3,575 during the years ended December 31, 2016, 2015 and 2014, respectively. For RSUs vested, the intrinsic value is the difference between market price and the vested price on the date of vest. The total intrinsic value of the RSUs vested was zero during the year ended December 31, 2016.

Stock-based compensation expense is included in general and administrative expense for each period as follows:

Stock-Based Compensation by Type of Award
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Employee stock options
$
3,436
 
$
4,939
 
$
5,951
 
RSUs
 
1,962
 
 
2,336
 
 
2,238
 
Total stock-based compensation expense
$
5,398
 
$
7,275
 
$
8,189
 

As of December 31, 2016, there was $3,805 of unrecognized stock-based compensation expense expected to be recognized related to unvested employee stock options and $2,462 of unrecognized stock-based compensation expense to be recognized related to unvested RSUs. These costs are expected to be recognized over a weighted-average period of 2.69 and 2.44 years, respectively.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Expected stock price volatility
79.6%
82%
88%
Risk-free interest rate
1.85%
2.12%
2.56%
Expected life term (in years)
6.03 years
6.07 years
6.0 years
Expected dividends
0%
0%
0%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $3.25, $3.17 and $11.26 per share during the years ended December 31, 2016, 2015 and 2014, respectively.

The expected life was determined using the simplified method outlined in ASC 718, “Compensation - Stock Compensation”, taking the average of the vesting term and the contractual term of the option. Expected volatility of the stock options was based upon historical data and other relevant factors, such as the volatility of comparable publicly-traded companies at a similar stage of life cycle. We have not provided an estimate for forfeitures because we have had nominal forfeited options and RSUs and believe that all outstanding options and RSUs at December 31, 2016, will vest. In the future, we may change this estimate based on actual and expected future forfeiture rates.

Note 8 − Earnings Per Share

Basic earnings per share are based on the weighted average number of shares outstanding for a period. Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock options, under our stock plan and warrants. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during those periods.

56

TABLE OF CONTENTS

The table below sets forth the basic and diluted loss per share calculations:

 
Year Ended December 31,
 
2016
2015
2014
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
Basic and diluted weighted average number of shares outstanding
 
55,985
 
 
52,384
 
 
51,570
 
Basic and diluted loss per share
$
(0.51
)
$
(0.56
)
$
(0.19
)

Note 9 − Common Stock

Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $.0001 par value common stock.

On August 21, 2015 we filed a universal shelf registration statement with the SEC enabling us to offer and sell from time to time up to $100 million of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35 million. As of December 31, 2016, common stock with an aggregate value of up to $11,831 remains available for offer and sale under the ATM agreement.

We sold 4,760,594 and 835,056 shares of common stock under the ATM program during the year ended December 31, 2016 and 2015, respectively. The average sales price per common share sold during the year ended December 31, 2016 was $4.16 and the aggregate proceeds from the sales totaled $19,791 during the period. Sales commissions, fees and other costs associated with the ATM transactions totaled $594 for 2016. The average sales price per common share sold during the year ended December 31, 2015 was $4.04 and the aggregate proceeds from the sales totaled $3,378 during the period. Sales commissions, fees and other costs associated with the ATM totaled $101 for 2015.

Note 10 − Equity

Warrants

During the year ended December 31, 2015 we issued warrants (“Advisor Warrants”) for the purchase of 25,000 shares of common stock for $7 per share, which expire in April 2020. The Advisor Warrants were issued for advisory services provided by a third party. Our Advisor Warrants were recorded at fair value on the issuance date and included in Additional Paid in Capital on our Consolidated Balance Sheet. The Advisor Warrants are exercisable by the holder, in whole or in part, until expiration, and may also be net-share-settled. Terms of the warrant agreement include no registration requirements for the underlying common stock and there are no anti-dilution provisions. The fair value at issuance of the warrants was recorded in Prepaid Expenses and Other Current Assets, and is being amortized over the twelve-month life of the service contract, with the expense included in Selling, General and Administrative Expense in our Consolidated Statements of Operations.

Information about the Advisor Warrants outstanding during the twelve months ended December 31, 2016 follows:

Original
Number of
Warrants
Issued
Exercise
Price per
Common
Share
Exercisable at
December 31,
2015
Became
Exercisable
Exercised
Terminated /
Cancelled /
Expired
Exercisable at
December 31,
2016
Expiration
Date
25,000
$7.00
25,000
25,000
April 2020

Note 11 − Employee Benefit Plan

We sponsor a defined contribution, 401k plan, covering substantially all our employees. Our matching contribution to the plan was approximately $90, $59 and $45 in 2016, 2015 and 2014, respectively.

57

TABLE OF CONTENTS

Note 12 − Income Taxes

The income tax provision is comprised of the following:

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Current:
 
 
 
 
 
 
 
 
 
Federal
$
 
$
10
 
$
(13
)
State
 
(133
)
 
(18
)
 
(2
)
Foreign
 
 
 
 
 
 
 
 
(133
)
 
(8
)
 
(15
)
Deferred:
 
 
 
 
 
 
 
 
 
Federal
 
 
 
 
 
 
State
 
 
 
 
 
 
Total income tax provision
$
(133
)
$
(8
)
$
(15
)

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
United States federal statutory rate
 
35.00
%
 
35.00
%
 
35.00
%
State taxes, net of federal benefit
 
(0.31
)%
 
(0.04
)%
 
(0.02
)%
Valuation allowance
 
(35.43
)%
 
(33.36
)%
 
(41.67
)%
Stock options
 
 
 
(1.62
)%
 
0.39
%
Prior year true-up
 
(0.06
)%
 
0.03
%
 
(0.13
)%
R&D Credit
 
0.66
%
 
0.38
%
 
 
Warrants
 
 
 
(0.14
)%
 
7.92
%
Other
 
(0.33
)%
 
(0.29
)%
 
(1.64
)%
Effective income tax rate
 
(0.47
)%
 
(0.04
)%
 
(0.15
)%

In 2016, 2015 and 2014, we had pre-tax losses of $28, $29 and $10 million, respectively, which are available for carry forward to offset future taxable income. We made determinations to provide full valuation allowances for our net deferred tax assets at the end of 2016, 2015 and 2014, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax assets.

Deferred tax assets (liabilities) consist of the following:

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Deferred tax assets:
 
 
 
 
 
 
Reserves and accruals
$
1,063
 
$
462
 
State tax
 
1
 
 
1
 
Research and development credits and other credits
 
1,092
 
 
908
 
Net operating loss carry forward
 
29,186
 
 
18,496
 
Stock based compensation
 
13,031
 
 
9,855
 
Other
 
88
 
 
102
 
Total deferred tax assets
 
44,461
 
 
29,824
 
 
 
 
 
 
 
 
Valuation allowance
 
(44,455
)
 
(29,814
)
Deferred tax assets after valuation allowance
 
6
 
 
10
 
 
 
 
 
 
 
 
Deferred tax liability:
 
 
 
 
 
 
Depreciation and amortization
 
(6
)
 
(10
)
 
 
 
 
 
 
 
Total deferred tax liability
 
(6
)
 
(10
)
 
 
 
 
 
 
 
Net deferred tax assets
$
 
$
 

58

TABLE OF CONTENTS

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.

Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at December 31, 2016 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at December 31, 2016. The net change in the total valuation allowance for the 12 months ended December 31, 2016 was an increase of $14,641. At December 31, 2016, we had federal and state net operating loss carry-forwards of approximately $74,728 and $58,079, respectively, expiring beginning in 2028 and 2017, respectively. At December 31, 2016, we had federal research and development credit carry-forwards of approximately $1,092 expiring beginning in 2031.

Internal Revenue Code Section 382 places a limitation (the “Section 382 Limitation”) on the amount of taxable income that can be offset by net operating loss carry forwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California the state in which our headquarters was once located has similar rules. Our capitalization described herein may have resulted in such a change. Generally, after a control change, a loss corporation cannot deduct net operating loss carry forwards generated in years prior to the deemed change of control under IRC Section 382 in excess of the Section 382 Limitation.

We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. As a result, we have provided contingent reserve under ASC 740-10 of $316 and $316 at December 31, 2016, and December 31, 2015, respectively. Our tax returns are subject to review by various tax authorities. The returns subject to review are those from 2005 forward.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We have accrued interest or penalties during the 12-month period ended December 31, 2016 in the amount of $5.

A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:

 
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Balance at the beginning of the year
$
316
 
$
316
 
$
316
 
Additions based on tax positions related to the current year
 
 
 
 
 
 
Additions for tax positions of prior years
 
 
 
 
 
 
Settlements
 
 
 
 
 
 
Lapse of applicable statute of limitations
 
 
 
 
 
 
Balance at the end of the year
$
316
 
$
316
 
$
316
 

Note 13 − Fair Value Measurement

We apply fair value accounting for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

The carrying amounts for cash and cash equivalents, investments in certificates of deposit, accounts payable and accrued expenses approximate their fair values due to the short period of time until maturity.

Mutual Funds: Valued at the quoted net asset value (NAV) of shares held.

59

TABLE OF CONTENTS

U.S. Government and U.S. Agency securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a Binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Consolidated Balance Sheet for December 31, 2014 were a warrant exercise price of $3.59 per share, a common share price of $5.49, a discount rate of 1.65%, and a volatility of 89.6%. The balance of the Series 1 Warrants expired in March 2015.

The following table shows our cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents of investments available for sale as of December 31, 2016 and 2015 (in thousands):

 
December 31, 2016
 
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash
and Cash
Equivalents
Investments
Available
for Sale
Cash
$
3,432
 
$
 
$
 
$
3,432
 
$
3,432
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds
 
3,195
 
 
 
 
 
 
3,195
 
 
3,195
 
 
 
U.S. government securities
 
1,254
 
 
 
 
 
 
1,254
 
 
 
 
1,254
 
U.S. agency securities
 
7,996
 
 
2
 
 
(3
)
 
7,995
 
 
 
 
7,995
 
 
 
12,445
 
 
2
 
 
(3
)
 
12,444
 
 
3,195
 
 
9,249
 
Total
$
15,877
 
$
2
 
$
(3
)
$
15,876
 
$
6,627
 
$
9,249
 
 
December 31, 2015
 
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash
and Cash
Equivalents
Investments
Available
for Sale
Cash
$
3,296
 
$
 
$
 
$
3,296
 
$
3,296
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds
 
5,005
 
 
 
 
 
 
5,005
 
 
5,005
 
 
 
U.S. government securities
 
1,806
 
 
 
 
(3
)
 
1,803
 
 
 
 
1,803
 
U.S. agency securities
 
8,579
 
 
1
 
 
(4
)
 
8,576
 
 
425
 
 
8,151
 
 
 
15,390
 
 
1
 
 
(7
)
 
15,384
 
 
5,430
 
 
9,954
 
Total
$
18,686
 
$
1
 
$
(7
)
$
18,680
 
$
8,726
 
$
9,954
 

The maturities of our marketable securities generally range from within one to two years. Actual maturities could differ from contractual maturities due to call or prepayment provisions.

The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2016, 2015 and 2014 (in thousands):

 
Fair Value Measurements Using Significant
Unobservable Inputs (Level 3)
 
Year ended
December 31, 2016
Year ended
December 31, 2015
Year ended
December 31, 2014
Beginning Balance
$
 
$
320
 
$
2,564
 
(Gain) losses included in net losses
 
 
 
117
 
 
(2,237
)
Settlements
 
 
 
(333
)
 
(7
)
Expiration of warrants
 
 
 
(104
)
 
 
Ending Balance
$
 
$
 
$
320
 

60

TABLE OF CONTENTS

Note 14 − Litigation

We have nine intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division, and United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)

On March 30, 2015, the United States Court for the Eastern District of Texas, Tyler Division, issued an order finding substantial overlap between the remanded portions of the Civil Action Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.), and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. The jury trial in this case was held on January 25, 2016. On February 4, 2016, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us $625.6 million in a verdict against Apple Inc. for infringing four of our US patents, marking it the second time a federal jury has found Apple liable for infringing VirnetX’s patented technology. The verdict includes royalties awarded to us based on an earlier patent infringement finding (Case 6:10-CV-00417-LED) against Apple. The jury found that Apple’s modified VPN On-Demand, iMessage and FaceTime services infringed VirnetX’s patents and that Apple’s infringement was willful. In addition to determining the royalty owed by Apple for its prior infringement, this verdict also includes an award based on the jury’s finding that Apple’s modified VPN On Demand, iMessage and FaceTime services have continued to infringe VirnetX’s patents. The post-trial hearing was held on May 25, 2016 in the United States Court for the Eastern District of Texas, Texarkana Division. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases (Case No. 6:10-cv-417, Docket No. 878 (“Apple I case”); Case No. 6:12-cv-855, Docket No. 220 (“Apple II case”)), ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II case will be retried after Apple I case. Events and developments subsequent to the order from the court are described to support Apple I and Apple II matters.

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra USA. Inc. (“Aastra”), Apple, Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and try only the case against Apple on the scheduled trial date. The jury trial of our case against Cisco was held on March 4, 2013. The jury in our case against Cisco came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents were denied and the case against Cisco was closed.

The jury trial of our case against Apple was held on October 31, 2012. On November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s

61

TABLE OF CONTENTS

September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. On December 16, 2014, USCAFC denied our petition requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision and remanded the case back to the Eastern District of Texas, Tyler Division, for further proceedings consistent with its opinion. On February 25, 2015, USCAFC granted Apple’s motions to lift stay of proceedings and vacate Case 6:13-CV-00211-LED. On March 30, 2015, the court issued an order finding substantial overlap between the remanded portions of this case and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case.

On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case.

The jury trial in this case was held on September 26, 2016. On September 30, 2016, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, in the case VirnetX Inc., et al. v. Apple Inc., No. Apple I, has awarded VirnetX $302.4 million in a verdict against Apple Corporation for infringing four VirnetX patents, marking the third time a federal jury has found Apple liable for infringing VirnetX’s patented technology.

The verdict includes royalties awarded to VirnetX, for unresolved issues in the Apple I case, remanded back from the USCAFC, related to (1) damages owed to VirnetX for infringement by Apple’s original VPN-on-Demand (VOD) and (2) the alleged infringement by Apple’s original FaceTime product, under the new claim construction of “secure communication link” pertaining to the ’504 and ’211 patents by the USCAFC, and the damages associated with that infringement. The hearing on all the post-trial motions was held on November 22, 2016. We are currently awaiting the court ruling and final judgement in this case.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

On November 6, 2012, we filed a new complaint against Apple in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case was scheduled for October 13, 2015. On March 30, 2015, the court issued an order finding substantial overlap between this case and the remanded portions of Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case. We are awaiting court order setting the date for a new jury trial in Apple II case.

VirnetX Inc. v. Apple, Inc. (Case 15-1934)

On July 10, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the United States Patent and Trademark Office, Patent Trial and Appeal Board (“PTAB”) in IPR2014-00237 and IPR2014-00238, related to U.S. Patent No. 8,504,697. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00238. We are currently evaluating our options in this case.

62

TABLE OF CONTENTS

VirnetX Inc. v. Apple, Inc. (Case 16-1211)

On September 28, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2014-00403 and IPR2014-00404 and on October 22, 2015 for IPR2014-00481 and IPR2014-00482 involving our U.S. Patent Nos. 7,188,180, and 7,987,274. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00403 and IPR2014-00481. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1480)

On November 30, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-partes reexamination no. 95/001,949 related to U.S. Patent No. 8,051,181. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on certain grounds. We are currently evaluating our options in this case.

VirnetX, Inc. v. Apple, Inc. (case 16-119)

On March 4, 2016, we filed a petition for writ of mandamus with the USCAFC, requesting the USCAFC’s intervention to revoke the PTAB’s decision joining Apple to IPR2015-01046 and IPR2015-01047, related to U.S. Patent Nos. 6,502,135 and 7,490,151. On March 18, 2016, the USCAFC denied the petition without prejudice to us raising the arguments on appeal after the PTAB’s final decisions. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 17-1131)

On October 31, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-00810, IPR2015-00812, on November 9, 2016 for IPR2015-00811, and on November 28, 2016 for IPR2015-00866, IPR2015-00868, IPR2015-00870, IPR2015-00871 involving our U.S. Patent Nos.8,868,705, 8,850,009, 8,458,341, 8,516,131, and 8,560,705. These appeals have been consolidated.

VirnetX Inc. v. The Mangrove Partners (Case 17-1368)

On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

Note 15 − Quarterly Financial Information (unaudited)

 
First
Second
Third
Fourth
 
(in thousands except per share)
2016
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
375
 
$
398
 
$
375
 
$
402
 
Loss from operations
 
(8,618
)
 
(5,353
)
 
(7,287
)
 
(7,247
)
Net loss
 
(8,610
)
 
(5,337
)
 
(7,387
)
 
(7,235
)
Basic earnings (loss) per common share
$
(0.16
)
$
(0.10
)
$
(0.13
)
$
(0.12
)
Diluted earnings (loss) per common share
$
(0.16
)
$
(0.10
)
$
(0.13
)
$
(0.12
)
 
First
Second
Third
Fourth
 
(in thousands except per share)
2015
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
375
 
$
400
 
$
375
 
$
405
 
Loss from operations
 
(5,759
)
 
(9,567
)
 
(6,102
)
 
(7,749
)
Net loss
 
(5,855
)
 
(9,546
)
 
(6,097
)
 
(7,736
)
Basic earnings (loss) per common share
$
(0.11
)
$
(0.18
)
$
(0.12
)
$
(0.15
)
Diluted earnings (loss) per common share
$
(0.11
)
$
(0.18
)
$
(0.12
)
$
(0.15
)

63

TABLE OF CONTENTS

Report of Independent Registered Public Accounting Firm

To the Board of Directors and
Stockholders of VirnetX Holding Corporation

We have audited the internal control over financial reporting of VirnetX Holding Corporation (the “Company”) as of December 31, 2016, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2016, based on the criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements as of and for the year ended December 31, 2016, of the Company and our report dated March 16, 2017, expressed an unqualified opinion on those financial statements.

/s/ Farber Hass Hurley LLP

Chatsworth, California
March 16, 2017

64

TABLE OF CONTENTS

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A.Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, December 31, 2016.

The purpose of this evaluation was to determine whether as of December 31, 2016 our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the SEC, (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2016, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal controls over financial reporting (as such term is defined in rules 13a-15 (f) under the Securities Exchange Act of 1934, as amended) during the fiscal year ended December 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures of Company assets are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2016. There were no changes in our internal control over financial reporting during the period ended December 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Farber Hass Hurley LLP has audited our internal control over financial reporting as of December 31, 2016; their report is included elsewhere herein.

Item 9B.Other Information.

None.

65

TABLE OF CONTENTS

PART III

Certain information required by Part III is omitted from this report and is incorporated by reference to our definitive proxy statement pursuant to Regulation 14A for our 2017 Annual Meeting of Stockholders (the “Definitive Proxy Statement”) which will be filed within 120 days of our fiscal year end.

Item 10.   Directors, Executive Officers and Corporate Governance.

The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the sections “Board of Directors,” “Nominee and Continuing Directors,” “Executive Officers,” “Composition of the Board of Directors,” “Board Meetings and Committees and Annual Meeting Attendance,” “Audit Committee Matters” and “Section 16(a) Beneficial Ownership Reporting Compliance.” Information regarding delinquent filers pursuant to Item 405 of Regulation S-K will be included under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” in our Proxy Statement for the 2017 Annual Meeting of Stockholders and is incorporated herein by reference.

Item 11.   Executive Compensation.

The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the sections “Compensation Committee Matters,” “Director Compensation,” “Executive Compensation,” “Compensation Committee Report,” “Summary Compensation Table,” “Outstanding Equity Awards at 2016 Fiscal Year-End,” and “Option Exercises in Fiscal Year 2016.”

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the section “Voting Securities and Principal Holders.”

Securities Authorized for Issuance Under the Equity Compensation Plans

We have a stock incentive plan for employees and others called the “VirnetX Holding Corporation 2013 Stock Plan”, or the Plan, which has been approved by our stockholders. The Plan provides for the granting of up to 14,124,469 shares of our common stock, including stock options and stock purchase rights, and will expire in 2023. As of December 31, 2016, there were 421,221 shares available to be granted under the Plan. We had 5,378,571 and 4,999,928 options outstanding at December 31, 2016, and December 31, 2015, respectively, with an average exercise price of $8.52 and $8.76, respectively. We had 423,435 and 359,956 restricted stock units outstanding at December 31, 2016 and December 31, 2015, respectively, with a weighted average grant price of $8.08 and $13.22 respectively.

Plan Category
Number of
Securities to be
Issued Upon
Exercise of
Outstanding
Options,
Warrants and
Rights
Weighted-Average
Exercise Price of
Outstanding
Options, Warrants
and Rights
Number of
Securities
Remaining
Available for
Future Issuance
Under Equity
Compensation
Plans
Equity compensation plans approved by security holders
 
5,827,006
 
$
8.48
 
 
421,221
 
Equity compensation plans not approved by security holders
 
 
 
 
 
 
 
Total
 
5,827,006
 
$
8.48
 
 
421,221
 

On April 25, and May 23, 2016 the Compensation Committee granted 100,000 options to Advisory members. On May 23, 2016, the Compensation Committee granted 291,500 options and 194,332 RSUs to the employees of VirnetX Inc. On June 2, 2016, the Compensation Committee granted 37,500 options and 24,999 RSUs to members of the Board of Directors of VirnetX, Inc.

Item 13.   Certain Relationships and Related Transactions, and Director Independence.

The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement under the sections “Transactions with Related Persons” and “Composition of Board of Directors.”

66

TABLE OF CONTENTS

Item 14.   Principal Accountant Fees and Services.

The information required by this item is incorporated by reference to the information set forth in the Definitive Proxy Statement for the 2016 Annual Meeting of Stockholders under “Principal Accountant Fees & Services.”

PART IV

Item 15.   Exhibits and Financial Statement Schedules.

(a)The following documents are filed as part of this Annual Report on Form
(1)Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K.
(2)Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto.
(3)Exhibits: See Exhibit Index immediately following the signature page of this Form 10-K.

67

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

 
VirnetX Holding Corporation
 
 
 
 
By:
/s/ Kendall Larsen
 
 
Name: Kendall Larsen
 
 
Title: Chief Executive Officer and President

Dated: March 16, 2017

68

TABLE OF CONTENTS

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kendall Larsen his or her attorney-in-fact, with full power of substitution, for him or her in any and all capacities, to sign any amendments to this Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his or her substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities indicated.

Name
Capacity
Date
 
 
 
/s/ Kendall Larsen
Director, Chief Executive Officer and President
March 16, 2017
Kendall Larsen
(Principal Executive Officer)
 
 
 
 
/s/ Richard H. Nance
Chief Financial Officer
March 16, 2017
Richard H. Nance
(Principal Financial Officer and
Principal Accounting Officer)
 
 
 
 
/s/ Robert D. Short III
Director
March 16, 2017
Robert D. Short III
 
 
 
 
 
/s/ Gary Feiner
Director
March 16, 2017
Gary Feiner
 
 
 
 
 
/s/ Michael F. Angelo
Director
March 16, 2017
Michael F. Angelo
 
 
 
 
 
/s/ Thomas M. O'Brien
Director
March 16, 2017
Thomas M. O’Brien
 
 

69

TABLE OF CONTENTS

EXHIBIT INDEX

Exhibit
Number
 
Incorporated by reference herein
Description
Form
Exhibit No.
Filing Date
File No.
3.1
Certificate of Incorporation of the Company.
8-K
3.1
11/01/2007
000-26895
3.2
By-Laws of the Company.
8-K
3.2
11/01/2007
000-26895
4.1
Form of Warrant Agency Agreement by and between the Company and Corporate Stock Transfer, Inc. as Warrant Agent.
S-1/A
4.1
01/16/2009
333-153645
4.2
Form of Series I Warrant.
8-K
4.1
09/03/2009
001-33852
4.3
Specimen Common Stock Certificate.
S-3
4.1
08/20/2015
333-206497
4.4
Form of Senior Indenture
S-3
4.2
08/20/2015
333-206497
4.5
Form of Subordinated Indenture
S-3
4.4
08/20/2015
333-206497
10.1
Form of Indemnification Agreement by and between the Company and each of Kendall Larsen, Robert D. Short III, Gary Feiner, Michael F. Angelo, Thomas M. O’Brien and Richard Nance.
8-K
10.3
07/12/2007
000-26895
10.2*
2007 Stock Plan, as amended on April 13, 2012.
10-Q
10.2
05/10/2012
001-33852
10.3*
Amended Form of Stock Option Agreement – 2007 Stock Plan.
10-Q
4.5
05/10/2011
001-33852
10.4*
Form of Restricted Stock Unit Award Agreement – 2007 Stock Plan.
10-Q
10.3
05/10/2012
001-33852
10.5*
2013 Equity Incentive Plan.
DEF 14A
Appendix A
04/12/2013
001-33852
10.6*
Form of Stock Option Agreement – 2013 Equity Incentive Plan.
10-K
10.6
03/02/2015
001-33852
10.7*
Form of Restricted Stock Unit Agreement – 2013 Equity Incentive Plan.
10-K
10.7
03/02/2015
001-33852
10.8
Voting Agreement among the Company and certain of its stockholders, dated as of December 12, 2007.
10-K
10.11
03/31/2008
001-33852
10.9
Securities Purchase Agreement, dated as of September 2, 2009, by and between the Company and the Purchasers (as defined therein).
8-K
10.1
09/03/2009
001-33852
10.10
Form of Registration Rights Agreement by and between the Company and the Purchasers (as defined therein).
8-K
10.2
09/03/2009
001-33852
10.11
Form of Underwriting Agreement between VirnetX Holding Corporation and Gilford Securities Incorporated.
S-1/A
1.1
01/16/2009
333-153645
10.12
Patent License and Assignment Agreement by and between the Company and Leidos, Inc. (formerly Science Applications International Corporation) dated as of August 12, 2005.
8-K
10.4
07/12/2007
000-26895

70

TABLE OF CONTENTS

Exhibit
Number
 
Incorporated by reference herein
Description
Form
Exhibit No.
Filing Date
File No.
10.13
Amendment No. 1 to Patent License and Assignment Agreement by and between the Company and Leidos, Inc. dated as of November 2, 2006.
8-K
10.6
07/12/2007
000-26895
10.14
Amendment No. 2 to Patent License and Assignment Agreement by and between VirnetX, Inc. and Leidos, Inc. dated as of March 12, 2008.
8-K
10.1
03/18/2008
001-33852
10.15
Security Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005.
8-K
10.5
07/12/2007
000-26895
10.16
Assignment Agreement between the Company and Leidos, Inc. dated as of December 21, 2006.
8-K
10.7
07/12/2007
000-26895
10.17
Professional Services Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005.
8-K
10.8
07/12/2007
000-26895
10.18
IP Brokerage Agreement by and between ipCapital Group, Inc. and VirnetX, Inc., effective as of March 13, 2008.
8-K
10.2
03/18/2008
001-33852
10.19
Engagement Letter by and between VirnetX Holding Corporation and ipCapital Group, Inc. dated March 12, 2008.
8-K
10.3
03/18/2008
001-33852
10.20**
Engagement Letter dated June 8, 2009, by and between McKool Smith, a professional corporation, and VirnetX, Inc.
10-Q
10.1
08/10/2009
001-33852
10.21**
Engagement Letter dated April 15, 2010, by and between McKool Smith, a professional corporation, and VirnetX, Inc.
10-Q
10.1
05/07/2010
001-33852
10.22**
Settlement and License Agreement, by and between Microsoft Corporation and VirnetX, Inc., dated May 14, 2010.
10-Q/A
10.1
01/31/2011
000-33852
10.23***
Amended Settlement and License Agreement, by and between Microsoft Corporation and VirnetX, Inc., dated December 17, 2014.
10-K
10.23
03/02/2015
001-33852
10.24*
Employment Offer Letter from VirnetX, Inc. to Richard H. Nance.
10-Q
10.4
05/10/2012
001-33852
10.25
Patent Licensing Representative Agreement, by and between IPValue Management, Inc. and VirnetX, Inc., dated May 8, 2015.
10-Q
10.1
05/11/2015
001-33852

71

TABLE OF CONTENTS

Exhibit
Number
 
Incorporated by reference herein
Description
Form
Exhibit No.
Filing Date
File No.
21.1
Subsidiaries of VirnetX Holding Corporation.
 
 
 
 
23.1
Consent of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm.
 
 
 
 
31.1
Chief Executive Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
 
 
 
 
31.2
Chief Financial Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act.
 
 
 
 
32.1†
Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
 
 
32.2†
Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
101.INS
XBRL Instance Document
 
 
 
 
101.SCH
XBRL Taxonomy Extension Schema Document
 
 
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
 
*Indicates management contract or compensatory plan.
**Confidential treatment has been granted by the U.S. Securities and Exchange Commission as to certain portions of this Exhibit.
***Portions of this Exhibit have been omitted pending a determination by the Securities and Exchange Commission as to whether these portions should be granted confidential treatment.
The certifications attached as Exhibit 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act of 1933, as amended, or the Securities Act of 1934, as amended, whether before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.

72

EX-21.1 2 h10042025x1_ex21-1.htm EXHIBIT 21.1

EXHIBIT 21.1

Subsidiaries of Registrant

Name of Entity
Jurisdiction of
Incorporation or
Organization
Network Research Corporation Japan Ltd. (known as Network Research Corporation Japan Kabushiki Kaisha in Japan)
Japan
VirnetX Inc.
Delaware

EX-23.1 3 h10042025x1_ex23-1.htm EXHIBIT 23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-149884, 333-153645 and 333-162145) and Form S-8 (No. 333-149883) of our reports dated March 16, 2017, relating to the consolidated financial statements of VirnetX Holding Corporation (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2016.

/s/ Farber Hass Hurley LLP

Chatsworth, CA

March 16, 2017

EX-31.1 4 h10042025x1_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Kendall Larsen, certify that:

1.I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2016;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
(Principal Executive Officer)

Date: March 16, 2017

EX-31.2 5 h10042025x1_ex31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Richard H. Nance, certify that:

1.I have reviewed this Annual Report on Form 10-K of VirnetX Holding Corporation for the fiscal year ended December 31, 2016;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Richard H. Nance
 
Richard H. Nance
 
Chief Financial Officer
(Principal Accounting and Financial Officer)

Date: March 16, 2017

EX-32.1 6 h10042025x1_ex32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2016 as filed with the Securities and Exchange Commission on March 16, 2017 (the “Report”), I, Kendall Larsen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
(Principal Executive Officer)

Date: March 16, 2017

EX-32.2 7 h10042025x1_ex32-2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of VirnetX Holding Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2016 as filed with the Securities and Exchange Commission on March 16, 2017 (the “Report”), I, Richard Nance, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
/s/ Richard H. Nance
 
Richard H. Nance
 
Chief Financial Officer
(Principal Accounting and Financial Officer)

Date: March 16, 2017

EX-101.INS 8 vhc-20161231.xml XBRL INSTANCE FILE 0001082324 2016-01-01 2016-12-31 0001082324 2016-06-30 0001082324 2017-03-10 0001082324 2016-12-31 0001082324 2015-12-31 0001082324 2015-01-01 2015-12-31 0001082324 2014-01-01 2014-12-31 0001082324 2013-12-31 0001082324 us-gaap:CommonStockMember 2013-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001082324 us-gaap:RetainedEarningsMember 2013-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0001082324 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0001082324 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001082324 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001082324 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0001082324 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0001082324 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0001082324 us-gaap:CommonStockMember 2016-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001082324 us-gaap:RetainedEarningsMember 2016-12-31 0001082324 us-gaap:CommonStockMember 2015-12-31 0001082324 us-gaap:RetainedEarningsMember 2014-12-31 0001082324 2014-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001082324 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001082324 us-gaap:RetainedEarningsMember 2015-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001082324 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001082324 us-gaap:CommonStockMember 2014-12-31 0001082324 us-gaap:MinimumMember 2016-12-31 0001082324 us-gaap:MaximumMember 2016-12-31 0001082324 us-gaap:GeographicDistributionForeignMember us-gaap:PatentsMember 2016-12-31 0001082324 country:US us-gaap:PatentsMember 2016-12-31 0001082324 us-gaap:RoyaltyAgreementsMember 2016-01-01 2016-12-31 0001082324 us-gaap:RoyaltyAgreementsMember 2016-12-31 0001082324 2014-03-31 0001082324 us-gaap:DebtSecuritiesMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001082324 us-gaap:MaximumMember 2016-01-01 2016-12-31 0001082324 us-gaap:MinimumMember 2016-01-01 2016-12-31 0001082324 2010-06-01 2014-12-31 0001082324 2010-06-01 2010-06-30 0001082324 2014-12-01 2014-12-31 0001082324 us-gaap:OfficeEquipmentMember 2014-12-31 0001082324 us-gaap:ComputerEquipmentMember 2015-12-31 0001082324 us-gaap:ComputerEquipmentMember 2016-12-31 0001082324 us-gaap:OfficeEquipmentMember 2016-12-31 0001082324 us-gaap:ComputerEquipmentMember 2014-12-31 0001082324 us-gaap:OfficeEquipmentMember 2015-12-31 0001082324 us-gaap:BuildingMember 2016-01-01 2016-12-31 0001082324 vhc:K2InvestmentFundLLCMember us-gaap:AirTransportationEquipmentMember 2016-01-01 2016-12-31 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2014-01-01 2014-12-31 0001082324 us-gaap:AirTransportationEquipmentMember vhc:K2InvestmentFundLLCMember 2015-01-01 2015-12-31 0001082324 vhc:Plan2013Member 2016-12-31 0001082324 vhc:Plan2013Member us-gaap:MinimumMember us-gaap:EmployeeStockOptionMember us-gaap:InvestorMember 2016-01-01 2016-12-31 0001082324 us-gaap:MinimumMember vhc:Plan2013Member us-gaap:EmployeeStockOptionMember us-gaap:ExecutiveOfficerMember 2016-01-01 2016-12-31 0001082324 vhc:Plan2013Member us-gaap:MinimumMember vhc:NonqualifiedStockOptionsMember 2016-01-01 2016-12-31 0001082324 us-gaap:MinimumMember vhc:Plan2013Member vhc:IncentiveStockOptionsMember 2016-01-01 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:Plan2013Member 2016-01-01 2016-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember vhc:Plan2013Member 2016-01-01 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange2Member 2016-01-01 2016-12-31 0001082324 vhc:ExercisePriceRange3Member us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001082324 vhc:ExercisePriceRange1Member us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember vhc:ExercisePriceRange2Member 2016-12-31 0001082324 vhc:ExercisePriceRange3Member us-gaap:EmployeeStockOptionMember 2016-12-31 0001082324 vhc:ExercisePriceRange1Member us-gaap:EmployeeStockOptionMember 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2013-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2014-12-31 0001082324 us-gaap:EmployeeStockOptionMember 2015-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2013-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2014-01-01 2014-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember 2014-12-31 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-12-31 0001082324 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-12-31 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-12-31 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-12-31 0001082324 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-12-31 0001082324 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-12-31 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-12-31 0001082324 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-12-31 0001082324 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-12-31 0001082324 vhc:UniversalShelfRegistrationStatementMember 2015-08-21 0001082324 vhc:ATMAgreementMember 2015-08-20 0001082324 vhc:ATMAgreementMember 2016-12-31 0001082324 vhc:ATMAgreementMember 2015-01-01 2015-12-31 0001082324 vhc:ATMAgreementMember 2016-01-01 2016-12-31 0001082324 vhc:AdvisorWarrantsMember 2016-01-01 2016-12-31 0001082324 us-gaap:WarrantMember vhc:AdvisorWarrantsMember 2016-12-31 0001082324 us-gaap:WarrantMember vhc:AdvisorWarrantsMember 2015-12-31 0001082324 vhc:AdvisorWarrantsMember us-gaap:WarrantMember 2016-01-01 2016-12-31 0001082324 us-gaap:StateAndLocalJurisdictionMember 2016-12-31 0001082324 us-gaap:DomesticCountryMember 2016-12-31 0001082324 us-gaap:StateAndLocalJurisdictionMember 2016-01-01 2016-12-31 0001082324 us-gaap:DomesticCountryMember 2016-01-01 2016-12-31 0001082324 us-gaap:ResearchMember us-gaap:DomesticCountryMember 2016-12-31 0001082324 us-gaap:ResearchMember us-gaap:DomesticCountryMember 2016-01-01 2016-12-31 0001082324 vhc:SeriesIWarrantsMember 2014-12-31 0001082324 vhc:SeriesIWarrantsMember 2014-01-01 2014-12-31 0001082324 us-gaap:CashMember 2016-12-31 0001082324 us-gaap:CashMember 2015-12-31 0001082324 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2015-12-31 0001082324 us-gaap:USGovernmentDebtSecuritiesMember 2016-12-31 0001082324 us-gaap:MutualFundMember 2016-12-31 0001082324 us-gaap:USGovernmentDebtSecuritiesMember 2015-12-31 0001082324 us-gaap:MutualFundMember 2015-12-31 0001082324 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2016-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member 2015-12-31 0001082324 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-12-31 0001082324 us-gaap:CashMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentDebtSecuritiesMember 2016-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CashMember 2016-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentDebtSecuritiesMember 2015-12-31 0001082324 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:MutualFundMember 2016-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2013-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2014-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2014-01-01 2014-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2015-01-01 2015-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2016-12-31 0001082324 us-gaap:PositiveOutcomeOfLitigationMember 2016-12-31 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember 2015-03-30 2015-03-30 0001082324 vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember us-gaap:PositiveOutcomeOfLitigationMember 2015-03-30 2015-03-30 0001082324 us-gaap:PositiveOutcomeOfLitigationMember vhc:VirnetXIncVAppleIncCase612CV00855LEDMember 2015-03-30 2015-03-30 0001082324 vhc:VirnetXIncVAppleIncCase612CV00855LEDMember us-gaap:PositiveOutcomeOfLitigationMember 2016-02-04 2016-02-04 0001082324 vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember us-gaap:PositiveOutcomeOfLitigationMember 2016-09-30 2016-09-30 0001082324 vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember us-gaap:PositiveOutcomeOfLitigationMember 2012-11-06 2012-11-06 0001082324 vhc:VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember us-gaap:PositiveOutcomeOfLitigationMember 2012-11-06 2012-11-06 0001082324 vhc:VirnetXIncVAppleIncCase612CV00855LEDAppleIIMember us-gaap:PositiveOutcomeOfLitigationMember 2016-07-29 2016-07-29 0001082324 vhc:VirnetXIncVAppleIncCase612CV00855LEDMember us-gaap:PositiveOutcomeOfLitigationMember 2016-07-29 2016-07-29 0001082324 vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember us-gaap:PositiveOutcomeOfLitigationMember 2016-07-29 2016-07-29 0001082324 vhc:VirnetXIncVCiscoSystemsIncEtAlCase610CV00417LEDAppleIMember us-gaap:PositiveOutcomeOfLitigationMember 2013-02-26 2013-02-26 0001082324 2016-10-01 2016-12-31 0001082324 2015-04-01 2015-06-30 0001082324 2015-01-01 2015-03-31 0001082324 2016-04-01 2016-06-30 0001082324 2016-07-01 2016-09-30 0001082324 2016-01-01 2016-03-31 0001082324 2015-07-01 2015-09-30 0001082324 2015-10-01 2015-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares vhc:Patent vhc:Institution xbrli:pure vhc:Vote vhc:Lawsuit vhc:Action vhc:Case false --12-31 2016-12-31 No No Yes Accelerated Filer 225740380 VirnetX Holding Corp 0001082324 58144888 2016 FY 10-K 1806000 2283000 400000 396000 218000 163000 190000 -12000 -19000 144778000 169391000 438000 7000 438000 7000 8189000 8189000 7275000 5398000 5398000 7275000 772000 296000 593000 5398000 8189000 7275000 7275000 4939000 5398000 8189000 2238000 5951000 2336000 1962000 3436000 22172000 18871000 19365000 16464000 7995000 1254000 1803000 8576000 5005000 3195000 15384000 12444000 9954000 1803000 9954000 0 9249000 1254000 7995000 8151000 0 9249000 0 2000 0 2000 1000 1000 0 0 0 3000 4000 0 3000 7000 0 3000 12445000 8579000 1254000 3195000 1806000 5005000 7996000 15390000 9249000 9954000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 2 &#8722; Summary of Significant Accounting Policies</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Use of Estimates</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;). In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Basis of Consolidation</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Revenue Recognition</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (&#8220;FASB&#8221;) revenue recognition guidance, &#8220;Revenue Arrangements with Multiple Deliverables.&#8221; This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;"><i>Patent License Agreements</i>: Upon signing a patent license agreement, including licenses entered upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</p><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Consideration for Past Sales</i>: Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, because delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</td></tr></table><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Current Royalty Payments</i>: Ongoing royalty payments cover a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</td></tr></table><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Non-Refundable Up-Front Fees and Minimum Fee Contracts</i>: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.</td></tr></table><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Non-Royalty Elements</i>: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.</td></tr></table><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;"><i><b>Deferred </b></i><i><b>R</b></i><i><b>evenue</b></i></p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In August 2013 we began receiving annual payments on a contract that requires payment to us over 4 years totaling $10,000 (&#8220;August 2013 Contract Settlement&#8221;). As of December 31, 2016, we received cash totaling $10,000, all of which is non-refundable. We recognized $1,500, $1,500 and $1,167 of revenue related to the August 2013 Contract Settlement during the years ended December 31, 2016, 2015 and 2014 respectively.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Activity under the August 2013 Contract Settlement was as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 8px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 8px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Deferred Revenue, beginning of year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">667</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Payment received</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Less: Amount amortized as revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,167</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Deferred Revenue, end of year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">4,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">3,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Royalty Expense</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Royalty expense for the years ended December 31, 2016, 2015 and 2014 was $884, $5,265 and $6,100, respectively and was a result of our royalty agreement with Leidos. The agreement provides for revenue sharing and legal reimbursements related to attorney time and expenses incurred by Leidos during discovery and other aspects of litigation matters that have been resolved.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Cash and Cash Equivalents</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Prepaid Expenses and Other Current Assets</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Prepaid Expense and Other Current Assets at December 31, 2016 includes the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. Beginning March 2014, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid Expenses-Non-current on the consolidated balance sheet.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Investments</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized. Unrealized gains and losses on our investments are included in other comprehensive income. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Property and Equipment</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Property and equipment are stated at historical cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Concentration of Credit Risk and Other Risks and Uncertainties</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. During the year ended December 31, 2016 and 2015, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Fair Value</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Intangible Assets</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Impairment of Long-Lived Assets</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Research and Development</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Income Taxes</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing if we will realize our deferred tax assets, we consider whether it is more likely than not that some portion of the deferred tax assets will not be realized.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. Consistent with our policy, and because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We account for our uncertain tax positions in accordance with U.S. GAAP. The purpose of this method is to clarify accounting for uncertain tax positions recognized. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates. We include interest and penalties, if any, in income tax expense. During the years ended December 31, 2016, 2015 and 2014, income tax expense included interest and penalties totaling $48, $0 and $11, respectively.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Derivative Instruments</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Our Series I Warrants were accounted for as derivative instruments as a result of an anti-dilution provision which, in accordance with U.S. GAAP, prevented them from being considered indexed to our stock and qualified for an exception to derivative accounting. The balance of our Series I Warrants expired during the year ended December 31, 2015.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Stock-Based Compensation</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs net of the applicable forfeiture rate and recognize the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is generally the vesting term of 4 years. We estimate the forfeiture rate based on our historical experience if any. See Note 7 - Stock-Based Compensation for additional information concerning our share-based compensation awards.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Earnings per Share</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during these periods.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Reclassifications</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Certain prior year amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year&#8217;s presentation.</p><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">New Accounting Pronouncements</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In August 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In June 2016, the FASB issued ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In March 2016, the FASB issued ASU No. 2016-09, Compensation &#8211; Stock Compensation (Topic 718) (&#8220;ASU 2016-09&#8221;), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard on our consolidated financial statements.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In November 2015, the FASB issued &#8220;<i>Accounting Standards Update No. 2015-17&#8212;Income Taxes (Topic 740)&#8221;.</i> Current GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, this Update requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. We do not expect the implementation of this ASU to have a material impact on our financial position or statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In August 2014, the FASB issued Accounting Standards Update No. 2014-15, &#8220;<i>Presentation of Financial Statements </i><i>&#8211; Going Concern&#8221;</i>, Subtopic 205-40, &#8220;<i>Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going </i><i>Concern.&#8221;</i> The amendments in this ASU apply to all entities and require management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term<i> substantial doubt,</i> (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or results of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In May 2014, the FASB issued ASU No. 2014-09 &#8220;<i>Revenue from Contracts with Customers</i>&#8221; (Topic 606). This ASU was subsequently amended by ASU No. 2016-10 and 2016-12. As amended, Topic 606 supersedes the revenue recognition requirements in Topic 605,<i> &#8220;Revenue Recognition&#8221;</i> including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments create a new Subtopic 340-40,<i> &#8220;Other Assets and Deferred Costs&#8212;Contracts with Customers&#8221;.</i> In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.</p></div> 6627000 8726000 18658000 19173000 3432000 3296000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Cash and Cash Equivalents</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.</p></div> 3296000 3432000 425000 0 3195000 3296000 0 6627000 5430000 3432000 5005000 8726000 0 3195000 25000 3.59 3.59 7.00 3.59 0 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 5 &#8722; Commitments and Related Party Transactions</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We lease our offices under an operating lease with a third party expiring in October 2017. We recognize rent expense on a straight-line basis over the term of the lease. Rent expense was $56, for each of the years ended December 31, 2016, 2015 and 2014. Future minimum rents due under the lease total $46 in 2017, when the lease expires. </p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">During 2016, 2015 and 2014 we leased the use of an aircraft from K2 Investment Fund LLC (&#8220;LLC&#8221;) for business travel for employees of the Company. We incurred approximately $772, $593 and $296 in rental fees (including fees and other reimbursements) to the LLC during the year ended December 31, 2016, 2015 and 2014, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. On January 31, 2015 we entered into a 12-month non-exclusive lease with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days&#8217; notice. The lease renews on an annual basis unless terminated by the Lessor or Lessee. Neither party has yet exercised their termination rights.</p></div> 58144888 53198835 Each share of common stock has the right to one vote 100000000 100000000 6000 5000 0.0001 0.0001 53198835 58144888 -9880000 -28562000 -29238000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Concentration of Credit Risk and Other Risks and Uncertainties</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. During the year ended December 31, 2016 and 2015, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Basis of Consolidation</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.</p></div> 133000 8000 15000 0 0 0 133000 2000 18000 13000 -10000 0 1167000 1500000 1500000 1000 1000 0 0 0 2500000 2500000 2500000 1500000 1500000 3000000 2000000 667000 4000000 2500000 1500000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Activity under the August 2013 Contract Settlement was as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 8px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 8px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Deferred Revenue, beginning of year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">667</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Payment received</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Less: Amount amortized as revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,167</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Deferred Revenue, end of year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">4,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">3,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> 6000 10000 10000 6000 18496000 29186000 29824000 44461000 0 0 0 0 0 13031000 9855000 1063000 462000 1092000 908000 88000 102000 6000 10000 44455000 29814000 59000 45000 90000 28000 25000 26000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Derivative Instruments</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Our Series I Warrants were accounted for as derivative instruments as a result of an anti-dilution provision which, in accordance with U.S. GAAP, prevented them from being considered indexed to our stock and qualified for an exception to derivative accounting. The balance of our Series I Warrants expired during the year ended December 31, 2015.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 7 &#8722; Stock-Based Compensation</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The following tables summarize information about stock-options and RSUs outstanding at December 31, 2016:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="center" colspan="10" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; font-weight: bold; padding-left: 0px; padding-right: 8px;">Options Outstanding</div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">Options Vested and Exercisable</div></td></tr><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 0px; padding-right: 8px;"><b>Range of<br /></b><b>Exercise Prices</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 19%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Number<br /></b><b>Outstanding</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Remaining<br /></b><b>Contractual<br /></b><b>Life (Years)</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Exercise<br /></b><b>Price</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Number<br /></b><b>Exercisable</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Remaining<br /></b><b>Contractual<br /></b><b>Life (Years)</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 0px;"><b>Weighted<br /></b><b>Average<br /></b><b>Exercise<br /></b><b>Price</b></div></td></tr><tr style="background-color: #cceeff;"><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">$&#160;&#8201;&#8201;0.24-&#8201;&#8201;&#8201;1.58&#8201;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">771,045</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.26</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">771,045</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.26</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">$&#160;&#8201;&#8201;1.74-&#8201;&#8201;&#8201;6.95&#8201;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,353,901</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3.66</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.74</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,558,275</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.82</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; padding-bottom: 1px; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">$&#160;14.52-&#8201;35.25&#8201;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,253,625</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5.71</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">23.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,142,873</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5.56</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">23.73</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,378,571</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3.94</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">8.52</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,472,193</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.96</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">9.02</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The following tables summarize activity under the Plan for the indicated periods:</p><div><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;"></div></td><td align="center" colspan="12" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 7px; padding-right: 0px;">Options</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 7px;"><b>Number of<br /></b><b>Shares</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 7px;"><b>Weighted<br /></b><b>Average<br /></b><b>Exercise<br /></b><b>Price</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 7px;"><b>Weighted<br /></b><b>Average<br /></b><b>Remaining<br /></b><b>Contractual<br /></b><b>Life (Years)</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 0px;"><b>Aggregate<br /></b><b>Intrinsic<br /></b><b>Value</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2013</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,976,849</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">7.86</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">261,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">15.21</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercised</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(679,321</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.41</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(70,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">13.38</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2014</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,489,028</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">9.33</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">694,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.47</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercised</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(143,100</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(40,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">25.61</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2015</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,999,928</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">8.76</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">429,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.77</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercised</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(50,357</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.40</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2016</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5,378,571</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8.52</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">3.94</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">810</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercisable at December 31, 2016</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">4,472,193</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">9.02</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2.96</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">810</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div><div>&#160;</div><div><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">RSUs</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Number of<br /></b><b>RSUs </b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Grant Date<br /></b><b>Fair Value </b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 8px; padding-right: 0px;"><b>Aggregate<br /></b><b>Intrinsic<br /></b><b>Value </b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2013</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">248,915</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">24.10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">154,332</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">15.30</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs vested</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(88,686</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">24.08</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(4,167</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">24.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2014</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">310,394</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">19.74</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">162,665</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5.57</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs vested</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(113,103</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">20.11</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2015</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">359,956</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">13.22</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">219,331</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.75</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs vested</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(155,852</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">15.27</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2016</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">423,435</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">8.08</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2016, which was $2.20, and the exercise price of the options. For options exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise. We received cash proceeds of $20, $165 and $278 from stock options exercised in 2016, 2015 and 2014, respectively. The total intrinsic value of options exercised was $91, $203 and $3,575 during the years ended December 31, 2016, 2015 and 2014, respectively. For RSUs vested, the intrinsic value is the difference between market price and the vested price on the date of vest. The total intrinsic value of the RSUs vested was zero during the year ended December 31, 2016.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Stock-based compensation expense is included in general and administrative expense for each period as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 0px; padding-right: 4px;">Stock-Based Compensation by Type of Award</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Employee stock options</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,436</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,939</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,951</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">RSUs</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,962</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2,336</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2,238</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total stock-based compensation expense</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">5,398</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">7,275</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">8,189</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">As of December 31, 2016, there was $3,805 of unrecognized stock-based compensation expense expected to be recognized related to unvested employee stock options and $2,462 of unrecognized stock-based compensation expense to be recognized related to unvested RSUs. These costs are expected to be recognized over a weighted-average period of 2.69 and 2.44 years, respectively.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expected stock price volatility</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">79.6%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">82%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">88%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Risk-free interest rate</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">1.85%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">2.12%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">2.56%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expected life term (in years)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">6.03 years</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">6.07 years</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">6.0 years</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expected dividends</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">0%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">0%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">0%</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $3.25, $3.17 and $11.26 per share during the years ended December 31, 2016, 2015 and 2014, respectively.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The expected life was determined using the simplified method outlined in ASC 718,<i> &#8220;Compensation - Stock </i><i>Compensation&#8221;,</i> taking the average of the vesting term and the contractual term of the option. Expected volatility of the stock options was based upon historical data and other relevant factors, such as the volatility of comparable publicly-traded companies at a similar stage of life cycle. We have not provided an estimate for forfeitures because we have had nominal forfeited options and RSUs and believe that all outstanding options and RSUs at December 31, 2016, will vest. In the future, we may change this estimate based on actual and expected future forfeiture rates.</p></div> 11000 0 -0.51 -0.19 -0.56 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Earnings per Share</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during these periods.</p></div> -0.18 -0.13 -0.11 -0.12 -0.12 -0.15 -0.16 -0.10 -0.11 -0.12 -0.18 -0.15 -0.12 -0.16 -0.10 -0.13 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 8 &#8722; Earnings Per Share</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Basic earnings per share are based on the weighted average number of shares outstanding for a period. Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock options, under our stock plan and warrants. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during those periods.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The table below sets forth the basic and diluted loss per share calculations:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 0px;">Year Ended December 31,</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 13px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 13px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;">Net loss</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(28,569</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(29,234</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(9,902</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 13px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: -13px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;">Basic and diluted weighted average number of shares outstanding</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">55,985</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">52,384</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">51,570</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;">Basic and diluted loss per share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.51</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.56</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.19</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr></table></div> 0.35 0.35 0.35 -0.0031 -0.0004 -0.0002 -0.0162 0 0.0039 0 0.0038 0.0066 -0.0033 -0.0029 -0.0164 -0.4167 -0.3336 -0.3543 -0.0015 -0.0004 -0.0047 1383000 1522000 P2Y5M8D P2Y8M8D 2462000 3805000 0.0165 0.896 2564000 0 320000 0 7000 333000 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 13 &#8722; Fair Value Measurement</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We apply fair value accounting for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 4%; margin-right: 0px; text-indent: 0px;">Level 1 &#8211; Quoted prices in active markets for identical assets or liabilities.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 4%; line-height: 16px; margin-right: 0px; text-indent: 0px;">Level 2 &#8211; Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 4%; line-height: 16px; margin-right: 0px; text-indent: 0px;">Level 3 &#8211; Inputs that are generally unobservable and typically reflect management&#8217;s estimate of assumptions that market participants would use in pricing the asset or liability.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The carrying amounts for cash and cash equivalents, investments in certificates of deposit, accounts payable and accrued expenses approximate their fair values due to the short period of time until maturity.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 4%; margin-right: 0px; text-indent: 0px;"><i>Mutual Funds</i>: Valued at the quoted net asset value (NAV) of shares held.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 4%; line-height: 16px; margin-right: 0px; text-indent: 0px;"><i>U.S. Government and U.S. Agency securities</i>: Fair value measured at the closing price reported on the active market on which the individual securities are traded.</p><p class="para" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 26px;"><i>Series I Warrants</i>: Fair value measured by using a Binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Consolidated Balance Sheet for December 31, 2014 were a warrant exercise price of $3.59 per share, a common share price of $5.49, a discount rate of 1.65%, and a volatility of 89.6%. The balance of the Series 1 Warrants expired in March 2015.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The following table shows our cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents of investments available for sale as of December 31, 2016 and 2015 (in thousands):</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="18" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 3px; padding-right: 0px;">December 31, 2016</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Adjusted<br /></b><b>Cost</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Gains</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Losses</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Fair<br /></b><b>Value</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Cash<br /></b><b>and Cash<br /></b><b>Equivalents</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 0px;"><b>Investments<br /></b><b>Available<br /></b><b>for Sale</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Cash</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,432</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,432</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,432</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Level 1:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Mutual funds</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. government securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,254</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,254</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,254</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. agency securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">7,996</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">7,995</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">7,995</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">12,445</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">12,444</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">9,249</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Total</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">15,877</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">15,876</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">6,627</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">9,249</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="18" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 3px; padding-right: 0px;">December 31, 2015</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Adjusted<br /></b><b>Cost</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Gains</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Losses</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Fair<br /></b><b>Value</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Cash<br /></b><b>and Cash<br /></b><b>Equivalents</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 0px;"><b>Investments<br /></b><b>Available<br /></b><b>for Sale</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Cash</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,296</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,296</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,296</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Level 1:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Mutual funds</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,005</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,005</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,005</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. government securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,806</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,803</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,803</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. agency securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8,579</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(4</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8,576</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">425</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8,151</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">15,390</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(7</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">15,384</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5,430</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">9,954</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Total</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">18,686</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(7</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">18,680</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">8,726</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">9,954</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The maturities of our marketable securities generally range from within one to two years. Actual maturities could differ from contractual maturities due to call or prepayment provisions.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2016, 2015 and 2014 (in thousands):</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Fair Value Measurements Using Significant<br /></b><b>Unobservable Inputs (Level 3)</b></div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Beginning Balance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">320</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,564</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">(Gain) losses included in net losses</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">117</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(2,237</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Settlements</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(333</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expiration of warrants</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(104</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Ending Balance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">320</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Fair Value</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The following table shows our cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents of investments available for sale as of December 31, 2016 and 2015 (in thousands):</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="18" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 3px; padding-right: 0px;">December 31, 2016</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Adjusted<br /></b><b>Cost</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Gains</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Losses</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Fair<br /></b><b>Value</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Cash<br /></b><b>and Cash<br /></b><b>Equivalents</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 0px;"><b>Investments<br /></b><b>Available<br /></b><b>for Sale</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Cash</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,432</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,432</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,432</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Level 1:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Mutual funds</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. government securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,254</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,254</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,254</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. agency securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">7,996</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">7,995</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">7,995</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">12,445</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">12,444</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">3,195</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">9,249</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Total</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">15,877</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">15,876</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">6,627</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">9,249</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="18" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 3px; padding-right: 0px;">December 31, 2015</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Adjusted<br /></b><b>Cost</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Gains</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Unrealized<br /></b><b>Losses</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Fair<br /></b><b>Value</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 3px;"><b>Cash<br /></b><b>and Cash<br /></b><b>Equivalents</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 3px; padding-right: 0px;"><b>Investments<br /></b><b>Available<br /></b><b>for Sale</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Cash</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,296</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,296</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,296</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Level 1:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Mutual funds</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,005</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,005</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,005</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. government securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,806</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(3</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,803</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,803</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">U.S. agency securities</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8,579</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(4</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8,576</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">425</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8,151</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">15,390</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(7</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">15,384</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5,430</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">9,954</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 38%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 3px;">Total</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">18,686</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 7%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(7</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 6%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">18,680</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">8,726</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">9,954</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2016, 2015 and 2014 (in thousands):</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Fair Value Measurements Using Significant<br /></b><b>Unobservable Inputs (Level 3)</b></div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Beginning Balance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">320</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,564</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">(Gain) losses included in net losses</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">117</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(2,237</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Settlements</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(333</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expiration of warrants</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(104</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Ending Balance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">320</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> 2237000 0 -117000 P3Y P15Y 4 4 4 4 23000000 0 0 223000000 200000000 23000000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Intangible Assets</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Impairment of Long-Lived Assets</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</p></div> -9887000 -28436000 -29226000 11000 48000 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 12 &#8722; Income Taxes</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The income tax provision is comprised of the following:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Current:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Federal</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(133</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(18</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Foreign</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(133</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(8</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Federal</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total income tax provision</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(133</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(8</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; margin-right: 0px; text-indent: 0px;">A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">United States federal statutory rate</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">35.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">35.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">35.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State taxes, net of federal benefit</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.31</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.04</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.02</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Valuation allowance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(35.43</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(33.36</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(41.67</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Stock options</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(1.62</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.39</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Prior year true-up</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.06</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.03</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">R&amp;D Credit</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.66</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.38</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Warrants</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.14</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">7.92</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Other</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(0.33</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(0.29</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(1.64</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Effective income tax rate</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(0.47</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(0.04</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(0.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)%</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In 2016, 2015 and 2014, we had pre-tax losses of $28, $29 and $10 million, respectively, which are available for carry forward to offset future taxable income. We made determinations to provide full valuation allowances for our net deferred tax assets at the end of 2016, 2015 and 2014, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax assets. </p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Deferred tax assets (liabilities) consist of the following:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred tax assets:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Reserves and accruals</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,063</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">462</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State tax</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Research and development credits and other credits</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,092</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">908</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Net operating loss carry forward</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">29,186</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">18,496</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Stock based compensation</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">13,031</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">9,855</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Other</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">88</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">102</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total deferred tax assets</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">44,461</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">29,824</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Valuation allowance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(44,455</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(29,814</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred tax assets after valuation allowance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">6</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred tax liability:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Depreciation and amortization</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(6</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total deferred tax liability</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(6</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Net deferred tax assets</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at December 31, 2016 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at December 31, 2016. The net change in the total valuation allowance for the 12 months ended December 31, 2016 was an increase of $14,641. At December 31, 2016, we had federal and state net operating loss carry-forwards of approximately $74,728 and $58,079, respectively, expiring beginning in 2028 and 2017, respectively. At December 31, 2016, we had federal research and development credit carry-forwards of approximately $1,092 expiring beginning in 2031.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Internal Revenue Code Section 382 places a limitation (the &#8220;Section 382 Limitation&#8221;) on the amount of taxable income that can be offset by net operating loss carry forwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California the state in which our headquarters was once located has similar rules. Our capitalization described herein may have resulted in such a change. Generally, after a control change, a loss corporation cannot deduct net operating loss carry forwards generated in years prior to the deemed change of control under IRC Section 382 in excess of the Section 382 Limitation.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. As a result, we have provided contingent reserve under ASC 740-10 of $316 and $316 at December 31, 2016, and December 31, 2015, respectively. Our tax returns are subject to review by various tax authorities. The returns subject to review are those from 2005 forward.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We have accrued interest or penalties during the 12-month period ended December 31, 2016 in the amount of $5. </p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 2px; padding-right: 2px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 2px; padding-right: 2px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 2px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Balance at the beginning of the year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Additions based on tax positions related to the current year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Additions for tax positions of prior years</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Settlements</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Lapse of applicable statute of limitations</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Balance at the end of the year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> 15000 8000 133000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Income Taxes</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing if we will realize our deferred tax assets, we consider whether it is more likely than not that some portion of the deferred tax assets will not be realized.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. Consistent with our policy, and because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We account for our uncertain tax positions in accordance with U.S. GAAP. The purpose of this method is to clarify accounting for uncertain tax positions recognized. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates. We include interest and penalties, if any, in income tax expense. During the years ended December 31, 2016, 2015 and 2014, income tax expense included interest and penalties totaling $48, $0 and $11, respectively.</p></div> 2000 126000 6000 -8000 13000 -4000 1806000 -477000 -1044000 1333000 1000000 1000000 -70000 81000 -11000 1156000 139000 0 6100000 0 -6100000 2000 -66000 296000 0 0 0 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Investments</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized. Unrealized gains and losses on our investments are included in other comprehensive income. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.</p></div> 0 0 121000 P10Y P12M 2017-10-31 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 14 &#8722; Litigation</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We have nine intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division, and United States Court of Appeals for the Federal Circuit (&#8220;USCAFC&#8221;).</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On March 30, 2015, the United States Court for the Eastern District of Texas, Tyler Division, issued an order finding substantial overlap between the remanded portions of the Civil Action Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.), and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. The jury trial in this case was held on January 25, 2016. On February 4, 2016, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us $625.6 million in a verdict against Apple Inc. for infringing four of our US patents, marking it the second time a federal jury has found Apple liable for infringing VirnetX&#8217;s patented technology. The verdict includes royalties awarded to us based on an earlier patent infringement finding<b> (Case 6:10-CV-00417-LED)</b> against Apple. The jury found that Apple&#8217;s modified VPN On-Demand, iMessage and FaceTime services infringed VirnetX&#8217;s patents and that Apple&#8217;s infringement was willful. In addition to determining the royalty owed by Apple for its prior infringement, this verdict also includes an award based on the jury&#8217;s finding that Apple&#8217;s modified VPN On Demand, iMessage and FaceTime services have continued to infringe VirnetX&#8217;s patents. The post-trial hearing was held on May 25, 2016 in the United States Court for the Eastern District of Texas, Texarkana Division. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases (Case No. 6:10-cv-417, Docket No. 878 (&#8220;Apple I case&#8221;); Case No. 6:12-cv-855, Docket No. 220 (&#8220;Apple II case&#8221;)), ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II case will be retried after Apple I case. Events and developments subsequent to the order from the court are described to support Apple I and Apple II matters.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (&#8220;Apple I&#8221;)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra USA. Inc. (&#8220;Aastra&#8221;), Apple, Cisco Systems, Inc. (&#8220;Cisco&#8221;), and NEC Corporation (&#8220;NEC&#8221;) in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and try only the case against Apple on the scheduled trial date. The jury trial of our case against Cisco was held on March 4, 2013. The jury in our case against Cisco came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco&#8217;s infringement of certain VirnetX patents were denied and the case against Cisco was closed.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The jury trial of our case against Apple was held on October 31, 2012. On November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple&#8217;s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple&#8217;s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple&#8217;s motion to alter or amend the judgment to the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury&#8217;s finding that all 4 of our patents are valid, confirming the jury&#8217;s finding of infringement of VPN on Demand under many of the asserted claims of our &#8216;135 and &#8216;151 patents, and confirming the district&#8217;s court&#8217;s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury&#8217;s damages award and the district court&#8217;s claim construction with respect to parts of our &#8216;504 and &#8216;211 patents and remanded the damages award and determination of infringement with respect to FaceTime &#8211;for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit&#8217;s September 14, 2014, decision concerning VirnetX&#8217;s litigation against Apple Inc. On December 16, 2014, USCAFC denied our petition requesting a rehearing and rehearing en banc of the Federal Circuit&#8217;s September 14, 2014, decision and remanded the case back to the Eastern District of Texas, Tyler Division, for further proceedings consistent with its opinion. On February 25, 2015, USCAFC granted Apple&#8217;s motions to lift stay of proceedings and vacate Case 6:13-CV-00211-LED. On March 30, 2015, the court issued an order finding substantial overlap between the remanded portions of this case and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The jury trial in this case was held on September 26, 2016. On September 30, 2016, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, in the case VirnetX Inc., et al. v. Apple Inc., No. Apple I, has awarded VirnetX $302.4 million in a verdict against Apple Corporation for infringing four VirnetX patents, marking the third time a federal jury has found Apple liable for infringing VirnetX&#8217;s patented technology.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The verdict includes royalties awarded to VirnetX, for unresolved issues in the Apple I case, remanded back from the USCAFC, related to (1) damages owed to VirnetX for infringement by Apple&#8217;s original VPN-on-Demand (VOD) and (2) the alleged infringement by Apple&#8217;s original FaceTime product, under the new claim construction of &#8220;secure communication link&#8221; pertaining to the &#8217;504 and &#8217;211 patents by the USCAFC, and the damages associated with that infringement. The hearing on all the post-trial motions was held on November 22, 2016. We are currently awaiting the court ruling and final judgement in this case.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (&#8220;Apple II&#8221;)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On November 6, 2012, we filed a new complaint against Apple in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple&#8217;s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple&#8217;s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case was scheduled for October 13, 2015. On March 30, 2015, the court issued an order finding substantial overlap between this case and the remanded portions of Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case. We are awaiting court order setting the date for a new jury trial in Apple II case.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Apple, Inc. (Case 15-1934)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On July 10, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the United States Patent and Trademark Office, Patent Trial and Appeal Board (&#8220;PTAB&#8221;) in IPR2014-00237 and IPR2014-00238, related to U.S. Patent No. 8,504,697. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00238. We are currently evaluating our options in this case.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Apple, Inc. (Case 16-1211)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On September 28, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2014-00403 and IPR2014-00404 and on October 22, 2015 for IPR2014-00481 and IPR2014-00482 involving our U.S. Patent Nos. 7,188,180, and 7,987,274. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00403 and IPR2014-00481. We are currently evaluating our options in this case.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Apple, Inc. (Case 16-1480)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On November 30, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-partes reexamination no. 95/001,949 related to U.S. Patent No. 8,051,181. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on certain grounds. We are currently evaluating our options in this case.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX, Inc. v. Apple, Inc. (case 16-119)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On March 4, 2016, we filed a petition for writ of mandamus with the USCAFC, requesting the USCAFC&#8217;s intervention to revoke the PTAB&#8217;s decision joining Apple to IPR2015-01046 and IPR2015-01047, related to U.S. Patent Nos. 6,502,135 and 7,490,151. On March 18, 2016, the USCAFC denied the petition without prejudice to us raising the arguments on appeal after the PTAB&#8217;s final decisions. We are currently evaluating our options in this case. </p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. Apple, Inc. (Case 17-1131)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On October 31, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-00810, IPR2015-00812, on November 9, 2016 for IPR2015-00811, and on November 28, 2016 for IPR2015-00866, IPR2015-00868, IPR2015-00870, IPR2015-00871 involving our U.S. Patent Nos.8,868,705, 8,850,009, 8,458,341, 8,516,131, and 8,560,705. These appeals have been consolidated.</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">VirnetX Inc. v. The Mangrove Partners (Case 17-1368)</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.</p></div> 7077000 7724000 22172000 18871000 5224000 5577000 625600000 302400000 368000000 9 700000 12604000 -2769000 19216000 3872000 287000 1967000 -26408000 -22015000 -515000 -9932000 -2099000 -29234000 -28569000 -9902000 -9902000 -29234000 -28569000 -7736000 -6097000 -5855000 -8610000 -7235000 -7387000 -5337000 -9546000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">New Accounting Pronouncements</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In August 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In June 2016, the FASB issued ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In March 2016, the FASB issued ASU No. 2016-09, Compensation &#8211; Stock Compensation (Topic 718) (&#8220;ASU 2016-09&#8221;), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard on our consolidated financial statements.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In November 2015, the FASB issued &#8220;<i>Accounting Standards Update No. 2015-17&#8212;Income Taxes (Topic 740)&#8221;.</i> Current GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, this Update requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. We do not expect the implementation of this ASU to have a material impact on our financial position or statement of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In August 2014, the FASB issued Accounting Standards Update No. 2014-15, &#8220;<i>Presentation of Financial Statements </i><i>&#8211; Going Concern&#8221;</i>, Subtopic 205-40, &#8220;<i>Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going </i><i>Concern.&#8221;</i> The amendments in this ASU apply to all entities and require management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term<i> substantial doubt,</i> (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or results of operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In May 2014, the FASB issued ASU No. 2014-09 &#8220;<i>Revenue from Contracts with Customers</i>&#8221; (Topic 606). This ASU was subsequently amended by ASU No. 2016-10 and 2016-12. As amended, Topic 606 supersedes the revenue recognition requirements in Topic 605,<i> &#8220;Revenue Recognition&#8221;</i> including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments create a new Subtopic 340-40,<i> &#8220;Other Assets and Deferred Costs&#8212;Contracts with Customers&#8221;.</i> In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.</p></div> 30732000 30055000 13414000 46000 56000 56000 56000 10000000 29000000 28000000 58079000 74728000 -12165000 -29177000 -28505000 -6102000 -5759000 -7749000 -8618000 -9567000 -7287000 -7247000 -5353000 2016-12-31 2027-12-31 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 1 &#8722; Formation and Business of the Company</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">VirnetX Holding Corporation, which we refer to as&#8221; we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, &#8220;the Company&#8221; or &#8220;VirnetX&#8221;, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology&#8482;, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Prior to 2012 our revenue was limited to an insignificant amount of software royalties pursuant to the terms of a single license agreement. During 2013 and 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement (see &#8220;Revenue Recognition&#8221;).</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 49 U.S. and 69 foreign patents with approximately 50 pending patent applications worldwide. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, M2M communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S and foreign patents and pending applications relates generally to securing communications over the internet and such covers all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, (f/k/a Science Applications International Corporation or SAIC) in 2006 and we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.</p></div> -3000 22000 4000 -1000 3000 0 69000 40000 68000 -4000 22000 7000 -4000 22000 7000 45500000 10673000 10527000 35000 10000 13000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 11 &#8722; Employee Benefit Plan</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We sponsor a defined contribution, 401k plan, covering substantially all our employees. Our matching contribution to the plan was approximately $90, $59 and $45 in 2016, 2015 and 2014, respectively.</p></div> 0 0 10000000 10000000 0.0001 0.0001 0 0 0 0 588000 685000 4000000 2759000 2374000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Reclassifications</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Certain prior year amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year&#8217;s presentation.</p></div> 9000 431000 0 19196000 3276000 0 11240000 23287000 42766000 20000 165000 278000 165000 278000 20000 P7Y P5Y <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Property and Equipment</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Property and equipment are stated at historical cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Our major classes of property and equipment were as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">December 31</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Office furniture</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">79</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">70</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">70</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Computer equipment</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">172</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">168</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">157</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Total</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">251</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">238</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">227</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Less accumulated depreciation</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(218</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(190</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(163</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">33</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">48</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">64</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> 48000 33000 64000 251000 70000 168000 172000 79000 157000 238000 70000 227000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 4 &#8722; Property and Equipment</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Our major classes of property and equipment were as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">December 31</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Office furniture</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">79</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">70</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">70</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Computer equipment</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">172</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">168</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">157</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Total</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">251</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">238</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">227</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Less accumulated depreciation</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(218</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(190</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(163</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">33</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">48</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">64</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Depreciation expense for the years ended December 31, 2016, 2015 and 2014 was $28, $26 and $25, respectively.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 15 &#8722; Quarterly Financial Information (unaudited)</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">First</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Second</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Third</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">Fourth</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="12" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 9px; padding-right: 0px;">(in thousands except per share)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 0px; padding-right: 9px;">2016<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">398</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">402</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Loss from operations</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(8,618</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,353</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,287</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,247</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Net loss</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(8,610</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,337</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,387</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,235</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Basic earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Diluted earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr></table><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">First</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Second</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Third</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">Fourth</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="12" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 9px; padding-right: 0px;">(in thousands except per share)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 0px; padding-right: 9px;">2015<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">400</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">405</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Loss from operations</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,759</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(9,567</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(6,102</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,749</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Net loss</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,855</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(9,546</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(6,097</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,736</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Basic earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.11</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.18</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Diluted earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.11</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.18</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr></table></div> 2004000 2499000 2277000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Research and Development</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.</p></div> -158238000 -129669000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;"><i><b>Deferred </b></i><i><b>R</b></i><i><b>evenue</b></i></p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In August 2013 we began receiving annual payments on a contract that requires payment to us over 4 years totaling $10,000 (&#8220;August 2013 Contract Settlement&#8221;). As of December 31, 2016, we received cash totaling $10,000, all of which is non-refundable. We recognized $1,500, $1,500 and $1,167 of revenue related to the August 2013 Contract Settlement during the years ended December 31, 2016, 2015 and 2014 respectively.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Activity under the August 2013 Contract Settlement was as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 8px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 8px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Deferred Revenue, beginning of year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">667</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Payment received</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Less: Amount amortized as revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,167</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Deferred Revenue, end of year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">4,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">3,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Revenue Recognition</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (&#8220;FASB&#8221;) revenue recognition guidance, &#8220;Revenue Arrangements with Multiple Deliverables.&#8221; This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;"><i>Patent License Agreements</i>: Upon signing a patent license agreement, including licenses entered upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</p><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Consideration for Past Sales</i>: Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, because delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</td></tr></table><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Current Royalty Payments</i>: Ongoing royalty payments cover a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</td></tr></table><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Non-Refundable Up-Front Fees and Minimum Fee Contracts</i>: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.</td></tr></table><table cellpadding="0" cellspacing="0" class="group-list" style="width: 100%; padding-bottom: 0px; padding-top: 0px; margin-top: 0px;"><tr style="font-size: 13px; font-family: Times New Roman, Times, Serif; vertical-align: top; color: #000000;"><td class="group-filler" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000;"></td><td class="group-list" style="font-size: 13px; font-family: Times New Roman, Times, Serif; width: 26px; vertical-align: top; color: #000000; text-align: left;">&#8226;</td><td class="group-item" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify;"><i>Non-Royalty Elements</i>: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.</td></tr></table></div> 5265000 884000 6100000 1555000 1249000 1550000 402000 400000 375000 398000 375000 375000 375000 405000 810000 P5Y8M16D P2Y3M4D P3Y7M28D P3Y11M8D P2Y3M4D P5Y6M22D P2Y P2Y11M16D 4.82 23.73 9.02 1.16 P10Y P3Y11M8D P2Y11M16D 0 0 0 0 P6Y0M25D P6Y0M11D P6Y 0 1.16 23.16 4.74 8.52 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Stock-based compensation expense is included in general and administrative expense for each period as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 0px; padding-right: 4px;">Stock-Based Compensation by Type of Award</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Employee stock options</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,436</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,939</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,951</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">RSUs</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,962</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2,336</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">2,238</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total stock-based compensation expense</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">5,398</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">7,275</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">8,189</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The income tax provision is comprised of the following:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Current:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Federal</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(133</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(18</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(2</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Foreign</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(133</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(8</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Federal</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total income tax provision</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(133</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(8</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Deferred tax assets (liabilities) consist of the following:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred tax assets:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Reserves and accruals</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,063</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">462</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State tax</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Research and development credits and other credits</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1,092</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">908</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Net operating loss carry forward</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">29,186</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">18,496</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Stock based compensation</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">13,031</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">9,855</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Other</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">88</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">102</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total deferred tax assets</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">44,461</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">29,824</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Valuation allowance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(44,455</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(29,814</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred tax assets after valuation allowance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">6</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Deferred tax liability:<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Depreciation and amortization</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(6</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Total deferred tax liability</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(6</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 67%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Net deferred tax assets</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The following tables summarize activity under the Plan for the indicated periods:</p><div><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;"></div></td><td align="center" colspan="12" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 7px; padding-right: 0px;">Options</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 7px;"><b>Number of<br /></b><b>Shares</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 7px;"><b>Weighted<br /></b><b>Average<br /></b><b>Exercise<br /></b><b>Price</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 7px;"><b>Weighted<br /></b><b>Average<br /></b><b>Remaining<br /></b><b>Contractual<br /></b><b>Life (Years)</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 7px; padding-right: 0px;"><b>Aggregate<br /></b><b>Intrinsic<br /></b><b>Value</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2013</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,976,849</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">7.86</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">261,500</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">15.21</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercised</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(679,321</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.41</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(70,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">13.38</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2014</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,489,028</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">9.33</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">694,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.47</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercised</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(143,100</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(40,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">25.61</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2015</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,999,928</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">8.76</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">429,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.77</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercised</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(50,357</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.40</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Outstanding at December 31, 2016</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5,378,571</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">8.52</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">3.94</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">810</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 7px;">Options exercisable at December 31, 2016</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">4,472,193</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 8%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">9.02</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">2.96</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">810</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expected stock price volatility</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">79.6%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">82%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">88%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Risk-free interest rate</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">1.85%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">2.12%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">2.56%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expected life term (in years)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">6.03 years</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">6.07 years</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">6.0 years</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Expected dividends</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">0%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">0%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">0%</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The table below sets forth the basic and diluted loss per share calculations:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 0px;">Year Ended December 31,</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 13px;">2016</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 13px;">2015</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 13px; padding-right: 0px;">2014</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;">Net loss</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(28,569</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(29,234</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(9,902</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 13px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: -13px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;">Basic and diluted weighted average number of shares outstanding</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">55,985</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">52,384</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">51,570</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 13px;">Basic and diluted loss per share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.51</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.56</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.19</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 2px; padding-right: 2px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 2px; padding-right: 2px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 2px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Balance at the beginning of the year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Additions based on tax positions related to the current year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Additions for tax positions of prior years</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Settlements</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Lapse of applicable statute of limitations</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 53%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 2px;">Balance at the end of the year</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">316</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">First</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Second</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Third</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">Fourth</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="12" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 9px; padding-right: 0px;">(in thousands except per share)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 0px; padding-right: 9px;">2016<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">398</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">402</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Loss from operations</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(8,618</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,353</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,287</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,247</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Net loss</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(8,610</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,337</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,387</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,235</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Basic earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Diluted earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr></table><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">First</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Second</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 9px;">Third</div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 9px; padding-right: 0px;">Fourth</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;"></div></td><td align="center" colspan="12" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 9px; padding-right: 0px;">(in thousands except per share)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="font-weight: bold; padding-left: 0px; padding-right: 9px;">2015<br /></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Revenue</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">400</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">375</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">405</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Loss from operations</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,759</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(9,567</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(6,102</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,749</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Net loss</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(5,855</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(9,546</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(6,097</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(7,736</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Basic earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.11</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.18</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 51%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 9px;">Diluted earnings (loss) per common share</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.11</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.18</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.12</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 12px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">RSUs</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Number of<br /></b><b>RSUs </b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Grant Date<br /></b><b>Fair Value </b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 8px; padding-right: 0px;"><b>Aggregate<br /></b><b>Intrinsic<br /></b><b>Value </b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2013</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">248,915</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">24.10</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">154,332</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">15.30</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs vested</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(88,686</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">24.08</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(4,167</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">24.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2014</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">310,394</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">19.74</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">162,665</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5.57</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs vested</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(113,103</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">20.11</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2015</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">359,956</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">13.22</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs granted</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">219,331</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.75</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs vested</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(155,852</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">15.27</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">RSUs cancelled</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 60%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">Outstanding at December 31, 2016</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">423,435</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">8.08</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">&#160;</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; margin-right: 0px; text-indent: 0px;">A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;"></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2016</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Year Ended<br /></b><b>December 31, 2015</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 17%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Year Ended<br /></b><b>December 31, 2014</b></div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">United States federal statutory rate</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">35.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">35.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">35.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">State taxes, net of federal benefit</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.31</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.04</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.02</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Valuation allowance</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(35.43</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(33.36</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(41.67</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Stock options</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(1.62</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.39</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Prior year true-up</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.06</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.03</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.13</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">R&amp;D Credit</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.66</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">0.38</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Warrants</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">(0.14</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">7.92</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">%</div></td></tr><tr><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 1px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Other</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(0.33</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(0.29</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">(1.64</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">)%</div></td></tr><tr style="background-color: #cceeff;"><td align="left" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 50%; color: #000000; padding-bottom: 4px; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">Effective income tax rate</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(0.47</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(0.04</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)%</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 3pt double; whitespace: nowrap;">(0.15</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 4px; whitespace: nowrap;">)%</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Information about the Advisor Warrants outstanding during the twelve months ended December 31, 2016 follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 0px; padding-right: 4px;"><b>Original<br /></b><b>Number of<br /></b><b>Warrants<br /></b><b>Issued</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 15%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Exercise<br /></b><b>Price per<br /></b><b>Common<br /></b><b>Share</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Exercisable at<br /></b><b>December 31,<br /></b><b>2015</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Became<br /></b><b>Exercisable</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; font-weight: bold; padding-left: 4px; padding-right: 4px;">Exercised</div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Terminated /<br /></b><b>Cancelled /<br /></b><b>Expired</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Exercisable at<br /></b><b>December 31,<br /></b><b>2016</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Expiration<br /></b><b>Date</b></div></td></tr><tr style="background-color: #cceeff;"><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">25,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 15%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">$7.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">25,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">25,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">April 2020</div></td></tr></table></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">The following tables summarize information about stock-options and RSUs outstanding at December 31, 2016:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="center" colspan="10" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; font-weight: bold; padding-left: 0px; padding-right: 8px;">Options Outstanding</div></td><td align="center" colspan="9" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; font-weight: bold; padding-left: 8px; padding-right: 0px;">Options Vested and Exercisable</div></td></tr><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 0px; padding-right: 8px;"><b>Range of<br /></b><b>Exercise Prices</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 19%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Number<br /></b><b>Outstanding</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Remaining<br /></b><b>Contractual<br /></b><b>Life (Years)</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Exercise<br /></b><b>Price</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Number<br /></b><b>Exercisable</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 8px;"><b>Weighted<br /></b><b>Average<br /></b><b>Remaining<br /></b><b>Contractual<br /></b><b>Life (Years)</b></div></td><td align="center" colspan="3" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 8px; padding-right: 0px;"><b>Weighted<br /></b><b>Average<br /></b><b>Exercise<br /></b><b>Price</b></div></td></tr><tr style="background-color: #cceeff;"><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">$&#160;&#8201;&#8201;0.24-&#8201;&#8201;&#8201;1.58&#8201;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">771,045</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.26</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">771,045</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.26</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">1.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">$&#160;&#8201;&#8201;1.74-&#8201;&#8201;&#8201;6.95&#8201;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3,353,901</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3.66</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.74</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2,558,275</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4.82</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr><tr style="background-color: #cceeff;"><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; padding-bottom: 1px; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;">$&#160;14.52-&#8201;35.25&#8201;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,253,625</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5.71</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">23.16</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">1,142,873</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">5.56</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: black 1pt solid; whitespace: nowrap;">23.73</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-bottom: 1px; whitespace: nowrap;">&#160;</div></td></tr><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 14%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 8px;"></div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 16%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">5,378,571</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">3.94</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">8.52</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">4,472,193</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 11%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">2.96</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 2%; color: #000000; text-align: right; padding-left: 5px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">$</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 9%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">9.02</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 1%; color: #000000; text-align: left; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="whitespace: nowrap;">&#160;</div></td></tr></table></div> 23190000 26672000 28310000 15.21 4.77 4.47 0 0 24.13 P4Y P4Y P4Y 0.40 1.15 0.41 4.75 15.30 5.57 0 0 429000 694000 261500 25000 25000 2.20 5.49 219331 162665 154332 0 4167 0 24.10 8.08 19.74 13.22 248915 359956 423435 310394 9.02 2500000 0.0185 0.0256 0.0212 4472193 203000 3575000 91000 24.08 20.11 15.27 78739 103817 135102 88686 113103 155852 0 70000 0 40000 0 0 0 421221 0.796 0.82 0.88 7.86 8.52 9.33 8.76 4976849 5378571 4489028 4999928 810000 13.38 25.61 0 3.25 3.17 11.26 5378571 3353901 1253625 771045 2558275 771045 1142873 4472193 1.58 6.95 35.25 1.74 14.52 0.24 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Stock-Based Compensation</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs net of the applicable forfeiture rate and recognize the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is generally the vesting term of 4 years. We estimate the forfeiture rate based on our historical experience if any. See Note 7 - Stock-Based Compensation for additional information concerning our share-based compensation awards.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.</p></div> 3.00 5.05 4.04 51236141 51996701 53198835 58144888 19196000 19195000 3276000 1000 3276000 278000 20000 278000 20000 165000 165000 4760594 835056 835056 4760594 50357 679321 143100 143100 679321 50357 9000 431000 431000 9000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 10 &#8722; Equity</p><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Warrants</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">During the year ended December 31, 2015 we issued warrants (&#8220;Advisor Warrants&#8221;) for the purchase of 25,000 shares of common stock for $7 per share, which expire in April 2020. The Advisor Warrants were issued for advisory services provided by a third party. Our Advisor Warrants were recorded at fair value on the issuance date and included in Additional Paid in Capital on our Consolidated Balance Sheet. The Advisor Warrants are exercisable by the holder, in whole or in part, until expiration, and may also be net-share-settled. Terms of the warrant agreement include no registration requirements for the underlying common stock and there are no anti-dilution provisions. The fair value at issuance of the warrants was recorded in Prepaid Expenses and Other Current Assets, and is being amortized over the twelve-month life of the service contract, with the expense included in Selling, General and Administrative Expense in our Consolidated Statements of Operations.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Information about the Advisor Warrants outstanding during the twelve months ended December 31, 2016 follows:</p><table align="center" style="width: 100%; border-collapse: collapse; margin-left: 0px; margin-top: 4px;"><tr><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 0px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 0px; padding-right: 4px;"><b>Original<br /></b><b>Number of<br /></b><b>Warrants<br /></b><b>Issued</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 15%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Exercise<br /></b><b>Price per<br /></b><b>Common<br /></b><b>Share</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Exercisable at<br /></b><b>December 31,<br /></b><b>2015</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Became<br /></b><b>Exercisable</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; font-weight: bold; padding-left: 4px; padding-right: 4px;">Exercised</div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Terminated /<br /></b><b>Cancelled /<br /></b><b>Expired</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 4px;"><b>Exercisable at<br /></b><b>December 31,<br /></b><b>2016</b></div></td><td align="center" valign="bottom" style="margin-bottom: 0px; font-size: 10px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: center; padding-left: 6px; margin-top: 0px; padding-right: 6px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="border-bottom: #000000 1pt solid; padding-left: 4px; padding-right: 0px;"><b>Expiration<br /></b><b>Date</b></div></td></tr><tr style="background-color: #cceeff;"><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 0px; padding-right: 4px;">25,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 15%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">$7.00</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">25,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 12%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 10%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">&#8212;</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 4px;">25,000</div></td><td align="right" valign="bottom" style="margin-bottom: 0px; font-size: 13px; font-family: Times New Roman, Times, Serif; width: 13%; color: #000000; text-align: right; padding-left: 0px; margin-top: 0px; padding-right: 0px; margin-right: 0px; text-indent: 0px;"><div class="group-p" style="padding-left: 4px; padding-right: 0px;">April 2020</div></td></tr></table></div> 11147000 15095000 34024000 5000 -37000 124589000 -90533000 6000 133072000 -15000 -158238000 5000 -100435000 32627000 144778000 169391000 -129669000 -12000 -19000 5000 2031-12-31 1092000 0 2238000 -117000 0 0 0 0 0 0 0 0 0 0 0 0 5000 316000 316000 316000 316000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Use of Estimates</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;). In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors.</p></div> 14641000 55984825 51570472 52384494 1.1 1 0.85 1 15876000 18680000 18686000 15877000 P2Y P1Y 104000 0 0 P12M April 30, 2020 2 P4Y 10000000 10000000 P12M P2Y 50 69 49 -0.0006 -0.0013 0.0003 0.0792 0 -0.0014 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 3 &#8722; Gain on Settlement</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">In June 2010, we received a $200,000 cash settlement from litigation with Microsoft, in which we agreed to dismiss the pending lawsuits and any damages. In December 2014, we received a $23,000 cash settlement resulting from litigation with Microsoft. The 2010 settlement agreement was amended in December 2014 to settle a subsequent lawsuit with Microsoft, raising the total cash settlement with Microsoft, as amended, to $223,000. In both the original settlement and the December 2014 amendment, we could not practically and objectively separate any settlement portion from the revenue element as discussed under the guidance of Accounting Standards Codification, or ASC, 605,<i> &#8220;Revenue Recognition&#8221;</i>, and as a result, the settlement proceeds are classified as a gain on settlement in our consolidated statement of operations.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Prepaid Expenses and Other Current Assets</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Prepaid Expense and Other Current Assets at December 31, 2016 includes the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. Beginning March 2014, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid Expenses-Non-current on the consolidated balance sheet.</p></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h3" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; font-style: italic; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Royalty Expense</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Royalty expense for the years ended December 31, 2016, 2015 and 2014 was $884, $5,265 and $6,100, respectively and was a result of our royalty agreement with Leidos. The agreement provides for revenue sharing and legal reimbursements related to attorney time and expenses incurred by Leidos during discovery and other aspects of litigation matters that have been resolved.</p></div> 2 2 2 2 2 2 34000 330000 30000 91000 0 3144000 -385000 -385000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 6 &#8722; Stock Plan</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the &#8220;Plan&#8221;), which has been approved by our stockholders. The 2013 Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the 2013 Plan. The 2013 Plan provides for the granting of stock options and restricted stock purchase rights (&#8220;RSU&#8221;) to our employees and consultants. Stock options granted under the 2013 Plan may be incentive stock options or nonqualified stock options. Incentive stock options (&#8220;ISO&#8221;) may only be granted to our employees (including officers and directors). Nonqualified stock options (&#8220;NSO&#8221;) and stock purchase rights may be granted to our employees and consultants.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">The 2013 Plan will expire in 2023. Options may be granted under the 2013 Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO. The exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the 2013 Plan typically vest over four years and have a 10-year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years. At December 31, 2016 there were 421,221 shares available for grant under the 2013 Plan.</p></div> 8000 P30D 19791000 3378000 100000000 35000000 594000 101000 4.04 4.16 1 11831000 <div style="font-family: 'Times New Roman'; font-size: 10pt;"><p class="h2" style="font-size: 13px; font-family: Times New Roman, Times, Serif; font-weight: bold; color: #000000; text-align: left; padding-left: 0px; margin-right: 0px; text-indent: 0px;">Note 9 &#8722; Common Stock</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $.0001 par value common stock.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">On August 21, 2015 we filed a universal shelf registration statement with the SEC enabling us to offer and sell from time to time up to $100 million of equity, debt or other types of securities. We also entered into an at-the-market (&#8220;ATM&#8221;) equity offering sales agreement with Cowen &amp; Company, LLC on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35 million. As of December 31, 2016, common stock with an aggregate value of up to $11,831 remains available for offer and sale under the ATM agreement.</p><p class="fpara" style="font-size: 13px; font-family: Times New Roman, Times, Serif; color: #000000; text-align: justify; padding-left: 0px; line-height: 16px; margin-right: 0px; text-indent: 0px;">We sold 4,760,594 and 835,056 shares of common stock under the ATM program during the year ended December 31, 2016 and 2015, respectively. The average sales price per common share sold during the year ended December 31, 2016 was $4.16 and the aggregate proceeds from the sales totaled $19,791 during the period. Sales commissions, fees and other costs associated with the ATM transactions totaled $594 for 2016. The average sales price per common share sold during the year ended December 31, 2015 was $4.04 and the aggregate proceeds from the sales totaled $3,378 during the period. Sales commissions, fees and other costs associated with the ATM totaled $101 for 2015.</p></div> 2500 120161 121000 121000 EX-101.SCH 9 vhc-20161231.xsd XBRL SCHEMA FILE 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 040100 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Formation and Business of the Company link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Gain on Settlement link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Commitments and Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Stock Plan link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 061400 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 061500 - Disclosure - Quarterly Financial Information (unaudited) link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 080400 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 081200 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 081300 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 081500 - Disclosure - Quarterly Financial Information (unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Formation and Business of the Company (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Gain on Settlement (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Commitments and Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Stock Plan (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Stock-Based Compensation, Information about Stock Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 090702 - Disclosure - Stock-Based Compensation, Summary of Activity (Details) link:presentationLink link:calculationLink link:definitionLink 090704 - Disclosure - Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) link:presentationLink link:calculationLink link:definitionLink 090706 - Disclosure - Stock-Based Compensation, Fair Value Assumptions Used (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - Employee Benefit Plan (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - Income Taxes, Components of Benefit (Provision) for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 091202 - Disclosure - Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 091204 - Disclosure - Income Taxes, Net Operating Losses (Details) link:presentationLink link:calculationLink link:definitionLink 091206 - Disclosure - Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 091208 - Disclosure - Income Taxes, Valuation Allowance, Operating Loss Carryforwards and Tax Credit Carry-forwards (Details) link:presentationLink link:calculationLink link:definitionLink 091210 - Disclosure - Income Taxes, Income Tax Uncertainties (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - Fair Value Measurement, Assumptions Used to Measure Fair Value of Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 091302 - Disclosure - Fair Value Measurement, Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Investment Category (Details) link:presentationLink link:calculationLink link:definitionLink 091306 - Disclosure - Fair Value Measurement, Changes in Fair Value of Level 3 Financial Instrument Liability (Details) link:presentationLink link:calculationLink link:definitionLink 091400 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 091500 - Disclosure - Quarterly Financial Information (unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 vhc-20161231_cal.xml XBRL CALCULATION FILE EX-101.DEF 11 vhc-20161231_def.xml XBRL DEFINITION FILE EX-101.LAB 12 vhc-20161231_lab.xml XBRL LABEL FILE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Award Type [Axis] Summary of Significant Accounting Policies [Abstract] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Income tax liability Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Additional paid-in capital Additional Paid in Capital Additional Paid-in Capital [Member] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Derivative liability Adjustments to Additional Paid in Capital, Warrant Issued Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Aircraft [Member] Air Transportation Equipment [Member] Rental fees incurred for use of plane Stock-based compensation Stock-based compensation expense Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract] Assets, Fair Value Disclosure [Abstract] Total assets Assets ASSETS Assets [Abstract] Current assets: Total current assets Assets, Current Fair Value Investments Available for Sale Available-for-sale Securities Unrealized Gains Unrealized Losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Adjusted Cost Available-for-sale Securities, Amortized Cost Basis Investments available for sale Available-for-sale Securities, Debt Securities, Current Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Offices [Member] Building [Member] Counterparty Name [Axis] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and cash equivalents Adjusted Cost Cash and Cash Equivalents Cash [Member] Fair Value Cash and Cash Equivalents Cash and Cash Equivalents, Fair Value Disclosure Non-cash transactions Original Number of Warrants Issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of Warrant or Right [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Line Items] Stock issued for cash exercise of warrants, net (in dollars per share) Exercise Price per Common Share (in dollars per share) Warrant exercise price (in dollars per share) Class of Warrant or Right [Domain] Commitments and contingencies (Note 5) Commitments and Related Party Transactions Commitments Disclosure [Text Block] Commitments and Related Party Transactions [Abstract] Common Stock [Member] Common stock, shares issued (in shares) Common stock, voting rights Common stock, shares authorized (in shares) Common stock, shares authorized (in shares) Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2016 and December 31, 2015, Issued and outstanding: 58,144,888 shares and 53,198,835 shares, at December 31, 2016 and December 31, 2015, respectively Common Stock, Value, Issued Common stock, par value (in dollars per share) Common stock, par value (in dollars per share) Common stock, shares outstanding (in shares) Employee Benefit Plan [Abstract] Deferred tax assets [Abstract] Components of Deferred Tax Assets and Liabilities [Abstract] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Computer Equipment [Member] Concentration of Credit Risk and Other Risks and Uncertainties Basis of Consolidation Current income taxes Current Income Tax Expense (Benefit) Foreign Current Foreign Tax Expense (Benefit) State Current State and Local Tax Expense (Benefit) Current [Abstract] Federal Current Federal Tax Expense (Benefit) Highly Liquid Debt Investments [Member] Debt Securities [Member] Less: Amount amortized as revenue State tax Federal Deferred Federal Income Tax Expense (Benefit) Payment received Deferred Revenue, Additions Deferred revenue, current portion Deferred Revenue [Abstract] Deferred Revenue, end of period Deferred Revenue, beginning of period Deferred Revenue Deferred Revenue [Domain] Deferred [Abstract] Deferred revenue, non-current portion Deferred Revenue, Noncurrent Activity under August 2013 Contract Settlement Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement [Line Items] Total deferred tax liability Deferred Tax Liabilities, Gross Deferred Revenue Arrangement, by Type [Table] Deferred tax assets after valuation allowance Deferred Tax Assets, Net of Valuation Allowance Net operating loss carry forward Total deferred tax assets Deferred Tax Assets, Gross Net deferred tax assets Deferred Tax Assets, Net State Deferred State and Local Income Tax Expense (Benefit) Stock based compensation Reserves and accruals Research and development credits and other credits Other Deferred Tax Assets, Other Deferred tax liability [Abstract] Depreciation and amortization Deferred Tax Liabilities, Property, Plant and Equipment Valuation allowance Deferred Tax Assets, Valuation Allowance Matching contribution to defined contribution plan Depreciation Depreciation expense Derivative Instruments Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation [Abstract] Federal [Member] Related-party payable Due to Related Parties, Current Basic and diluted loss per share (in dollars per share) Basic and diluted loss per share (in dollars per share) Earnings Per Share, Basic and Diluted Earnings Per Share Basic earnings (loss) per common share (in dollars per share) Diluted earnings (loss) per common share (in dollars per share) Calculation of basic and diluted loss per share [Abstract] Earnings Per Share Earnings Per Share [Text Block] Earnings Per Share [Abstract] United States federal statutory rate Effective Tax Rate Reconciliation [Abstract] State taxes, net of federal benefit Stock options R&D Credit Other Valuation allowance Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Accrued payroll and related expenses Compensation cost not yet recognized [Abstract] Weighted-average period for recognition of unrecognized stock-based compensation expense Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Unrecognized stock-based compensation expense expected to be recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Stock Options [Member] Employee Stock Options [Member] Unrecognized stock-based compensation expense expected to be recognized Equity [Abstract] Equity Component [Domain] Named Executive Officers [Member] Executive Officer [Member] Fair value assumptions [Abstract] Asset Class [Axis] Fair Value, Hierarchy [Axis] Discount rate Fair Value Inputs, Discount Rate Measurement Frequency [Axis] Fair Value Measurement [Abstract] Expected volatility rate Asset Class [Domain] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Measurement Frequency [Domain] Recurring [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Fair Value Hierarchy [Domain] Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value Measurement Fair Value Disclosures [Text Block] Fair Value Cash and Available-for-Sale Securities Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Significant Investment Category Significant Unobservable Inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Level 1 [Member] Changes in fair value of Level 3 liabilities [Roll Forward] Summary of Changes in Fair Value of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] (Gain) losses included in net losses Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets [Line Items] Estimated useful lives Finite-Lived Intangible Assets, Major Class Name [Domain] Number of patents allegedly infringed upon by Apple, Inc. Gain Contingencies [Line Items] Gain Contingencies [Table] Gain Contingency, Nature [Domain] Gain of settlement (Note 3) Cash settlement resulting from litigation Gain Contingencies, Nature [Axis] General and Administrative Expense [Member] Geographic Distribution [Axis] Foreign [Member] Geographic Distribution, Foreign [Member] Geographic Distribution [Domain] Intangible Assets Intellectual Property [Member] Impairment of Long-Lived Assets Income Taxes [Abstract] Income Statement Location [Axis] Loss before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income Statement Location [Domain] Income Tax Authority [Axis] Interest and penalties included in income tax expense Income Tax Authority [Domain] Income Taxes Income Tax Disclosure [Text Block] Income tax expense Total income tax provision Income Tax Expense (Benefit) CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Income Taxes [Abstract] Income Tax Examination, Penalties and Interest Expense [Abstract] Income Taxes Cash paid for income taxes Income tax liability Increase (Decrease) in Income Taxes Payable Accounts payable and accrued liabilities Deferred revenue Increase (Decrease) in Deferred Revenue Related-party payable Accrued payroll and related expenses Increase (Decrease) in Employee Related Liabilities Changes in assets and liabilities: Royalty payable Increase (Decrease) in Royalties Payable Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Cash paid for interest Investments Investments [Abstract] 10% Shareholder [Member] Investor [Member] Fair value of warrants issued for services Term of lease Lease term Lessee Leasing Arrangements, Operating Leases, Term of Contract Operating lease expiring date Lease Expiration Date Litigation Legal Matters and Contingencies [Text Block] Total liabilities Liabilities Total liabilities and stockholders' equity Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY Total current liabilities Liabilities, Current Current liabilities: Litigation Case [Domain] Litigation Case [Axis] Amount of damages awarded in patent infringement case Loss Contingency, Damages Awarded, Value Number of intellectual property infringement lawsuits pending Loss Contingency, Pending Claims, Number Mutual Funds [Member] Mutual Fund [Member] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Maximum [Member] Minimum [Member] Activity under August 2013 contract settlement [Roll Forward] Cash flows from financing activities: Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash flows from operating activities: Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash flows from investing activities: Net decrease in cash and cash equivalents Net Cash Provided by (Used in) Continuing Operations Net loss Net loss Net loss Net loss New Accounting Pronouncements Office Furniture [Member] Operating expense: Total operating expense Operating Expenses Future minimum rents due in 2017 Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Rent expense Operating Leases, Rent Expense, Net Operating loss carryforwards Pre-tax losses available for carry forward Loss from operations Loss from operations Operating loss carryforwards, expiration dates Operating Leased Assets [Line Items] Formation and Business of the Company [Abstract] Formation and Business of the Company Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Change in unrealized gain (loss) on investments, net of tax Change in equity adjustment from foreign currency translation, net of tax Interest and other income, net Comprehensive income: Other comprehensive gain (loss), net of tax: Other comprehensive income (loss), net of tax Total other comprehensive income (loss), net of tax Patents [Member] Purchase of investments Payments to Acquire Available-for-sale Securities Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Employee Benefit Plan Pension and Other Postretirement Benefits Disclosure [Text Block] Plan Name [Domain] Plan Name [Axis] Positive Outcome of Litigation [Member] Preferred stock, shares issued (in shares) Preferred stock, shares authorized (in shares) Preferred stock, par value (in dollars per share) Preferred stock, shares outstanding (in shares) Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2016 and December 31, 2015, Issued and outstanding: 0 shares at December 31, 2016 and December 31, 2015 Preferred Stock, Value, Issued Prepaid expenses and other current assets Prepayment of facility lease for corporate promotional and marketing purposes Prepaid Rent Prepaid expenses, non-current Prepaid Expense, Noncurrent Prepaid Expense and Other Assets, Current [Abstract] Reclassifications Proceeds from exercise of warrants Proceeds from sale of common stock Proceeds from sale or maturity of investments Proceeds from exercise of options Useful lives Property, Plant and Equipment, Type [Domain] Property and Equipment Property and Equipment [Abstract] Classes of Property and Equipment Property and equipment, net Property and equipment, net Property and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property and equipment, gross Property, Plant and Equipment, Gross Property, Plant and Equipment, Type [Axis] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Quarterly Financial Information (unaudited) Quarterly Financial Information [Text Block] Quarterly Financial Information (unaudited) [Abstract] Range [Axis] Range [Domain] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Counterparty Name [Domain] Research and development Research and Development Expense Research and Development Research and Development [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Purchase Rights ("RSU") [Member] Accumulated Deficit [Member] Retained Earnings [Member] Accumulated deficit Deferred Revenue Revenue Recognition, Deferred Revenue [Policy Text Block] Revenue Recognition Concentration of Credit Risk and Others Risks and Uncertainties [Abstract] Royalty expense Royalties expense as a result of royalty agreement with Leidos August 2013 Contract [Member] Royalty Agreements [Member] Revenue Revenue Options exercisable, aggregate intrinsic value RSUs, aggregate intrinsic value [Abstract] Options outstanding, weighted average remaining contractual life Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Options vested and exercisable, weighted average remaining contractual life Options vested and exercisable, weighted average exercise price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price Term of award Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Options outstanding, weighted average remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options exercisable, weighted average remaining contractual life Outstanding, end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Expected life term Total intrinsic value of RSUs vested Options outstanding, weighted average exercise price (in dollars per share) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Sale of Stock [Domain] Stock-Based Compensation by Type of Award Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Stock Option Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Fair Value Assumptions Basic and Diluted Loss Per Share Calculations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Unrecognized Tax Benefits Reconciliation Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block] Quarterly Financial Information Restricted Stock Units Activity Schedule of Operating Leased Assets [Table] Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Line Items] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Property, Plant and Equipment [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Information about Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Information about Stock Options Outstanding Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of Stock by Class [Table] Selling, general and administrative expenses Options granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price RSUs cancelled (in dollars per share) Option vesting term Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period RSUs, weighted average grant date fair value [Abstract] Stock-Based Compensation [Abstract] Share-based Compensation [Abstract] Options exercised (in dollars per share) RSUs granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Terminated/Cancelled/Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Exercised (in shares) RSUs, number of RSUs [Roll Forward] Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Exercisable, beginning of period (in shares) Exercisable, end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Options, weighted average exercise price [Roll Forward] Common share price (in dollars per share) Per share market price of common stock on last trading day of year (in dollars per share) RSUs granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period RSUs cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Outstanding, end of period (in dollars per share) Outstanding, beginning of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding, end of period (in shares) Outstanding, beginning of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Options exercisable, end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Number of shares authorized (in shares) Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Options exercisable, end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Options, additional disclosures [Abstract] Total intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value RSUs vested (in dollars per share) Vested RSUs (in shares) Became Exercisable (in shares) RSUs vested (in shares) Options cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Fair value assumptions used in estimating fair value of each option grant [Abstract] Expected dividends Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Shares available for grant (in shares) Expected stock price volatility Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, end of period (in shares) Outstanding, beginning of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Equity Award [Domain] Options outstanding, aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Options, number of shares [Roll Forward] Options cancelled (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Options granted, weighted average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Options outstanding, number outstanding (in shares) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Options vested and exercisable, number exercisable (in shares) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Exercise price range, upper range limit (in dollars per share) Exercise price range, lower range limit (in dollars per share) Exercise Price Range [Axis] Stock-Based Compensation Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock issued for cash, net (in dollars per share) Balance (in shares) Balance (in shares) Shares, Outstanding State [Member] Statement [Line Items] Statement, Equity Components [Axis] CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY [Abstract] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract] Statement [Table] CONSOLIDATED BALANCE SHEETS [Abstract] Stock issued for cash, net Exercise of options Stock Issued During Period, Value, Stock Options Exercised Stock issued for cash, net (in shares) Number of shares of common stock sold (in shares) Exercise of options (in shares) Options exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock issued for cash exercise of warrants, net Stockholders' equity: Equity Stockholders' Equity Note Disclosure [Text Block] Balance Balance Total stockholders' equity Stockholders' Equity Attributable to Parent Subsidiary, Sale of Stock [Line Items] Sale of Stock [Axis] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward [Axis] Federal tax credit carryforward, expiration dates Tax Credit Carryforward [Table] Tax credit carryforwards Tax Credit Carryforward [Line Items] Relationship to Entity [Domain] Title of Individual [Axis] Change in value of derivative liability Gain (loss) on change in value of derivative liability Unrealized Gain (Loss) on Derivatives Additions for tax positions of prior years Additions based on tax positions related to the current year Settlements Lapse of applicable statute of limitations Accrued interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Balance at the end of the year Balance at the beginning of the year Unrecognized Tax Benefits Use of Estimates Use of Estimates, Policy [Policy Text Block] US Agency Securities [Member] U.S. Government Securities [Member] Net change in valuation allowance Warrants [Member] Warrants [Abstract] Weighted average shares outstanding basic and diluted (in shares) Basic and diluted weighted average number of shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted U.S. [Member] UNITED STATES A type of employee stock option where the holders pay ordinary income tax on the difference between the grant price and the price at which they exercise the option. Nonqualified Stock Options [Member] A type of employee stock option that can be granted only to employees and confer a U.S. tax benefit. ISOs are also sometimes referred to as incentive share options or Qualified Stock Options by IRS. Incentive Stock Options [Member] Exercise price of stock options granted as percentage of fair market value of shares at the date of grant. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercise Price as Percentage of Fair Value Exercise price of option granted as percentage of fair market value of shares at date of grant Refers to plan 2013 of equity based compensation arrangement plan. Plan 2013 [Member] 2013 Plan [Member] Fair value portion of cash and investment in debt and equity securities categorized neither as held-to-maturity nor trading. Cash and Available-for-sale Securities, Fair Value Disclosure Fair Value This item represents the cost of cash and debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Cash and Available-for-sale Securities, Amortized Cost Basis Adjusted Cost Period of maturity of a debt security categorized as neither trading nor held-to-maturity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Available-for-sale Securities, Debt Maturity Period Maturities of available for sale securities Amount of expiration of warrants of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Fair Value Measurement With Unobservable Inputs Reconciliation, Expiration Of Warrants Expiration of warrants Represents warrants designated as Series I Warrants. Series I Warrants [Member] Series I Warrants [Member] Represents warrants designated as Advisor Warrants. Advisor Warrants [Member] Refers to the term of the service contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Service Contract, Term Life of service contract Date the warrant is to expire, in CCYY-MM-DD format. Expiration date for Warrants Expiration date Number of financial institutions holding the company's cash and cash equivalents. Concentration Risk, Number of Financial Institutions Number of financial institutions holding company's cash Term of contract for which deferred revenue is recognized, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Term of Contract Term of contract Represents amount of contract. Contract Amount Contract amount Amount of contract payments received to date. Contract Payments Received To Date Non-refundable cash payment received to date Represents the threshold period of payment of fees after delivery for fees to be generally presumed not to be fixed or determinable, and for revenue to be deferred and recognized as earned, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Period of Payment of Fees after Delivery for Fees to be Generally Presumed Not to be Fixed or Determinable, and for Revenue to be Deferred and Recognized as Earned Threshold period of payment of fees after delivery for fees to be generally presumed not to be fixed or determinable, and for revenue to be deferred and recognized as earned Period of time between issuance and maturity of investment securities, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Contractual Maturities of Investment Securities Contractual maturities of investment securities Royalties Expense [Abstract] Royalty Expense [Abstract] Patent License Agreements [Abstract] Document and Entity Information [Abstract] Represents the number of pending patents applications. Number of Pending Applications for Patents Number of pending patent applications Represents number of patents owned. Number Of Patents Owned Number of patents owned Refers to Prior year true-up. Prior year true up Prior year true-up Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to warrants. Effective Income Tax Rate Reconciliation, Warrants, Percent Warrants The entire disclosure for gain on settlement. Gain on Settlement [Text Block] Gain on Settlement Gain on Settlement [Abstract] Disclosure of accounting policy for prepaid expenses and other current assets. Prepaid Expenses and Other Current Assets [Policy Text Block] Prepaid Expenses and Other Current Assets Disclosure of accounting policy for royalties expense. Royalties Expense [Policy Text Block] Royalty Expense Refers to the number of cases ordered to be retried by the court. Number of cases ordered to be retried by court Information about litigation regarding VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II"). VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II") [Member] Information about litigation regarding VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I"). VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member] Information about litigation regarding VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED). VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) [Member] Refers to the number of civil actions consolidated by the court. Number of civil actions consolidated by court Number of civil actions consolidated by court For an amount of damages awarded to the plaintiff in the legal matter, the daily interest payment awarded the plaintiff up to final payment of awarded damages. Loss Contingency, Damages Awarded, Value Daily Interest Amount of interest payment awarded up to final judgment, per day For an amount of damages awarded to the plaintiff in the legal matter, the daily payments awarded for damage infringement to the plaintiff up to final payment of awarded damages. Loss Contingency, Damages Awarded, Value Daily Payment Amount of damage infringement payment awarded up to final judgment, per day Represents Options within the stated exercise price range. Exercise Price Range 2 [Member] $1.74 - 6.95 [Member] Represents Options within the stated exercise price range. Exercise Price Range 1 [Member] $0.24 - 1.58 [Member] Represents options within the stated exercise price range. Exercise Price Range 3 [Member] $14.52 - 35.25 [Member] Amortization of warrant issuance costs during the period. Amortization of Warrant Issuance Costs Amortization of warrant issuance costs The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for non-current goods or services that bring economic benefits for period more than 12 months. Increase Decrease In Prepaid Expense Noncurrent Prepaid expense - Non-current Litigation [Abstract] The entire disclosure of the description of the plan, the basis for determining contributions, including the employee groups covered, and the nature and effect of significant matters affecting comparability of information for all periods presented. For leveraged ESOPs and pension reversion ESOPs, the disclosure may include the basis for releasing shares and how dividends on allocated and unallocated shares are used. Stock Plan [Text Block] Stock Plan Stock Plan [Abstract] The counterparty from which the Company leased the use of an aircraft for business travel for employees of the Company K2 Investment Fund LLC [Member] Refers to the rate of aircraft lease in dollars per flight hour. Rate of Aircraft Lease Rate of aircraft lease (in dollars per flight hour) Refers to the term of notice for cancellation of lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Term of Notice for Cancellation of Lease Term of notice for cancellation of lease Represents aggregate proceeds from sale agreement of shares of common stock. Aggregate Proceeds from Sale Agreement of Shares of Common Stock Aggregate proceeds from sales of common stock Aggregate value of securities offered for sale. Securities Offered for Sale, Aggregate Value Securities offered for sale, aggregate value Cost associated with sale of common stock. Stock issuance cost Sales commissions, fees and other costs associated with issuance of common stock Refers to single prospectus for multiple, undefined future offerings. Universal Shelf Registration Statement [Member] An at-the-market ("ATM") equity offering sales agreement with Cowen & Company, LLC on August 20, 2015, under which offering and sale of shares of common stock is done. ATM Agreement [Member] Average price of a single share of common stock issued during the period. Common Stock Issued During Period, Average Price Per Share Average sales price per common share (in dollars per share) Refers to number of votes entitled to each share of common stock. Number of votes entitled to each share of common stock Refers to the aggregate value of shares of common stock available for offer and sale. Common Stock, Shares Available for Offer and Sale, Value Aggregate value of common stock available for offer and sale The entire disclosure for common stock. Common Stock Disclosure [Text Block] Common Stock Common Stock [Abstract] Number of shares of stock issued during the period as a result of warrant exercises. Stock Issued During Period, Shares, Warrants Exercised Stock issued for cash exercise of warrants (in shares) Amount of increase in additional paid in capital (APIC) resulting from the issuance of advisor warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Adjustments to Additional Paid in Capital, Advisor Warrant Issued Advisor warrant issuance EX-101.PRE 13 vhc-20161231_pre.xml XBRL PRESENTATION FILE GRAPHIC 14 h10042025x1_linechart1.jpg GRAPHIC begin 644 h10042025x1_linechart1.jpg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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.6.0.2
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2016
Mar. 10, 2017
Jun. 30, 2016
Document and Entity Information [Abstract]      
Entity Registrant Name VirnetX Holding Corp    
Entity Central Index Key 0001082324    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Accelerated Filer    
Entity Public Float     $ 225,740,380
Entity Common Stock, Shares Outstanding   58,144,888  
Document Fiscal Year Focus 2016    
Document Fiscal Period Focus FY    
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2016    

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 6,627 $ 8,726
Investments available for sale 9,249 9,954
Prepaid expenses and other current assets 588 685
Total current assets 16,464 19,365
Prepaid expenses, non-current 2,374 2,759
Property and equipment, net 33 48
Total assets 18,871 22,172
Current liabilities:    
Accounts payable and accrued liabilities 1,806 2,283
Accrued payroll and related expenses 1,522 1,383
Related-party payable 0 11
Income tax liability 396 400
Deferred revenue, current portion 1,500 1,500
Total current liabilities 5,224 5,577
Deferred revenue, non-current portion 2,500 1,500
Commitments and contingencies (Note 5) 0 0
Total liabilities 7,724 7,077
Stockholders' equity:    
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at December 31, 2016 and December 31, 2015, Issued and outstanding: 0 shares at December 31, 2016 and December 31, 2015 0 0
Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at December 31, 2016 and December 31, 2015, Issued and outstanding: 58,144,888 shares and 53,198,835 shares, at December 31, 2016 and December 31, 2015, respectively 6 5
Additional paid-in capital 169,391 144,778
Accumulated deficit (158,238) (129,669)
Accumulated other comprehensive loss (12) (19)
Total stockholders' equity 11,147 15,095
Total liabilities and stockholders' equity $ 18,871 $ 22,172
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2016
Dec. 31, 2015
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 58,144,888 53,198,835
Common stock, shares outstanding (in shares) 58,144,888 53,198,835
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Revenue $ 1,550 $ 1,555 $ 1,249
Operating expense:      
Royalty expense 884 5,265 6,100
Research and development 2,499 2,277 2,004
Selling, general and administrative expenses 26,672 23,190 28,310
Gain of settlement (Note 3) 0 0 (23,000)
Total operating expense 30,055 30,732 13,414
Loss from operations (28,505) (29,177) (12,165)
Gain (loss) on change in value of derivative liability 0 (117) 2,238
Interest and other income, net 69 68 40
Loss before taxes (28,436) (29,226) (9,887)
Income tax expense (133) (8) (15)
Net loss $ (28,569) $ (29,234) $ (9,902)
Basic and diluted loss per share (in dollars per share) $ (0.51) $ (0.56) $ (0.19)
Weighted average shares outstanding basic and diluted (in shares) 55,984,825 52,384,494 51,570,472
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]      
Net loss $ (28,569) $ (29,234) $ (9,902)
Other comprehensive gain (loss), net of tax:      
Change in equity adjustment from foreign currency translation, net of tax 3 (1) 0
Change in unrealized gain (loss) on investments, net of tax 4 (3) 22
Total other comprehensive income (loss), net of tax 7 (4) 22
Comprehensive loss $ (28,562) $ (29,238) $ (9,880)
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Total
Balance at Dec. 31, 2013 $ 5 $ 124,589 $ (90,533) $ (37) $ 34,024
Balance (in shares) at Dec. 31, 2013 51,236,141        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash exercise of warrants, net   9     9
Stock issued for cash exercise of warrants (in shares) 2,500        
Stock-based compensation   8,189     8,189
Exercise of options   278     278
Exercise of options (in shares) 679,321        
Vested RSUs (in shares) 78,739        
Derivative liability   7     7
Comprehensive income:          
Net loss     (9,902)   (9,902)
Other comprehensive income (loss), net of tax       22 22
Comprehensive loss         (9,880)
Balance at Dec. 31, 2014 $ 5 133,072 (100,435) (15) 32,627
Balance (in shares) at Dec. 31, 2014 51,996,701        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash exercise of warrants, net   431     431
Stock issued for cash exercise of warrants (in shares) 120,161        
Stock issued for cash, net   3,276     3,276
Stock issued for cash, net (in shares) 835,056        
Advisor warrant issuance   121     121
Stock-based compensation   7,275     7,275
Exercise of options   165     165
Exercise of options (in shares) 143,100        
Vested RSUs (in shares) 103,817        
Derivative liability   438     438
Comprehensive income:          
Net loss     (29,234)   (29,234)
Other comprehensive income (loss), net of tax       (4) (4)
Comprehensive loss         (29,238)
Balance at Dec. 31, 2015 $ 5 144,778 (129,669) (19) 15,095
Balance (in shares) at Dec. 31, 2015 53,198,835        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash, net $ 1 19,195     19,196
Stock issued for cash, net (in shares) 4,760,594        
Stock-based compensation   5,398     5,398
Exercise of options   20     20
Exercise of options (in shares) 50,357        
Vested RSUs (in shares) 135,102        
Comprehensive income:          
Net loss     (28,569)   (28,569)
Other comprehensive income (loss), net of tax       7 7
Comprehensive loss         (28,562)
Balance at Dec. 31, 2016 $ 6 $ 169,391 $ (158,238) $ (12) $ 11,147
Balance (in shares) at Dec. 31, 2016 58,144,888        
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares
Dec. 31, 2016
Dec. 31, 2015
Stock issued for cash exercise of warrants, net (in dollars per share)   $ 3.59
Stock issued for cash, net (in dollars per share)   $ 4.04
Minimum [Member]    
Stock issued for cash, net (in dollars per share) $ 3.00  
Maximum [Member]    
Stock issued for cash, net (in dollars per share) $ 5.05  
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net loss $ (28,569) $ (29,234) $ (9,902)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation 28 26 25
Amortization of warrant issuance costs 30 91 0
Stock-based compensation 5,398 7,275 8,189
Change in value of derivative liability 0 117 (2,238)
Changes in assets and liabilities:      
Prepaid expenses and other current assets 66 (2) (296)
Prepaid expense - Non-current 385 385 (3,144)
Accounts payable and accrued liabilities (477) (1,044) 1,806
Accrued payroll and related expenses 139 1,156 0
Royalty payable 0 (6,100) 6,100
Related-party payable (11) (70) 81
Income tax liability (4) (8) 13
Deferred revenue 1,000 1,000 1,333
Net cash (used in) provided by operating activities (22,015) (26,408) 1,967
Cash flows from investing activities:      
Purchase of property and equipment (13) (10) (35)
Purchase of investments (10,527) (10,673) (45,500)
Proceeds from sale or maturity of investments 11,240 23,287 42,766
Net cash (used in) provided by investing activities 700 12,604 (2,769)
Cash flows from financing activities:      
Proceeds from exercise of options 20 165 278
Proceeds from exercise of warrants 0 431 9
Proceeds from sale of common stock 19,196 3,276 0
Net cash provided by financing activities 19,216 3,872 287
Net decrease in cash and cash equivalents (2,099) (9,932) (515)
Cash and cash equivalents, beginning of period 8,726 18,658 19,173
Cash and cash equivalents, end of period 6,627 8,726 18,658
Cash paid for income taxes 126 6 2
Cash paid for interest 0 0 0
Non-cash transactions      
Fair value of warrants issued for services $ 0 $ 121 $ 0
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.6.0.2
Formation and Business of the Company
12 Months Ended
Dec. 31, 2016
Formation and Business of the Company [Abstract]  
Formation and Business of the Company

Note 1 − Formation and Business of the Company

VirnetX Holding Corporation, which we refer to as” we”, “us”, “our”, “the Company” or “VirnetX”, is engaged in the business of commercializing a portfolio of patents. We seek to license our technology, including GABRIEL Connection Technology™, to various original equipment manufacturers, or OEMs, that use our technologies in the development and manufacturing of their own products within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets. Prior to 2012 our revenue was limited to an insignificant amount of software royalties pursuant to the terms of a single license agreement. During 2013 and 2012 we had revenues from settlements of patent infringement disputes whereby we received consideration for past sales of licensees that utilized our technology, where there was no prior patent license agreement (see “Revenue Recognition”).

Our portfolio of intellectual property is the foundation of our business model. We currently own approximately 49 U.S. and 69 foreign patents with approximately 50 pending patent applications worldwide. Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, M2M communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S and foreign patents and pending applications relates generally to securing communications over the internet and such covers all our technology and other products. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024. Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary; VirnetX, Inc., from Leidos, (f/k/a Science Applications International Corporation or SAIC) in 2006 and we are required to make payments to Leidos, based on cash or certain other values generated from those patents. The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 − Summary of Significant Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. The critical accounting policies we employ in the preparation of our consolidated financial statements are those which involve impairment of long-lived assets, income taxes, fair value of financial instruments and stock-based compensation.

Use of Estimates

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, “Revenue Arrangements with Multiple Deliverables.” This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, including licenses entered upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, because delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.
Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.

Deferred Revenue

In August 2013 we began receiving annual payments on a contract that requires payment to us over 4 years totaling $10,000 (“August 2013 Contract Settlement”). As of December 31, 2016, we received cash totaling $10,000, all of which is non-refundable. We recognized $1,500, $1,500 and $1,167 of revenue related to the August 2013 Contract Settlement during the years ended December 31, 2016, 2015 and 2014 respectively.

Activity under the August 2013 Contract Settlement was as follows:

2016
2015
2014
Deferred Revenue, beginning of year
$
3,000
 
$
2,000
 
$
667
 
Payment received
 
2,500
 
 
2,500
 
 
2,500
 
Less: Amount amortized as revenue
 
1,500
 
 
1,500
 
 
1,167
 
Deferred Revenue, end of year
$
4,000
 
$
3,000
 
$
2,000
 

Royalty Expense

Royalty expense for the years ended December 31, 2016, 2015 and 2014 was $884, $5,265 and $6,100, respectively and was a result of our royalty agreement with Leidos. The agreement provides for revenue sharing and legal reimbursements related to attorney time and expenses incurred by Leidos during discovery and other aspects of litigation matters that have been resolved.

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Prepaid Expenses and Other Current Assets

Prepaid Expense and Other Current Assets at December 31, 2016 includes the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. Beginning March 2014, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid Expenses-Non-current on the consolidated balance sheet.

Investments

Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized. Unrealized gains and losses on our investments are included in other comprehensive income. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. During the year ended December 31, 2016 and 2015, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing if we will realize our deferred tax assets, we consider whether it is more likely than not that some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. Consistent with our policy, and because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP. The purpose of this method is to clarify accounting for uncertain tax positions recognized. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates. We include interest and penalties, if any, in income tax expense. During the years ended December 31, 2016, 2015 and 2014, income tax expense included interest and penalties totaling $48, $0 and $11, respectively.

Derivative Instruments

Our Series I Warrants were accounted for as derivative instruments as a result of an anti-dilution provision which, in accordance with U.S. GAAP, prevented them from being considered indexed to our stock and qualified for an exception to derivative accounting. The balance of our Series I Warrants expired during the year ended December 31, 2015.

We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs net of the applicable forfeiture rate and recognize the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is generally the vesting term of 4 years. We estimate the forfeiture rate based on our historical experience if any. See Note 7 - Stock-Based Compensation for additional information concerning our share-based compensation awards.

In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.

Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during these periods.

Reclassifications

Certain prior year amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year’s presentation.

New Accounting Pronouncements

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard on our consolidated financial statements.

In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In November 2015, the FASB issued “Accounting Standards Update No. 2015-17—Income Taxes (Topic 740)”. Current GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, this Update requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. We do not expect the implementation of this ASU to have a material impact on our financial position or statement of operations.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, “Presentation of Financial Statements – Going Concern”, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The amendments in this ASU apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or results of operations.

In May 2014, the FASB issued ASU No. 2014-09 “Revenue from Contracts with Customers” (Topic 606). This ASU was subsequently amended by ASU No. 2016-10 and 2016-12. As amended, Topic 606 supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition” including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments create a new Subtopic 340-40, “Other Assets and Deferred Costs—Contracts with Customers”. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.6.0.2
Gain on Settlement
12 Months Ended
Dec. 31, 2016
Gain on Settlement [Abstract]  
Gain on Settlement

Note 3 − Gain on Settlement

In June 2010, we received a $200,000 cash settlement from litigation with Microsoft, in which we agreed to dismiss the pending lawsuits and any damages. In December 2014, we received a $23,000 cash settlement resulting from litigation with Microsoft. The 2010 settlement agreement was amended in December 2014 to settle a subsequent lawsuit with Microsoft, raising the total cash settlement with Microsoft, as amended, to $223,000. In both the original settlement and the December 2014 amendment, we could not practically and objectively separate any settlement portion from the revenue element as discussed under the guidance of Accounting Standards Codification, or ASC, 605, “Revenue Recognition”, and as a result, the settlement proceeds are classified as a gain on settlement in our consolidated statement of operations.

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.6.0.2
Property and Equipment
12 Months Ended
Dec. 31, 2016
Property and Equipment [Abstract]  
Property and Equipment

Note 4 − Property and Equipment

Our major classes of property and equipment were as follows:

December 31
2016
2015
2014
Office furniture
$
79
 
$
70
 
$
70
 
Computer equipment
 
172
 
 
168
 
 
157
 
Total
 
251
 
 
238
 
 
227
 
Less accumulated depreciation
 
(218
)
 
(190
)
 
(163
)
$
33
 
$
48
 
$
64
 

Depreciation expense for the years ended December 31, 2016, 2015 and 2014 was $28, $26 and $25, respectively.

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.6.0.2
Commitments and Related Party Transactions
12 Months Ended
Dec. 31, 2016
Commitments and Related Party Transactions [Abstract]  
Commitments and Related Party Transactions

Note 5 − Commitments and Related Party Transactions

We lease our offices under an operating lease with a third party expiring in October 2017. We recognize rent expense on a straight-line basis over the term of the lease. Rent expense was $56, for each of the years ended December 31, 2016, 2015 and 2014. Future minimum rents due under the lease total $46 in 2017, when the lease expires.

During 2016, 2015 and 2014 we leased the use of an aircraft from K2 Investment Fund LLC (“LLC”) for business travel for employees of the Company. We incurred approximately $772, $593 and $296 in rental fees (including fees and other reimbursements) to the LLC during the year ended December 31, 2016, 2015 and 2014, respectively. Our Chief Executive Officer and Chief Administrative Officer are the managing partners of the LLC and control the equity interests of the LLC. On January 31, 2015 we entered into a 12-month non-exclusive lease with the LLC for use of the plane at a rate of $8 per flight hour, with no minimum usage requirement. The agreement contains other terms and conditions normal in such transactions and can be cancelled by either us or the LLC with 30 days’ notice. The lease renews on an annual basis unless terminated by the Lessor or Lessee. Neither party has yet exercised their termination rights.

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Plan
12 Months Ended
Dec. 31, 2016
Stock Plan [Abstract]  
Stock Plan

Note 6 − Stock Plan

We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the “Plan”), which has been approved by our stockholders. The 2013 Plan provides for the issuance of up to 2,500,000 shares of our common stock. To the extent that any award should expire, become un-exercisable or is otherwise forfeited, the shares subject to such award will again become available for issuance under the 2013 Plan. The 2013 Plan provides for the granting of stock options and restricted stock purchase rights (“RSU”) to our employees and consultants. Stock options granted under the 2013 Plan may be incentive stock options or nonqualified stock options. Incentive stock options (“ISO”) may only be granted to our employees (including officers and directors). Nonqualified stock options (“NSO”) and stock purchase rights may be granted to our employees and consultants.

The 2013 Plan will expire in 2023. Options may be granted under the 2013 Plan with an exercise price determined by our Board of Directors, or a duly appointed committee thereof, provided, however, that the exercise price of an option granted to any employee shall be not less than 100% of the fair market value at the date of grant in the case of ISO or 85% of the fair market value at the date of grant in the case of an NSO. The exercise price of an ISO or NSO granted to one of our Named Executive Officers shall not be less than 100% fair market value of the shares at the date of grant and the exercise price of an ISO granted to a 10% shareholder shall not be less than 110% of the fair market value of the shares on the date of grant. Stock options granted under the 2013 Plan typically vest over four years and have a 10-year term. All RSUs are considered to be granted at the fair value of our stock on the date of grant because they have no exercise price. RSUs typically vest over four years. At December 31, 2016 there were 421,221 shares available for grant under the 2013 Plan.

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation
12 Months Ended
Dec. 31, 2016
Stock-Based Compensation [Abstract]  
Stock-Based Compensation

Note 7 − Stock-Based Compensation

The following tables summarize information about stock-options and RSUs outstanding at December 31, 2016:

Options Outstanding
Options Vested and Exercisable
Range of
Exercise Prices
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
$   0.24-   1.58 
 
771,045
 
 
2.26
 
$
1.16
 
 
771,045
 
 
2.26
 
$
1.16
 
$   1.74-   6.95 
 
3,353,901
 
 
3.66
 
 
4.74
 
 
2,558,275
 
 
2.00
 
 
4.82
 
$ 14.52- 35.25 
 
1,253,625
 
 
5.71
 
 
23.16
 
 
1,142,873
 
 
5.56
 
 
23.73
 
 
5,378,571
 
 
3.94
 
$
8.52
 
 
4,472,193
 
 
2.96
 
$
9.02
 

The following tables summarize activity under the Plan for the indicated periods:

Options
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
Outstanding at December 31, 2013
 
4,976,849
 
$
7.86
 
 
 
 
 
Options granted
 
261,500
 
 
15.21
 
 
 
 
 
Options exercised
 
(679,321
)
 
0.41
 
 
 
 
 
Options cancelled
 
(70,000
)
 
13.38
 
 
 
 
 
Outstanding at December 31, 2014
 
4,489,028
 
$
9.33
 
 
 
 
 
Options granted
 
694,000
 
 
4.47
 
 
 
 
 
Options exercised
 
(143,100
)
 
1.15
 
 
 
 
 
Options cancelled
 
(40,000
)
 
25.61
 
 
 
 
 
Outstanding at December 31, 2015
 
4,999,928
 
$
8.76
 
 
 
 
 
Options granted
 
429,000
 
 
4.77
 
 
 
 
 
Options exercised
 
(50,357
)
 
0.40
 
 
 
 
 
Options cancelled
 
 
 
 
 
 
 
 
Outstanding at December 31, 2016
 
5,378,571
 
$
8.52
 
 
3.94
 
$
810
 
Options exercisable at December 31, 2016
 
4,472,193
 
$
9.02
 
 
2.96
 
$
810
 
 
RSUs
Number of
RSUs
Weighted
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
Outstanding at December 31, 2013
 
248,915
 
$
24.10
 
$
 
RSUs granted
 
154,332
 
 
15.30
 
 
 
RSUs vested
 
(88,686
)
 
24.08
 
 
 
RSUs cancelled
 
(4,167
)
 
24.13
 
 
 
Outstanding at December 31, 2014
 
310,394
 
$
19.74
 
$
 
RSUs granted
 
162,665
 
 
5.57
 
 
 
RSUs vested
 
(113,103
)
 
20.11
 
 
 
RSUs cancelled
 
 
 
 
 
 
Outstanding at December 31, 2015
 
359,956
 
$
13.22
 
$
 
RSUs granted
 
219,331
 
 
4.75
 
 
 
RSUs vested
 
(155,852
)
 
15.27
 
 
 
RSUs cancelled
 
 
 
 
 
 
Outstanding at December 31, 2016
 
423,435
 
$
8.08
 
$
 

Intrinsic value is calculated as the difference between the per-share market price of our common stock on the last trading day of 2016, which was $2.20, and the exercise price of the options. For options exercised, the intrinsic value is the difference between market price and the exercise price on the date of exercise. We received cash proceeds of $20, $165 and $278 from stock options exercised in 2016, 2015 and 2014, respectively. The total intrinsic value of options exercised was $91, $203 and $3,575 during the years ended December 31, 2016, 2015 and 2014, respectively. For RSUs vested, the intrinsic value is the difference between market price and the vested price on the date of vest. The total intrinsic value of the RSUs vested was zero during the year ended December 31, 2016.

Stock-based compensation expense is included in general and administrative expense for each period as follows:

Stock-Based Compensation by Type of Award
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Employee stock options
$
3,436
 
$
4,939
 
$
5,951
 
RSUs
 
1,962
 
 
2,336
 
 
2,238
 
Total stock-based compensation expense
$
5,398
 
$
7,275
 
$
8,189
 

As of December 31, 2016, there was $3,805 of unrecognized stock-based compensation expense expected to be recognized related to unvested employee stock options and $2,462 of unrecognized stock-based compensation expense to be recognized related to unvested RSUs. These costs are expected to be recognized over a weighted-average period of 2.69 and 2.44 years, respectively.

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Expected stock price volatility
79.6%
82%
88%
Risk-free interest rate
1.85%
2.12%
2.56%
Expected life term (in years)
6.03 years
6.07 years
6.0 years
Expected dividends
0%
0%
0%

Based on the Black-Scholes option pricing model, the weighted average estimated fair value of employee stock options granted was $3.25, $3.17 and $11.26 per share during the years ended December 31, 2016, 2015 and 2014, respectively.

The expected life was determined using the simplified method outlined in ASC 718, “Compensation - Stock Compensation”, taking the average of the vesting term and the contractual term of the option. Expected volatility of the stock options was based upon historical data and other relevant factors, such as the volatility of comparable publicly-traded companies at a similar stage of life cycle. We have not provided an estimate for forfeitures because we have had nominal forfeited options and RSUs and believe that all outstanding options and RSUs at December 31, 2016, will vest. In the future, we may change this estimate based on actual and expected future forfeiture rates.

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.6.0.2
Earnings Per Share
12 Months Ended
Dec. 31, 2016
Earnings Per Share [Abstract]  
Earnings Per Share

Note 8 − Earnings Per Share

Basic earnings per share are based on the weighted average number of shares outstanding for a period. Diluted earnings per share are based upon the weighted average number of shares and potentially dilutive common shares outstanding. Potential common shares outstanding principally include stock options, under our stock plan and warrants. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during those periods.

The table below sets forth the basic and diluted loss per share calculations:

Year Ended December 31,
2016
2015
2014
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
Basic and diluted weighted average number of shares outstanding
 
55,985
 
 
52,384
 
 
51,570
 
Basic and diluted loss per share
$
(0.51
)
$
(0.56
)
$
(0.19
)
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.6.0.2
Common Stock
12 Months Ended
Dec. 31, 2016
Common Stock [Abstract]  
Common Stock

Note 9 − Common Stock

Each share of common stock has the right to one vote. The holders of common stock are entitled to receive dividends whenever funds are legally available and when declared by our Board of Directors, subject to the prior rights of holders of all classes of stock outstanding having priority rights as to dividends. Our restated articles of incorporation authorize us to issue up to 100,000,000 shares of $.0001 par value common stock.

On August 21, 2015 we filed a universal shelf registration statement with the SEC enabling us to offer and sell from time to time up to $100 million of equity, debt or other types of securities. We also entered into an at-the-market (“ATM”) equity offering sales agreement with Cowen & Company, LLC on August 20, 2015, under which we may offer and sell shares of our common stock having an aggregate value of up to $35 million. As of December 31, 2016, common stock with an aggregate value of up to $11,831 remains available for offer and sale under the ATM agreement.

We sold 4,760,594 and 835,056 shares of common stock under the ATM program during the year ended December 31, 2016 and 2015, respectively. The average sales price per common share sold during the year ended December 31, 2016 was $4.16 and the aggregate proceeds from the sales totaled $19,791 during the period. Sales commissions, fees and other costs associated with the ATM transactions totaled $594 for 2016. The average sales price per common share sold during the year ended December 31, 2015 was $4.04 and the aggregate proceeds from the sales totaled $3,378 during the period. Sales commissions, fees and other costs associated with the ATM totaled $101 for 2015.

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.6.0.2
Equity
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Equity

Note 10 − Equity

Warrants

During the year ended December 31, 2015 we issued warrants (“Advisor Warrants”) for the purchase of 25,000 shares of common stock for $7 per share, which expire in April 2020. The Advisor Warrants were issued for advisory services provided by a third party. Our Advisor Warrants were recorded at fair value on the issuance date and included in Additional Paid in Capital on our Consolidated Balance Sheet. The Advisor Warrants are exercisable by the holder, in whole or in part, until expiration, and may also be net-share-settled. Terms of the warrant agreement include no registration requirements for the underlying common stock and there are no anti-dilution provisions. The fair value at issuance of the warrants was recorded in Prepaid Expenses and Other Current Assets, and is being amortized over the twelve-month life of the service contract, with the expense included in Selling, General and Administrative Expense in our Consolidated Statements of Operations.

Information about the Advisor Warrants outstanding during the twelve months ended December 31, 2016 follows:

Original
Number of
Warrants
Issued
Exercise
Price per
Common
Share
Exercisable at
December 31,
2015
Became
Exercisable
Exercised
Terminated /
Cancelled /
Expired
Exercisable at
December 31,
2016
Expiration
Date
25,000
$7.00
25,000
25,000
April 2020
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.6.0.2
Employee Benefit Plan
12 Months Ended
Dec. 31, 2016
Employee Benefit Plan [Abstract]  
Employee Benefit Plan

Note 11 − Employee Benefit Plan

We sponsor a defined contribution, 401k plan, covering substantially all our employees. Our matching contribution to the plan was approximately $90, $59 and $45 in 2016, 2015 and 2014, respectively.

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes
12 Months Ended
Dec. 31, 2016
Income Taxes [Abstract]  
Income Taxes

Note 12 − Income Taxes

The income tax provision is comprised of the following:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Current:
 
 
 
 
 
 
 
 
 
Federal
$
 
$
10
 
$
(13
)
State
 
(133
)
 
(18
)
 
(2
)
Foreign
 
 
 
 
 
 
 
(133
)
 
(8
)
 
(15
)
Deferred:
 
 
 
 
 
 
 
 
 
Federal
 
 
 
 
 
 
State
 
 
 
 
 
 
Total income tax provision
$
(133
)
$
(8
)
$
(15
)

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
United States federal statutory rate
 
35.00
%
 
35.00
%
 
35.00
%
State taxes, net of federal benefit
 
(0.31
)%
 
(0.04
)%
 
(0.02
)%
Valuation allowance
 
(35.43
)%
 
(33.36
)%
 
(41.67
)%
Stock options
 
 
 
(1.62
)%
 
0.39
%
Prior year true-up
 
(0.06
)%
 
0.03
%
 
(0.13
)%
R&D Credit
 
0.66
%
 
0.38
%
 
 
Warrants
 
 
 
(0.14
)%
 
7.92
%
Other
 
(0.33
)%
 
(0.29
)%
 
(1.64
)%
Effective income tax rate
 
(0.47
)%
 
(0.04
)%
 
(0.15
)%

In 2016, 2015 and 2014, we had pre-tax losses of $28, $29 and $10 million, respectively, which are available for carry forward to offset future taxable income. We made determinations to provide full valuation allowances for our net deferred tax assets at the end of 2016, 2015 and 2014, including NOL carryforwards generated during the years, based on our evaluation of positive and negative evidence, including our history of operating losses and the uncertainty of generating future taxable income that would enable us to realize our deferred tax assets.

Deferred tax assets (liabilities) consist of the following:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Deferred tax assets:
 
 
 
 
 
 
Reserves and accruals
$
1,063
 
$
462
 
State tax
 
1
 
 
1
 
Research and development credits and other credits
 
1,092
 
 
908
 
Net operating loss carry forward
 
29,186
 
 
18,496
 
Stock based compensation
 
13,031
 
 
9,855
 
Other
 
88
 
 
102
 
Total deferred tax assets
 
44,461
 
 
29,824
 
 
 
 
 
 
 
Valuation allowance
 
(44,455
)
 
(29,814
)
Deferred tax assets after valuation allowance
 
6
 
 
10
 
 
 
 
 
 
 
Deferred tax liability:
 
 
 
 
 
 
Depreciation and amortization
 
(6
)
 
(10
)
 
 
 
 
 
 
Total deferred tax liability
 
(6
)
 
(10
)
 
 
 
 
 
 
Net deferred tax assets
$
 
$
 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible.

Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets at December 31, 2016 will not be fully realizable. Accordingly, management has maintained a full valuation allowance against its net deferred tax assets at December 31, 2016. The net change in the total valuation allowance for the 12 months ended December 31, 2016 was an increase of $14,641. At December 31, 2016, we had federal and state net operating loss carry-forwards of approximately $74,728 and $58,079, respectively, expiring beginning in 2028 and 2017, respectively. At December 31, 2016, we had federal research and development credit carry-forwards of approximately $1,092 expiring beginning in 2031.

Internal Revenue Code Section 382 places a limitation (the “Section 382 Limitation”) on the amount of taxable income that can be offset by net operating loss carry forwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California the state in which our headquarters was once located has similar rules. Our capitalization described herein may have resulted in such a change. Generally, after a control change, a loss corporation cannot deduct net operating loss carry forwards generated in years prior to the deemed change of control under IRC Section 382 in excess of the Section 382 Limitation.

We are required to recognize the financial statement effects of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. As a result, we have provided contingent reserve under ASC 740-10 of $316 and $316 at December 31, 2016, and December 31, 2015, respectively. Our tax returns are subject to review by various tax authorities. The returns subject to review are those from 2005 forward.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We have accrued interest or penalties during the 12-month period ended December 31, 2016 in the amount of $5.

A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Balance at the beginning of the year
$
316
 
$
316
 
$
316
 
Additions based on tax positions related to the current year
 
 
 
 
 
 
Additions for tax positions of prior years
 
 
 
 
 
 
Settlements
 
 
 
 
 
 
Lapse of applicable statute of limitations
 
 
 
 
 
 
Balance at the end of the year
$
316
 
$
316
 
$
316
 
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurement
12 Months Ended
Dec. 31, 2016
Fair Value Measurement [Abstract]  
Fair Value Measurement

Note 13 − Fair Value Measurement

We apply fair value accounting for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

The carrying amounts for cash and cash equivalents, investments in certificates of deposit, accounts payable and accrued expenses approximate their fair values due to the short period of time until maturity.

Mutual Funds: Valued at the quoted net asset value (NAV) of shares held.

U.S. Government and U.S. Agency securities: Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a Binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Consolidated Balance Sheet for December 31, 2014 were a warrant exercise price of $3.59 per share, a common share price of $5.49, a discount rate of 1.65%, and a volatility of 89.6%. The balance of the Series 1 Warrants expired in March 2015.

The following table shows our cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents of investments available for sale as of December 31, 2016 and 2015 (in thousands):

December 31, 2016
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash
and Cash
Equivalents
Investments
Available
for Sale
Cash
$
3,432
 
$
 
$
 
$
3,432
 
$
3,432
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds
 
3,195
 
 
 
 
 
 
3,195
 
 
3,195
 
 
 
U.S. government securities
 
1,254
 
 
 
 
 
 
1,254
 
 
 
 
1,254
 
U.S. agency securities
 
7,996
 
 
2
 
 
(3
)
 
7,995
 
 
 
 
7,995
 
 
12,445
 
 
2
 
 
(3
)
 
12,444
 
 
3,195
 
 
9,249
 
Total
$
15,877
 
$
2
 
$
(3
)
$
15,876
 
$
6,627
 
$
9,249
 
December 31, 2015
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash
and Cash
Equivalents
Investments
Available
for Sale
Cash
$
3,296
 
$
 
$
 
$
3,296
 
$
3,296
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds
 
5,005
 
 
 
 
 
 
5,005
 
 
5,005
 
 
 
U.S. government securities
 
1,806
 
 
 
 
(3
)
 
1,803
 
 
 
 
1,803
 
U.S. agency securities
 
8,579
 
 
1
 
 
(4
)
 
8,576
 
 
425
 
 
8,151
 
 
15,390
 
 
1
 
 
(7
)
 
15,384
 
 
5,430
 
 
9,954
 
Total
$
18,686
 
$
1
 
$
(7
)
$
18,680
 
$
8,726
 
$
9,954
 

The maturities of our marketable securities generally range from within one to two years. Actual maturities could differ from contractual maturities due to call or prepayment provisions.

The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2016, 2015 and 2014 (in thousands):

Fair Value Measurements Using Significant
Unobservable Inputs (Level 3)
Year ended
December 31, 2016
Year ended
December 31, 2015
Year ended
December 31, 2014
Beginning Balance
$
 
$
320
 
$
2,564
 
(Gain) losses included in net losses
 
 
 
117
 
 
(2,237
)
Settlements
 
 
 
(333
)
 
(7
)
Expiration of warrants
 
 
 
(104
)
 
 
Ending Balance
$
 
$
 
$
320
 
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.6.0.2
Litigation
12 Months Ended
Dec. 31, 2016
Litigation [Abstract]  
Litigation

Note 14 − Litigation

We have nine intellectual property infringement lawsuits pending in the United States District Court for the Eastern District of Texas, Tyler Division, and United States Court of Appeals for the Federal Circuit (“USCAFC”).

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)

On March 30, 2015, the United States Court for the Eastern District of Texas, Tyler Division, issued an order finding substantial overlap between the remanded portions of the Civil Action Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.), and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. The jury trial in this case was held on January 25, 2016. On February 4, 2016, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us $625.6 million in a verdict against Apple Inc. for infringing four of our US patents, marking it the second time a federal jury has found Apple liable for infringing VirnetX’s patented technology. The verdict includes royalties awarded to us based on an earlier patent infringement finding (Case 6:10-CV-00417-LED) against Apple. The jury found that Apple’s modified VPN On-Demand, iMessage and FaceTime services infringed VirnetX’s patents and that Apple’s infringement was willful. In addition to determining the royalty owed by Apple for its prior infringement, this verdict also includes an award based on the jury’s finding that Apple’s modified VPN On Demand, iMessage and FaceTime services have continued to infringe VirnetX’s patents. The post-trial hearing was held on May 25, 2016 in the United States Court for the Eastern District of Texas, Texarkana Division. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases (Case No. 6:10-cv-417, Docket No. 878 (“Apple I case”); Case No. 6:12-cv-855, Docket No. 220 (“Apple II case”)), ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II case will be retried after Apple I case. Events and developments subsequent to the order from the court are described to support Apple I and Apple II matters.

VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) (“Apple I”)

On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra USA. Inc. (“Aastra”), Apple, Cisco Systems, Inc. (“Cisco”), and NEC Corporation (“NEC”) in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and try only the case against Apple on the scheduled trial date. The jury trial of our case against Cisco was held on March 4, 2013. The jury in our case against Cisco came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents were denied and the case against Cisco was closed.

The jury trial of our case against Apple was held on October 31, 2012. On November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. On December 16, 2014, USCAFC denied our petition requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision and remanded the case back to the Eastern District of Texas, Tyler Division, for further proceedings consistent with its opinion. On February 25, 2015, USCAFC granted Apple’s motions to lift stay of proceedings and vacate Case 6:13-CV-00211-LED. On March 30, 2015, the court issued an order finding substantial overlap between the remanded portions of this case and the ongoing Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case.

On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case.

The jury trial in this case was held on September 26, 2016. On September 30, 2016, a Jury in the United States Court for the Eastern District of Texas, Tyler Division, in the case VirnetX Inc., et al. v. Apple Inc., No. Apple I, has awarded VirnetX $302.4 million in a verdict against Apple Corporation for infringing four VirnetX patents, marking the third time a federal jury has found Apple liable for infringing VirnetX’s patented technology.

The verdict includes royalties awarded to VirnetX, for unresolved issues in the Apple I case, remanded back from the USCAFC, related to (1) damages owed to VirnetX for infringement by Apple’s original VPN-on-Demand (VOD) and (2) the alleged infringement by Apple’s original FaceTime product, under the new claim construction of “secure communication link” pertaining to the ’504 and ’211 patents by the USCAFC, and the damages associated with that infringement. The hearing on all the post-trial motions was held on November 22, 2016. We are currently awaiting the court ruling and final judgement in this case.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) (“Apple II”)

On November 6, 2012, we filed a new complaint against Apple in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case was scheduled for October 13, 2015. On March 30, 2015, the court issued an order finding substantial overlap between this case and the remanded portions of Case 6:10-CV-00417-LED (VirnetX vs. Cisco et. al.). The court consolidated the two civil actions under Civil Action Case 6:12-CV-00855-LED (VirnetX Inc. v. Apple, Inc.) and designated it as the lead case. On July 29, 2016, the court issued a new order, vacating its previous orders consolidating the cases Apple I case and Apple II case, ordering that the two cases be retried separately, and setting the retrial date for Apple I case with jury selection to begin on September 26, 2016. The court also ordered that the issue of willfulness in both cases is bifurcated and that the Apple II will be retried after Apple I case. We are awaiting court order setting the date for a new jury trial in Apple II case.

VirnetX Inc. v. Apple, Inc. (Case 15-1934)

On July 10, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the United States Patent and Trademark Office, Patent Trial and Appeal Board (“PTAB”) in IPR2014-00237 and IPR2014-00238, related to U.S. Patent No. 8,504,697. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00238. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1211)

On September 28, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2014-00403 and IPR2014-00404 and on October 22, 2015 for IPR2014-00481 and IPR2014-00482 involving our U.S. Patent Nos. 7,188,180, and 7,987,274. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on the grounds discussed in IPR2014-00403 and IPR2014-00481. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 16-1480)

On November 30, 2015, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in inter-partes reexamination no. 95/001,949 related to U.S. Patent No. 8,051,181. The oral arguments in this case were heard on November 7, 2016. On December 9, 2016, the USCAFC affirmed the PTAB based on certain grounds. We are currently evaluating our options in this case.

VirnetX, Inc. v. Apple, Inc. (case 16-119)

On March 4, 2016, we filed a petition for writ of mandamus with the USCAFC, requesting the USCAFC’s intervention to revoke the PTAB’s decision joining Apple to IPR2015-01046 and IPR2015-01047, related to U.S. Patent Nos. 6,502,135 and 7,490,151. On March 18, 2016, the USCAFC denied the petition without prejudice to us raising the arguments on appeal after the PTAB’s final decisions. We are currently evaluating our options in this case.

VirnetX Inc. v. Apple, Inc. (Case 17-1131)

On October 31, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-00810, IPR2015-00812, on November 9, 2016 for IPR2015-00811, and on November 28, 2016 for IPR2015-00866, IPR2015-00868, IPR2015-00870, IPR2015-00871 involving our U.S. Patent Nos.8,868,705, 8,850,009, 8,458,341, 8,516,131, and 8,560,705. These appeals have been consolidated.

VirnetX Inc. v. The Mangrove Partners (Case 17-1368)

On December 16, 2016, we filed appeals with the USCAFC, appealing the invalidity findings by the PTAB in IPR2015-01046, and on December 20, 2016 for IPR2015-1047, involving our U.S. Patent Nos. 6,502,135, and 7,490,151. These appeals also involve Apple, Inc. and one of them involves Black Swamp IP, LLC.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Financial Information (unaudited)
12 Months Ended
Dec. 31, 2016
Quarterly Financial Information (unaudited) [Abstract]  
Quarterly Financial Information (unaudited)

Note 15 − Quarterly Financial Information (unaudited)

First
Second
Third
Fourth
(in thousands except per share)
2016
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
375
 
$
398
 
$
375
 
$
402
 
Loss from operations
 
(8,618
)
 
(5,353
)
 
(7,287
)
 
(7,247
)
Net loss
 
(8,610
)
 
(5,337
)
 
(7,387
)
 
(7,235
)
Basic earnings (loss) per common share
$
(0.16
)
$
(0.10
)
$
(0.13
)
$
(0.12
)
Diluted earnings (loss) per common share
$
(0.16
)
$
(0.10
)
$
(0.13
)
$
(0.12
)
First
Second
Third
Fourth
(in thousands except per share)
2015
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
375
 
$
400
 
$
375
 
$
405
 
Loss from operations
 
(5,759
)
 
(9,567
)
 
(6,102
)
 
(7,749
)
Net loss
 
(5,855
)
 
(9,546
)
 
(6,097
)
 
(7,736
)
Basic earnings (loss) per common share
$
(0.11
)
$
(0.18
)
$
(0.12
)
$
(0.15
)
Diluted earnings (loss) per common share
$
(0.11
)
$
(0.18
)
$
(0.12
)
$
(0.15
)
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”). In doing so, we have to make estimates and assumptions that affect our reported amounts of assets, liabilities, revenues, and expenses, as well as related disclosure of contingent assets and liabilities. In some cases, we could reasonably have used different accounting policies and estimates. In some cases, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ materially from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. We refer to accounting estimates of this type as critical accounting policies and estimates, which we discuss further below. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors.

Basis of Consolidation

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Revenue Recognition

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, “Revenue Arrangements with Multiple Deliverables.” This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, including licenses entered upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, because delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term. For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but generally not in advance of collection.
Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.
Deferred Revenue

Deferred Revenue

In August 2013 we began receiving annual payments on a contract that requires payment to us over 4 years totaling $10,000 (“August 2013 Contract Settlement”). As of December 31, 2016, we received cash totaling $10,000, all of which is non-refundable. We recognized $1,500, $1,500 and $1,167 of revenue related to the August 2013 Contract Settlement during the years ended December 31, 2016, 2015 and 2014 respectively.

Activity under the August 2013 Contract Settlement was as follows:

2016
2015
2014
Deferred Revenue, beginning of year
$
3,000
 
$
2,000
 
$
667
 
Payment received
 
2,500
 
 
2,500
 
 
2,500
 
Less: Amount amortized as revenue
 
1,500
 
 
1,500
 
 
1,167
 
Deferred Revenue, end of year
$
4,000
 
$
3,000
 
$
2,000
 
Royalty Expense

Royalty Expense

Royalty expense for the years ended December 31, 2016, 2015 and 2014 was $884, $5,265 and $6,100, respectively and was a result of our royalty agreement with Leidos. The agreement provides for revenue sharing and legal reimbursements related to attorney time and expenses incurred by Leidos during discovery and other aspects of litigation matters that have been resolved.

Cash and Cash Equivalents

Cash and Cash Equivalents

We consider all highly liquid investments purchased with original maturities of three months or less at the date of purchase to be cash equivalents. Our cash and cash equivalents are not subject to significant interest rate risk due to the short maturities of these investments.

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

Prepaid Expense and Other Current Assets at December 31, 2016 includes the current portion of prepaid rent for a facility lease for corporate promotional and marketing purposes. Beginning March 2014, the prepayment totaling $4,000 is being amortized over the 10-year term of the lease. The unamortized non-current portion of the prepayment is included in Prepaid Expenses-Non-current on the consolidated balance sheet.

Investments

Investments

Investments are classified as available-for-sale and are recorded at fair market value. Unrealized gains and losses are reported as other comprehensive income. Realized gains and losses are recorded in income in the period they are realized. Unrealized gains and losses on our investments are included in other comprehensive income. We invest our excess cash primarily in highly liquid debt instruments including corporate, government and federal agency securities, with contractual maturities less than two years. By policy, we limit the amount of credit exposure to any one issuer.

Property and Equipment

Property and Equipment

Property and equipment are stated at historical cost, less accumulated depreciation and amortization. Depreciation and amortization are computed using the accelerated and straight line methods over the estimated useful lives of the assets, which range from five to seven years. Repair and maintenance costs are charged to expense as incurred.

Concentration of Credit Risk and Other Risks and Uncertainties

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits. A portion of those balances are insured by the Federal Deposit Insurance Corporation, or FDIC. During the year ended December 31, 2016 and 2015, we had, at times, funds that were uninsured. We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We have not experienced any losses on our deposits of cash and cash equivalents.

Fair Value

Fair Value

The carrying amounts of our financial instruments, including cash equivalents, accounts payable, and accrued liabilities, approximate fair value because of their generally short maturities.

Intangible Assets

Intangible Assets

We record intangible assets at cost, less accumulated amortization. Amortization of intangible assets is provided over their estimated useful lives, which can range from 3 to 15 years, on either a straight-line basis or as revenue is generated by the assets.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

We identify and record impairment losses on long-lived assets used in operations when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable, but not less than annually. Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Research and Development

Research and Development

Research and development costs include expenses paid to outside development consultants and compensation related expenses for our engineering staff. Research and development costs are expensed as incurred.

Income Taxes

Income Taxes

We account for income taxes using the asset and liability method. The asset and liability method requires the recognition of deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between the tax basis and financial reporting basis of our assets and liabilities. We calculate current and deferred tax provisions based on estimates and assumptions that could differ from actual results reflected on the income tax returns filed during the following years. Adjustments based on filed returns are recorded when identified in the subsequent years. The effect on deferred taxes for a change in tax rates is recognized in income in the period that the tax rate change is enacted. In assessing if we will realize our deferred tax assets, we consider whether it is more likely than not that some portion of the deferred tax assets will not be realized.

A valuation allowance is provided for deferred income tax assets when, in our judgment, based upon currently available information and other factors, it is more likely than not that all or a portion of such deferred income tax assets will not be realized. The determination of the need for a valuation allowance is based on an on-going evaluation of current information including, among other things, historical operating results, estimates of future earnings in different taxing jurisdictions and the expected timing of the reversals of temporary differences. We believe the determination to record a valuation allowance to reduce a deferred income tax asset is a significant accounting estimate because it is based, among other things, on an estimate of future taxable income in the United States and certain other jurisdictions, which is susceptible to change and may or may not occur, and because the impact of adjusting a valuation allowance may be material. In determining when to release the valuation allowance established against our net deferred income tax assets, we consider all available evidence, both positive and negative. Consistent with our policy, and because of our history of operating losses, we do not currently recognize the benefit of all of our deferred tax assets, including tax loss carry forwards, that may be used to offset future taxable income. We continually assess our ability to generate sufficient taxable income during future periods in which our deferred tax assets may be realized. If and when we believe it is more likely than not that we will recover our deferred tax assets, we will reverse the valuation allowance as an income tax benefit in our statements of operations.

We account for our uncertain tax positions in accordance with U.S. GAAP. The purpose of this method is to clarify accounting for uncertain tax positions recognized. The U.S. GAAP method of accounting for uncertain tax positions utilizes a two-step approach to evaluate tax positions. Step one, recognition, requires evaluation of the tax position to determine if based solely on technical merits it is more likely than not to be sustained upon examination. Step two, measurement, is addressed only if a position is more likely than not to be sustained. In step two, the tax benefit is measured as the largest amount of benefit, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement with tax authorities. If a position does not meet the more likely than not threshold for recognition in step one, no benefit is recorded until the first subsequent period in which the more likely than not standard is met, the issue is resolved with the taxing authority, or the statute of limitations expires. Positions previously recognized are derecognized when we subsequently determine the position no longer is more likely than not to be sustained. Evaluation of tax positions, their technical merits, and measurements using cumulative probability are highly subjective management estimates. Actual results could differ materially from these estimates. We include interest and penalties, if any, in income tax expense. During the years ended December 31, 2016, 2015 and 2014, income tax expense included interest and penalties totaling $48, $0 and $11, respectively.

Derivative Instruments

Derivative Instruments

Our Series I Warrants were accounted for as derivative instruments as a result of an anti-dilution provision which, in accordance with U.S. GAAP, prevented them from being considered indexed to our stock and qualified for an exception to derivative accounting. The balance of our Series I Warrants expired during the year ended December 31, 2015.

We recognize derivative instruments as either assets or liabilities on the accompanying Consolidated Balance Sheets at fair value. We record changes in the fair value (i.e., gains or losses) of the derivatives in the accompanying Consolidated Statements of Operations.

Stock-Based Compensation

Stock-Based Compensation

We account for stock-based compensation using the fair value recognition method in accordance with U.S. GAAP. We recognize these compensation costs net of the applicable forfeiture rate and recognize the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is generally the vesting term of 4 years. We estimate the forfeiture rate based on our historical experience if any. See Note 7 - Stock-Based Compensation for additional information concerning our share-based compensation awards.

In addition, as required we record stock and options granted to non-employees at fair value of the consideration received or the fair value of the equity instruments issued as they vest over the performance period.

Earnings Per Share

Earnings per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. During 2016, 2015 and 2014 we incurred losses; therefore, the effect of any common stock equivalent would be anti-dilutive during these periods.

Reclassifications

Reclassifications

Certain prior year amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year’s presentation.

New Accounting Pronouncements

New Accounting Pronouncements

In August 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. This update addresses a diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows under Topic 230, Statement of Cash Flows, and other Topics. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or statement of operations.

In June 2016, the FASB issued ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. This ASU is effective for interim and annual reporting periods beginning after December 15, 2019. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 will be effective for the Company beginning in its first quarter of 2018. We are currently evaluating the impact of adopting the new stock compensation standard on our consolidated financial statements.

In February 2016, FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. For public companies, ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, and requires a modified retrospective adoption, with early adoption permitted. We are evaluating the impact this guidance will have on our financial position and statement of operations.

In November 2015, the FASB issued “Accounting Standards Update No. 2015-17—Income Taxes (Topic 740)”. Current GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, this Update requires that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this Update apply to all entities that present a classified statement of financial position. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendments in this Update. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. We do not expect the implementation of this ASU to have a material impact on our financial position or statement of operations.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, “Presentation of Financial Statements – Going Concern”, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The amendments in this ASU apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We adopted this ASU in 2016 and the implementation did not have a material impact on our financial position or results of operations.

In May 2014, the FASB issued ASU No. 2014-09 “Revenue from Contracts with Customers” (Topic 606). This ASU was subsequently amended by ASU No. 2016-10 and 2016-12. As amended, Topic 606 supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition” including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments create a new Subtopic 340-40, “Other Assets and Deferred Costs—Contracts with Customers”. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

XML 39 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]  
Activity under August 2013 Contract Settlement

Activity under the August 2013 Contract Settlement was as follows:

2016
2015
2014
Deferred Revenue, beginning of year
$
3,000
 
$
2,000
 
$
667
 
Payment received
 
2,500
 
 
2,500
 
 
2,500
 
Less: Amount amortized as revenue
 
1,500
 
 
1,500
 
 
1,167
 
Deferred Revenue, end of year
$
4,000
 
$
3,000
 
$
2,000
 
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.6.0.2
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2016
Property and Equipment [Abstract]  
Classes of Property and Equipment

Our major classes of property and equipment were as follows:

December 31
2016
2015
2014
Office furniture
$
79
 
$
70
 
$
70
 
Computer equipment
 
172
 
 
168
 
 
157
 
Total
 
251
 
 
238
 
 
227
 
Less accumulated depreciation
 
(218
)
 
(190
)
 
(163
)
$
33
 
$
48
 
$
64
 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2016
Stock-Based Compensation [Abstract]  
Information about Stock Options Outstanding

The following tables summarize information about stock-options and RSUs outstanding at December 31, 2016:

Options Outstanding
Options Vested and Exercisable
Range of
Exercise Prices
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
$   0.24-   1.58 
 
771,045
 
 
2.26
 
$
1.16
 
 
771,045
 
 
2.26
 
$
1.16
 
$   1.74-   6.95 
 
3,353,901
 
 
3.66
 
 
4.74
 
 
2,558,275
 
 
2.00
 
 
4.82
 
$ 14.52- 35.25 
 
1,253,625
 
 
5.71
 
 
23.16
 
 
1,142,873
 
 
5.56
 
 
23.73
 
 
5,378,571
 
 
3.94
 
$
8.52
 
 
4,472,193
 
 
2.96
 
$
9.02
 
Stock Option Activity

The following tables summarize activity under the Plan for the indicated periods:

Options
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
Outstanding at December 31, 2013
 
4,976,849
 
$
7.86
 
 
 
 
 
Options granted
 
261,500
 
 
15.21
 
 
 
 
 
Options exercised
 
(679,321
)
 
0.41
 
 
 
 
 
Options cancelled
 
(70,000
)
 
13.38
 
 
 
 
 
Outstanding at December 31, 2014
 
4,489,028
 
$
9.33
 
 
 
 
 
Options granted
 
694,000
 
 
4.47
 
 
 
 
 
Options exercised
 
(143,100
)
 
1.15
 
 
 
 
 
Options cancelled
 
(40,000
)
 
25.61
 
 
 
 
 
Outstanding at December 31, 2015
 
4,999,928
 
$
8.76
 
 
 
 
 
Options granted
 
429,000
 
 
4.77
 
 
 
 
 
Options exercised
 
(50,357
)
 
0.40
 
 
 
 
 
Options cancelled
 
 
 
 
 
 
 
 
Outstanding at December 31, 2016
 
5,378,571
 
$
8.52
 
 
3.94
 
$
810
 
Options exercisable at December 31, 2016
 
4,472,193
 
$
9.02
 
 
2.96
 
$
810
 
Restricted Stock Units Activity
RSUs
Number of
RSUs
Weighted
Average
Grant Date
Fair Value
Aggregate
Intrinsic
Value
Outstanding at December 31, 2013
 
248,915
 
$
24.10
 
$
 
RSUs granted
 
154,332
 
 
15.30
 
 
 
RSUs vested
 
(88,686
)
 
24.08
 
 
 
RSUs cancelled
 
(4,167
)
 
24.13
 
 
 
Outstanding at December 31, 2014
 
310,394
 
$
19.74
 
$
 
RSUs granted
 
162,665
 
 
5.57
 
 
 
RSUs vested
 
(113,103
)
 
20.11
 
 
 
RSUs cancelled
 
 
 
 
 
 
Outstanding at December 31, 2015
 
359,956
 
$
13.22
 
$
 
RSUs granted
 
219,331
 
 
4.75
 
 
 
RSUs vested
 
(155,852
)
 
15.27
 
 
 
RSUs cancelled
 
 
 
 
 
 
Outstanding at December 31, 2016
 
423,435
 
$
8.08
 
$
 
Stock-Based Compensation by Type of Award

Stock-based compensation expense is included in general and administrative expense for each period as follows:

Stock-Based Compensation by Type of Award
Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Employee stock options
$
3,436
 
$
4,939
 
$
5,951
 
RSUs
 
1,962
 
 
2,336
 
 
2,238
 
Total stock-based compensation expense
$
5,398
 
$
7,275
 
$
8,189
 
Fair Value Assumptions

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option pricing model using the following weighted average assumptions:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Expected stock price volatility
79.6%
82%
88%
Risk-free interest rate
1.85%
2.12%
2.56%
Expected life term (in years)
6.03 years
6.07 years
6.0 years
Expected dividends
0%
0%
0%
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.6.0.2
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2016
Earnings Per Share [Abstract]  
Basic and Diluted Loss Per Share Calculations

The table below sets forth the basic and diluted loss per share calculations:

Year Ended December 31,
2016
2015
2014
Net loss
$
(28,569
)
$
(29,234
)
$
(9,902
)
Basic and diluted weighted average number of shares outstanding
 
55,985
 
 
52,384
 
 
51,570
 
Basic and diluted loss per share
$
(0.51
)
$
(0.56
)
$
(0.19
)
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.6.0.2
Equity (Tables)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Information about Warrants Outstanding

Information about the Advisor Warrants outstanding during the twelve months ended December 31, 2016 follows:

Original
Number of
Warrants
Issued
Exercise
Price per
Common
Share
Exercisable at
December 31,
2015
Became
Exercisable
Exercised
Terminated /
Cancelled /
Expired
Exercisable at
December 31,
2016
Expiration
Date
25,000
$7.00
25,000
25,000
April 2020
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2016
Income Taxes [Abstract]  
Components of Income Tax Expense (Benefit)

The income tax provision is comprised of the following:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Current:
 
 
 
 
 
 
 
 
 
Federal
$
 
$
10
 
$
(13
)
State
 
(133
)
 
(18
)
 
(2
)
Foreign
 
 
 
 
 
 
 
(133
)
 
(8
)
 
(15
)
Deferred:
 
 
 
 
 
 
 
 
 
Federal
 
 
 
 
 
 
State
 
 
 
 
 
 
Total income tax provision
$
(133
)
$
(8
)
$
(15
)
Effective Income Tax Rate Reconciliation

A reconciliation of the United States federal statutory income tax rate to our effective income tax rate is as follows:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
United States federal statutory rate
 
35.00
%
 
35.00
%
 
35.00
%
State taxes, net of federal benefit
 
(0.31
)%
 
(0.04
)%
 
(0.02
)%
Valuation allowance
 
(35.43
)%
 
(33.36
)%
 
(41.67
)%
Stock options
 
 
 
(1.62
)%
 
0.39
%
Prior year true-up
 
(0.06
)%
 
0.03
%
 
(0.13
)%
R&D Credit
 
0.66
%
 
0.38
%
 
 
Warrants
 
 
 
(0.14
)%
 
7.92
%
Other
 
(0.33
)%
 
(0.29
)%
 
(1.64
)%
Effective income tax rate
 
(0.47
)%
 
(0.04
)%
 
(0.15
)%
Deferred Tax Assets and Liabilities

Deferred tax assets (liabilities) consist of the following:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Deferred tax assets:
 
 
 
 
 
 
Reserves and accruals
$
1,063
 
$
462
 
State tax
 
1
 
 
1
 
Research and development credits and other credits
 
1,092
 
 
908
 
Net operating loss carry forward
 
29,186
 
 
18,496
 
Stock based compensation
 
13,031
 
 
9,855
 
Other
 
88
 
 
102
 
Total deferred tax assets
 
44,461
 
 
29,824
 
 
 
 
 
 
 
Valuation allowance
 
(44,455
)
 
(29,814
)
Deferred tax assets after valuation allowance
 
6
 
 
10
 
 
 
 
 
 
 
Deferred tax liability:
 
 
 
 
 
 
Depreciation and amortization
 
(6
)
 
(10
)
 
 
 
 
 
 
Total deferred tax liability
 
(6
)
 
(10
)
 
 
 
 
 
 
Net deferred tax assets
$
 
$
 
Unrecognized Tax Benefits Reconciliation

A reconciliation of beginning and ending amounts of unrecognized tax benefits follows:

Year Ended
December 31, 2016
Year Ended
December 31, 2015
Year Ended
December 31, 2014
Balance at the beginning of the year
$
316
 
$
316
 
$
316
 
Additions based on tax positions related to the current year
 
 
 
 
 
 
Additions for tax positions of prior years
 
 
 
 
 
 
Settlements
 
 
 
 
 
 
Lapse of applicable statute of limitations
 
 
 
 
 
 
Balance at the end of the year
$
316
 
$
316
 
$
316
 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2016
Fair Value Measurement [Abstract]  
Cash and Available-for-Sale Securities Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Significant Investment Category

The following table shows our cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents of investments available for sale as of December 31, 2016 and 2015 (in thousands):

December 31, 2016
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash
and Cash
Equivalents
Investments
Available
for Sale
Cash
$
3,432
 
$
 
$
 
$
3,432
 
$
3,432
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds
 
3,195
 
 
 
 
 
 
3,195
 
 
3,195
 
 
 
U.S. government securities
 
1,254
 
 
 
 
 
 
1,254
 
 
 
 
1,254
 
U.S. agency securities
 
7,996
 
 
2
 
 
(3
)
 
7,995
 
 
 
 
7,995
 
 
12,445
 
 
2
 
 
(3
)
 
12,444
 
 
3,195
 
 
9,249
 
Total
$
15,877
 
$
2
 
$
(3
)
$
15,876
 
$
6,627
 
$
9,249
 
December 31, 2015
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash
and Cash
Equivalents
Investments
Available
for Sale
Cash
$
3,296
 
$
 
$
 
$
3,296
 
$
3,296
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds
 
5,005
 
 
 
 
 
 
5,005
 
 
5,005
 
 
 
U.S. government securities
 
1,806
 
 
 
 
(3
)
 
1,803
 
 
 
 
1,803
 
U.S. agency securities
 
8,579
 
 
1
 
 
(4
)
 
8,576
 
 
425
 
 
8,151
 
 
15,390
 
 
1
 
 
(7
)
 
15,384
 
 
5,430
 
 
9,954
 
Total
$
18,686
 
$
1
 
$
(7
)
$
18,680
 
$
8,726
 
$
9,954
 
Summary of Changes in Fair Value of Level 3 Liabilities

The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the year ended December 31, 2016, 2015 and 2014 (in thousands):

Fair Value Measurements Using Significant
Unobservable Inputs (Level 3)
Year ended
December 31, 2016
Year ended
December 31, 2015
Year ended
December 31, 2014
Beginning Balance
$
 
$
320
 
$
2,564
 
(Gain) losses included in net losses
 
 
 
117
 
 
(2,237
)
Settlements
 
 
 
(333
)
 
(7
)
Expiration of warrants
 
 
 
(104
)
 
 
Ending Balance
$
 
$
 
$
320
 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Financial Information (unaudited) (Tables)
12 Months Ended
Dec. 31, 2016
Quarterly Financial Information (unaudited) [Abstract]  
Quarterly Financial Information
First
Second
Third
Fourth
(in thousands except per share)
2016
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
375
 
$
398
 
$
375
 
$
402
 
Loss from operations
 
(8,618
)
 
(5,353
)
 
(7,287
)
 
(7,247
)
Net loss
 
(8,610
)
 
(5,337
)
 
(7,387
)
 
(7,235
)
Basic earnings (loss) per common share
$
(0.16
)
$
(0.10
)
$
(0.13
)
$
(0.12
)
Diluted earnings (loss) per common share
$
(0.16
)
$
(0.10
)
$
(0.13
)
$
(0.12
)
First
Second
Third
Fourth
(in thousands except per share)
2015
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
375
 
$
400
 
$
375
 
$
405
 
Loss from operations
 
(5,759
)
 
(9,567
)
 
(6,102
)
 
(7,749
)
Net loss
 
(5,855
)
 
(9,546
)
 
(6,097
)
 
(7,736
)
Basic earnings (loss) per common share
$
(0.11
)
$
(0.18
)
$
(0.12
)
$
(0.15
)
Diluted earnings (loss) per common share
$
(0.11
)
$
(0.18
)
$
(0.12
)
$
(0.15
)
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.6.0.2
Formation and Business of the Company (Details)
Dec. 31, 2016
Patent
Finite-Lived Intangible Assets [Line Items]  
Number of pending patent applications 50
Patents [Member] | U.S. [Member]  
Finite-Lived Intangible Assets [Line Items]  
Number of patents owned 49
Patents [Member] | Foreign [Member]  
Finite-Lived Intangible Assets [Line Items]  
Number of patents owned 69
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2016
USD ($)
Institution
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Mar. 31, 2014
USD ($)
Patent License Agreements [Abstract]        
Threshold period of payment of fees after delivery for fees to be generally presumed not to be fixed or determinable, and for revenue to be deferred and recognized as earned 12 months      
Activity under August 2013 contract settlement [Roll Forward]        
Deferred Revenue, beginning of period $ 3,000 $ 2,000 $ 667  
Payment received 2,500 2,500 2,500  
Less: Amount amortized as revenue 1,500 1,500 1,167  
Deferred Revenue, end of period 4,000 3,000 2,000  
Royalty Expense [Abstract]        
Royalties expense as a result of royalty agreement with Leidos $ 884 5,265 6,100  
Prepaid Expense and Other Assets, Current [Abstract]        
Prepayment of facility lease for corporate promotional and marketing purposes       $ 4,000
Lease term 10 years      
Concentration of Credit Risk and Others Risks and Uncertainties [Abstract]        
Number of financial institutions holding company's cash | Institution 2      
Income Taxes [Abstract]        
Interest and penalties included in income tax expense $ 48 $ 0 $ 11  
Stock-Based Compensation [Abstract]        
Option vesting term 4 years      
Minimum [Member]        
Property and Equipment [Abstract]        
Useful lives 5 years      
Finite-Lived Intangible Assets [Line Items]        
Estimated useful lives 3 years      
Maximum [Member]        
Property and Equipment [Abstract]        
Useful lives 7 years      
Finite-Lived Intangible Assets [Line Items]        
Estimated useful lives 15 years      
Highly Liquid Debt Investments [Member] | Maximum [Member]        
Schedule of Available-for-sale Securities [Line Items]        
Contractual maturities of investment securities 2 years      
August 2013 Contract [Member]        
Deferred Revenue [Abstract]        
Contract amount $ 10,000      
Term of contract 4 years      
Non-refundable cash payment received to date $ 10,000      
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.6.0.2
Gain on Settlement (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended 55 Months Ended
Dec. 31, 2014
Jun. 30, 2010
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2014
Gain on Settlement [Abstract]            
Cash settlement resulting from litigation $ 23,000 $ 200,000 $ 0 $ 0 $ 23,000 $ 223,000
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.6.0.2
Property and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Property and Equipment [Line Items]      
Property and equipment, gross $ 251 $ 238 $ 227
Less accumulated depreciation (218) (190) (163)
Property and equipment, net 33 48 64
Depreciation expense 28 26 25
Office Furniture [Member]      
Property and Equipment [Line Items]      
Property and equipment, gross 79 70 70
Computer Equipment [Member]      
Property and Equipment [Line Items]      
Property and equipment, gross $ 172 $ 168 $ 157
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.6.0.2
Commitments and Related Party Transactions (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating Leased Assets [Line Items]      
Rent expense $ 56 $ 56 $ 56
Future minimum rents due in 2017 $ 46    
Term of lease 10 years    
Offices [Member]      
Operating Leased Assets [Line Items]      
Operating lease expiring date Oct. 31, 2017    
K2 Investment Fund LLC [Member] | Aircraft [Member]      
Operating Leased Assets [Line Items]      
Rental fees incurred for use of plane $ 772 $ 593 $ 296
Term of lease 12 months    
Rate of aircraft lease (in dollars per flight hour) $ 8    
Term of notice for cancellation of lease 30 days    
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Plan (Details)
12 Months Ended
Dec. 31, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period 4 years
2013 Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of shares authorized (in shares) 2,500,000
Shares available for grant (in shares) 421,221
2013 Plan [Member] | Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Term of award 10 years
Vesting period 4 years
2013 Plan [Member] | Stock Options [Member] | Named Executive Officers [Member] | Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price of option granted as percentage of fair market value of shares at date of grant 100.00%
2013 Plan [Member] | Stock Options [Member] | 10% Shareholder [Member] | Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price of option granted as percentage of fair market value of shares at date of grant 110.00%
2013 Plan [Member] | Incentive Stock Options [Member] | Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price of option granted as percentage of fair market value of shares at date of grant 100.00%
2013 Plan [Member] | Nonqualified Stock Options [Member] | Minimum [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price of option granted as percentage of fair market value of shares at date of grant 85.00%
2013 Plan [Member] | Restricted Stock Purchase Rights ("RSU") [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period 4 years
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation, Information about Stock Options Outstanding (Details) - Stock Options [Member]
12 Months Ended
Dec. 31, 2016
$ / shares
shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options outstanding, number outstanding (in shares) | shares 5,378,571
Options outstanding, weighted average remaining contractual life 3 years 11 months 8 days
Options outstanding, weighted average exercise price (in dollars per share) $ 8.52
Options vested and exercisable, number exercisable (in shares) | shares 4,472,193
Options vested and exercisable, weighted average remaining contractual life 2 years 11 months 16 days
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 9.02
$0.24 - 1.58 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Exercise price range, lower range limit (in dollars per share) 0.24
Exercise price range, upper range limit (in dollars per share) $ 1.58
Options outstanding, number outstanding (in shares) | shares 771,045
Options outstanding, weighted average remaining contractual life 2 years 3 months 4 days
Options outstanding, weighted average exercise price (in dollars per share) $ 1.16
Options vested and exercisable, number exercisable (in shares) | shares 771,045
Options vested and exercisable, weighted average remaining contractual life 2 years 3 months 4 days
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 1.16
$1.74 - 6.95 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Exercise price range, lower range limit (in dollars per share) 1.74
Exercise price range, upper range limit (in dollars per share) $ 6.95
Options outstanding, number outstanding (in shares) | shares 3,353,901
Options outstanding, weighted average remaining contractual life 3 years 7 months 28 days
Options outstanding, weighted average exercise price (in dollars per share) $ 4.74
Options vested and exercisable, number exercisable (in shares) | shares 2,558,275
Options vested and exercisable, weighted average remaining contractual life 2 years
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 4.82
$14.52 - 35.25 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Exercise price range, lower range limit (in dollars per share) 14.52
Exercise price range, upper range limit (in dollars per share) $ 35.25
Options outstanding, number outstanding (in shares) | shares 1,253,625
Options outstanding, weighted average remaining contractual life 5 years 8 months 16 days
Options outstanding, weighted average exercise price (in dollars per share) $ 23.16
Options vested and exercisable, number exercisable (in shares) | shares 1,142,873
Options vested and exercisable, weighted average remaining contractual life 5 years 6 months 22 days
Options vested and exercisable, weighted average exercise price (in dollars per share) $ 23.73
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation, Summary of Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Options, additional disclosures [Abstract]        
Per share market price of common stock on last trading day of year (in dollars per share) $ 2.20      
Proceeds from exercise of options $ 20 $ 165 $ 278  
Stock Options [Member]        
Options, number of shares [Roll Forward]        
Outstanding, beginning of period (in shares) 4,999,928 4,489,028 4,976,849  
Options granted (in shares) 429,000 694,000 261,500  
Options exercised (in shares) (50,357) (143,100) (679,321)  
Options cancelled (in shares) 0 (40,000) (70,000)  
Outstanding, end of period (in shares) 5,378,571 4,999,928 4,489,028  
Options exercisable, end of period (in shares) 4,472,193      
Options, weighted average exercise price [Roll Forward]        
Outstanding, beginning of period (in dollars per share) $ 8.76 $ 9.33 $ 7.86  
Options granted (in dollars per share) 4.77 4.47 15.21  
Options exercised (in dollars per share) 0.40 1.15 0.41  
Options cancelled (in dollars per share) 0 25.61 13.38  
Outstanding, end of period (in dollars per share) 8.52 $ 8.76 $ 9.33  
Options exercisable, end of period (in dollars per share) $ 9.02      
Options, additional disclosures [Abstract]        
Options outstanding, weighted average remaining contractual life 3 years 11 months 8 days      
Options exercisable, weighted average remaining contractual life 2 years 11 months 16 days      
Options outstanding, aggregate intrinsic value $ 810      
Options exercisable, aggregate intrinsic value 810      
Proceeds from exercise of options 20 $ 165 $ 278  
Total intrinsic value of options exercised $ 91 $ 203 $ 3,575  
Restricted Stock Units (RSUs) [Member]        
RSUs, number of RSUs [Roll Forward]        
Outstanding, beginning of period (in shares) 359,956 310,394 248,915  
RSUs granted (in shares) 219,331 162,665 154,332  
RSUs vested (in shares) (155,852) (113,103) (88,686)  
RSUs cancelled (in shares) 0 0 (4,167)  
Outstanding, end of period (in shares) 423,435 359,956 310,394  
RSUs, weighted average grant date fair value [Abstract]        
Outstanding, beginning of period (in dollars per share) $ 13.22 $ 19.74 $ 24.10  
RSUs granted (in dollars per share) 4.75 5.57 15.30  
RSUs vested (in dollars per share) 15.27 20.11 24.08  
RSUs cancelled (in dollars per share) 0 0 24.13  
Outstanding, end of period (in dollars per share) $ 8.08 $ 13.22 $ 19.74  
RSUs, aggregate intrinsic value [Abstract]        
Outstanding, end of period $ 0 $ 0 $ 0 $ 0
Total intrinsic value of RSUs vested $ 0      
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation expense $ 5,398 $ 7,275 $ 8,189
General and Administrative Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation expense 5,398 7,275 8,189
Employee Stock Options [Member]      
Compensation cost not yet recognized [Abstract]      
Unrecognized stock-based compensation expense expected to be recognized $ 3,805    
Weighted-average period for recognition of unrecognized stock-based compensation expense 2 years 8 months 8 days    
Employee Stock Options [Member] | General and Administrative Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation expense $ 3,436 4,939 5,951
Restricted Stock Units (RSUs) [Member]      
Compensation cost not yet recognized [Abstract]      
Unrecognized stock-based compensation expense expected to be recognized $ 2,462    
Weighted-average period for recognition of unrecognized stock-based compensation expense 2 years 5 months 8 days    
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation expense $ 1,962 $ 2,336 $ 2,238
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-Based Compensation, Fair Value Assumptions Used (Details) - $ / shares
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Fair value assumptions used in estimating fair value of each option grant [Abstract]      
Expected stock price volatility 79.60% 82.00% 88.00%
Risk-free interest rate 1.85% 2.12% 2.56%
Expected life term 6 years 11 days 6 years 25 days 6 years
Expected dividends 0.00% 0.00% 0.00%
Options granted, weighted average grant date fair value (in dollars per share) $ 3.25 $ 3.17 $ 11.26
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.6.0.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Calculation of basic and diluted loss per share [Abstract]                      
Net loss $ (7,235) $ (7,387) $ (5,337) $ (8,610) $ (7,736) $ (6,097) $ (9,546) $ (5,855) $ (28,569) $ (29,234) $ (9,902)
Basic and diluted weighted average number of shares outstanding (in shares)                 55,984,825 52,384,494 51,570,472
Basic and diluted loss per share (in dollars per share)                 $ (0.51) $ (0.56) $ (0.19)
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
Common Stock (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
USD ($)
Vote
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Aug. 21, 2015
USD ($)
Aug. 20, 2015
USD ($)
Subsidiary, Sale of Stock [Line Items]        
Common stock, voting rights Each share of common stock has the right to one vote      
Number of votes entitled to each share of common stock | Vote 1      
Common stock, shares authorized (in shares) | shares 100,000,000 100,000,000    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001 $ 0.0001    
Universal Shelf Registration Statement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Securities offered for sale, aggregate value     $ 100,000  
ATM Agreement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Securities offered for sale, aggregate value       $ 35,000
Aggregate value of common stock available for offer and sale $ 11,831      
Number of shares of common stock sold (in shares) | shares 4,760,594 835,056    
Average sales price per common share (in dollars per share) | $ / shares $ 4.16 $ 4.04    
Aggregate proceeds from sales of common stock $ 19,791 $ 3,378    
Sales commissions, fees and other costs associated with issuance of common stock $ 594 $ 101    
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.6.0.2
Equity (Details) - $ / shares
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Warrants [Abstract]      
Exercise Price per Common Share (in dollars per share)   $ 3.59 $ 3.59
Advisor Warrants [Member]      
Class of Warrant or Right [Line Items]      
Life of service contract 12 months    
Warrants [Member] | Advisor Warrants [Member]      
Warrants [Abstract]      
Original Number of Warrants Issued (in shares) 25,000    
Exercise Price per Common Share (in dollars per share) $ 7.00    
Exercisable, beginning of period (in shares) 25,000    
Became Exercisable (in shares) 0    
Exercised (in shares) 0    
Terminated/Cancelled/Expired (in shares) 0    
Exercisable, end of period (in shares) 25,000 25,000  
Expiration date April 30, 2020    
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.6.0.2
Employee Benefit Plan (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Employee Benefit Plan [Abstract]      
Matching contribution to defined contribution plan $ 90 $ 59 $ 45
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes, Components of Benefit (Provision) for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Current [Abstract]      
Federal $ 0 $ 10 $ (13)
State (133) (18) (2)
Foreign 0 0 0
Current income taxes (133) (8) (15)
Deferred [Abstract]      
Federal 0 0 0
State 0 0 0
Total income tax provision $ (133) $ (8) $ (15)
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Effective Tax Rate Reconciliation [Abstract]      
United States federal statutory rate 35.00% 35.00% 35.00%
State taxes, net of federal benefit (0.31%) (0.04%) (0.02%)
Valuation allowance (35.43%) (33.36%) (41.67%)
Stock options 0.00% (1.62%) 0.39%
Prior year true-up (0.06%) 0.03% (0.13%)
R&D Credit 0.66% 0.38% 0.00%
Warrants 0.00% (0.14%) 7.92%
Other (0.33%) (0.29%) (1.64%)
Effective income tax rate (0.47%) (0.04%) (0.15%)
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes, Net Operating Losses (Details) - USD ($)
$ in Millions
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Taxes [Abstract]      
Pre-tax losses available for carry forward $ 28 $ 29 $ 10
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Deferred tax assets [Abstract]    
Reserves and accruals $ 1,063 $ 462
State tax 1 1
Research and development credits and other credits 1,092 908
Net operating loss carry forward 29,186 18,496
Stock based compensation 13,031 9,855
Other 88 102
Total deferred tax assets 44,461 29,824
Valuation allowance (44,455) (29,814)
Deferred tax assets after valuation allowance 6 10
Deferred tax liability [Abstract]    
Depreciation and amortization (6) (10)
Total deferred tax liability (6) (10)
Net deferred tax assets $ 0 $ 0
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes, Valuation Allowance, Operating Loss Carryforwards and Tax Credit Carry-forwards (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Taxes [Abstract]      
Net change in valuation allowance $ 14,641    
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards 28,000 $ 29,000 $ 10,000
Federal [Member]      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards $ 74,728    
Operating loss carryforwards, expiration dates Dec. 31, 2027    
Federal [Member] | Research and Development [Member]      
Tax Credit Carryforward [Line Items]      
Tax credit carryforwards $ 1,092    
Federal tax credit carryforward, expiration dates Dec. 31, 2031    
State [Member]      
Operating Loss Carryforwards [Line Items]      
Operating loss carryforwards $ 58,079    
Operating loss carryforwards, expiration dates Dec. 31, 2016    
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes, Income Tax Uncertainties (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Taxes [Abstract]      
Accrued interest and penalties $ 5    
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Balance at the beginning of the year 316 $ 316 $ 316
Additions based on tax positions related to the current year 0 0 0
Additions for tax positions of prior years 0 0 0
Settlements 0 0 0
Lapse of applicable statute of limitations 0 0 0
Balance at the end of the year $ 316 $ 316 $ 316
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurement, Assumptions Used to Measure Fair Value of Warrants (Details) - $ / shares
12 Months Ended
Dec. 31, 2014
Dec. 31, 2016
Dec. 31, 2015
Fair value assumptions [Abstract]      
Warrant exercise price (in dollars per share) $ 3.59   $ 3.59
Common share price (in dollars per share)   $ 2.20  
Series I Warrants [Member]      
Fair value assumptions [Abstract]      
Warrant exercise price (in dollars per share) 3.59    
Common share price (in dollars per share) $ 5.49    
Discount rate 1.65%    
Expected volatility rate 89.60%    
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurement, Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Investment Category (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Adjusted Cost $ 6,627 $ 8,726 $ 18,658 $ 19,173
Adjusted Cost 12,445 15,390    
Unrealized Gains 2 1    
Unrealized Losses (3) (7)    
Fair Value 12,444 15,384    
Adjusted Cost 15,877 18,686    
Fair Value 15,876 18,680    
Investments Available for Sale $ 12,444 15,384    
Minimum [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Maturities of available for sale securities 1 year      
Maximum [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Maturities of available for sale securities 2 years      
Cash [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Adjusted Cost $ 3,432 3,296    
Fair Value 3,432 3,296    
Cash and Cash Equivalents 3,432 3,296    
Mutual Funds [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Adjusted Cost 3,195 5,005    
Unrealized Gains 0 0    
Unrealized Losses 0 0    
Fair Value 3,195 5,005    
Investments Available for Sale 3,195 5,005    
U.S. Government Securities [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Adjusted Cost 1,254 1,806    
Unrealized Gains 0 0    
Unrealized Losses 0 (3)    
Fair Value 1,254 1,803    
Investments Available for Sale 1,254 1,803    
US Agency Securities [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Adjusted Cost 7,996 8,579    
Unrealized Gains 2 1    
Unrealized Losses (3) (4)    
Fair Value 7,995 8,576    
Investments Available for Sale 7,995 8,576    
Recurring [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Fair Value 6,627 8,726    
Fair Value 9,249 9,954    
Cash and Cash Equivalents 6,627 8,726    
Investments Available for Sale 9,249 9,954    
Recurring [Member] | Cash [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Fair Value 3,432 3,296    
Cash and Cash Equivalents 3,432 3,296    
Recurring [Member] | Level 1 [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Fair Value 3,195 5,430    
Fair Value 9,249 9,954    
Cash and Cash Equivalents 3,195 5,430    
Investments Available for Sale 9,249 9,954    
Recurring [Member] | Level 1 [Member] | Mutual Funds [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Fair Value 3,195 5,005    
Fair Value 0 0    
Cash and Cash Equivalents 3,195 5,005    
Investments Available for Sale 0 0    
Recurring [Member] | Level 1 [Member] | U.S. Government Securities [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Fair Value 0 0    
Fair Value 1,254 1,803    
Cash and Cash Equivalents 0 0    
Investments Available for Sale 1,254 1,803    
Recurring [Member] | Level 1 [Member] | US Agency Securities [Member]        
Cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category [Abstract]        
Fair Value 0 425    
Fair Value 7,995 8,151    
Cash and Cash Equivalents 0 425    
Investments Available for Sale $ 7,995 $ 8,151    
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurement, Changes in Fair Value of Level 3 Financial Instrument Liability (Details) - Significant Unobservable Inputs (Level 3) [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Changes in fair value of Level 3 liabilities [Roll Forward]      
Beginning balance $ 0 $ 320 $ 2,564
(Gain) losses included in net losses 0 117 (2,237)
Settlements 0 (333) (7)
Expiration of warrants 0 (104) 0
Ending balance $ 0 $ 0 $ 320
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.6.0.2
Litigation (Details) - Positive Outcome of Litigation [Member]
$ in Thousands
Sep. 30, 2016
USD ($)
Patent
Jul. 29, 2016
Case
Feb. 04, 2016
USD ($)
Patent
Mar. 30, 2015
Action
Feb. 26, 2013
USD ($)
Nov. 06, 2012
USD ($)
Patent
Dec. 31, 2016
Lawsuit
Gain Contingencies [Line Items]              
Number of intellectual property infringement lawsuits pending | Lawsuit             9
VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) [Member]              
Gain Contingencies [Line Items]              
Number of civil actions consolidated by court | Action       2      
Amount of damages awarded in patent infringement case     $ 625,600        
Number of patents allegedly infringed upon by Apple, Inc. | Patent     4        
Number of cases ordered to be retried by court | Case   2          
VirnetX Inc. v. Cisco Systems, Inc. et al. (Case 6:10-CV-00417-LED) ("Apple I") [Member]              
Gain Contingencies [Line Items]              
Number of civil actions consolidated by court | Action       2      
Amount of damages awarded in patent infringement case $ 302,400         $ 368,000  
Number of patents allegedly infringed upon by Apple, Inc. | Patent 4         4  
Number of cases ordered to be retried by court | Case   2          
Amount of interest payment awarded up to final judgment, per day         $ 34    
Amount of damage infringement payment awarded up to final judgment, per day         $ 330    
VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED) ("Apple II") [Member]              
Gain Contingencies [Line Items]              
Number of civil actions consolidated by court | Action       2      
Number of patents allegedly infringed upon by Apple, Inc. | Patent           4  
Number of cases ordered to be retried by court | Case   2          
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Financial Information (unaudited) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Quarterly Financial Information (unaudited) [Abstract]                      
Revenue $ 402 $ 375 $ 398 $ 375 $ 405 $ 375 $ 400 $ 375 $ 1,550 $ 1,555 $ 1,249
Loss from operations (7,247) (7,287) (5,353) (8,618) (7,749) (6,102) (9,567) (5,759) (28,505) (29,177) (12,165)
Net loss $ (7,235) $ (7,387) $ (5,337) $ (8,610) $ (7,736) $ (6,097) $ (9,546) $ (5,855) $ (28,569) $ (29,234) $ (9,902)
Basic earnings (loss) per common share (in dollars per share) $ (0.12) $ (0.13) $ (0.10) $ (0.16) $ (0.15) $ (0.12) $ (0.18) $ (0.11)      
Diluted earnings (loss) per common share (in dollars per share) $ (0.12) $ (0.13) $ (0.10) $ (0.16) $ (0.15) $ (0.12) $ (0.18) $ (0.11)      
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &N(<$H?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ :XAP2F;S"V"" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGB06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " !KB'!*2L(Z!N\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+!:L,P#(9?9?B>*$Z@'2;U9:6G#08K;.QF;+4UBV-C:R1]^R5> MFS*V!]C1TN]/GT"M#D+[B,_1!XQD,=V-KNN3T&'#3D1! "1]0J=2.27ZJ7GP MT2F:GO$(0>D/=42HJVH%#DD910IF8!$6(I.MT4)'5.3C!6_T@@^?L&,YCU\(-,,,(HTO?!30+,5?_Q.8.L$MR3'9)#<-0#DW.33MP M>'MZ?,GK%K9/I'J-TZ]D!9T#;MAU\FOSL-WOF*PKOBZJIN"K/5^+JA;U_?OL M^L/O)NR\L0?[CXVO@K*%7W&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " !KB'!*UW6*X* " "B"0 & 'AL+W=O 9/<>?B35X84\%[735R$5Z4:I^C2!XNK*;RB;>L MT5].7-14Z:DX1[(5C!XMJ:XB',>SJ*9E$RX+N[83RX)?554V;"<">:UK*OZN M6<7OBQ"%'PLOY?FBS$*T+%IZ9C^9^M7NA)Y%@Y5C6;-&EKP)!#LMPA5ZWJ+, M$"SBM61W.1H'QI4]YV]F\NVX"&.S(U:Q@S(FJ'[=V(95E;&D]_&G-QH.FH8X M'G]8_V*=U\[LJ60;7OTNC^JR"/,P.+(3O5;JA=^_LMZA- QZ[[^S&ZLTW.Q$ M:QQX)>TS.%REXG5O16^EIN_=NVSL^]Y](4E/@PFX)^"!@-&GA*0G) ,!D4\) MI"<0AQ!UKMC8;*FBRT+P>R"ZXVVIR2+T3'3T#V;1!MM^T^&1>O6VC(OH9LST MB'6'P",$&A"1MCT(8$A@C3TZ?A38^(CD$;'U$03>0@+ZF%AZ,J*G,)V =&+I M9$2?.2'R$1DLD(("J4?/'8$.D5I$TYU!G.,$3X1A!LK,/)FY(^,C4 PK9*!" MYO.1(P% ,"R1@Q*YSW>R90U )B3FH,3_[1Z *KF3C;YD &!WYM;&->]_*#B7#8RV'.EKU%[V9TX5TQO)7[28;WHAFF85.RDS##38]%U#=U$\;;O MB**A+5O^ U!+ P04 " !KB'!*L<@-.X\# !A$ & 'AL+W=O8BB_G"V3=E_^5<_G8;P1[3:7\MG^:8>_+H^=OXKN MK1RKQK9]Y=J@LZ=M^"L\%)B.!5/B[\I>^\5Y, [ER;GOX\4?QVT8CT2VMH=A M;*+TAU=;V+H>6_(RMX6KOZG.@[G;9B%P=&> MRI=Z^.:NO]MY0#H,YM%_L:^V]O&1Q/=Q<'4__0T.+_W@FKD5C]*4/V_'JIV. MU[G]MS*Y .<"O!> ^K @F0L24A#=R*:A_E8.Y6[3N6O0W9[6I1P7!3PD?C(/ MX\UI[J;?_&A[?_=UA_DF>AW;F2/[6P27D?>)@B>2^!Z)?/]W"!0A<*I/EO4@ MUR=B?3+5JV4]0=S?(F:*M%/$&$S).'@H2]'()$HD49PD(22WB%YTDJ,B M4O'*:P=D1P*7I**2!&Y T#&;E_])O:>130EEHK($083"W/#4!W,C^Q*X,!45)G =,I2/(N\Y9&,"5Z:BR@1NPS3ESTA( MQ6O/"&5E(E>F6E$FRLI$KDQ-E8E/XR\YUCY N2RU%26R#5(G2!$5CX0 M4-8DB[XKR2*$U%MF:R*VIJ351^'8$H (II)B.\[45)'L3N3:<66XTI*\J(29]5D6+O=ZX^?Y:=L]5VP=/;O#;QFES=W)NL+[)^),?W-GO M]^\7M3T-XVGJS[O;IO=V,;C+O*&/[O]5V/T'4$L#!!0 ( &N(<$HS(',^ M0@( +@' 8 >&PO=V]R:W-H965T&ULC95MKYL@&(;_ MBO$'%'RKVJC)VF79DBUISK*SS[2EU1P4![2>_?L!>HPB:]L/E9?[?I[K082L MH^R-EQ@+Y[TF#<_=4HAV P _EKA&?$5;W,B9,V4U$K+++H"W#*.3-M4$^!"N M08VJQBTR/;9G14:O@E0-WC.'7^L:L;];3&B7NY[[,?!274JA!D"1M>B"?V+Q MJ]TSV0-CE%-5XX97M'$8/N?N)V^S\Z R:,5KA3L^:3NJE .E;ZKS[92[4!%A M@H]"A4#R<<,[3(B*)#G^#$'=,:L,U7_'-TRD7)'('$=*N/YWCEN^?5:.?73\3 MQ8/-;O '@S\:O/"N(1@,@6$ /9DN]3,2J,@8[1S6OZT6J4WA;0*YF$UM7]S-/:W#9WC:@^D) ^*?PM[; MV7W0N_+JW-?^X??C.A2](EO:0]=/D?O+F]W9LNQG\CK^G28-'S9[XOS^^^R? M!N>],Z]Y:W>N_%(WBOQ-@ZN M;(?_X'!K.U=-LW@I5?YMO!;U<+V/;Y)DHO$$.1'D@P _)ZB)H'X0]$\)>B)H M1(A&5X;8[/,NWZP:=P^:<7FO>9]%\*1]] _]X!#LX9T/3^M'WS9)LHK>^GDF MR':$R!D$'HC(3_ZP(#D+6TGH\KV!'44H\1ZRIY DY44HUDTU\-6<;WB^9OEZ MX.LY/T-A&B') *G',,4Q\F/'@F+D+ .2.N/EQJS$ MQ#.1QFCD+<7$,L'>4E "8D%MRJI-J5J48MN4&/$112NX8T R39%P8&2L-"3L!"'08JFQ1B8 )D8D%T M<[@,2"IS.) P^T+?*V?K^S-(JCS%RN4OTX.!? @DBE*2K50RH'O!:"H8(,% M*UJ5<+G@, ;KI1B]E,]\YP':>E+<>B8,2@RM$JR8PV52)E@U@\N,6>BXP/<@ MB(EP([#PF%ETI;!L!D4"SA,F09\@S0T.ETFEL6P&EV5" M+@CG^Q_0!FAP YPP9FY(?(P!Z^9AB9C_ #O!DF!AQP)\5P3:%@UNBT![61QG M1AM)2B"#]'5"ZXRL (.$.!4ZQ8L0S?;4E6W.PWFE#0[N5G?]WG0V^C@3/[Q4-I3 MU]^F_KX9#SCC0^>NT^$M>IP@-_\#4$L#!!0 ( &N(<$I,6OND90( ,H' M 8 >&PO=V]R:W-H965T&UL?55=;YLP%/TKB/<48KXC M@E2"IDW:I*C3MF>'. '58&8[H?OWLPVEU';[$NS+.?>>R(!Z\>9": >YV-*KQP:*X%F1.NP!WX^]#K:]6^0J M=J1%3FX&RX#7I$/\(I^(OYK.%*Q\Y8L MY[9#/6M)[U!TV;N/VUV52;P"_&[1R%9K1SHY$?(L-]_.>]>7@A!&-9<9H'C< MT0%A+!,)&7_GG.Y24A+7Z]?L7Y1WX>4$&3H0_*<]\V;OIJYS1A=XP_R)C%_1 M["=RG=G\=W1'6,"E$E&C)IBI7Z>^,4ZZ.8N0TL&7Z=GVZCE.;Y)PIMD)8": MA;"-/R4$,R%X(WQ>(9P)H4;P)BNJ-Q7DL,@I&1TZ?=T!RD.TW86B^[4,JF:K M=Z(]3$3O11KFWEWFF2'E! $KR'9!>"+Y4@'8*I3 H(/W!0XF(O#?0RH3$B=V M$8'59J#XP=IF9.>'5GZH^.&:O]7:-$%B!>D59 /2*,XTLS98!@*MZ94%EF4^ ML&N.K)HCTW-LY\=6?FQZ3C3/$R1:J0PTNR9BHS6N,B&^769BE9F8,E--9F)4 MT-I],!$;S4EE0L 'GR.UZDQ-G=K9*%.CA-;P@XG8Z"?'A'RD,[/JS R=F?9O M+#/[4=?_US:8..K:UZDLL"Q-]3/@K6ZT#M&KFA;,J,KZ+_U!+ P04 " !KB'!*^W 7!#$% Z&P & 'AL M+W=O@/8O+,SLQ_/SMKS8UE]JS?.-9/O MNV)?WT\W37.XBZ+Z=>-V>?VE/+A]^\];6>WRIKVLWJ/Z4+E\W1OMBDC%<1+M M\NU^NICW]YZKQ;S\:(KMWCU7D_ICM\NK?QY<41[OIS#]<>/K]GW3=#>BQ?R0 MO[O?7?/'X;EJKZ)S*^OMSNWK;;F?5.[M?OH3W*UTVAGTBC^W[EA?_)YTJ;R4 MY;?NXI?U_33N(G*%>VVZ)O+VZ],M75%T+;5Q_#TT.CW[[ PO?_]H?=4GWR;S MDM=N619_;=?-YGZ:32=K]Y9_%,W7\OBS&Q(RT\F0_:_NTQ6MO(ND]?%:%G7_ M.7G]J)MR-[32AK++OY^^M_O^^WCZ)\7!3#90@X$Z&R@U:H"# 9X-,!DUT(.! M_L^#'34P@X$Y&^AQ#\E@D)P-H.^KZ-19?>\_YDV^F%?E<5*=)M A[^8IW"7M M^+YV-_OA[/]K!Z!N[WXN+,RCSZZ=0?)PDJA+B?(E2T&"ON11D&A?\B1(C"]9 M"9+D+(G:3,_I*C%=U=OK2_N4I'N2)+UDWTM($$NN *5-9DG&7#:SL4'2,4^" M#$E,*ZY!'2LM9XYBYL@SSTCF)XFYS!P4)J!!=J1%1[IO!2\=6=G>B/:&!0IQ M3$; L$A)YZ_&%%X0B1A$(@1!UT7"7"AS$:GG)16]I((7NK12YB4#.M565T1> M*)D82B:$0F;J,N,)IV0.K<8U7B!6#,0*@1!0/%CF)$DMJL T;;DHDB\6/!G* MOIBY2K,4 UT+ <:"X"FA" 7NB<)O3.('(M,/%%N;$(>:D#$"G",94-1SD,RL MI3-[=57FQR/3!K30MV12/@TB;U:R:$8U?B@RN("3R\;4"^?2S&99@!H@PPDD M.EDZ7G:@S"SDS&)E!W)DS9152 9S=5WG1R2C#:6BCA8>R*$U8^&, M:OQ09*RA<*JEA0=RJO5)!T82 X=(B6ITL0RBLDJ2O)K8!GB!,DM18"FM<1Z04](@M(4>AIS)I$1S<^6!,MY0P!O=@1^0 MUXITDT:!@!;8\YF ++!WHLQ)E(H[NDTCYZ1.D]C8T-J108D2*.G6B)R!!NGC MD]4UE1^.C$J4"D6Z-2*O 15;[Z,:_S&.C%PME8ETK6O.4A.C"A*%]%F#Y+7=1T.=+5-22Y2D#[.U< 3.VJTVRRB7HHLW!MU;I=_RZGV[KR:;A@ M1.FE.&,Y"""U)3&*HR#88$:Z'I6YK1U%F?.+HET/1^')"V-$_-X#Y6.!0O1> M>.[.K3(%7.8#.<-W4#^&H] KO*C4'8->=KSW!#0%>@QWA\S@+>"E@U&NYI[I MY,3YJUE\J0L4F$! H5)&@>CA"@>@U CI&+]F3;18&N)Z_J[^R?:N>SD1"0=. M?W:U:@NT15X-#;E0][I;J:O7,@RW.;X:H1FSGS#1"A-]1!SN$7&P0+ .L*2(G"DB MRT\^I'BX\9@P6XOI)P\_?7"[Q$Z7^-XE"FYP_,F9W1YGZ07KC@E<7U3P<;+_%357YNM<^WD6[D_-(_3;=L>'X*@66]=632? MJJ,[=/]YJ>JR:+O#^C5HCK4K-L.@P.T\5\./>Y7LRKMW:_.[C/ M]:1Y*\NB_F_I]M7I<4K3CQ-?=J_;MC\1+.;'XM7]Z=J_CI_K[BBX1-GL2G=H M=M5A4KN7Q^D3/>0F[@<,Q-\[=VJNOD_Z5)ZKZFM_\-OF<1KVBMS>K=L^1-%] MO+N5V^_[2)V.?\>@T\LU^X'7WS^B_S(DWR7S7#1N5>W_V6W:[>,TG4XV[J5X MV[=?JM.O;DPHFD[&[']W[V[?X;V2[AKK:M\,?R?KMZ:MRC%*)Z4LOIT_=X?A M\S3&_QB&!_ X@"\#*+X[P(P#S/ICO[OB V\^"]#S0RRS/#U\R%"+KHETLPNL22 MU7"^O9AAO;O*T.("% >P0P%X%2$G,TQF)!^0P(#-. MHS@3V2(L8V-%Q@#+LI"QY@AJCD#2$0X0PP"Q2IHX%EF?F>A*)ZFY"Q6$T3B]N2:F3&;%(NE$)>S$"QY3[[DJ8BD M,I;/YG)DKK7&8D6O #,3-SJ'3!9[],+R^D2L[Y!%J3$9IMDJRT1>R22(U XI"*XLIP"@-?1.-'8"T!5AI 2-SJ[DD;QLQ*N8!)I5K-D/&HQ=9#P'N,FEYM&=U=5&OB M9Z@<4<;X1&/_(6! 1LTQ](Z05(5#7&Q#-=? KS)?P\G8BAA8D?&42<96Q-J* MR(BFP &4\7QMB,&)F1[!@96 B%D>S75IB+$R-U \Y&D:_V M,/8DUIY$1K:0#'RD>Y&0CP? V' J.QZ 64YBCRTQMB76MD1&=FBLS211#S6 MNG8_E%X*L%FGVM-E,38G!N\FQA<"FP6#MQ/513!XL5!Y:X9BV?>@0(FG.67L M%@Q>4E0'P??>+T:]&K'2V', ^:87NP4#MU!FS*#"9Y3)7AA@IELR4K*F?(\P M]@H&7J'\F%%M9U*2-6;21#;P@+I^S&\W)K!/F!"(EB\<(W3[S(69["P1EF72 MXW.$1>2I] 9[DP'>9*4W&>THW1S*J084I7$D31EA&26>=L)@@S+ H*PT**,- M)8Z5/0%*)Y<#ZC:Y6]6>W2O@359ZDP'>I.=:0THQ,"^/6NQ(!CB2E8YD[KW> MC%I_B.1WD5NMV(<,\"'K*90&^Y !/A1)'QJA^%ZZ&B&69?UNG+/:X&KOMW3U MZ["OWDS6U=NA[;=0K\Y>]NZ?N-\[%N>7])"?=^"_ASG_(/!'4;_N#LWDN6K; MJASVCU^JJG6=PO!3-Z-;5VPN!WOWTO9?D^Y[?=Z(/Q^TU7'\D2&X_-*Q^!]0 M2P,$% @ :XAP2E*C9M*T 0 T@, !@ !X;"]W;W)K<.3,>YZ.Q3ZX#\.1%2>T*VGG?'QAS50>*NRO3@\:;QEC% M/9JV9:ZWP.L(4I*EN]T-4UQH6N;1=[)E;@8OA8:3)6Y0BMO7(T@S%C2A;XY' MT78^.%B9][R%K^"_]2>+%EM8:J% .V$TL= 4]"XY'+,0'P.^"QC=ZDQ")6=C MGH+QN2[H+@@""94/#!RW"]R#E($(93S/G'1)&8#K\QO[QU@[UG+F#NZ-_"%J MWQ7TEI(:&CY(_VC&3S#7J)D%I2C^,NU" MQWV<;K+W,VP;D,Z = 'E[DU([%3[WL>GC@YI-B;*CAC*^(= MBG?HO93)=9*S2R":8XY33+J.62(8LB\ITJT4Q_0O>+H-WV\JW$?X_C>%_R#( M-@FR2)#]M\2MF/T?2=BJIPIL&Z?)D&PO=V]R:W-H965TTJFXA_A A+#@Q+,41KIXDK*WGFC)A:4HOC[N L=]V&\ MV:<3;!V03(!D!MS&/&Q,%)4_<,^+S)J!V+'W'0]/O#TDV)LR.&,KXAV*=^B] M%-M]FK%+()IBCF-,LHR9(QBRSRF2M13'Y!]XL@[?K2K<1?CN#X7[=8)TE2"- M!.E_2UR+N?XK"5OT5(%MXC0Y4II>QTE>>.>!O4OBFWR&C]/^G=M&:$?.QN/+ MQO[7QGA *9LK'*$6/]AL2*A].-[@V8YC-AK>=-,/8O,W+GX#4$L#!!0 ( M &N(<$H->I+ELP$ -(# 9 >&PO=V]R:W-H965TM]]V1,5>VH(6[PPY,N*G1:N&#:1OF.@NB M2B"M&-]LWC MI*%%EGQG6V38>R4-G"UQO=;"_CR!PB&G6WIS/,NF]='!BJP3 M#7P!_[4[VV"QF:62&HR3:(B%.J>/V^-I'^-3P#<)@UN<2:SD@O@2C8]53C=1 M$"@H?6008;O"$R@5B8*,'Q,GG5-&X/)\8W^?:@^U7(2#)U3?9>7;G!XHJ: 6 MO?+/.'R J9Y[2J;B/\$55 B/2D*.$I5+*RE[YU%/+$&*%J_C+DW:A_%F=X.M M _@$X#/@D !L3)24OQ->%)G%@=BQ]YV(3[P]\M";,CI3*])=$.^"]UIL[Q\R M=HU$4\QIC.'+F#F"!?8Y!5]+<>+_P/DZ?+>J<)?@NS\4'M8)]JL$^T2P_V^) M:S%O_TK"%CW58)LT38Z4V)LTR0OO/+"//+W)[_!QVC\+VTCCR 5]>-G4_QK1 M0Y"RN0LCU(8/-AL*:A^/#^%LQS$;#8_=](/8_(V+7U!+ P04 " !KB'!* MV-5;P+,! #2 P &0 'AL+W=O+%EM8*JFA<])TQ$*=T]O=X9B&^!CP7<+H5F<2*CD;\Q*,QRJG21 $"DH? M& 1N%[@#I0(1RGB=.>F2,@#7YW?V^U@[UG(6#NZ,>I:5;W-Z0TD%M1B4?S+C M \SU?*!D+OXS7$!A>%"".4JC7%Q).3AO],R"4K1XFW;9Q7V<;O;I#-L&\!G M%\!-S,.F1%'Y)^%%D5DS$COUOA?AB7<'CKTI@S.V(MZA>(?>2[&[3C)V"41S MS'&*X>N8)8(A^Y*";Z4X\K_@?!N^WU2XC_#];PK_D3_=)$@C0?K?$K=B_E3) M5CW58)LX38Z49NCB)*^\R\#>\O@FO\*G:?\B;",[1\[&X\O&_M?&>$ IR16. M4(L?;#$4U#X&UL?5/;;MP@$/T5 MQ >$7=:;1"O;4C91U4JIM$J5Y)FUQQ<%&!?P.OW[ G88J]DZV&DR&V5TJ87T>0.&1T2S\<3VW=N.!@>=J)&GZ >^Y.QEML M9BE;!=JVJ(F!*J-WV\,Q"?$QX*6%P2[.)%1R1GP+QKUG(6%>Y2O;>F:C-Y24D(E>NF>'KCO31&[E%T"T11S'&/X M,F:.8)Y]3L'74ASY/W"^#M^M*MQ%^.X/ARN?(CU/@/ M-AL2*A>.-_YLQC$;#8?=](/8_(WSWU!+ P04 " !KB'!**NG/L[0! #2 M P &0 'AL+W=OW<0>&0TRU]1_C4\!W"8-;G$FLY(KX$HU/54XW41 H*'UD$&&[P2,H%8F" MC!\3)YU31N#R_,;^(=4>:KD*!X^HGF7EVYP>*:F@%KWR3SA\A*F>=Y1,Q7^& M&Z@0'I6$'"4JEU92]LZCGEB"%"U>QUV:M _C#><3;!W )P"? <>4AXV)DO+W MPHLBLS@0._:^$_&)MR<>>E-&9VI%N@OB7?#>BNWAD+%;))IBSF,,7\;,$2RP MSRGX6HHS_P?.U^&[586[!-_]H?!^G6"_2K!/!/O_EK@6<_PK"5OT5(-MTC0Y M4F)OTB0OO// /J1'9+_#QVG_(FPCC2-7].%E4_]K1 ]!RN8NC% ;/MAL**A] M/-Z'LQW';#0\=M,/8O,W+GX!4$L#!!0 ( &N(<$JA9*"(M0$ -(# 9 M >&PO=V]R:W-H965TL!CMNW'V#7M39K?X![.>?<#R[9@.;%M@".O"JI M;4Y;Y[HC8[9L07%[@QUH?U.C4=QYTS3,=@9X%4E*LC1)]DQQH6F11=_9%!GV M3@H-9T-LKQ0W;R>0..1T0]\=CZ)I77"P(NMX S_!_>K.QEML5JF$ FT%:F*@ MSNG=YGC:!7P$/ D8[.),0B47Q)=@?*]RFH2$0$+I@@+WVQ7N0$A M$Q^C1&GC2LK>.E23BD]%\==Q%SKNPWBSW4^T=4(Z$=*9'CBS3'UO2F#,[8BWOGDK?=>B\W^<\:N06C"G$9,NL3,".;5YQ#I M6HA3^@\]7:=O5S/<1OIV&?V0K OL5@5V46#WWQ)7,(>_BV2+GBHP39PF2TKL M=9SDA7<>V+LTOLD'?)SV!VX:H2VYH/,O&_M?(SKPJ20W?H1:_\%F0T+MPO'@ MSV8&PO=V]R:W-H965TTSES@)*L0ID$OW[PLDEV5;M"^ C=_SLS'9B.;%M@".O&G5V9RV MSO4'QFS9@A;V!GOH_$V-1@OG3=,PVQL0501IQ?AN=\NTD!TMLN@[F2+#P2G9 MP)TYZ9(R M -?G*_NG6+NOY2PL/*+Z*2O7YO2>D@IJ,2CWA.-GF.OY0,E<_%>X@/+A08G/ M4:*R<27E8!WJF<5+T>)MVF47]W&Z2:ZP;0"? 7P!W$< FQ)%Y1^%$T5F<"1F MZGTOPA/O#]SWI@S.V(IXY\5;[[T4^SN>L4L@FF..4PQ?QRP1S+,O*?A6BB/_ M!\ZWXJK!-'&:+"EQZ.(DK[S+ MP#[P^":_PZ=I_R9,(SM+SNC\R\;^UX@.O)3=C1^AUG^PQ5!0NW"\\V/*N5>LRVGC?'1AS M10-:N"O308LWE;%:>#1MS5QG0901I!7CF\T-TT*V-$^C[V3SU/1>R19.EKA> M:V%_'4&9(:-;^NEXEG7C@X/E:2=J> '_O3M9M-C,4DH-K9.F)1:JC-YM#\ 'Q(&MSB34,G9F-=@?"DSN@F"0$'A X/ [0+WH%0@0AEO$R>=4P;@\OS) M_AAKQUK.PL&]43]EZ9N,WE)20B5ZY9_-\ 13/=>43,5_A0LH# ]*,$=AE(LK M*7KGC9Y84(H6[^,NV[@/XPU/)M@Z@$\ /@-N8QXV)HK*'X07>6K-0.S8^TZ$ M)]X>./:F",[8BGB'XAUZ+_EV?YVR2R":8HYC#%_&S!$,V><4?"W%D?\#Y^OP MW:K"783O_E!XLTZ0K!(DD2#Y;XEK,?N_DK!%3S78.DZ3(X7IVSC)"^\\L'<\ MOLGO\'':OPE;R]:1L_'XLK'_E3$>4,KF"D>HP0\V&PHJ'XY[/-MQS$;#FV[Z M06S^QOD'4$L#!!0 ( &N(<$H(G):[M $ -(# 9 >&PO=V]R:W-H M965T)W^?0$3UVVLO SS#ES9AB*29LGVP,X]"R%LB7NG1N.A-BZ!\GL MC1Y ^9M6&\F<-TU'[&" -1$D!:%9]IY(QA6NBN@[FZK0HQ-(=?' ^\ZUUPD*H86 ??P?T8SL9;9&%IN 1EN5;(0%OBN]WQ= CQ,>"1 MPV179Q0JN6C]%(PO38FS( @$U"XP,+]=X1Z$"$1>QJ_$B9>4 ;@^O[!_BK7[ M6B[,PKT6/WGC^A+GFLE&X!SU]AE3/.XQ2\5_A"L*'!R4^1ZV%C2NJ1^NT M3"Q>BF3/\\Y5W*=TDR?8-H F %T >D&L@2C&G.8:N8Y8(XMF7%'0KQ8F^@M-M^'Y3X3[" M]_\H_+!-<-@D.$2"PYLE;L3DV7])R*JG$DP7I\FB6H\J3O+*NPSL'8UO\C=\ MGO9OS'1<6731SK]L['^KM0,O);OQ(]3[#[88 EH7CK?^;.8QFPVGA_2#R/*- MJS]02P,$% @ :XAP2J8SB9VT 0 T@, !D !X;"]W;W)K&UL?5/;;IPP$/T5RQ\0+[!-5RM RJ:J$JF55JG:/GMA "N^ M$-LLZ=]W; BE+>V+[1G/.7-F/,Y'8Y]=!^#)JY+:%;3SOC\RYJH.%'- M-XVQBGLT;[6Z:XT+3,H^]LR]P,7@H-9TO!@9=[S%KZ _]J?+5IL8:F% NV$T<1"4]"[Y'C:A_@8\$W Z%9G M$BJY&/,ZH+L@""14/C!PW*YP#U(&(I3Q,G/2)64 KL]O[!]C[5C+A3NX M-_*[J'U7T ,E-31\D/[)C \PU_..DKGX3W %B>%!">:HC'1Q)=7@O%$S"TI1 M_'7:A8[[.-UDV0S;!J0S(%T AYB'38FB\@_<\S*W9B1VZGW/PQ,GQQ1[4P5G M;$6\0_$.O=8TQ:3KF"6"(?N2(MU*<4K_@J?;\&Q381;AV6\* M_T&PWR381X+]?TOPT.*2@=CGUT#X,FKDMIEM/&^.S#FB@:4<%>F XTWE;%* M>#1MS5QG0901I"3CF\T-4Z+5-$^C[V3SU/1>MAI.EKA>*6'_'$&:(:-;^N9X M;.O&!P?+TT[4\!/\K^YDT6(S2]DJT*XUFEBH,GJ[/1R3$!\#?K8ZKFF9"K^.UQ 8GA0@CD*(UU<2=$[;]3$@E*4>!WW M5L=]&&]X,L'6 7P"\!FPCWG8F"@JOQ=>Y*DU [%C[SL1GGA[X-B;(CAC*^(= MBG?HO>3;?9*R2R":8HYC#%_&S!$,V><4?"W%D?\#Y^OPW:K"783O/BB\7B=( M5@F22)#\M\2UF)M/2=BBIPIL':?)D<+T.D[RPCL/["V/;_(>/D[[#V'K5CMR M-AY?-O:_,L8#2ME&PO=V]R:W-H965T-V@3N0,A"AC-\3)YU3!N#R_,I^'VO'6L[3Y1,Q7^'"T@,#THP1VFDBRLI>^>-FEA0BN(OXRYTW(?Q M9I=.L'5 ,@&2&;"/>=B8*"K_PCTO,FL&8L?>=SP\\?:08&_*X(RMB'&PO=V]R:W-H965T=;*^()V(?1'QGS5@1;^QO9@\*:Q3HN IFN9[QV( M.H&T8CS+7C,MI*%EGGQG5^9V"$H:.#OB!ZV%^W$"9<>"[NB+XT&V78@.5N:] M:.$+A*_]V:'%%I9::C!>6D,<- 6]VQU/AQB? AXEC'YU)K&2B[5/T?A8%S2+ M@D!!%2*#P.T*]Z!4)$(9WV=.NJ2,P/7YA?U]JAUKN0@/]U9]DW7H"GI+20V- M&%1XL.,'F.MY1X@L+PJ 1S5%;YM))J\,'JF06E:/$\[=*D?9QN.)]A MVP ^ _@"N$UYV)0H*7\G@BAS9T?BIM[W(C[Q[LBQ-U5TIE:D.Q3OT7LM=V^S MG%TCT1QSFF+X.F:)8,B^I.!;*4[\+SC?AN\W%>X3?/^;PG_D/VP2'!+!X;\E M;L7\J9*M>JK!M6F:/*GL8-(DK[S+P-ZE1V2_PJ=I_RQ<*XTG%QOP95/_&VL# MH)3L!D>HPP^V& J:$(]O\.RF,9N,8/OY!['E&Y<_ 5!+ P04 " !KB'!* M*B2,DK4! #2 P &0 'AL+W=O:%EGTG4R18>^DT' RQ/9*-*T+#E9D'6_@%[C? MWCFF(CP$/ @:[.)-0R1GQ*1C?JYQN@B"04+K MP/UV@3N0,A!Y&<\3)YU3!N#R_,K^-=;N:SES"W4%)!S7OI[G'X M!E,]>TJFXG_ !:0/#TI\CA*EC2LI>^M032Q>BN(OXRYTW(?Q9K^?8.N 9 (D M,^ FYF%CHJC\"W>\R P.Q(R][WAXXNTA\;TI@S.V(MYY\=9[+\7V\RYCET T MQ1S'F&09,TS_ M2\(6/55@FCA-EI38ZSC)"^\\L+=)?).W\'':?W+3"&W)&9U_V=C_&M&!E[*Y M\B/4^@\V&Q)J%XZ?_-F,8S8:#KOI!['Y&Q=_ 5!+ P04 " !KB'!*H/K> MV;X" !\"P &0 'AL+W=OIWO1)"!.]UU6CU_')F/8^2?3N)&JN[V0K&OOF(%7-C1VJ8Z);)?C>%=55 M0FF:)S4OFWBSN1:/LOI5 M[LUI'1=QM!<'?J[,L[Q^$<.&YG$T[/Z;N(C*PKN56(V=K+2[1KNS-K(>6.Q2 M:O[>W\O&W:_]FSP;RG !#04T%A1.)^F%W,H_<<,W*R6OD>H_?LN[,V;W9+_- MKIMTG\*]LXO7=O:R8+Y% D!P3,$T&8P/=> M0)$%(,@\$82989$"BA2 8.Z)($R.19909 D(_(-'F,#!LQ0[* 44_M$C$ N< M/0LXE0$*__0A*'#\#-KU@='T5\Y37V<*(I8%=+"O608H9KX. @7T-3J+/?S ("( O\;X3R@J=79 MPC\? "(*Y!OA/"!@=9KL!X"R0+X1S@,"5L_\?(,@/]^2F^:G%NKHVCX=[>2Y M<3WGS>S86CZ0:Y[^P?N^]#M7Q[+1T:LTM@5SC=)!2B/L6M([Z^63;87'024. MIGM'>_ 502P,$% @ :XAP2H@)6A>V 0 T@, M !D !X;"]W;W)K&UL;5/;;MP@$/T5Q >$7>Q- MHY5M*9NJ2J166J5J^\S:8QL%C -XG?Y]!^RX;NH78(9SSEP8LM'8%]<">/*F M5>=RVGK?'QES90M:N!O30X#1MPUQO0521I!7CN]TMTT)VM,BB[VR+ MS Q>R0[.EKA!:V%_GT"9,:=[^NYXEDWK@X,562\:^ [^1W^V:+%%I9(:.B=- M1RS4.;W?'T]IP$? 3PFC6YU)J.1BS$LPGJJ<[D)"H*#T04'@=H4'4"H(81JO MLR9=0@;B^ORN_B76CK5@Z4S,5_A2LH MA(=,,$9IE(LK*0?GC9Y5,!4MWJ9==G$?IYM#.M.V"7PF\(5P%^.P*5#,_+/P MHLBL&8F=>M^+\,3[(\?>E,$96Q'O,'F'WFO!DR1CUR T8TX3AJ\P^P7!4'T) MP;="G/A_=+Y-3S8S3"(]64<_'+8%TDV!- JD_Y28?BAQ"_,Q"%OU5(-MXC0Y M4IJABY.\\BX#>\_CF_R%3]/^3=A&=HY7C?VOC?& J>QN<(1:_&"+H:#V MX?@)SW8:L\GPII]_$%N^&PO=V]R:W-H965T*:F@%H-T3SA^A+F>=Y3,Q7^&&T@? M'C+Q&B5*&U=2#M:AFEE\*DJ\3'NGXSY.-TDZP[8!? ;P!7",.FP2BIF_%TX4 MF<&1F*GWO0A/O#]QWYLR.&,KXIU/WGKOK>#)(6.W0#3'G*<8OHK9+Q',LR\2 M?$OBS/^!\VUXLIEA$N')6OWP'_UTDR"-!.E?)=Z_*7$KYOA&A*UZJL T<9HL M*7'0<9)7WF5@'WA\DS_AT[1_$:;IM"57=/YE8_]K1 <^E=V='Z'6?[#%D%"[ M<+SW9S.-V60X[.&PO=V]R:W-H965T IWX;OCI:T;XQRDR'M6PS8Z]F'P5S\ M%[@#MW"7B=4H)=?^&Y2#-E+,+#85P=ZFM>W\.DXG23*'X0%T#J!+0.9UR"3D M,__ #"MR)<= 37??,_?$NR.U=U,ZI[\*?V:3U]9[+VC\F).[(YHQYPE#5YC= M@B"6?9&@F,29_A-.\? 8S3#VX?%:/8UP@@0E2#Q!LM9/HDV)&.8_1>Y1D3U" M0#5=AL@3]7WR%SY-H*],U6VG@ZLTMMM\3U12&K"I1 _V MZ1H[]!:#0V7<-K5[-;7^9!C9SU.-+*.U^ -02P,$% @ :XAP2KI]QWNV M 0 T@, !D !X;"]W;W)K&UL;5/MCIT@$'T5 MP@,LRG4_[=IVJ1-;K9I^YNKHY(%QP)>MV]?0-?:K7^ &>:<.3,,^83F MQ78 CKQJU=N"=LX-1\9LU8$6]@8'Z/U-@T8+YTW3,CL8$'4$:<5XDMPQ+61/ MRSSZSJ;,<71*]G VQ(Y:"_/[! JG@J;TS?$LV\X%!ROS0;3P#=SWX6R\Q5:6 M6FKHK<2>&&@*^I@>3UF(CP$_)$QV\;I$RSUW%*R M%/\%KJ!\>%#BF'Q4K1XG7?9QWV:;[*[!;8/X N KX"'F(?- MB:+R#\*),CS'O5;)- M3S68-DZ3)16.?9SDC7<=V$<>W^1O^#SM7X5I96_)!9U_V=C_!M&!EY+<^!'J M_ =;#06-"\=[?S;SF,V&PV'Y06S]QN4?4$L#!!0 ( &N(<$J(.'5MN $ M -(# 9 >&PO=V]R:W-H965T)W^?0?LN&[J%V"&<\Y<&++1V!?7 M GCRJE7G-/ =_(_^;-%BBTHE M-71.FHY8J'/ZL#^>TH"/@&<)HUN=2:CD8LQ+,+Y4.=V%A$!!Z8."P.T*CZ!4 M$,(T?LV:= D9B.OSF_JG6#O6]/,/8LLW+OX 4$L#!!0 ( &N(<$KHM*?XX $ M $% 9 >&PO=V]R:W-H965T@?"Y0@-X/ 93Z2%KZ"^C9>A;;PQE+W M# ;9\\$3T!3H,3A?,H.W@.\]S'*W]TPE-\Y?C/&I+I!O$@(*E3(,1"]W> )* M#9%.X^?*B39)$[C?O[%_L+7K6FY$PA.G/_I:=04Z(:^&ADQ4/?/Y(ZSU),A; MB_\,=Z :;C+1&A6GTGZ]:I**LY5%I\+(Z[+V@UWGY22.UC!W0+@&A%O R>K@ M1C\2\XN#;?Y?@SM%?X#7QZ'+T2T_2"]&U=Z$.QU;3A7H%/Q'W17._T>;0:% M1IEMIO=BF.^"2#DJ_F0; H@\I M6I/AQMKN0(@I&I#,W*D.6O>E4EHRZT)=$]-I8&4HDH+0U6I').,MSM.0.^D\ M5;T5O(631J:7DND_1Q!JR/ :7Q//O&ZL3Y \[5@-O\#^[D[:161F*;F$UG#5 M(@U5AA_6AV/B\0'PPF$PBSWRG9R5>O/!]S+#*V\(!!36,S"W7. 1A/!$SL;[ MQ(EG25^XW%_9OX7>72]G9N!1B5=>VB;#>XQ*J%@O[+,:GF#J)\%H:OX'7$ X MN'?B- HE3/A%16^LDA.+LR+9Q[CR-JS#Q'\MBQ?0J8#>%)!1*#C_RBS+4ZT& MI,>S[YB_XO6!NK,I?#(<1?CFS!N7O>1TEZ3DXHDFS''$T 5F/2.(8Y\E:$SB M2/\KI_'R3=3A)I1OENK[?9Q@&R78!H+M/RWN;EJ,8>[C(DE4)(D0[&]$8I@O M-R)D<7$2=!V>K$&%ZMLP+HOL/!4/-%S\)WPS[ADBNE+#@K MJSOGI7%3/ <"*NNW]VZOQ[<\!E9UTYB2^;\B_PM02P,$% @ :XAP2B6S M@'VW 0 T@, !D !X;"]W;W)K&UL;5/;;MP@ M$/T5Q <$F_4VZZ!^5O&FTD<]XT+;&] 59'D!2$)LD7 M(AE7N,RC[V3*7 ].< 4G@^P@)3-O1Q!Z+'"*WQU/O.U<<) R[UD+/\']ZD_& M6V1AJ;D$9;E6R$!3X-OT<,Q"? SXS6&TJS,*E9RU?@[&][K 21 $ BH7&)C? M+G '0@0B+^-EYL1+R@!EA8TKJ@;KM)Q9O!3)7J>=J[B/T\U^/\.V 70&T 5P M$_.0*5%4?L\<*W.C1V2FWOA6BB/]!*?;\-VFPEV$[];9OV;;!-DF018)LO]*3#^4N!7S M4259]52":>,T653I0<5)7GF7@;VE\4W^A4_3_LA,RY5%9^W\R\;^-UH[\%*2 M*S]"G?]@BR&@<>%X[<]F&K/)<+J??Q!9OG'Y%U!+ P04 " !KB'!*^$?Q M;]@! E!0 &0 'AL+W=O62,B(\M4#X6:(6^ L_=H54F@,M\( ?X ^KO ML!-ZA1=*W3'H9<=[3T!3H!^KS38S^3;AI8-1GLT]XV3/^:M9_*X+Y)N&@$*E M#('HX03W0*D!Z3;>9B9:)$WA^?R+_F"]:R][(N&>TW]=K=H"I9_&KK?C..V$Z5SF+@CF M@F I"*P.GH1LYS^)(F4N^.B)Z>P'8E[Q:A/HLZE,T!Z%W=/-2QT]E4&RSO') M@.:<[9037.2$2P[6_$4D<(H$%K"^ $1NP-H)6%M > &(K[J<NE]Z>*_VSV$^ZX5R!QOEWFM3J.VM94&B4F29Z M+J8_=UHH/LR7$EYNQO(34$L#!!0 ( &N(<$JW&2=>RP, !X2 9 M>&PO=V]R:W-H965T>Z<1)T #.@M.9_?LQEV:#?=S3+P&<4^4JN\[Q97F3S8_V+(3R M?E9EW:[\LU*7AR!H]V=1Y>TG>1&U_NVE$?FA-ZK*@(5A$E1Y M4?OK9=_VW*R7\JK*HA;/C==>JRIO_MN(4MY6/OEO#5^*TUEU#<%Z>&_T53%X.127JMI"UUXCCRG^DAR>>=@8]XELA;NW=N]>E\B+EC^[CS\/* M#[N(1"GVJG.1Z\>KV(JR[#SI./X=G?I3GYWA_?N;]\]]\CJ9E[P56UE^+P[J MO/)3WSN(8WXMU1=Y^T.,"<6^-V;_EW@5I89WD>@^]K)L^U]O?VV5K$8O.I0J M_SD\B[I_WD;_;V;8@(T&;#+@[%T#/AKPR8#1NP;1:!!]U" >#6+#(!AR[P=S MEZM\O6SDS6N&>KCD7=G10ZRG:]\U]K/3_Z?'L]6MKVN6ALO@M7,T8C8#AMUA M:$($VOO4!4-=;)AESE*:=[%%&#;'[!"&SS%/"!/A8#D<#]X[X#,',78000=1 M[R":.4B, 468!>XDAIW$(,H4.TB@@P1$D!E1#IBDQ]0]AH>A41M;&\0LT,X& M)8DCWP4,=V&'FYE5.F#B^TAB*]R/@':_ T MB%SCF\%X,Q"O0;]-9O42V>5@@^R:V=F@6:E9LC;&9"F D&/=)ZPJE-D)+QQ%Q##/60@2-I4)@AQB MP+ 8,%L,B+EV.9B;S.8F)2X7F)O,YB8/34F"($<9,4Q-%MF46;A<8-:Q&$1A M[G,@R+$P,4Q-9E.3F(-W#/.. =XY)P;SCB'>61.#0 XM8Y@QS&:,:8,]S><7,R%V\$2O1G/H+B-;;RVNMNC/A7>MTR?'8'^.-]@T][(:S]/]NAIN3 MO_/F5-2M]R*5/I'WY^:CE$KH*,-/>G[/(C],'Z4XJNYUH=^;X<9B^%#R,M[& M!-.5T/H74$L#!!0 ( &N(<$K*2MXB,P( *D& 9 >&PO=V]R:W-H M965TK$F6U(]_;SK2$W4?[$]O'W?>?B^#AI*'OC.8!PWDM2\:6;"U$O$.)9#B7F M#[2&2NX<*2NQD$MV0KQF@ ^:5!(4>%Z,2EQ4;IIHVPM+$WH6I*C@A3G\7):8 M_5L!HVP=#T5$!#(A%+ QR7^'"Q )5Y%('QDE M7'^=[,P%+:V*#*7$[V8L*CTV9F<66=HT(;"$H"5(W[<(H26$5\)M#Y$E1%=" M?),PLX39O1YB2XCO):'J['ZK_W%7/X0F3+J M\]=[\L2XM%[2T/^2H(L2LIB5P01=3.#U,9LQQN\C=E,J5PR24;:A!E.AKH*1 M0#SO^UB/(6$0#"(=8P:(YPF50;K;SV/9W83TT@TG3R;4_+!;T=GCM$ T*1!I M@:A7C'!PM 83:TQEBA%ZWB#;]03*\T:PS1@V0#Q_BMC>%=!N M6'F?*@SBTH M@9UTT^-.1L^54*7M6-N^^A2H6S2PK_S%VI^P;_S%UK3-J[QIXC\P.Q45=_94 MR+NK;]B14@$R>N]!=H5&PO=V]R:W-H965TV$[=_7-BQ+ MS"1*7P";<\Z<&92-@O/$_N<5D0\L8;6ZLV1\8I( M->0G3S2G9T*CO&7O7@ZV'I^MH1+>E>:@FB;A>ZH66IE92//[VH.\34Q/'SN_IGD[Q* M9D<$W;#R=W&0^=*=N-,4V[U1YA)J]9#@(4^^BA7K,NL,$(PP: M$)Y2'T($4(AU,*$'UP$V4P3VKR';*21.8!,8S!,;/K[*,X(%0E @- +AE4!L M%:K#Q 93=YE&R,H5P."9E2R "6YD&X%F(\!L8IGM,-$HR*< 64XV C-[6\# M@6(,^XU!O_'4KVTWG@3!V#([A81V9:>0.(2-)J#1!"BL%6.=3&+8D T L=;2 M%H#<6*\ST.D,<#J'!>:@P/SQ/P;Y<&_Q'_AG>M XT61NE0O"V(OP/N;:[HU6 MB*9V\2T)L-6M4/ ?18,;%<*/% U/.@1*[*X*@6+[AX! D=UKO-%N4E%^,CNU MSPVE@%>C=R)I?ZU."V:4^9+HCQG?"3T4MG!V3:J\S.]*1,4F5 M1_])?=1<';*_@%02P,$% @ :XAP M2L8QO=6! @ ]@@ !D !X;"]W;W)K&ULC5;; MCILP$/T5Q VS0YR %C"UG63[][4-2Q(8TKR /9QS M9L9X/$XNC+^+G%)I?51E+19V+F4S=QR1Y;0BXH4UM%9?#HQ71*HI/SJBX93L M#:DJ'>RZH5.1HK;3Q-BV/$W8299%3;?<$J>J(OSOBI;LLK"1_6EX+8ZYU 8G M31IRI#^I_-5LN9HYO9KFE9:B45QY].U.Y]:N+M^%/]BTE>);,C@JY9^;O8 MRWQASVQK3P_D5,I7=OE*NX0"V^JR_T[/M%1P'8GRD;%2F*>5G81D5:>B0JG( M1_LN:O.^M%^B64>#";@CX)Z PH<$KR-X5X+_D.!W!'] <-I4S-ILB"1IPMG% MXNWO;8C>16CNJ]7/M-$LMOFFED&!7Q0P#<"_IV -UBH%A,:3&TP M03A(]?^0S4/(7:0!&&D 1.H/(@U&/OP)'R'H(P1\! ,?8PR.9["3"'02 4XF MHIR! K/G?WH,"L1 !-$@30@SD29RX1IT 8EX0F*BC-'SJ2*P3)<(CZ/PW>%1 M@$<;)XJ&Y0R @GA0*QL A..)OXO@FD;>$[L0 .'9Q-&!X-)'0.W[HT-R7+93 MNP N6P34K8^'7B"0-_#CW!S^%>5'TUB%E;%3+?49>F/MF_<2Z^8QL*]T4S=- MY2K3W@A^$'XL:F'MF%2MR320 V.2JAC=%Q5CKBXA_:2D!ZF'D1KSMA.W$\F: M[I;A]%>=]!]02P,$% @ :XAP2AW1$/NK @ (@L !D !X;"]W;W)K M&ULE5;M;MHP%'V5* _0Q)=\0 5(I=.T29M4==KV MVP4#49,XLPUT;S_'"1DEQU+ICR8VYYYSK^-CW_E)JE>]%\($;U59ZT6X-Z:Y MCR*]WHN*ZSO9B-K^LI6JXL8.U2[2C1)\XX*J,J(XSJ**%W6XG+NY)[69?F[V)C](IR&P49L^:$TS_+T1?0% MI6'05_]-'$5IX6TF5F,M2^W^!^N#-K+J66PJ%7_KGD7MGJ>>_QR& Z@/H"& M7$#4";G,/W'#EW,E3X'J%K_A[3=F]V379MU.NJ5PO]GDM9T]+B=),H^.+5&/ M6748NL"P 1%9]D&"D,2*1N&3),4$$YCCQ!%,WA%DF""!!(DC2-X1Y%=% DP\ MP2(I%$F!R!039) @^WB9.23(00:SJS([3.HPM<-0&K=_6&@*A:9CH32^$IJ. MA!)B1)Z=,X,Z,Z#C(6 QWM[QQQ>5>1S"0!9T;9$QB&:>K\^@31X8?6"7(I!O MFS+L)C8!]?@HL)]8'6P8AASCV8:$'4,W.(:P8P@YYKI:"/)\6\*.(6"&=.:AP&:@&^X6 MPF8@<'.,JP6@S'/F$G8, 3-DOHL8FX%NN&((FX'0)7-]2B'0Z)2*+EJ42JB= M:\YTL):'VG6&%[-# _A KL7Y#^^ZQ^]<[8I:!R_2V$;)M3-;*8VPN<1W=MGV MMF$=!J78FO8UM^^JZ]JZ@9%-WY%&0UN\_ =02P,$% @ :XAP2OF'5]QW M P 4!$ !D !X;"]W;W)K&ULE9AO;YLP$,:_ M"N(# +[C;Y5$:CI-F[1)U:9MKVGB)*B ,R!)]^UG#&44GR?W3<#.XWM\!S_ M7MU$\]R>..^^WNQ.O\M839U[+?PZBJ?).-INCWYX;GN_5 MH*KT(0ABO\J+VMVL5-]CLUF)2U<6-7]LG/9257GS9\M+<5N[S'WM^%8<3UW? MX6]6Y_S(O_/NQ_FQD2U_BK(O*EZWA:B=AA_6[CV[VV+6#U"*GP6_M;-SIT_E M28CGOO%YOW:#?D:\Y+NN#Y'+PY4_\++L(\EY_!Z#NI-G/W!^_AK]HTI>)O.4 MM_Q!E+^*?7=:NZGK[/DAOY3=-W'[Q,>$(M<9L__"K[R4\GXFTF,GRE;].KM+ MVXEJC"*G4N4OP[&HU?$VQG\=1@^ <0!, U -\ 9=O5HVX. M7V-V![(VN[Y3E4+])R??RM[K!F-8^=<^T*C9#AJ8:=BD\&7TR0(HBRUHPS%& M.@"2A'0+@GIDA NV<(ET6H6A@FPS'!U4](HU8V28&%$ M:0P7)B--,B+ \C;/M)IE7F"H&0MHF@+"QU -9@"2V=_MC 3NG@$QBW )]2#* M9ND&'IB,:# 9$D9+L$;1O*[,BU*#$0TPLR&8Z0@G"0O"R&!%(\QL&*9$26SP MH2EF-A@SG6/F,9,1#3*S(9GI*/^W=C3*S(9E4F1*B::9V>#,=)[-M0.:9Z!X M-CRL@>89WL$ST#R##<^@\\R\Q&1$\PPV/(/.<^QEAAL%:)[!AF?0>4:,, M, M7Q\TT& #-"5*#,\HH($&&Z!!!SHT7R4::+ !&G2@(8I22$P7BB8:;(BF1,SP MU@.::+ A&G2B0R\UO*&1)AHIHC-#")IH? ?12!.--D0C071H_(I#P[>S#=*H M(XV1!X9;!6FFT89IU)EF$,DEA\F+9AIMF*9$:6#PH9E&&Z919QK0^*9!&FJT M@1IUJ!D+(35]8B(--=I 38E2PY,7::C1!FK4H9;5TS+R9PO:BC='M91OG9VX MU&H?8=8[;1?<@UH0_Y,/>PU?\^98U*WS)#JYK%:+WX,0'9>S"3Q9VQ//]U.C MY(>N/TWD>3.L\8=&)\[C_H4_;:)L_@)02P,$% @ :XAP2KVK5C%A!0 M!AL !D !X;"]W;W)K&ULC9E;;^,V$(7_BN'W MR"*'U"5P#,16BA9H@6 7;9^5A(F-M2U74I+MOZ]N<:690R?[L+:5CS-'%'EF M)"W?B_)'M76NGOT\[(_5S7Q;UZ?KQ:)ZW+I#7@7%R1V;OSP7Y2&OFY_ERZ(Z ME2Y_Z@8=]@L=AM'BD.^.\]6R.W9?KI;%:[W?'=U].:M>#X>\_'?M]L7[S5S- M/PY\V[ULZ_; 8K4\Y2_NNZO_/-V7S:_%.BN)'^^.WIYMYV"IR>_=8MR'RYN/-;=Q^WT9J=/PS!)V? M<[8#Q]\_HO_2G7QS,@]YY3;%_N_=4[V]F2?SV9-[SE_W];?B_53GF[[-2U M;2[78WNPNSK=WYKYK)JC;RM*]'+QU@8:F'7/Z!&CSL2BB7Y.H5&*M1;#68*- M)"B<(IE$HGB*W($H"6&A!.>"N@ T"6!P ,#F"Z F02P;#)[)NF88S\;@<9) M+$QB11)EV&RM>R8:)V'(1B(J8EHS$"9.L-8(:HW A$0X0 P#Q."2Q#A @,D M0$'"9JMG[.@T3=K\TXS; ,XD:,J$IS*13L.07VJ) M1:D16"8Q'2D[PB:J58C]))2Z4[X\!VB%_5D9:2>IQ^$5=E\E[9=2[O$#-#;Y)(@C M/M.22@,B/LV2B@.?B2ILPPKXO@!$L:^?QS:J99]K0EYP!FC< M/";*4]@T]EHMO=:$O#0,D/U2'FR/6MJC;*D':-(>\5T[,)>;:@!YNVJ-G5%+ M9S2AX8)CD8?W,AO :#[#&8":5LUZ%&-?U-(73>@+@6U*IV(CFM!3!PF;!H'F M5-P-D.PER::IY>4;<2H<]Q/]] %.-WV2\IP]81LBV9J:D!=#DOUDVR,1O^R M4Y&.Q%)%G#5$'@>BP=@DD2^UHD\SP20 MI_+B2+(]Y=;P.9(!Y,HH7PT@[,T$GD&(FX$!FMXXDB'+14L.;84,<=.M,)6. M[9ZLW. ^)R?LY(0:7=Z=#]"X*VB:)BT6&L#2(!;;6V+:!)Z"2MC/"?BYXH6; M9'O:].?BDDG*!OS&.@-4TY_['I9A2R=@Z4JL--"@-C<"_*X"8#H,^!1D"#-! MZ"F>A.L(R7;7*-Y5D'P8(G;TITA&LFENUX9GG@TN6@8]4>$.9&2GFP3<9#> M BL_0]ADY4]EXX)E9-]LE"\$+AP&% Y^U[8>H.C"E?HB]=CW3[_'AT]O\RYU>V[ 79\K:ZS_I7, M_V'Z-T1_Y.7+[EC-'HJZ+@[=^X'GHJA=HS ,FA6_=?G3^/=?MU[CY7O9O M9OH?=7$:WCHMSJ^^5O\!4$L#!!0 ( &N(<$JT[R<.SP( # + 9 M>&PO=V]R:W-H965T6]UU4C M%_Y1J?8Q".3VR&HJ'WC+&OUFST5-E;Z*0R!;P>C..M55@,,P"6I:-OZRL+87 ML2SX255EPUZ$)T]U3<6?%:OX9>$C_VIX+0]'90S!LFCI@7UGZD?[(O0M&%AV M9V9599AT'K][4G^(:1S'YRO[)UN\+F9#)7OFU:]RIXX+/_.]'=O34Z5>^>4S MZPN*?:^O_BL[LTK#328ZQI97TOYZVY-4O.Y9="HU?>^>96.?EY[_Z@8[X-X! M#PXX^M"!] YD<$ ?.T2]0S1Q"+I2;&_65-%E(?C%$]W?VU(S1>@QTMW?&J-M MMGVGVR.U];R,4%H$9T/48U8=!H\P:$ $FGT(@:$0*^RXX]L SRZ"A+>0M0M) M4C@) M9)K#^YJ3.#"2*0(+($T0U!/FE4ATDLIK&8F.39I%@7E.(TGI3K@C*4 MY7"^,9AO[.:+0Y@@ 0F2^SN6@@3I'1WK,/'''7-!0,='] M$XEA_6% 6LY$]J!Q6U&>.!]/%X7)=&[7$ J3:=+!:&VHF3C8E4QZ6WYJE/GZ MCJS#VO>$S=HQL:_T.M@M;_]HNEWR&Q6'LI'>ABN]U-C58\^Y8CK)\$&/_%&O MK\.E8GMECJD^BVZ'ZRZ*M_U^&@Q+\O(O4$L#!!0 ( &N(<$KP2.1Y3 ( M )(' 9 >&PO=V]R:W-H965T43M9Q M\2I+ .6]U:R1:[]4JET%@2Q*J*F<\18:_<^)BYHJ/17G0+8"Z-$FU2P@\WD2 MU+1J_#RSL;W(,WY1K&I@+SQYJ6LJ_FV \6[MA_XM\%R=2V4"09ZU] R_0/UN M]T+/@E'E6-70R(HWGH#3VG\*5[O4\!9XJ:"3D[%G*CEP_FHFWX]K?VX, 8-" M&06J'U?8 F-&2-OX.VCZXY(F<3J^J7^UM>M:#E3"EK,_U5&5:S_UO2.A>\-Q?^ *S"-&R=ZC8(S:7^]XB(5KP<5;:6F;_VS:NRS&_1O:7@" M&1+(F! F'R9$0T+TV81X2(C?$V*[6WTI=F]V5-$\$[SS1/]V6VH.4;B*]>X7 M)F@WV_ZGMT?JZ#6/R9()$O<1(36&=G\:%KG9(T[@1@5B*U ?"<0.AN%,6ZM&!,YQ6),C)M=H&87 MB,#",8LQB6,68Y:.68Q)<;,):C9!!-PCB#"QB:U3--_>S/B0%L,"MV#\ B%X8PDCN%@ MP2^-,A_X)#HVEB=B;C8GOM$-I^\/[S)]M_I)Q;EJI'?@2M^; M]G8[<:Y FYS/]'$M=8,<)PQ.R@R7>BSZ-M%/%&^'#AB,;3C_#U!+ P04 M" !KB'!*5(33?^ " !X"@ &0 'AL+W=O9(6]G2LUM;E=,Q./$L+NBZMZI3G2?EW1C-VF=B> M?5UX2?<'+A>UZ68.8V5;9K3HDI9895T-[%OO=&*2%X!OU)Z MJ5IC2V;RRMB;G,RW$]N5 =&,;KBTD(C'F=[1+).&1!A_M$V[<2F%[?'5^J/* M7>3RFE3TCF6_TRT_3.S(MK9TEYPR_L(NSU3G@VU+)[^B9YH)7$8B?&Q85JG_ MUN94<99K*R*4/'FOGVFAGI?Z34BT#!8@+4"-0/C^3.!K@?\A"#X5!%H0#!5@ M+!@$9.V=I23.S MFD$=)NPRBS[C-80C0FCB0& <,]33HZZ'NSX1!%&7N0>8+O$ 68F[S&.?\=TN M\@28P0;S##%>EYE#C)'XXLNM67X=\*J/D! ^(!^^*+XRX' "HBGK%[CY#'T#?JY F@ MB!L;'I\!*L9FSPB^) Q?,BX=\@! M-OPL:@:W_& <1T&$C/26 (C\2!2L&3D >CAT@_ _P1,X>-*_H68QUDC4WB/W MQBSK)4P1M_UG:%:@QHN-!)S6+WM.R[WJ82IKPTX%E^796FW:I%LDOPS&^LP; MS3U@?2':JKH+^C!?]V3?DW*?%I7URKCX(JF/QHXQ3D7P(CG;.H@VL)ED=,?E M,!3CLFZ&Z@EG1]WG.4VS.?T'4$L#!!0 ( &N(<$I(3S&*W ( /H* 9 M >&PO=V]R:W-H965TA=>>JHJ*/VM6\LO21_[;Q%-Q.$H]$:P6#3VP[TS^:!Z% M&@6]RJZH6-T6O/8$VR_].S1_0)DF&,3/@EW:P;NG4WGF_$4/ONR6?J@C8B7; M2BU!U>/,-JPLM9**X[<5]7M/31R^OZE_,LFK9)YIRS:\_%7LY''I9[ZW8WMZ M*N43OWQF-B'L>S;[K^S,2@77D2B/+2];\^UM3ZWDE551H53TM7L6M7E>K/X; M#29$EA#U!!S?),26$/>$F-PD)):0](0(W21@2\ .(>AR-XMY3R5=+02_>*([ M#PW5QP[-L=JNK9XTNV-^4^O9JMGS*L%X$9RUD,6L.TPTP* >$2CUWB*"+-;1 MB)[@]-IB V'(->8>PF37F <(D\/!QN!ZQ$8@'@JD(2R0@ *)$4BN!)"SH! F M@DTP:((!@=@QZ3#88.I;NY:"%BE@D3@6Z=@BM!]G?S^"O J*@$$1("CWM'88 M,K *9\K&V8/-N["K<#(PG P()X4%9!:4#6.:(?=R!U%A M,A$.7/D(*'T2N>&0\6;D)'=+'X#%,9DZR7#I(Z#VB7L%6]#0"-BN,0B-KJ%@ M\']>,7$PS57K;?FIEOK_;C#;-W!WD>X'G/DUFF^Z/N&?3-<5?J/B4-2M]\RE MZC9,3[#G7#(58SA3A^FH&M%^4+*]U*]$O8NN&^L&DC>VTPSZ=G?U%U!+ P04 M " !KB'!**&6N;Y<" "'"0 &0 'AL+W=O>)?49+(IY832OUY,Y/F=0&;SFOR8G^I/)7O>5JYK4LA[RDE< M7D5G[.A4=HR]ZLFWP\+U=42TH'NI*8AZ7>B:%H5F4G'\:4C=5E,[=L?O[%], M\BJ9'1%TS8K?^4%F"S=QG0,]DG,AG]GU*VT2BERGR?X[O=!"P74D2F//"F&> MSOXL)"L;%A5*2=[L.Z_,^VJ_1%'C!CO@Q@&W#BC^U"%H'((/A_!3A[!Q"'L. MGDW%U&9#)%G..;LZW"YO3?1?A&:AJOY>&TVQS3=5'J&LEV4X">?>11,UF-1B M< >#6H2GV%L)#$FD>.".;P760T3@WT(V0T@\@8,(P#P#XQ_GFF M0PQ.1J),0)%D*)+X,,$4))@^ON;(A[O#!V) _?:PH*BSHCCR_9%0T4@?HOO_ M5]J XH[22$41V(HKA(%\<%\%_U<^<+^A % *^DK!0&E,!6Y*!'1E,MB^PH=5 MX'Y#0,,E45\E>E@%;DH4 RJ#/R"^LS9V([H+NPT(;G($='FG@YN (%!_+_$Z MIU%)^L;:WB176IUG/GJ+9VMX)/FCL%>4'X:>\$LZ.2756 MFA/MR)BD*D;_2=4A4[>B=E+0H]3#B1IS>S6P$\GJYMKCM7>OY3]02P,$% M @ :XAP2@-D$)'N 0 UP0 !D !X;"]W;W)K&UL?539;IPP%/T5Q ?$;+-D!$AA1E4KM=(H5=MG#UP6Q<;4-D/Z]_5"" &4 M%^Q[?& =M.JD9)QBJ4Q>(=%Q MP(4A48("S]LCBIO636/CN_(T9KTD30M7[HB>4LS_94#8D+B^^^9X;JI::@=* MXPY7\!/DK^[*E84FE:*AT(J&M0Z',G&?_-,ETG@#^-W (&9[1U=R8^Q%&]^* MQ/5T0D @EUH!J^4.9R!$"ZDT_HZ:[A12$^?[-_4OIG95RPT+.#/RIREDG;A' MURF@Q#V1SVSX"F,].]<9B_\.=R *KC-1,7)&A/DZ>2\DHZ.*2H7B5[LVK5D' M>[([C+1M0C 2@HG@[S\EA",A?"=$GQ*BD1 M",B68GISP1*G,6>#P^W?[;"^ M1/XI4MW/M=,TVYRI]@CEO:?1\3%&=RTT8C*+"688?T(@I3Z%"+9"9,&*'GP, M<%XC0N\CY+*&[ _;282;=8:&'\YK. ;; M&F0&0$HGFC'A=)9A:S-YC68):0 M\QJR6[3[LH9$NT6F:/9[*?#*C(YP&ULC5;;CILP$/T5Q'N7.[F((&V"JE9JI6BK;9\=X@2T@*GM MA.W?US:$!#,A>0';G'/FS& 81PVA'RS#F!N?95&QE9EQ7B\MBZ49+A%[(36N MQ),#H27B8DJ/%JLI1GM%*@O+M>W0*E%>F7&DUK8TCLB)%WF%M]1@I[)$]-\: M%Z19F8YY67C+CQF7"U8B(?V'^7F^IF%F]RCXO<<5R4AD4'U;FJ[-,'$50 MB-\Y;MC-V)"I[ CYD)/O^Y5I2T>XP"F7$DC5O$AFAQC>D.)/ON?9RIR;QAX?T*G@;Z3YAKN$ M/HLO^!S[@0<.E$Q$A) MP=352$^,D[)3$59*]-G>\TK=FT[_0H,);D=P>X(33A*\CN!="?XDP>\(OD:P MVE14;1+$41Q1TABT?;TUDKO(6?JB^JE<5,56ST1YF%@]Q_["B:RS%.HPZQ;C MWF"N"$NH]R%<*,3:'='=88#-&.'90T@RAH0SV(0'YNDIOC?(TX4%?%# 5P+^ M0,#3"M5B0H6I%$9+8S-&.'JF8\@7QX.=!J#3 '#J:TY;3# ,HJ6S@4!SS2V MN5/6$#0; F8#S6PXBJ&7]2$BF4(,;,Y FS/ 9JC9G#U34P"DEQ32"6"S<]#L M'-CK=SZ6!2BP>&*O+QZ^E(>(9 HQL.G8\,_+?F*K=Z IIX\AR21DZ/7.C]8! MO,YUKP[T\>M["$+IFPA4TG>1==,E2DR/J@,S(R6GBLN?[<6,'>&BAZE.&PO M=V]R:W-H965TR7-*S=9VKZ]2);\ MHHJ\8GOAR$M94O%WPPK>K%SBWCI>\W.F3(>7+&MZ9C^9^E7OA6YYO/*MJPH MC)+V\:<3=?LQ3>#P_:;^Q4Y>3^9 )=ORXG=^5-G*G;G.D9WHI5"OO/G*N@E- M7*>;_7=V987&C1,]1LH+:7^=]"(5+SL5;:6D'^TSK^RSZ?1O87A T 4$?0") MGP:$74#X&1 ]#8BZ@ @$>.U4[-KLJ*+)4O#&$>WVUM1D$5E$>O53TVD7VW[3 MRR-U[S6)YO.E=S5"';-IF6# D)[PM'H_1( -L0E&X<'] -LQ$?KWR&Z,Q%/< M1(C.,[3QX2!^XONX0(0*1%8@NA,@8*$P!L[U/YC=<^;.[ 0U.T$$0F 68R)@ M%F,FP"S&Q+C9(P)38!9C9L LQH!4WB$,>9 &4]3L%!& :3!FH@BN+*8# MTP!C0MSL##4[0P2 D0W&@"W>8DP,S&+,@W_H'#4[1P3 %F\P!FSQ%F$">)J, MF>$.W9DE/GYN^L@P,!$0:)P)J!),!11ZD ODP4E/$ F8#2@$TP&%8#Z@T(.$ M(.C%L28!(@%3 H5@3F#0Z"##H! >#M[@8BV9.-NB13HIOU3*W$^#WKXP6MNZ M"/1O3,%D+^Q/F;;:^D'%.:^D<^!*7_OVI M?A=ME=,V%*^["L[KR\CD'U!+ P04 " !KB'!*QAE6BL4! !%! &0 M 'AL+W=O<:JDT J1V(4QV&XQHRT'!69RQUED8F+ MIBV'HPS4A3$B_^R BCY'$?I,O+3G1ML$+K*.G.$GZ%_=49H(CRI5RX"K5O! M0IVC+]'VD%B\ [RVT*O)/+!.3D*\V>!;E:/0%@042FT5B!FNL =*K9 IX]UK MHG%+2YS./]6?G7?CY404[ 7]W5:ZR=$&!174Y$+UB^B_@O>S0H$W_QVN0 W< M5F+V* 55[AN4%Z4%\RJF%$8^AK'E;NR'E?63IRT38D^(1T*4_I.0>$+ROX34 M$](9 0]67&\.1),BDZ(/Y'"Z';&7*-JFIONE3;IFNS73'F6RUV*51!F^6B&/ MV0V8>(*);Q'[>T02WD(.]Y#UXPC!IL:QT'BQT-CQDPD_VJR6!9)%@<0)I#=. M9SYV V;M,'QPNIE978 \S:S>0Z)P5BF>G(]]8#^(/+=AS5&[ ZF%T&#D MP@=S:QOSIL> 0JWM]-',Y7"SAT"+SC]://XYBK]02P,$% @ :XAP2LLT M-BRJ @ $ H !D !X;"]W;W)K&UL?991KYL@ M%,>_BO%]5U"TVK1-=EV6+=F2F[O<[9FVM#57Q0%M[[[] *VQ<.R+ O[/.;\# M>&!UY>)=GAA3P4=3MW(=GI3JEE$D=R?64/G$.];J+PQ&;%3^KNFK9BPCDN6FH^/?,:GY=ASB\#;Q6QY,R ]%F MU=$C^\746_RKAK6RXFT@V&$=?L;+$J?&P"I^5^PJ)^W I++E_-UT MON_7(3)$K&8[95Q0_;JPDM6U\:0Y_@Y.PS&F,9RV;]Z_VN1U,ELJ6 MG=9A'@9[=J#G6KWRZS:0])IT2N)@ M/%+<0:0@1 I +!R(U ^!"G=A?5&!I6)4"GD? < MTDR%Q, ,81<)>Z'<_0M(\$R1Q'"5Q$"9)#.+C>$ZB8%"2;QZG_CSYF4#:&;3 M@2LE!DHE<7\![%="GP70S++ !1,#%9.X!\@@FAX.R$5Y).E!HLG1;.Y*/ZDX M5JT,MESI4]Z>Q0?.%=/NT)-V=]+7L[%3LX,RS85NB_Z.TG<4[X;[5S1> C?_ M 5!+ P04 " !KB'!*VW5>^)@" !P"0 &0 'AL+W=O MD*1[^P%V72=<5_D3 S[GW'-ON(;Y11-2ZG461VAYYS=2# M:'ECWNR%K)DV4WF(5"LYVSE2744XCM.H9F43+N=N;2.7J%$T@^7X1/J+9 M&N66X!"_2WY1HW%@4WD1XM5.ONT686P=\8IOM95@YG'F*UY55LGX^-N+AD-, M2QR/W]6_N.1-,B],\96H_I0[?5R$>1CL^)Z=*OTL+E]YGQ -@S[[[_S,*P.W M3DR,K:B4^PVV)Z5%W:L8*S5[ZYYEXYZ77O^=!A-P3\ # :6?$I*>D'P0R*<$ MTA/(#2'J4G&U63/-EG,I+H'L_MZ6V5V$9L14?VL77;'=.U,>95;/2TK2>72V M0CWFJW1\'6#E(Y+X&K+V(6D&FTC /!/'3\8YY!06 M(* <0+DJE#93:$Z3.HP31>$I&2B6!0,0SV?E.2P0 H*I(#/XL9GAZ$CGSB/ MXYN2KU(O&UQXJ+6/0O$8=64Y RUGOF4Z(9"# OG]12M @>*.HA5>HAG)\$08 M%,/=%@.IHMMV@T!X(LY$5R- (IF0 +OV$6&_J)1,2, ]AQ+ !;W--@$V4#&5 M+MR;"&A.ZGW%(-#$-P3!S8DH(#&U ^#V1.G]>Q7![8* ?O%V:P\:EY7F<59, M1(+["N7W;%;:+AD+?\# M4$L#!!0 ( &N(<$H!(1M\;@( -(( 9 >&PO=V]R:W-H965TO;0C+P0N]";;Y__$W0_ 0-82^L1PA;KR7N&)[,^>\W@' LAR5D#V1&E7B MSH70$G(QI5? :HK@69E*#!S+"D )B\J,([5VI'%$;AP7%3I2@]W*$M*_"<*D MV9NV^5AX*:XYEPL@CFIX13\1_U4?J9B!/LJY*%'%"E(9%%WVYK.]2VUE4(K7 M C5L,#9D*B="WN3DVWEO6I((891Q&0**RQT=$,8RDN#XTP4U^SVE<3A^1/^B MDA?)G"!#!X)_%V>>[\V-:9S1!=XP?R'-5]0EY)M&E_UW=$=8R"6)V",CF*E? M([LQ3LHNBD IX7M[+2IU;;KX#YO>X'0&IS?8P:+![0SNA\%;-'B=P9L80)N* MJDT*.8PC2AJ#MH^WAO)?9.\\4?U,+JIBJWNB/$RLWF/?WT;@+@-UFJ35. .- MW2N B-YOX>BV2)R9W1EO<)@K7&LL2>>2(-1#N-H\7>5WASEL?'T 3QO 4P&\ M8:&""632:@*EJ5J-?@M?NX4_8_2#3RH=: ,$&L9)K9-6XP\873N8/(]@EL=, MDRYK1K"A%C;4P+H3V' &.RGY8561+BE&F!LMYD:#Z4TP-ZN8JXIT23'"W&HQ MMQI,?X*Y7<5<5:1+BA&F;>G/&TL#&DP/'&N5=%V2+DK&K)^R8:N&\1&F[?8_ M(+T6%3-.A(NVHYK#A1".!*/U)*J9BP^,?H+1A&ULC57;CMHP$/V5*!^ L0J0%5+52*Z&MVCZ;,)!H[3BU M#=G^?6TG9$,PN[P0>W(N,T/LR5K&7T4)()TW2FJQ=$LIFR>$1%$"Q6+&&JC5 MFP/C%$NUY4<=8ZO/M[&ZR_(O\I4MTO=- TV[Q3[1$J>L[C9)&ALQ;J,:L.$XPP_H! M2GVP"&P6J^"&GLRO'=:WD. :L;E%A)X]B=!:9VCXX56=J5T@L@I$1B :"\R] M2:,ZS,)@ZB[)69Q.*OD$=)5*;$TEMJ3B3SH:W[@$L\!NDEA-$HO)'8&Y56#^ M>,<75H'% QWO,.E#S4RM+NGGS5RE-\V,9]$=%]^SGS//XA-.#YH-%-WQN7.> M?8M$//6Q@9*)#QI=(13XT5S/PBG8J3:S810=1L!S8*Z@=W@W/WY@?JQJX>R8 M5!>9N6X.C$E0N7@S]:66:F0-&P('J9=SM>;=O=UM)&OZF82&P9C_!U!+ P04 M " !KB'!*:HZBL0D& !&)@ &0 'AL+W=O*S83&VM;KJ0DV[>O M)"M>BW-&H6_B6#FD#H><+T-*\[>B_%YMO*\G/_:[0W4[W=3U\68VJU8;O\^K MS\71'YJ_/!7E/J^;K^7SK#J6/E]WC?:[F4P2.]OGV\-T,>^N/92+>?%2[[8' M_U!.JI?]/B__N_>[XNUV*J;O%[YMGS=U>V&VF!_S9_^GK_\Z/I3-M]FYE_5V M[P_5MCA,2O]T.[T3-U^=:QMTBK^W_JVZ^'W2#N6Q*+ZW7WY;WTZ3UI'?^57= M=I$W'Z]^Z7>[MJ?&Q[]]I]/S/=N&E[^_]_Y+-_AF,(]YY9?%[I_MNM[<3M/I M9.V?\I==_:UX^]7W S+323_ZW_VKWS7RUDESCU6QJ[J?D]5+51?[OI?&RC[_ MP;R',#84<;J+Z!^ME CS;0?0,=V\#T#4S08'8:>Q?, M+WF=+^9E\38I3^OAF+?+3MR89KI6[<5N=KJ_-?&LFJNO"^/:$19\6LZ?U\"XEN<2])XZT(,.LB"8)XWM-(?30*P,AK*DHM1)&X2$BD1J31I$!:@RX9BX&#@L M$S&LD\9E'H)Y MD:PQQ"Q;P8!6@#4C0T."9BN8K5X6.5T"8OE.2&)( M2"8+! :FN(*8 B-3 &:F*@P+$G&CQ0P3%&)"2J8+3!YAKQ@MYH9 X""CI2(E M&& +# 9!R6!2PW2!TUED\:.5. 255J1"H"FH9,8@0>(,E#0# M*1(D32UD!ZAX.SC_),T_F82E5R_ZR Y0\79P+DL%E@S7!]C4\6L!HT0@M819I6B:%M0*0,$6_QH#2 M:",39I&F!1+9_2(-4]1K##H-2BB21IHBK)FBD/Y U4P1 SJ-0:<1Z,(TTI1B MR Y5C=AA3J,0[KA%ASFE37P::H>#N8,@90)F/^ MHQCF?/D*RAA,&1-#&4/Y ?8!0&6TXE8=IHR)H8R)H@Q2\7F$*6-B*&.B-FU M-1(=3!D30QD311FD8J-C,64LH@QS-&@Q9>P5E+&8,C:&,A;P@\X14/$[68LI M8P%EJ)V/-VVCDJ$1S!=+^4+7KJ4[,A07JAJ)"V:5!0=49.U:NBZZ-J>) '477[<<' MWD#"1X9YQHY.@1S$Y2-S]?G+SO_5+>_ MMO-7GMYL.GVIBV/_UM;L_.K8XG]02P,$% @ :XAP2I ?-YE1 @ A < M !D !X;"]W;W)K&ULA55=CYLP$/PKB/><^8:+ M"-(E4=5*K11=U?;9(4Y 9S"UG7#]][4-X8CM2UZPO M&]RRE5MQWBT!8&6%&LB>2(=:\>9(: .Y6-(38!U%\*!(#0:!YR6@@77K%KF* M[6B1DS/'=8MVU&'GIH'TWQIATJ]D#>Y^'98N9XTA# JN52 8KB@ M#<)8"@D;?T=-=]I2$N?SJ_H7E;O(90\9VA#\IS[P:N5FKG- 1WC&_)7T7]&8 M3^PZ8_+?T05A 9=.Q!XEP4P]G?+,.&E&%6&E@>_#6+=J[$?]*\U."$9",!'\ MY"XA' GA!R&Z2XA&0J01P)"*JLT61J'XI@ZK8ZITH M#Q/12Q$_QSFX2*$1LQXPP0SC3P@@U*TF M0FN>H>*'-WDF=H'(*A I@>A&(-4*-6 2A6D51DMC8R+"0$_5Q 1Q$MF]QE:O ML<5KIGD=,/$=KR;"][6,MR9F$03A)U\FL9I-3+.)?@*3AV9-Q"(,0\VM!?2) MU=1J-;74]5FSFCZT:B(6OA=I5N_)W#C-K$XSPVGB:3[6V1=IL77HL4,'>%#9NA//R ]U2US]H2+ MFU+=9T=".!(6O2=1Q$JTQ&F!T9'+:2KF=&@,PX*3;NQY8&J\Q7]02P,$% M @ :XAP2G]NA-O< @ 7PP !D !X;"]W;W)K&ULC5?OA:G%7!H8:I+L0N+1Q/"+9'&C,"<#UCZ$&D/1[.KW MW ,PU 2&,A^N<3P97SP$+F$"E7"_>!QHQ-$1N,H)_CI3'QUH1!J2@9]1J!'T MTY!\W0B"LTN/N7K_9/4N*Z7W*I2^/]E;SE8(Q;4WW;;P=#]K_%//_4$L#!!0 ( &N(<$HVMRIW@@, )(/ 9 M>&PO=V]R:W-H965TO.)C LDVX"2!__^YJ=Z5(PYM(W[(3YU)[CZ,D M&^DG*<\#P\AV)QX'V8,X\T3]9#Y@C(?GX,A_3%W-9?7(.-3$?T.]_(TTCU=V_-# M<(GDB[@M>34?JFO5Y+?\RB.%YY$H'SL19<5?;7?)I(@K*RJ4.'@OGV%2/&^5 M_;L,%UB5P*H%RO=G KL2V!\"YU.!4PF/Y:-'[Q8^J6S,U>ATSRQP:U]Q2Q4Q*QFHPCN.VF767(35AJ!#J."PT MCHG5T5MM#],NX3A>FYDA3)MXPJSX;6;>96R0D@5BA@)FB3&DS:PP!DQ\_65J M-E\'O.TBS,4+9..-8A<&[&:!?0>WX. 6G,*"TPP!9'Y2(JQ DC(=)NR#+F.[ M%/0!POB@5YYZV)EC\0!FTM)./5T&ZEDBM.'EFVO!O6.*4AZ@9@A%;6J#JB*4QPBH_1SSZ,)]8(%0C,!^ M7"*43QF(?H5%[U+@<8U0ED=ARVTPS"$4E4&"V&.>71MT*,+A&*F#SPN$UNS1:LB45K_[^C/ MQ7J5Y7?1>5$^=(QT#LLHDS5,OTJ_1/^2/C>?.]^6)2[U358MX;F_IDF)L(I> M)W5KWM/3P?!T-.B8ZI=TO3[]+2^>\N@J3:HB3U?1VZK:IF7SA0]%QQ _%VLX M^Z1\AN6LT[+JVI2L^3)]*,H:(7!5)_6V]?A?TZX1:/CH'/9X5Y0MF)PMERG\ M#K^N^,F.43YM;];9,GJS+I*Z:ZG%9@,G?E47R]_BZ.H^*=,J^KBMJQIP U;> MB3KN>;R!+UL[:3[Y*2VS8A5^]LU?.]^^?GYHG?.@?_HO+9C TRN>;YVTEGV; MK*O6,&8.65H76NDM_%]_]W>AVW3^\DNJ>;O,0/Z=^VV6.R MAN=;D[S-'].JQAU74?*89.OD9IU&<.VC"EYH/OVI3!^2;!6E7X!"5H 5.$51 MWP->+KT%-5^\+FHX[MW/- >/H[S(3^6=]L- I$M 5EP![N\!]P"OI*U'>>[P MG K&=9;<9.NLSM(V+.%F(76OHH?DF:"#4R;+9;F%J^:\&'B/'H'7RF*]IM?* M=$TW5/?8?.>2?S]]2'!O,F'[S);%)HWJY(N9OD4.7J>W*6P-9WQ,\VT:&^ 3 M^2GRW2>T8UOMD9UCZAH=24JF:(9H"0P.*$F:+V&&Z/A#4:?1I,4)>4T[UD(D MZAXX"M#=?R TJ)];YP=X)2NNF*(!<".X#MLT.NKW^OW^( )4BBJD<]'9MKXO MRNS?T]4KY*/P*_Z/?X2EUQ'9T MJU6&. :H@?3B%&CH,GG( %4"-W"[V?*-6Z6WV3)K$0?W$2%DQ09DO7NXGC![ MM"ZJ#F)6!7!O+P+3?@]YMP*A<\DRSPHF61M)4<<@ M7K[:9#GI+DAP.GGS3Z#O1<5M!')$O4Y)2&3&->I@7$5S5\W'W@%QB6[+8J./ M%GEXUF,D0R<1(,CR/@&VB0?(^ SK 3("TATMO5,<>)O7*:!.[0AL&4D108F) MUG63@A1(4D8;%(X$TK&U#VD=I)T_)A5H'W1*V7J+5!>?W MDT< ' D<&-N6E-]W1TZ__C^T^7%GR\^7+W]^2)Z]_'J\+OTLE&[K\W' &>Z MLXA!AXBH ?25@4,QC"G 73_='G-VEXOLMWR.4(FOUH2.[LC= V_S M,DW61!GO?'3-K'JQ:RBY+X%=,I8&]AD@H'O8]H[#N+K^>/XO?_[X[O7%Y=4_ M1!?_^OGM]5\//V1'78[^[3V),JT3=(263R*TG+/0TOV*(YJ\9NGEH&<967QX MT(WN>IF@W[ZHZR1?IB*U&8XPZGK.N5M[WP'R 0A3P4OP&'TZ00C[TOP%8^N_ M7:+N]*8HGY)RU5HZ UW8*VJMK.]^2N14M"=.C@ M&]J!42T9XP",:KT3/,C#CYR7O0."9ZO'K(*'!1WH?5SD@7ML:7 '[+'SG<9S M+=O3 6/OME<=0!M?HH*\\(X>* 'L.VS0(_ENE_6N856$ _G0;554+:/#\-8T?86$7@*U!:\+]!"H M]^$!"U![CN?3%E2?A._20] PNNL-1T8+6%F7:;J2M:!%.(*;MDGJ;8F\>??+ M>Z 1VMD^:-QF.:#4/FAXBT[W,]WN%Y0P'0*76^2+1H?O!(8+@M!V0B^N1$J* MR-1UH&6_TP40@VIWE^4YSHL(0XZ.%[R=H@JY\SVZ<$B3,Z,G=IRM\R0KJ*WM MXV7%)TDI03 %#O!-DI66CAB1S6$.55H^9LOV(MX8_R;N]<=ME>4ID$T48.Y3 MDJ&3O$6$#GIIAS9'1H-!]/?_WWPV'/X0'39CM>< MEGWC; /O!=XI5!$)V] NH\6GZ&RY_#8>%U!H6%M7I M\CXOUL7=IX06T;5Y$!8VG@]A83#48P)XNH6% ME!E@/>A;AB@"(VC:GSYCOX.X<"Q,=FAU( M+A4\!"B);F6X[ZOM$K#Q*:OOY?6WGT[K=)T^W!G]#>R M32"0);I(V..TS;/;C#6,#7Q>LKD(IBY_2Q%ZGV";=/0@WPUIY<*EX$)4 -!- MAJH"H@:JY15H_##>$CEULD'_%IFVBMOZ":TP)3%"W/'#MD0^7N.;N':XIALZ MU22"$[Y;I^:LDKLR);-8+WK-@$#=C]9.2P+TO$\,[U3::8QIE<4%6-\M#L!& MME56/6QK>.$)E(\4R";A^3(%08$<21604[X(=-4?DJHFDDP#RN+@#S[4.F,[ M11.Q:&S<8,GPR@LXN8R&J]DAUMAD= RCZGT0LV9T"1(8P!77(G?CI!=]A*D\ MA$=:MUX#TF[1A:'\.JL(OK=P%BLC3.$RS57:%*MT3==$Q)?U,Z%8\@"#@+ * M*X5OQHOH<^^J1W"?+HQU1VX9H6'CC4D?B#G;S&2W\/O:8-A34:Y73P!DV0H_ M8G<$"P=0 1YF,-8MNO(1OL 'TR6C 1J'3NMLDS9QMWA$8H47 JD_4)08Z!8< M+SI+*^,K5=H=55LT\#*8@%6 A)95]\X=1+CF)'(R>N+\<%<+_"7*DPVB#<6H M/+L[@1DV:7U? #=/UE4!. H":&+--1XLY +_EH)\A2R9Y59PZ/.DI!GL M-W\&7ML#%0/(Z/;F5_@.)34 +($#8(K(!*A!;S71 K]3)/!VS*=0J<$_<8=\&F9M+!HD^*TD=5A*/.%9% M*UX:+H-E%*8T0(,63!Z'XUYTA7*)7#"9* 2*X'U &I$L@8N4(MI=FJ@.,_OOW^M^^3Z&J9$;$_M&2Y*E5J6C!;4S\_$,Q94C,# MQRQGRN1+CF\B7VEI,9DV0@JY&W1"7(TAU6L9"+:;#49EX05RF)U$<^#Y? +R MM0Q%%1S\YCXA;VB$O!>,B3!]0*VU-&Q % 7R.@-\&+X(K((B])"N,%VWPPE" MKKVK"[^G#[65TC[G)!1@)%I:*=; B54&<5!%V]"OY"F#F[(1LR3QT^3VED[G M'G$.60*Z9#8<+H-4)ZBCBT^F6JZ+"BDTB8@2#U)WOL.S &M,530.0@7?ZUJ. M$3U(-]88)H=>F)>8<#!^+X%NHY7+@ZX>%ERX=/.P+IX5I(V30]J ,@H\O^); M%%PTR1YXLUB2!]VX6*-M%>3OK"06A[),D=^=KDGL82#%GH(%5,73@^Q,(.[5 MY=;"I^HP6/>BSZSW7IA3_T5WE!ZX%61< *=R18SXZ[ 2*?ZQB%;TQT]G9Y^L M0/46S7M$8(N8I4H UHZ@"Z B+4YWWQIY:2UG"&-G =BQ#K,Q.OL MMY3Y?;$$?L\,0%@J?*EWY(R.&W4!D$\2EFJ!BFS7L%_>#*\;I1%XA8Z<;9PP MIK/@:U8PTB_$F[!@8H$-Z <)6FM*&J=?+>0F*:S"(LG P+>,CW M=+%D(5(_/* N'.U-*AB3KDCPODE$*[23%3FK'(@796;4-690+?R# [Y)UUGZ MF/K0AA/.5R(\+;-R"7RNQALD2(=D!B\V4K_F;LEP /^]*]3KS;JTM06$SIIH M*.H2$M'!QLO1)M*W#)V"J05@* MNGY-0F8&@JP1V&Z*I"0;U K8U;(N2M@P!A;0KLX-B2*;P'UZ$-%"LT+JW@P: M:X?110+A2@!& 1A]"HH8ZBHJ\M'E/ENO61)>BA'GAETSPJ46[-(&35:79 M%^$2DK-3MONBM:,H*]3SCQ42@KM,O]+P>X 8N,K(7@"(_3"!P]79^79Z/"=6* M;>U(DK%YUU!U,7TX@3]DJH!+'[)7>+QC^W *<)6-8Z LW$I4\&\/4" @PQ>#&Y"W MK.ZSAV[S1(D!-Q42M (=03 GW5)D<:706D>G\PQD:(Z]T^-X9S;B'$E2FGLG M!EM+#=^8"^L(RU<8Y -$H(I^)%J@TL*;LZL?55!HXCCM^VZ;D602-TTW9\XJ M>6OO%9=>.]C94V/H-1)/'@^I!:-@'3;VT$LXAZH M,04QG28@\:4BT&TK*Z2NV4OFB'MLP2"F+U$T/@^QII/"OPPL:;(J'[2DJ4ASH 1Q/JFI0!] ;\^E)9"?'T[?$/%\DPI?4*<]?(%3$NEIO"YC7R@1-T[; MRTC.';#A;'NWA>61@9I$LKLD%Z,R\\J<3D/71]Q/21W?4G/CY2&\VUNQ@(VC MYQ2##VH,K,+QCCB5P) I=WK=1G1EV(M5=074PX01[BV14C46\IB!R[JAIN39Q&M3 TL:!7RIDMT:W00 .DT3C*Z<.%=923 MGT:H(MW%>R#II%7#,RLW< )];!2-(3*5\51*H$6FZAH +=IP:C! :XT^H899 M3$<2R:/IO&?#>F<( 3&.O*A=JZOK*%0G?502:\ZJWP"@J1&/[P'76VM.*6S! M[!7]E!R0<^'F$$K,JO"',S:6-)[L?C"8620B/KN+&NEI'"C#H]/WB'T)2B7, M#M<4;4%19:+QH1FLV!3J$R)_$SI>28O=PC,5*GP_&C+RGK(1\$;%UBRHC$(I M-5_K# T9A.Z&6!@_RJ!_2B0 6;B*4;0XOD?;W+X3R,(S@I>=/#/*+IG;FH=Q MZ@1'16*V]]1GT6 CRH1'P1162Y6E75HBL6KWMV M^D6ZFMTK0^BC;ZD!%!?XNQ;[B]X:MC9]6>)EEP B];7"$#Y-6:4WM6?LM,XND/LRHTV?INN.!/FCH+_Q5%)RFM+PW,N-U$?H(H HZ>"60S@_S.;=)Y) M0"&=FB5Z8W=8 CW.R%C&5E**1P#Y,T_9#5=1#7A)E+H MK )V0&8F##N,A4AZ>8 VE%%M(B9^L1>]WO4SHS6<%V636(TL<7+OV;Y>)BB_ M P3RU'B7S:560Q<. ?(8)@@^&G)I3- LMY%2JL%O;.:ND$LJQ"_Q_I8M!SC% M7/)R@9?>B>JI=-2RQAZ*3TNJMZ $XYQ/Z!*INZ6X^"?C]^=<7'6$!OOYB<57 M6B#\CX\*T6:3_%J4#4=%5F\]7[OGHZ(#*JH,5:-TO3*6PBKM&@5U0[P^Z:J! MB?#4MB1@F9 \M(N@HKR2.4#V]$DI*L_6AD?7F30DE##(5B%W218))%'G\,*U M8,]O7K\]-W$R*J1UR6@JG4W$W;&B9%KR=L<1"O3&N%PB3Y!%$1%9%<30U>:L M-NB&:Q6OX#;?5GC'+1R)P=^DSX7:[#!03;YNVX$TQ@L E/_&81^<0X1VI$A6\8?M\Z2I"F1M>(%>(UP9 \5R?[]#U^8XT+@LB6#@0H=MGJ:S \+*O M6:1J.4XCB4CV_#WW:+1YM"4*K,/,LU'!%RL,STB-BZJ)>FK6PZFB#3$"OH.T M2+$D@LZYY>\M)V6S ^J\E_H@RZ, J U(?4IJR)T U]!*>""=9QA^XACI,/H& M2 -J.FQ67=I@:I'858UBH*#583#[P>Y&Y*^WMVH^9/PKK5[#?.5&'=48RT'1 M/_80^&?'SM#8BD.3,;*/4*P#I!8[A*!7(MP6O[)UTMFK P-GVP@S'%,B660X MA+:3/?S:,5UWI14+?U6O@]$X299&?^FV1O@T7LE12TYL"0S''-^L"T*Z!TE^ M<&7S-"4V 0AX>]O;MR@\'QEFY;-ZR=J]QF !O#]"YEJ1VJYD0SCL>JV?C:WY M>N?OUD#&F&9-\!0R)_8.S"#N"/C 534-S_@XPA&&9@\P65,WR%E!EW==PW0W M;9AD^@4$0]=?3$,Q32(AV#(]4Y_I1CV*> Y=_GM4\I/UDBBPK6]#!^-LD$L W7>IG>KADXHJ?9(X3? %PPTFVVQGMAI0QKT1;YT4TA M,DOCUW003SLB*BF$-[,A&^CWI$.I=6#$CE2"+7(/&G*VB9/+3FLF6) !VA*+ M3EU,**^^:,9".U?"[OJW3((K0N;L%L4>\NF+SB:B1@L1)0A###>P7\Z6)]5Y M@QGQ&A:!%!OI-RV&0BT::G<(RVD%AANH(GD6L7.?= P\(9(97?Y\6SB+=4Y: MAX5CB8FAP:;4[Z$A?N2]M7?!EGG*G/INUA!F7;M[]DP&YE+"^67?(C]W+S2X M_VN"EO@I7!#FJ>P]Z8*005J*@3CE((C4/HPRI%Q+=[M&_(N1PZ#=E_:.(?IW ML'5'C[3QG":6Q(NB$-($6(^&'Y(7;)P.[!S?_!5N8 52 ]]O=<@:ZB8>>MDS M2D=EE:R[J1N'HAB1O@D[204$:2@,-?I]M<5 E>ZC0M@FGO4O$$9BY%Q&%3J+ M,$#Y@,Q[%FXPH>"B>\_]P$0W/I2']0 :6Q]'M:TPEHRD7-BF4 76CI\Y=^V9 MT(^<:BS7ZQY4$D=-50D"4( 2-2^*H-#D&?(L()4&:C8DX>F@<$\B. MW)JL2&SRR2GOJ^L>^40*+Z*]U2E2#')QWP"P(M*ET'3 X>AWY#ONL<.NJHUY MGH*8Q7;C0D7X'U^(9R=&"O;($C:M1?1,2V4,%>=T(!#S;[/:1*+?=E-?)Z $ M"YP59/<"81#) -8 T/P<.0"2Y%'DNKU%K UB54]L\;#H+4<<$E]@QBY2"PRA MN@A@T2V66Y +[**GL%+U@XO_&="2,;!C4[I62_#>WK+[!)'$"0G;1W$M"R/U M8"<+DP>1EG1C'QIF]]*"$E3@Q4EYT7*\I/^+#6[4,L*>Y#(V04!/5 MR;1?+.@F*$U$R(PTE>4:Y/;;9Y?^<(1(>#8K/O#89BH=%7'PL*$D6P@)8?U4 MG,)M>6"%'V,XT*!F0O+58W0 '%DI28J""[.X MJE@C0N#O&#] O&D#"(AZR ZT(?T+R*(8WD@62+\DRBQDL;"]6/4R%AV0_*]6 ML%IFKVANOB56+XL\<$*.0S53&,E;TX8, /L2BK:/=G:=BIZ:-OQ3Q1;?^3*9+DO>Q=BWS<2<'0U)RT,EG[M #!H$6VZH1 M9U-2%*/]0BFAW=7ZV;D%)/LKN % :-%!J?Q0)+SP;YQ[76,Q>S5O%;-!YTZH M7MR!=;@E<<>(916?V"1Y(G&!3JCSV0NBI!OAON(:8L-#YI;U I6? P-CNJHY MIA%5J+Z^VN M4DH'>AO]HIG=DH+E!@PFE5M PLMX\$,4R,Y69Z=4% P1PBCG?'OBG?PJ)H3F MM$& WX;/B/VWCE4LP]+5(I@0&\5B);CSO\&YL^9,B\[)E/5@R;[9@651S,;4 M\2JB4QLF?/=6S:";CK.=^/$_.V"G]ER69##NP#'2%#:;@"*<.4C:\1=K,9HK M]!=7QL,KID5KYVZD)SBF]..LE_9B<;#B]"1TGE@E6Q?NY3:$5W/EB3,?'7&& M:SC]2)SVW+7,->2)6"@\,1;);3K03!3 IHV9=!7IR8)-T!24XU1 M5*ZD"T79W6'*3CXIRJ92"D3C',9J1OK%DCXQ8/F;-.J_55*(ACO9&$P,X8C3 M-**LO%ETVGW>="UM]J]K,\#J.FG)46);*2L40@7:*F?@Z$@QNSTD*_/)H+TE M#%KMZPYO,T,>(SHXN2Q-&U='H>K'V9JH-.'2[>>E!* 7(R!U?2N.<.#CUE,% M(-+^P$O5TH&UE:@Z?,15'5/W!Z[FZ#G,;]"( _)@ZH*J, M>DW>,(DETK3H<]'7N$8#\3EU^X:8P/X,(#>TSPE<(IPD$J ^,S4FXISB,2,A MMX(O1:/ZD#YYB;UED1>H8FJ8E!.^.F68?7V.@]S>X&N?'R@LT 0=7WTVKWTH M>C3]*<84&*Y(X1_H+GM#[K+CZ^(!KO5PU#]Y%9U[)T!/RAG0&Y=(>A[$0T+? M:'!WCU,EMKP8U2E1)EMA1'S%] A B*E02[( WA=/3CXXC%6ZHW,4E(9FLX/6TRWZ6_A&!=9F!.3CBZ")2H@L#%&*%-?IJ!@&#L@ M46PT>JV8QY!? ?6JFI+OK;W-/I"S5-),XJQ'%O[!)N&#=*32+ZL)+IX%XM+@MCNW#%*$I86Z\EE52" MK"1$@2-ED.X5H3A)"NMS"'9UK\33& ?J^[+8WMV3Q2_ZDXD5U%V[^.G MGC8Y(SG]P;I"%:"L:1T*]2HL4LXH!Q][:5/D:V2D*0;)3BPKALG3,3M M/J3H+V)?Y",R/OA!*OAZ/PD)G WF)RX=U8&4GJI<6R'^2YDFH5].6+FR)?Z[]LT6,6.ST2N%1GURXRV(N<'9FT9Q\[\'6M1&:1 ,T+ MJ$.0/0HTVU**S-%$R=XT\,X>H?2F.%X\_$P=-Q#)R_'?FG-NJC-FV M2KTX O(+-;3IC/SP3HRU6RR#"P]Y7ML;2EZ%D>A2>IF6;RS785&(3$/NREM$ MX*LO_MQ'U [.1&E3_M"QJ*D*0BQRQ1>H3.NR4 N1X4T2E)SZ',VP,X-U_UE4 MYP.H2@0(#L]L$A[!H9WRF1"FR>E@1I1H^(,7J*,D:-P_$?SK^3+D.$#O]D\W M)M%/U_?)$6!QEU8@=4PF2B=_*L2P@MJPYL.^]BI?^$'"C*5P/2[H>ABQ^*7\&DW*+MF&,GZ(R$,7VIHZ9[C]W0<%2_3&2-MWLI9LS;[,(";'. M :@ ^[+:7]I-G^ Z3-[L4TVUSF:6.1,N^;1,PUWF\B=K+;]3^PK1S0RY8@" M[SIB5=_/+TRBHZ'T#2*NX7A'"(1.NA0G3F=+N+G%;1U;E\23)'V1+ 3D;)-5 M$KXGE;;6R5.US02"R&96R08T:[YEAMSP03<7-PJNC4V^)MZO= M[#5$R0V;4;/&6C@>'U]"^YCUR,AN6O HD\S8"6ONN-58=?,-.SE5LSP:\FX) M+.3?QZ%,QIB[ 1')_?4:E<6I-8,2NJA?[!VG @R_FD2_BBL:I70LS@P:]F/" M*36N5]/;T2;/%4+(?Z79FX8 Z$(4JISX@%+&RU_=G4>1]/^I)6UW[Z5.QO% M77360P[GG.RY3V-SGSK>1^\%YSB01,9&G'"%9O%I.$FKCLF^F<#Z$>,34BR[ MDK,M]"B:+? _??[/.9NQ2F?XP6P8#:9S8-BSB-MM#"#8@#M%9-&3%\FC8Z C6(I;- M]G+21B_Z1&WTKG>4#C[\S7W(,#'(\((Q?Y%T/A(_"CI5-4LDN1MI0P]Q-2V4 M8LI5Q"T"R>LCLOC'95W(19\U7 EDLM)3V6_,#Z0;7KHCT!%-X.0H2!>C(>3A MEQPT2*@<1K.1I/Z2((89I9962/ 4(>S1>"H&AUDL\57F">-YWFV\7(O5U1:) M0(TY*YM[9Y&0G=]GZ6UT064M4"1G(B1%2.FW,[^1EGE RG*0+YQ$?T!=+#BC MX,%U)9V<@H!,ND[T /H7%19-V,D$7Q_-R5%PNZ9TCOL"@P=IB+PP^+NM MT!4@N@P7'B$KH9$D<'_LQN382*J1)!M?2;R$)%EEDHKF%8EBZV?.F=W 0-=K M]E2(BY:*7)L]T>I&?9"CGDUJ!W!Z.!%>%H,!\"M]TAIBHOXQ,=CFG)@B@:4V M70-Y!7H-2_J4IFCPY@4P2<*:)<]I;0KIKTR A0U1Y?(F[9J=I/=_ O!W_[*/ M#D]MS4W[CB:?)6):R"CID4(X\&?_TII[A9&'!&/<]JY:8%2(0AH6O35#T\S' M^*[0#ORB:3)":)'?@61*4CLCDU:LD4%:Z1;O$ITL>>T*BL(A<#UEE7'0:BJ03.X6 M%*!<(IJ %' *>M7!_1;$9E>6'Q@8[ 4).5(EK)H/75VL;'$ ',K(.,L_FLH) M4GE'Z?VEXS61: X?4YR\'@DC:/ER \O7D%"+B/X:81- M6RTB/=KST$R_S5= M]=NKCV;5%/F,+OZ;U/4N^SMQ> N+(:66:94*>R<]+*_3L2 S[P=GWB3O@JWL MO7,Q+;#Z1TUH(]6?21X8CH E/-A\7V?L$.A9C,IMIX^'$J5I)[I0KN"/6F?P MM4(AYH2'U1;5I(>'(N/,.E.@D'RAQ6UL$C=B=&9A$*Y$+?-M\^9E(40L60Y, M\"(J3/ >L5W6SQ@<]/O?F7*XS=()S>(@=]R71ZHZ2/<7P!3/ 8N#P M)>\GM$&9"![R#CXW(4T?0#==M>6+2O8N22.-O;<7*[NP'8[;2[<)&!WK=$\! MYOF.1V-BW+FJEY"/.KG!]'5;;C&+<*0Y6_3(A=A)OVM0. #GUNGQ@R\\60T C7]VY"7LW5+RLJ%(XZ6]O.S\%G M+ALCB+HQ'Z%2.*\,*V\BT)/Q4DG;Z@4-4W*%, M-]8S"8>Y3+'6@]AP3?60=]EM&AW_%8_YI/V./X].XR[ICYCFB&2S_N '^:?? M&XY/_:_DGT%O,I>/T6PVB/OC233L#:3WM", 7<$QI@. M)]&D-T,[#RYG$ _&PW@^&\&7DRE^B1_CT6P>3V8XVV(,@\YAS&@DY0JF?-:7[VRF/G!!#Y=\;W>=W!?@PQG=Z"* MW2'=>@M/8!.N;?S\VR/9P*@7>X%0& MG4];'>EX.EO$(WCT).KWQMUO6,7O>,;R_4DT&/5&\_8;N_+^+^<$[' M.QKMW=-TP16KQKWQ[) M#<8CK!N'*^P-)H=L::Q;&DYZTP 0=F]I@L>T6,0+ MVM*\-]M_3./A0K8T.VA+DSY.&.IL[UE)NIMW30;ZZ/B&1P M$'N;Y2++I<9!B(78ZT=_MB[73\177^/5<HE'??^21^=;Q?!Y/X3Z>X$#]N?^,BUE4:)&>&HP.OR.C M 1PX 7RP0#K_)"](;]>(>Z0+XWU_QM#Q#P"(0C^/2V+0RWSFIL22#0P.5A^ M44=)K6!/NF^2=QUSY+>1@'37[]BIK]P\1]?2PNF,[' ,&[B!>3(&M 6T#N39&MR8[.3OS=102 M.,IH@71H1N(UD*5X,%]T5UZN38] 0-UY?T(FU]Q)9=P[92,LU'G5J6N[S05? MTC T^!+'8]CUBQ=PT+P(5NV>X%<6"J^=%/G$I$:<:FJ$30,:]J8+OKF]\5@K MAK7)B6]W8.^B8QPCT-L:94%KA$W&^G&= "RNEO<%-824<#&XRO@ -51T,[>, M:M-*\'#J\[SZP_!>82M64R(XCP7&!E.8U&S1FWX7S8?PO_EW5)'Q]!9+ OME M>0<]M.4->X,A_G<";YAQUZ@,D6\76Z0_LU(T[0$E9IH+'V?VHWPR;U,^#+4# MZ7\G__^C9E\=!NHXG#QC#[-Q]&',5U&&KV /@P/@G\%,,TM1_[9)/;\38V&S MI@O')\HX-29CBT5.$+!6'-C6:WH(H'YV=8[AQ":2Q:.PIX$89&VRV[0RF32L M3YJ&M?^)?4:KN3%:!=[=F>1UXV+"R]*CN+S/ ?E9=A[34G#_3)2-',J \C/% MG 5A]KH\W_V0;?BX-MUD?#R-Q0IB#:?D:J2R'Y*S^]\CU:IP4ZU(E"%%DGHY M1134"#.*L_R&<( =0WQ.5*#%GI%*[ <02AO.A#W.:9RCZ'@(RBZPB1/ZO !. M/N;/H-WT42GYL;6"EV$;:#>+.2AJ("K,Q]%D -)G/S!H8UNP@'YO,N"E]-%X M)I\&L-103!'&5H;ZP+N_[;N-"R^BR+QU@1R1E]5,";P7+8G\;.I>>82Q^& U MI;+Y&C%V#,U=,V,7)<*A^!AMDY*EGJK-X@M4F-\K)V8JVJPPA M85+@*)%/_(/PI+-4ZMQBP^?DDCE'>I\\RHVD(A6V51''FLH>.(@%^23KD]B+ M1II$8V:%T]B+JUW\>RI],+D^!GO5!^Q3;_C5CWKP]P##'X1Y^4[VCS9:VPE6 MX2)["=;KY7I?&.^_QEX;=R*O<]9#[=8A 4A=79QCC;L;*JK *RRH< 3Y6[$? M(<=C8CL$!"[^RXL_0EO<)ENO)&B)5,22.L(T>D.<%T^ -G^?;!Y^T%BIF()8 M"B?0/988>R:K)JR8W-L^ +HC'A17J.N2&J^,P"%@&DT42CL:L'BCJD>Y>\S! M()Z/!G"X&RX4[WFMG.4G7B= *3;5AU.@?I[C>/9M!]/%F-Z9SZ:Q'V@2!UI MPOYH#V4!\M/F4.53V5$S ),#FX3>\I&RN/J0EA[3Y 4?.AN)=..>DU!H(6IL M&2;+#&()4^(TESTNEI)7!$K)!=!*CL2,;BC9ENV^IYR7@#7?M/,DZ0<\O<-O5%;/"Y_3.F&; M3C-&I)WK9[>PA"G849O>M'G155&H:EDTDMJ+U7/66-%E=]N0'-PI1Q+"=_21 MJ9_2]6,JX;"DOFI BA1KT2X?L;WI@0I/T16P5RJ:^I-C8VR$_5Z8]]J8TEV MYVTKVJ$.H5%'70W>GS9'ZF(OQL3Y4?-EK-_+S/"6;V+#W8P77*5P(N,7NWUN MD^C'=)EL_.(']T M^6CD9TN96D1:+2\_2B&Z4$AN\*&]A'U@"7OP?91Q'A!E2JY.2W83PL[L9LM$ M8-P?L#(=<_]3$BMM;B#J)%ACU TI[$DJ3KV\EWH@9CRC@5!H(*9;^7'YBSZ% MY;-U:3PYS"_2W+N;T;GKMV[P15\VZU?50[),_^E/5'.@?$S_)# =&IAZ8UW? M>T7!;9TS*713$BIJR)K:/O\P\Z;0K%>F2XIU_1U%Y (^'J!_E&@$?AY1LA%E M'J'F_Z8H0=//.[%:W^!4I0G\5Q,Q[91=[_*<7;]>BV\G ,HCG?:()SZ2J<^( MDN?83\PK].D7-M;>2UQ.$7F^6\2=:EY);*Q)TVX^D/F=#O^@L]NW;%K*:(*T MY[O6OPQ=SO@7IT\AU^ &E7/@SQP\^!NK7',/9X1(^-1KW1 ME#Z-!SUT\7_7"*2T^-&;TH PU0*6]5'^J.(UC"@62Y) M-WVM=3OZ&)=% \WA'YW L! S([Q.>YGU%D-XD'DW;G4D.QPNZ .LC)Z[Z#QF M>'8\:\(',>T[3 0-$B1N%80%2DZUDK*8*SBY3DC:P-@$?!JFDBQ97CUUU2O' M?%#MY4VR:A0I)[N%R+7P(M#K0'EBVP;#JX;M-HV0B.I\9?WWPU;-2@EL__#Q M':]=*TD[W6>:;H+8KRSG5^P-EM1VZFX[L?2[2V<;KO+(NI]1THPZU M4_N+;$%JJ]K3VZ!G<],=(!X[-2A.."RXJG]7OA"8]17U,2D?M?\%-E?"FO? M"N+^E#)+X;8:TA$-X/^Z.Y_0M?046/D&!H.KM^C/R#G"&^7 <)FCXR&1" MO Z>0K(1/"LNOQ$JY3U%'NJ]8EJRO-K3UNYX2BP3X^X">["=79SG/G1<2)>G MV\ >IQ$'F:<)2\UU"E8P=PKG:J!Z]97=.$JM.6\FVMN,PE2";BR57,V!;6?H M"\12!KA>XYW2:\SOAF]RRSSCE)-GWTRXP8TD3*VPD0/U.^CYWEA+LDTJOT.A M'.A*[?G=5<3OG>)6'70X8,USP(LD_EFA2:L]6TIG=V0USGK0A^%V"NSD#J9= M0B8E40]=&!\Q]8:R'6A,"$]H)K4'@*2]1\5\,A7URU0,2$? A:8@FP0S&PR; M-FTXM> ,2TH!@G5JV!+IXP6_H^>Z"JQXG,85U6V(5ZG<%T>9:P58<0R&M+<9\F*RG1 MQ98F+*X#(W$\/EZZ"@"R!B9>;M>J,"_9Z*<$<)562U";\7D@0QDG,5*R#]=: M81L1)WC*\GMJ*4+<,W"0W?,C<6!'"&6D'$S>#@"QE>0TLD5/SI=4;EQRIV4U$&138!&H2SC_BD( M!$CF1N*VX0]!FL'5D1K28:C6@-O$K-&K%/L)I$]X\1Z3$CL+M+LS7).,P6^W MW^1R!%0E$QTGPWY_HGC$DW,;'%,@4D^SH\"]M@4EP>K9C\1S6EU('7H4)8L\ MU1:T[=K\)E-=AC6S8C4W,ZDC-9@J!Q)HU\69LB9Q.YKT@F8*I]9;3L.)35F; MJG;O\(^V0JB?07#<+M2I/H)AHI1Y9?^KW@RG65BS98P)?Z245J?$;Z=-R Y* MPH$W'A7Y4>-"U6UT,J64NI]YESQ(?JTM]-[1?*-KB ;41%?> :^F@=+)^'AO MVV$<]M37&31MH;*.47_ARO?/GFO%+ZV),G^CIFN[R20I\$5^NO=!+HU0^A&O MI2G,V/2R:1N#4*EI*K]38G %"SI8;4.Z&9OX=!L2>?/,.VW'J-YGP/% XC*6 M&@F H8Y%'/?^L-5>MX#:4M#67R:A/ :1KE%DXWW?4"U,N@FPA#N,A;%UTV1G M9G*K[<"RD$[10$S='K:B.F15(TS([2LGM\Y9EM-TY57TCL8;F.J#_[HM3#B^ M]):23BL8@\+7D1M4+NUQ^FTK>C+HT SZ\0;Q3V0]@IJVKP/&^[>OF;&!0'%C M%/\=K 0KTE>XSP8ULX4.AS4P=RJ4#OA.C)P?=M8F15WM[FS #*#F;QPZ6SJ*(5_KQ4CW0:" MK9:IFKU!H5W9 _M4R4:V97>D!B.;#;CKEZ"65AMQMGAV="%'6Y_6BN)6T6E9 M<^TZMK5*+_-V3W%K]4J=MK]N._&:JN;8:\&EL>2VQQEQ'TE^6F/B!]=P:'LGQV"TRWF\MU3$GH-2K61_M;_ MC3#KSF*;@P:8FCYN#>)_RW_1($D+/6?Q8C$%XGV,?C?\PT[+?PV&\1@S\?D) M^FLLZUO$P_%"K)Q'6+UX/IMA$BHZ[MB-1]^A*#2-IT/\C5]IBZK_M4O1LYYXE\=YXGIS0O@\,=H],8_ M,$ET@GE8DP$>QVC1QU]GE)+*8=N K?T($U[']BPY#Q@^X%G.^"SQNS[E=,VH M*H.\0+G02'N2^FJ_(#!/UP0OA5.U"3$-D8_D6H,Y$7J[JDE.U9N;<54VQC(,?N[ M53P/+>+9I(AA.1YN"3D%KAQ"_MD5#$1^.):5GK!^V*7B[OAQLNM'T"R-*JG: MDG>CAHA#PW@RA8WA[3Y1GN3&1N6I:>A@T'XPBXXQ'1'1,:3N'8\X9@%_=R)Z MX'R>6L[D ?I]S9\7K)>'ENLOO*FGO3-UD+M_V1O%8RO?.B^IZ2*GOJ5YG5*[ M"T1S4_(VRV]1Z6$ESI1\UAK0P>;/KS.NU 9D=EO6!ADOD@JMP?9G@-EU^B4! M >+Z>0UG^SKC2\-6)W],'@KS6!\>4O0ZZJ@:)W*>E4NLWZP1HY^OSL_>F,*? M/5,,\&V^[$6//1QGG<;\Y_$Y&OZGKP;#T_.?3_O]^61R^N[B]0GF 7"3BI&) M96]O]ZMWJ7V\T.&%UKG;C('J5DU'XKU.'KS4>0Q)IULA_C);M!2&QH9$=+:Z MIS[O:3R8X9ZB8P7$(]"F#10V&0#7S2O;4GG(YRO0:&K6A9"#TCVN);84ZYJR:I(8 M1Q%M[)YBEK"V+L^"S$:+/MIYY%2,]L<3X7FCX;M8%W>BM.G2A1Q745D\JWE6 M-HVIS8X!$,O_)>4ZHZJE-0<&.Z1)+\]Q&.]/6@2 5"";C/*!&+3\AH=I_8$$R3B<$1G M/2%-.B/]H!/&BNZA3>@K])M] ^_$AXMSKPJJ*0)Y84LD_T$D_6%;8A U&8]L M@P'@-W=$#=C4B7F-: L@/LV'BT>OG7D$@05[);MFBXESTGI PN)_W>9L>"G1 M4W[;4[ J"&Q? R01@,I+"G\V(>?2\6'+X_F-$( ODJ&2+!++Y;9*# GV\%%/ M%)[;D$.6<^;24R8W]X#+%)9=$QE:W:'#:YD)WN,M1"^:J>/O$"I3" *=Y_DJ MP<8 1+?+9^T+*C4>?;(@-K]J>9^NMI0V2,,A.6X10\W#$J)7W@)0(!?,4^*ATU"^QBK-LW1EF&8'M-C: M?!"(^:!<$&N!>!%[A\1\3 <;EN&'?SSSH:R$H]%T?@C_V<%ZS,UU6>B0MS'B MN\"R@HA&*&J^3S= KN ^;**/#T!1)1SJ(XE,F%A5TY$+10'^D0$AN)+.&/94Q0R_P M/>?BPV\&6C(WDD)#.40X+Z4T*=Y31@70AP%MQH@MJR1;V^+PDF1Y2RD=9E[V M18_Z]GF=SL$IOIO!]\GP*S>6%[!*'\4%8+4^!U3N\N5<"DHY=D\#6U4E.<.% M.8N@8(7YU2++2JB8MT8-9R.?#:)R\91;DB[)@%0Q0>1>D3I&+'4,!P.4.KAV M/I8O'ND]D7O&ZLYD4<#:9%WRQ,=[D-D-R?VCBMFPA3]4#L@3(_?DR61G_SH.K11L,3 M=8^-O1'X2"&LRZVS-@DKH4ASD .; )Y(5JW\"1?$GCU5B!>]N$6K12%L;-H[ M_>;\;Y)E>HUZD#C&J.FKD'#WZDKPM1G"@1Y= >7@]@(XE00>TCKS3X9A'2L) M8CVA3$5GL5;K M=CO$U.SQ/VU++5P@(8O$3B%1+Y""OO;<+=V=J.E(8*.L.41BB;&NLUNL',T5 M#MTY<6-\ 7?QBI#%RI.J?B^#DUI+_E^R&BDO'BZ7C[K0)H5X_$=ZG[I$1H_"D08IMH:(L:"<' M%>)VNZ863)FTQ..U8SYT!I>-60RCE;QM(*#1D;I)CE!U5W^X:2^T#4]JD4M$ MYKV__/X:EMN0P<7,6 U1BJ'R+;;&E+]C,LBI(J(O'XWZP][X$"7-M0*%%+:& MPFLMA81M5,_@OXV54(9C6HU1"'"IL* J89QQIKDH$EN21FS!Z(>6_9KXPN/! MB1$FBB=OQK9: AJA3]9-GT<0+4^+_%1$R^.?/[YF@G,\/&'14DQA!PYGQ!/@ M#V@JBIVJ,4A^ A(6X*&8^\A9RC6/MKFVG%YG^6]B!$25IY;2[,(Q906>!#;S M)#!1AA6"1@)4.:Q5F20)ZY;BMOG&D0CI[-IF81KF#[',TAM"DM?/>PPW M,0<$?&+[^X<"%(9I/.D/8U!]XF@6CP=S^'.,'Q?8] /0 P$,/RSZ&!N@?"@E M4D*4'X21;8Y2-]=?M,'.>TRZUVI_I0@]N@-&S6=^\^D>O?VPKNQ3L8JN"TQR MF,",/YD<+_P)./LX]"46R+!8C-0 SN%]LD1EOKJG,\)^G5014&.\,C0=<):CQ40.TT>Y7C2/^X!)@_E ME6H=RQ!U7KU> " MN+O5PDMLVA?FZTY.YHO$FMA$!K=$7U4OJ56/862Q5#!++'8H;O#4^3?,F99R08\=Q"S2M5+0? 1K==X0* M2\,W5&O4\0<0\2:C=ZV:YG812M8R/_(,NS"%/5/UV<_NI$(;S]=(M-""]>(RX6[W\SC@]@MHT-!N=KEW=9$_CL4"RDH,E=? MHY@Y1@%CZ_3NFIK&R6TA- 'WX&=]WI4%1>YB[M&VDE8=WD8".HL6,!$CO];& M>:ER,IB>#D ./_$-&\/Y'X -M'%O9V-I&>)^8^02T_Q\*/&>B/S.DR+@N=]@ MFN\C*/<*E)8V,@.Y$+M!2 \84$/FV"1B_-\=!0* F@_^6*08S_N^.CKZ(RB$ MX@0Y?D]1FD(K3NHD,X,^U(L6D^_[_4&\&"]VWVB1_/]+CU,]S'*DWWA*>"P1(0GQ<'U MJ&%-2A!S0&;'@I <3U@FF:EJ8W&G,%YT9N&M#;.-2+?]K8>^ZVK.X,Q'3*\; MT3_3/Y!:3U P11G!_7,8>Y=G88IREMYC8M;Q;''S\+/3J3?#=.[].?/GGPWV MD/MYC"/,^D"RX.,$B[PO\.-X,H]'XP%^G #4!B-9(38JZ./SVB5'H4A!\-33 MW97PV\?%NGA^AVW?82%EC54^G(,;3>-7,&9BYQ0[@GP'?P3U< MU+'I->ZA#S:2K7FLU$-E7HJJ^AM]IN*.,]'54[)Y@"51Q7B\W)3U2N4S3../ M0](11 EVRPO;7$"^[JKJFA#2FHME8\5Z=",\W1=\^JR'5 "/I80W47BE&0"C M0*A."D^*G9F1P-Q1'*M49%)SGVU&P@M$0O%$V3X4!4MQGVA\3_,E>\/5ZB>) MOYQNZP/;?&,RN=QZRL?;/ &N!5.V>I6\X-6]24$3DQ3TDE'?9"6 X(IS!:[) M%_@&E=I[/X>,ZO$\U+;2^@F3(ZT%=12-J'L;]W+CS^/^D'(OV416F&K3T?$\ MGG)AV0GV6J8,K'@XG\D'K+1IF]+0PWUY>"3/C,S#HXGI2F-Z%AWCBR?MVO_< M,L8VC^F;3R/S"4O=MIH@?>N WP3D20O(8ZPT;3Y/.H \B6<3[.1SO !.2> " M[DE-? !NL_'" _*$ZBGRP^,I/]Q?")!G6.'U94 VO7H&)\80;="8L%>F>4E7ATM9N.?U,X]ND_@_U[D6@H^P1.FL- MDL/^3%30 O/&J>#,/M2*;8J4&(Q,#"(U>;-%Q[A"FH1:'CZ!U3Z(JW-GF;I. M3:+YC38 6VD#L)8,@\2=?2K6<]!.40X_)0;Z_93.^O--.1:,TQ:][,_%FB0V M-YJ),&-;4G.2]?,I5F)<(E*FD)(IPMF;UHF0]X!E.=,W5JSF1RND=9#7# M%"MWD3.F!0EEMI=<:2H$AL C>(;H.GE,A5;R$TP"6!OCR.X,.QPBP.ILHS$K M-DY"WW/*7-$0E",FH>&IU+JMN/930H7X4JY&Y74L $MR19BJ_!9%==J1597^)?!VG3\E9O$-)6L MJ"&NY"L)3FK2B'-9M?:K/YC<M7U& )]K- 1(N/!W*_R5=HM[Q P5K"H7CG"![3R@89<=U0UP@&:]DLX)I M%6;G*3'RJ*1Y1B?2WPVK_V5?^!63P +H^P,'CXZQ^C_-J187ZM3![FM'SB0; M$0I88N9[)P3KS.Z7KL/T!^+3/O9\0NSA#G3F(2FX>2F(\XD+W]@'/@"!O+0$ M\O/#Z1LBGF^T:]W[+,\VVPU^@5,2Z6F\+F-?"!%OLE13.5\N_D'5*NU+D>#. M6Z=A)>C@)#W>);FT5&5^F].)ZAZ)@RJYY)MNJ(96 &+K(^7-2N-T+E:.XQT- MN!VI"1)UIE=0.+5GK%;6V=KR*=4.L%(MK3E7K 7U6:XDPZ'+P42:-;?G:!!/ M\"W^EQ,S!_%@.O,E#H^I[MG&U_;U;I8VQT^(Z$Z7S#T34X5WI];MT.]EW,2C MV"]3JR57N5E7-)1_IP +P7H+^R%!R_WON[2"&<]86K-MWDB?92@RA/6_".+V M@J0"K"QE+$OPE]22./7ZL#*]YV=SD[6'G%M"ZN"CHN:7\_D8^V_%PRG_8,(QK,K J-&5A '<)70!ZT/[L39@:I%Q=M% M&+!TGA,46GI$9XVY@Q_$:ZPY98-AAC:L7-/4 M01!C"8 #T"D77M1BBD#GH%8)ON+*>60?V,(S%6K%MJ(:N]HY6EBBTRU?4\;" M5&A7"\M!_Y1[=3E5:&EQTK$EM^\@-PILLS%YYB?R-P_C](,SBL3=>#8&4?.Q M;7=:!SK^&839\9-7[I$\5MCH7)(7JE ]574YM=J[2O5;DOM[;O7).^XXG=M" MJO2ZVE(KQXN)F;/L*M3F79=[1K'=2J68O896/"_4RE09M8[,5H_FN;E*]/9NQYP&+;>1Z )=X\4NA9,@@\H3K(E1Z*4$(N!,U70FPY>EMQHM)\'EM ME5SI&GB)W,92;OR3L?^SZ?Z6M3T\WS;: =S2W@VW[5)-*+I)?BU<,SS>DZS> M.L%(C;!=.GVL>"U9)&H9KM*N45!)QZLJ(5<6Z^$IB40PK4@T^D"J:J/QU2?P M!:7FJ_F52 >IJAKLHA4 9)% ?G4.Q^A+E=7?O'Y[WCNPV;BM!*UMD6("((B! MV%J=0C5M;L4VET41P5H5TB)+8S[8Y]!H>L*=1;85U>TU<"3QY29]+M1XB@YV M^;IMD-/ "2R)0/E";#"",[C/'BKK!,#E6-_(BN;VZ;."GVA3%VZUKH4M ;NC M=019\ILEV$6:#Y6I]2S-[>KLS:KK$K(A9=<]BZQ;>MTM,YXN$[$;U9239]V@ M36DQ( /40'JP.5N' -AZ0!7GDAJ_Z&^VEUD'0?;I[YE+;MEPVQ@ITNK3#(OA8TQV-,5:P;.(?#/C@VIL16' M5NWLU8&!LVV$6>86?J/A HX[IP7>:^OI./2Y M'?U-21119Y:Q*I"^0AVB:P1KXY4<+2&)04O7RZ,':$;2/KLI1NVETE*]3FYO M>_L6A<:_)?C%]'$B^U$59:N3(AW00W!./9>#2N=_YN3:B,K];1 M4P3[C3;C/+@N9L.]@8\C6"D3>BG29K Y)^=;VV#N+]A0UZV!0VVSB"YJR0#A MZ*26F; Y7Q=P2AHGTG62^("1K'GHTCE!U#K?6;:+E\:J' :I=9&K_F=G\S:B:WQV/RG=GX(YN>K@,C=J02 M.91[T$BU<*?3^U.:;(N;PY*<3J564Q.U.[>.A:;-A&-/O*:WV:T)I-W3H5DB MBL3F]G7];KO;U(8;WIX%>YZZ,L)MX2S6.6D=%HXEUOQ@]:YIKT**$7"*9YB0 MZLP)"+6V3QM L&?/TBDRX(N?6DB_R4(WK\ M9N%Z+=WM&I$U1CZ%GH&:NTUQ6+&C@=NNER8PR@L)$M)D8A@QSMD$G<'.\Z_0UUDS@0V3-*:&6%\?A=U(WCJFR,>@-VTC,1R^0%H6:+H";= M1T4=PSS#;2 FRLCFC"IT%F& \@&YS:/"S9B#-5&(>WH!_QY 8^L%J[85!D9F MDC @5('M"N33Q7\0_B4;'2^RU4V[=(Y](X46TM]KVF*;L9VZ**+D'.=6[ M> 39\+Q1[ZXP;3=]J C_XPOQ[ 3\Y7[C0K/5;E +2WGG0##F)53]PHL.@MA\\27VAF-J@^!%B$2O:;\B ]OU>S5:,89B&\V(B3;%OM;#M%C8 M7NPV?8R)_*]6L%IFKVBWOR56+XL\<$(.JC93&,E;T!EIZJ]I1'^7A MV"T>SS$;;'[)N%?RC5YE$MP=IK!CG<810G#!L#)B3TX\(9M/F_V-WWJP6!5I M18-NTI3ETHXK#."\QS! ]F];E2@3&!'.Y(4+'B-Y)#6ZK+-:+ M.[ .MR1^+3$;@:#S;D=!_,\CHXT]FC0Z#G>#@8KLT<&\EMK:C[L*?*XM#MHDNG? MCV5-*H[8YB%<%V0CE(5,?'5VNL*,)<0BH]'SE8MW,CDJ&87V2?:P;/A@V<_N M&.2P^-47D6:(]Q9+]B_]#9"%U6U:="Y)8H97F!U8OL:\3QWD(F^U8<(7=M6, MY>IJX>:'E>V G1JB@ZUT"YM/0^'Z'/'O^/6UI=H5^O4KO[%SSS'0=[?7.\YZ M:2\6]S9.3Y+JB=7,=>%>=D]X-5>>#/31RD"M=#,\L-,?B5N?N\:^AJQ$!WO* M7-TS"EJ[F[,5ET^H7+13H/*.B*F'-PM;#5&_4-.L;6P.R[N%LT/AEB1AM<]; M23XP%,E_W*D&A3A*V:L<[;:(."(@[W),J$N9!"0@RZE&T[KM=>]3KA'K,';K M""+Y5LM@2'C*6$U1OUCR*48P?Y/&A& 5'>(#3GH2$U00EM(THE3;670:=9XW MW5+)Q"9?F;4[-$K]$ZQ"J$!;;>9T)Y7*D"L)$<5;8.F$UJC0LGAU08$XF.U< M/%.@;MWH0:DA-39 V,0^"J=O/X\KH,Q])V!#BI-5'&["QZVG"D"D_>?F/%LW MYT*-)YCY>44IGXU44Y,/ZT^*]>$H1 M$W'=Z+"Y2Z-\2]2.J&5-LA)3:)N)6KF44K/Y6FFL=K%8*"2T5KQ]PDSW+T9F M=M?46@6.AO'A?.INGI4=QT%)'?+6@X\HF22-V/!&=]Y,8KBT>@ *:<02'[V6 MK??)BM]EQ# 21S#&-+6QF4RF?\ Y2JI\R!*JVI$YL]];L?4UR[IO4I=3/Z8. MJ"JCL0<<1QKVQ=636Y)&ZX'H7%1&KL9(7%.]Y2&6LC\YS@TH=8+0N'T8WB!U M_JD]$^>T-;[X^$4@(1_"U MSP\4D&JBZJ\^F]>P>!1.?XKQ'H8_2SW(^^@-^0R/KXL'("'#4?_D573NG1X] M*>=';UPBU7L0!P]]HQD0/2 M#[-T1^=H.,T]X/ ?.CH)NW*.7ITK[@8=IRA'S)M==D(B=HS[]+0&7F-I7+_6 MEL"<7(ITZ2B;"3..MC<@(T0W***@Z0ROOW'3W685\DO6)6RP/:?LV-HYW#AC M%DM>(*HY&V-#DX;.+$*X X+REF =BV3%[(W<(J@6UC4:FYUJON:!G(U:[@1L ML,(G2 :',0"?\$D3/"3F7U;[&4M6V8K42;J9B4VH5BMQW@B*,1IJ4?J'YAK. MWN;BUIW1( )W$:',7$M>4#\;(4WNDPA^I>";6Q;=3W)97> M25S;)$4\NQ/)593=^_BIITV^5,[OL9Y5)F]+0B,51_ROI1AC$T;)%CUGB]4C@4GUUN\A@+W)V9$H0^-B! MKY]K;KA!@HQ[8[$Y[6]<, ?'AK'V%/!LNHJ0\,C76.N519-&5J]8W@1#]HH# MA!2V#COA11,G>-/#.'J74HE;.>[Y>!@Z[J&3>&:_M%9IM"L@57]6!R(K?93O M>%K8L(?/7%G_N(VL&9*"_0'SH6#5E!&&V*%5\@+"% M1N0^LZ[#X_=T'!4OTQDC;=[*5;6,*FVA)B MG0-0 ?9EU4RB=^I4Z'KD"0Y>/[,7VZ0KGJ-U1\ZT:QX]TV\IO71-^?NMPDN- MS- ]6:$'90O_3[+I@,O4\ RJK7P@6U;[E"_J!WM3.QHE^E&6E^= M.REA[[+;-#K^*RJ8)^UW_'ET&G=)?\0T1T22^X,?Y)]^;S@^];^2?P:]R5P^ M1K/9(.Z/ =5[PRD,,K..T:>]Q41''V%UQGC1'T2CWG0:C>$E M)$Z3>3R AC3(>3:-*;X2W"Y0"U&@_C M^6P$7TZF^"5^C$>S>3R9X6R+,0PZAS&!9(UGPWBP&,%\"]S(H@?27_ *"2:9 MJ@*_!^XG;:;Q"21[.:?R?-Q]&4< V<5L&L_'1 U[\VDDW-[\^['A41A.A=? ^0XZGTYE4ZOH M>#I;Q*,A5F[L]\;=;RQ1HEUCU/'QC(MIG$2#40_H;>N-W7L:([;,%W%_."=$ M :J[;T_3!?/$<6\\.V1+@_$("R#@"GM<<77?EL:ZI>&D-PT 8?>6)GA,BT6\ MH"W->[/]QS0>+F1+LX.V-.G#-9_Q(?4/V%'SB1?N:.I<=+GC>M\'_>;ZB-P& M![%T04B"D <<))#Q07W/R)^+A (C3*N7T0EB1V.L;SLD8$R+4"/?# 9QZ/1$&_FJ.\_\LA<]7@^CZ=S+.,* M _7G_C,NMI(<24\-1H??N]$ D(@.<;! +M&USNDPGDZ1%4QFX64.!GB_4&@: M4M'7CG5^)>Y-HM$$[M*$^.*H-QQV+70X ,H%PB3$))N3'+]L@7G@V MO:XP_+FB7.G'U"L^0^75Q%GI"NX'+SY"?@#C_=\>/DUT_CJ,+<8^+V4Y% M6E21QJ,IJ4R+$7+(":#-@$]W$"^F0&\ 04!TB5$O8"VA,[1#(8&C<('L&4E0 M<+;Q8+YH':E+.VQJ4/.IZY:#GJ L9B7"9%)@;5JIQ-YHJ1=^Q,:=4#W_TZOE M?8$RD)JG@'#B YMBE:[=(!4C,[6EWT7P(_YM_1]GYI[=8_,8O0#/HS2?? ><8#/&_$WC#C+M&*8NB2;!$]S-+ M6],>D";V=,''F?THG\S;Y.NG&IW][_C_.Z,>/IFHARYUCZ,AR#HCP094\-N^ M>"Y):%U80E(M%YN-R-)S2_T+*#;?C+V2L2GHW@8Q+)VQ]YRF5;I-7?$C4(BQ M4<>"*W6#9#(KXR;$KEL3#[Q%%JG58U8!P30C= 1^U$\I]NF0 M6DY==1$,G?VH!:&L!&-F>,L6QX8R@J ZYV +1K*+W1+9)/HQ728;_[D+(V5> M2XH2?/P>\%79X_=X92BD:<_P4WZ0P44"UG#"1JP9JJ'R1Q>WE9_/@$RL8;1A M?V=V;*>A"VAZD6LLH'W%E(4Z_I%#MUMO7OL9FC9^5$*$2H*1N-D,9?W#B*<4 MK7IEZG%8Z0+D(I0RCZF! =G/\3.U:&##%K4S*$JXHGDGN/4-MH11L7\Q3-HI MN][E.;M^948;!.613GO$$Q_QU*V[;)Q&S@%>XIQH)<^Q[%:P]/49><7L[WI: M?K*:%B;B$/F"VK;:Q%R*0>3X7NN[:CZ0^2;G/P@%]BV;EC*:X-WZKO4OGY$X MSQB!X;@>H_I4_C00^5D>]$ M:U/AS*)9;TH#PE0+6-8G&XQ5E]OT=/M #I[W,>HLA/,CN$]SJ2'8X7- '6!D]=]%YS/#L>-:$ M#R)L2U(P1GW$5,=5\\YZ7U]6+=7)33MV7+@G' Q:U;\K(0K,^HJ*&I2/IO/ MLMQBQBO0GK@_)4LYG*M!LF@ _]==!H$.L'*BG/0;& P.:0'*$XHC?N*BGU6( M/7<'H!P/YO%X,15L"\CQH)OV :D7U"N%SWX^C["G"M.E4/;?>!R/IP.<83X< MAU$?'^'F*_@4(E@(:N*]#B7R39%H>Z^8@@RO]I0#.Z9>+]2X)K '6]?!>>Z# MFYSJK,]E(EW**E:?,VD_B,_",:O=U+?#H1<@R8ZS'UU&HF#;0D9;=P%.,MH? M3W$UKT%"K3Q/H4F] +V3K/7VOV<2M^LDNS=3'KW"O6Y\:"<;M8.2'=L;C]QN M2DBK;CYMO*3=S[Q+'CAPS4DRZ$@>ZQJB 35Q9^Z UPY=^KU-Y^J6\;2>UID7 MRX8%L[%_DX:Q<>4,<9/'T4\ETA2GM.)/F'L2^/Z=%&^$"9R%W3Q[?G);E!(D MY3J] W[\M:X,C+=[XEQG4RDL$*7G!.@ENC.N=75'.]@VBD8&OE_;G;GENYX; MY5_-SI:R,Z>29K6C4A[5T7+*4IHH?XI$H\J]46\<9 M.$?G#+NK^+HU1L^\=1-6T?-L;QH&::C]K?G,.^2#T>!5]'Y+GB$N=3>*!XNV M9X*_]7^CO"&GM*:#!NBV&[<&\;_EOVB05B%.[-8,K'0(XARP#/S#3LM_#8;Q M&+V4_ 3]-9;U+>+A>"'\Z C#M.:S&9K 4:9G"9^^PRL_C:=#_(U?:9/D_]HC M'2ZFG4?*OS6?"1\IJJ_M(^5O_=]V'NF\;[U'#'7X:N2<)_[5<9[HL%F (':, MX@G^@2;J"1HP)P,\CM&BC[_.R"#.IAC UGZ$YO:Q/4OV0L '/,L9GR5^UR=C MZ(P\UOS*CJ"B+!H'*:\*##D$:0*JTC%>QQ-E(JZ#(4]-J+G!T\$,1.5X2,T@0W((J)#< M5!+^XYB-L&-"2Z,;H/)E_KQ@@3&T7'_AW]+(LTOVV#-&2[+YG\Z=_].Y\__& MSIUOO+ID/VK6D_/5Z^CXZ.3M[;$]*[')_+XKF?&'<^\3\J] MSW0W2.INIGQM"K78_'--;]%^3&R*,+74(OB*[J,.#7C MSZ1>E_80Z5[1)]LVH[C]UN8@;$KZ-< M_;TT"97DZG\0F\%_1#LHSMMP<1I7RFS7MFD.(K&E;IV)YB/C,+0^.\6\F[]- MPJ]A;\>=,SU9RY;]([;<;S&?$U7O75XR_OD"W5YZ^0MR_MT MM5UST$[;R.28SW8QV/-P[P[/ .0HILW7A^%=!C,]NC;2I"P[$-:,Q3;F%C.1 M==/#;6X(EOD!9&B^^Q-5Q,S=?!7+LD\C88E[F/<@>L\A!&2V M;J'G9.?/?]GFP(+[Q();+G4R@C@LA-M.VL=FG[RXKUU#+0+^<(=6L3< M&>)8G9D@;9QRW#!=-(9S5=Z87)4N!#5)*\ZNNA_=9&HUQ40-<1=\2G";UVY[ MY)=#^*-QJKWC\B,'"-"7J627!P#PADMK;J2=9$FKQ@9AG*L_Z[I>Q C#T*PZ M(6,7SWR4RF%1F$W@LGU9UFY+$%N M[%P.P@4-?JG;KXX*5$KKX762MQO_22A?HJ/S5E W78$$APXF" Q!1,TT\9[CS7SR0@38HDHL"*L.=O6_N6/!#?><%1 MF#O>:B\'T,E/^.I:IYYM$HC_?3;B&R(R(\CEZ0]>BQLL.NBD>3CJ+O!1IUB3?4ZL_2 %6XO00V!!GI? M(^*2$QUWD2W=@Q,3&IO@6'?WEIC D82W$!RK%7E;F@PTMZ4>QD9W*"/18*!! MJ?,@?SALWM2G%$U^QB;6KJ$?;2*IDT9D(.6F%KT$4EW#?@/0ABV@#:8[H7;P M&KX*@$>8= HW!C-,#R7BQ(WC:%T\P;#I"#W3L89AA#ZBW%<8C=)>.X<3[1MNQ>Z3UN>F9MIAMYP5 MI)..B==8_<*BO1(Y%*\I)2Y^@:EWU(&CL5MJ<&4J:^RR^GPR8?G"ZHU\X)7[ MPY9@V+T>!N%P^.39U#8X##\.8P5F(ZV\@]UFT8\N20M81'<)>=5(X M]S_LI/CM>-C=@&=,?<%ZF""]].W]).QW@/WA+,0]AL/?\D_D\/?\PSG@O=WG M].(%=QW95P[T#0PQ*!TD)G\V,_FSCZ%&EL'5'/RVYA9X#UDEQ3G>MNH>S"\^ MQFS!;DD7?W5I#.46[L9R+T=UQZ7R,E7W/'809>"UM@Z6===5HV?G#L]*<_W[ M,:RYE0/?>.F5X@UVXLJ./75?QH,1S-GC"]C\P:FS+[?K?;/UI5&ED(+O=FDV M^]*.6[9O)^WXS$\[-OZ]+OE5,WX/$P;.FR7/R9?[G-:N/[8;.[R ][T)PHVB MF_;5YK!:>>!4;Z)0[69OD6;$^[X5= G4\]U*W1Z8@FKU#0>F:YCL7L-A1/C; MEM)]&\,IV]%G$@:<^V>%[I;MVQ)0MQ^DMKR5+&[RG^Q)^N[&QCU9TRU/XJ(W M;=M]YL.0-6@^#WW;D7C=,I5A'G;KW#$MN_WE9-K.I6XE;3>?F%I%.X0[^C/H M;SM^[IS69'LWGP@: !LRYL%L]4"%.I!7_OLH?Z.=OL"K],'X J?-']U8G=:/ M[IN3YH^NB['UHSMLZT]:+@[A(N?Z>]\YFI[4V6K+"F?8PZG%[3K(NMR\#%C:FXVT:$^ZEXQB]2%FY.9+"-FVROA[\58J?KYE'I]WC M_T?T=]DA_C(=D-WV 8;IY#F 6MQO%;CMK$$1!<:XTKL<6E.]D MAS:BHZ#^I"N3CN/*TD%MZ^SZO8W'ZYSAS!^D!67?E4:+X+*WL(2]3KOF8!4& M_1UR EKN"6>IA(NV@E^_XCCL;A_*@ENE4ZP$S]-8;NLPZ"%\(JLJ-JEPK*)- MC.6.X5558!Q"*JW>L."L]HG:-;X6P3A(F#&9T[MDD=WU)@YC=ZUZ&9UR/%85 M=>I>8 @FN:1VTAJJM8<8(RV)NN)X6M.CQ__0I1U0G&,'"[EPC1TOM#H&2G;L MGVGW$HC:XX >+#^VB'T9KD23D1M3"P=KR M^Z1>WAOK5G;#3>*H.=LM]:OTOLP($C['2P/TH)5NUA(:+.!E6$E MD=9HE#C4?M:O,M(>:=K69;$$2>M+90>A:0/'A-5)VFHGR@"AXP^="A8R"7R- M94W:7W<6.0D,.PZ<*:4!M;_V[S(F/#GAAIP1V$GVWF?K=3 1ITQ/M;-X*Q++ MJPGR$A(=JM!R_,ZMK/)R^ARJ ++#L!XJJ-))'D)OOZRX2DNVWE-A)7R-VW;( M,.4/5!LY!%R=!5-VOFPS=+O!O;.FR@%[,'.$X'C ;GUDM.3W3'<8-^Y*=(ZG M(8?!YXFX*GD;]..I^?7ER(K+YKQH?.P B.]X0J#:2Z8L= LPA <"ML6(. M![:B9:?AA"*"AZV(X.;D'!MGK]EKYYIUAF\VCDC+%>T"$+XCC;,. DX=?OZ% M^Q\-PL2F:V<^ CMBEI\H]'),/$/:EW8UI&X3OJ: V%F@",/UM$G0F=03^L1+ ME>YG%U\2;D]/(F!:;\M\GS_WD)I ;8WWZPL"=8^UKPY0V_1CTNY;.O/!57_V M@*-1[*>%P<'B!W';_P* D <:Y2*,EOU-'IIN-J&FAJ\*QCMWC4DO>;'=Z+LS MYC6KN#%UV"GD>]!QUGMCO74TI4$'I:U3D_Z85D[H1S@-D M6\_T ;KC=P9LFVCOJGH3L(HXN7N!@DW=.7R#X'VGX^A"92F7\X;*Y70]Q'W2 M;7$<-R.QZY6KZ(QKX1SP\"4^0BE$AS\! M&'E"VC*V-.\#RN[L,+DZ!75:3['KLV/>=R;YTX/J)Q(^'JDO!DF$N&O[J 'E MGN EUQ,M, ^7 ?G+=MW#RISTY'D@Q^U->M.+^N,#AF)7M+@[SY;!>CTXV)!K M.HTZ/*(?BD>8D)\9[IS0\_>^2YZJ;=O 1!G"W)T0;\^^S&OK?D#IF?K](G4P M3=BR_!;O*GOLUCQE9(]2CZ:O! M\/3\_U^8KH&!A:FIKH^K"^Y%DP@W)F>69>8HP/:NHERIF@2Z)[ZTJ 0T"8,U M*J"G3 !-24G,303E-O ..4C2AY[G@N+;9"R) _.0%F!W-S4]-24'$50I"J4% MD"5YR+ZN4< >ITB> U_I"CH7L0AI-5A)42:J[["E6?3@=@8U\A2"*XM!<0YU M .AJUARDT#> A+Z)H3DD]#64P,Y5\,2S40L1AO"^%FSG.BPP2PM 3D\#SVUE ME::D0\IA4,LU)1%CZ ,]3E C@"*CR4J!\## %P@D'?M%G64X1![F1%Q?@>BC MG @9IU]<7&(' %!+ P04 " !KB'!*-\?Y[3T" """@ #0 'AL+W-T M>6QEU%7 M*]?.UW+USCX?=*+T/Q^ MR.RB!_3S/Z3_&?D!]<)2!]T6I7$AQ?Y.6<#4)AS0FK $7Q-&5XK:K()PRK8> MGEH@DTPJI,T1&6V119I''XZ\9T^OX^%42.5J^PK^?]5-/PCTGA5(&1L$3K$' MTK@F6H,2-\9QDQWX70AU]G);&X6E(MMH.L=C@AM,D954.:BA3(1[*(T9%%:. MHF5E1RWKP :UEMP8.26E%,1IZ#,ZP]!FP-B]O=J?BSWN38'\''LD(49616^: M57?F>&JAD[S+YKEW:<.C>%%-UU*_;\URA//MW8$[!07=.']3# (,.ZEKMGW' M:"DX^,7\LF!T9,$T)GT=5$E%'PV?O2J9 4!AM :E:;:+?%6D7L)&]]=I4QRK M>7J"FI]ZGTL0H C;%6WN_G/>Y?^L>/;F[R6[K\JAX"?4:!O5"8B+0_04Y;?ND*CJ_.]!M02P,$ M% @ :XAP2D7U=8-2! !24 \ !X;"]W;W)K8F]O:RYX;6S%FE%O MHS@0@/^*Q5-/ZET"AG:W:BNE";V-E"9V[2YS$5[!SMMEN_OT9LE&=E(SN M99HG C'PRJJ"LN[0Y*\Y)9H:19BXT)B&05 MOPOV0PB3"Y)**^R6C.7N4&YL0-I3CQ=W0>A^6V;=/C^$$2\E#XB^$>X//5Z$ M#3@>Y' VS6>3\6@P3T?D83 93(TJD#G#V2698^>Y Q !F?#7(X>\H\R 2 3,X&F<]G0P_R"H"\.B?DM0=Y M#4!>G^]R#_)O'N07 /(++N3C/AJV0?*A-D)R8XA:$KOFQ+_<7P'(K[B0>5U5 M3&\;JERLI'"[,1?6!T6A:A?6_4#>AR)Y'Q?S3V=&XF8RY]:6O!GLDX&.099, MIMW>VNFO->&_M=@8^ M&>2/$%L@[I9KGM1F GTF2!:(ZBZ"H'V%'?2CWB&(?$U)!A*T" M$#/Q,2$C1,A&Z$Y$R,6<.0[SFX\)Z2%"UL,IL?X"]3$A8T38QOC@U\Z9A#02 M86NDE5HG%B20Z!,%T@5'(9/0LYBD$Q-2"D56"AC :>1C0IZAR)X!*UQ*?4RP M@75.SU#?,Q3R#$7VS,<:EUR,N&6B/+PQ(/"4F&?D(-2][NZ\T9!>*;)=3GK[Y?G<1LGWJ_.PUY)T;V#H!Y M5"?'D'=B9.^R?5*4;&7C4@Q'[F-"?HF1_7*(^U"6ZNV@SYA JDF057.(^;Y&_I:%RS!]3$@U"7:)TUDP7I*! M,76U.<"$;),@V^8DYN*?VEB_JY) VDF0M7,*<[AFL++(-&D6NU>8<=*\ ME%C693ETVV9RHEC[;4]SC/UG2??_ 5!+ P04 " !KB'!*S:,18@," "@ M(@ &@ 'AL+U]R96QS+W=O1P_I";<8'Q M)^]]^I_EN]WNL$E/W>;W*;7EBXI_"U3AZR"=#U)ZD,T'&3W(YX.<'A3G@R(] M:#4?M*('WBM?;P5ZZQ7VVFBSS==; M@=[*UUN!WLK76X'>RM=;@=[*UUN!WLK76X'>RM=;@=[*U]N WL;7VX#>QM?; M@-YVA;,2=%C"U]N WL;7VX#>QM?;@-[&U]N WL;7VX#>QM?;@-[&U]N!WL[7 MVX'>SM?;@=[.U]N!WGZ%LVYTV,W7VX'>SM?;@=[.U]N!WL[7VX'>SM?;@=[. MUSL"O2-?[PCTCGR](] [\O6.0._(USL"O>,5[BK1925?[PCTCGR](] [\O6. M$[US4P]I^U*&0[O/ER[Y-/S;F@G&>*%W&55(X/R\.X7GJ M1T3X](>4Q[]02P,$% @ :XAP2M7!E&ULS=I=3\(P% ;@OT)V:UCI%WX$N%%OU43_0-T.;&%;F[8@ M_GN[H28:3#1"\MXPMM.=\VXTSQ6SIU='8;1KFR[,LRI&=\58*"IJ3IB^/8]\@6LQM:FDT31]?[ZWWK>6:<:^K" MQ-IV;-N5WYJ.WQOFGIIA3:AJ%\[2@FQTNTM=0KHVSU(U9.P7$[[?V)^G^^ZW MY'U=TI^BV>6R+JBTQ:9-M^3!>3)EJ(ABV^2A,I[*Q^CK;O6>]\'X>&?:U)CM M&O9E07ZZ'/&UH<,!ALHQ)\>T+>C0J*&P_^3_&OBQ&PKK:>Q\JOI8'WB\%.DA M50/K%Q[S$:G?.B65OQJ>6I_NAWVQ?CU\/_3"/XN!#8?_O?7CY1 @.21(#@62 M0X/DF(+D. ?)<0&2XQ(D!Y^@!$$1E:.0RE%,Y2BH&UL4$L! A0#% @ :XAP2M=UBN"@ @ H@D !@ M ( !^ @ 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ :XAP2G"*OZ]S P 30X !@ ( !"Q( M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP M2@"JZ,[A 0 '04 !@ ( !MAT 'AL+W=O&PO=V]R:W-H M965T&UL4$L! A0#% @ :XAP2H(!9."U 0 T@, !D M ( !TR8 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ :XAP2B M2'&T 0 T@, !D ( ! MDRP 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ :XAP2B)/M?ZS 0 T@, !D ( !53( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP2J8SB9VT M 0 T@, !D ( !%3@ 'AL+W=O&PO=V]R:W-H965TL[ !X;"]W;W)K&UL4$L! A0#% @ :XAP2MO2]4NS 0 T@, !D M ( !UST 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ :XAP2H@)6A>V 0 T@, !D ( !HD0 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M:XAP2KI]QWNV 0 T@, !D ( !HDH 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP2HNU>(C" 0 M-P0 !D ( !E5 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP2K<9)U[+ P 'A( !D M ( !BU8 'AL+W=O(C," "I!@ &0 @ &-6@ >&PO=V]R:W-H M965T&UL4$L! M A0#% @ :XAP2L8QO=6! @ ]@@ !D ( !P%\ 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP M2KVK5C%A!0 !AL !D ( !"&D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP2E2$TW_@ @ > H M !D ( !*70 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP2@-D$)'N 0 UP0 !D M ( !(7T 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ :XAP2L895HK% 0 100 !D ( !QX0 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ :XAP2@$A M&WQN @ T@@ !D ( !&PO=V]R:W-H965T1 !X;"]W;W)K&UL4$L! A0#% @ :XAP2I ?-YE1 @ A < !D M ( !QY< 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ :XAP2H\[% ?R

&UL4$L! A0#% @ :XAP2C?'^>T] M @ @@H T ( !/Q4! 'AL+W-T>6QE&PO=V]R M:V)O;VLN>&UL4$L! A0#% @ :XAP2LVC$6(# @ H"( !H M ( !)AP! 'AL+U]R96QS+W=O XML 73 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 FilingSummary.xml IDEA: XBRL DOCUMENT 3.6.0.2 html 160 295 1 false 46 0 false 10 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://virnetx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://virnetx.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://virnetx.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://virnetx.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 030000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://virnetx.com/role/ConsolidatedStatementsOfComprehensiveLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 5 false false R6.htm 040000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquity CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 040100 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://virnetx.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 050000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://virnetx.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 060100 - Disclosure - Formation and Business of the Company Sheet http://virnetx.com/role/FormationAndBusinessOfCompany Formation and Business of the Company Notes 9 false false R10.htm 060200 - Disclosure - Summary of Significant Accounting Policies Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 060300 - Disclosure - Gain on Settlement Sheet http://virnetx.com/role/GainOnSettlement Gain on Settlement Notes 11 false false R12.htm 060400 - Disclosure - Property and Equipment Sheet http://virnetx.com/role/PropertyAndEquipment Property and Equipment Notes 12 false false R13.htm 060500 - Disclosure - Commitments and Related Party Transactions Sheet http://virnetx.com/role/CommitmentsAndRelatedPartyTransactions Commitments and Related Party Transactions Notes 13 false false R14.htm 060600 - Disclosure - Stock Plan Sheet http://virnetx.com/role/StockPlan Stock Plan Notes 14 false false R15.htm 060700 - Disclosure - Stock-Based Compensation Sheet http://virnetx.com/role/StockbasedCompensation Stock-Based Compensation Notes 15 false false R16.htm 060800 - Disclosure - Earnings Per Share Sheet http://virnetx.com/role/EarningsPerShare Earnings Per Share Notes 16 false false R17.htm 060900 - Disclosure - Common Stock Sheet http://virnetx.com/role/CommonStock Common Stock Notes 17 false false R18.htm 061000 - Disclosure - Equity Sheet http://virnetx.com/role/Equity Equity Notes 18 false false R19.htm 061100 - Disclosure - Employee Benefit Plan Sheet http://virnetx.com/role/EmployeeBenefitPlan Employee Benefit Plan Notes 19 false false R20.htm 061200 - Disclosure - Income Taxes Sheet http://virnetx.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 061300 - Disclosure - Fair Value Measurement Sheet http://virnetx.com/role/FairValueMeasurement Fair Value Measurement Notes 21 false false R22.htm 061400 - Disclosure - Litigation Sheet http://virnetx.com/role/Litigation Litigation Notes 22 false false R23.htm 061500 - Disclosure - Quarterly Financial Information (unaudited) Sheet http://virnetx.com/role/QuarterlyFinancialInformationUnaudited Quarterly Financial Information (unaudited) Notes 23 false false R24.htm 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://virnetx.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://virnetx.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 080400 - Disclosure - Property and Equipment (Tables) Sheet http://virnetx.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://virnetx.com/role/PropertyAndEquipment 26 false false R27.htm 080700 - Disclosure - Stock-Based Compensation (Tables) Sheet http://virnetx.com/role/StockbasedCompensationTables Stock-Based Compensation (Tables) Tables http://virnetx.com/role/StockbasedCompensation 27 false false R28.htm 080800 - Disclosure - Earnings Per Share (Tables) Sheet http://virnetx.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://virnetx.com/role/EarningsPerShare 28 false false R29.htm 081000 - Disclosure - Equity (Tables) Sheet http://virnetx.com/role/EquityTables Equity (Tables) Tables http://virnetx.com/role/Equity 29 false false R30.htm 081200 - Disclosure - Income Taxes (Tables) Sheet http://virnetx.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://virnetx.com/role/IncomeTaxes 30 false false R31.htm 081300 - Disclosure - Fair Value Measurement (Tables) Sheet http://virnetx.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://virnetx.com/role/FairValueMeasurement 31 false false R32.htm 081500 - Disclosure - Quarterly Financial Information (unaudited) (Tables) Sheet http://virnetx.com/role/QuarterlyFinancialInformationUnauditedTables Quarterly Financial Information (unaudited) (Tables) Tables http://virnetx.com/role/QuarterlyFinancialInformationUnaudited 32 false false R33.htm 090100 - Disclosure - Formation and Business of the Company (Details) Sheet http://virnetx.com/role/FormationAndBusinessOfCompanyDetails Formation and Business of the Company (Details) Details http://virnetx.com/role/FormationAndBusinessOfCompany 33 false false R34.htm 090200 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 090300 - Disclosure - Gain on Settlement (Details) Sheet http://virnetx.com/role/GainOnSettlementDetails Gain on Settlement (Details) Details http://virnetx.com/role/GainOnSettlement 35 false false R36.htm 090400 - Disclosure - Property and Equipment (Details) Sheet http://virnetx.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://virnetx.com/role/PropertyAndEquipmentTables 36 false false R37.htm 090500 - Disclosure - Commitments and Related Party Transactions (Details) Sheet http://virnetx.com/role/CommitmentsAndRelatedPartyTransactionsDetails Commitments and Related Party Transactions (Details) Details http://virnetx.com/role/CommitmentsAndRelatedPartyTransactions 37 false false R38.htm 090600 - Disclosure - Stock Plan (Details) Sheet http://virnetx.com/role/StockPlanDetails Stock Plan (Details) Details http://virnetx.com/role/StockPlan 38 false false R39.htm 090700 - Disclosure - Stock-Based Compensation, Information about Stock Options Outstanding (Details) Sheet http://virnetx.com/role/StockbasedCompensationInformationAboutStockOptionsOutstandingDetails Stock-Based Compensation, Information about Stock Options Outstanding (Details) Details 39 false false R40.htm 090702 - Disclosure - Stock-Based Compensation, Summary of Activity (Details) Sheet http://virnetx.com/role/StockbasedCompensationSummaryOfActivityDetails Stock-Based Compensation, Summary of Activity (Details) Details 40 false false R41.htm 090704 - Disclosure - Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) Sheet http://virnetx.com/role/StockbasedCompensationStockbasedCompensationByTypeOfAwardDetails Stock-Based Compensation, Stock-Based Compensation by Type of Award (Details) Details 41 false false R42.htm 090706 - Disclosure - Stock-Based Compensation, Fair Value Assumptions Used (Details) Sheet http://virnetx.com/role/StockbasedCompensationFairValueAssumptionsUsedDetails Stock-Based Compensation, Fair Value Assumptions Used (Details) Details 42 false false R43.htm 090800 - Disclosure - Earnings Per Share (Details) Sheet http://virnetx.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://virnetx.com/role/EarningsPerShareTables 43 false false R44.htm 090900 - Disclosure - Common Stock (Details) Sheet http://virnetx.com/role/CommonStockDetails Common Stock (Details) Details http://virnetx.com/role/CommonStock 44 false false R45.htm 091000 - Disclosure - Equity (Details) Sheet http://virnetx.com/role/EquityDetails Equity (Details) Details http://virnetx.com/role/EquityTables 45 false false R46.htm 091100 - Disclosure - Employee Benefit Plan (Details) Sheet http://virnetx.com/role/EmployeeBenefitPlanDetails Employee Benefit Plan (Details) Details http://virnetx.com/role/EmployeeBenefitPlan 46 false false R47.htm 091200 - Disclosure - Income Taxes, Components of Benefit (Provision) for Income Taxes (Details) Sheet http://virnetx.com/role/IncomeTaxesComponentsOfBenefitProvisionForIncomeTaxesDetails Income Taxes, Components of Benefit (Provision) for Income Taxes (Details) Details 47 false false R48.htm 091202 - Disclosure - Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Sheet http://virnetx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxRateToEffectiveIncomeTaxRateDetails Income Taxes, Reconciliation of Federal Statutory Income Tax Rate to Effective Income Tax Rate (Details) Details 48 false false R49.htm 091204 - Disclosure - Income Taxes, Net Operating Losses (Details) Sheet http://virnetx.com/role/IncomeTaxesNetOperatingLossesDetails Income Taxes, Net Operating Losses (Details) Details 49 false false R50.htm 091206 - Disclosure - Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) Sheet http://virnetx.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsLiabilitiesDetails Income Taxes, Components of Deferred Tax Assets (Liabilities) (Details) Details 50 false false R51.htm 091208 - Disclosure - Income Taxes, Valuation Allowance, Operating Loss Carryforwards and Tax Credit Carry-forwards (Details) Sheet http://virnetx.com/role/IncomeTaxesValuationAllowanceOperatingLossCarryforwardsAndTaxCreditCarryforwardsDetails Income Taxes, Valuation Allowance, Operating Loss Carryforwards and Tax Credit Carry-forwards (Details) Details 51 false false R52.htm 091210 - Disclosure - Income Taxes, Income Tax Uncertainties (Details) Sheet http://virnetx.com/role/IncomeTaxesIncomeTaxUncertaintiesDetails Income Taxes, Income Tax Uncertainties (Details) Details 52 false false R53.htm 091300 - Disclosure - Fair Value Measurement, Assumptions Used to Measure Fair Value of Warrants (Details) Sheet http://virnetx.com/role/FairValueMeasurementAssumptionsUsedToMeasureFairValueOfWarrantsDetails Fair Value Measurement, Assumptions Used to Measure Fair Value of Warrants (Details) Details 53 false false R54.htm 091302 - Disclosure - Fair Value Measurement, Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Investment Category (Details) Sheet http://virnetx.com/role/FairValueMeasurementAdjustedCostGrossUnrealizedGainsGrossUnrealizedLossesAndFairValueByInvestmentCategoryDetails Fair Value Measurement, Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value by Investment Category (Details) Details 54 false false R55.htm 091306 - Disclosure - Fair Value Measurement, Changes in Fair Value of Level 3 Financial Instrument Liability (Details) Sheet http://virnetx.com/role/FairValueMeasurementChangesInFairValueOfLevel3FinancialInstrumentLiabilityDetails Fair Value Measurement, Changes in Fair Value of Level 3 Financial Instrument Liability (Details) Details 55 false false R56.htm 091400 - Disclosure - Litigation (Details) Sheet http://virnetx.com/role/LitigationDetails Litigation (Details) Details http://virnetx.com/role/Litigation 56 false false R57.htm 091500 - Disclosure - Quarterly Financial Information (unaudited) (Details) Sheet http://virnetx.com/role/QuarterlyFinancialInformationUnauditedDetails Quarterly Financial Information (unaudited) (Details) Details http://virnetx.com/role/QuarterlyFinancialInformationUnauditedTables 57 false false All Reports Book All Reports vhc-20161231.xml vhc-20161231.xsd vhc-20161231_cal.xml vhc-20161231_def.xml vhc-20161231_lab.xml vhc-20161231_pre.xml true true ZIP 78 0001567619-17-000463-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001567619-17-000463-xbrl.zip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�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�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�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end

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